id,date_observed,date_basis,date_precision,benefit_status,title,summary,headline,metric,brief,confidence,claim_status,design,certainty,category,unexpected,system,model_version,developer,developer_country,deployer,deployer_country,location,case_jurisdictions,domain,segment,sector,policy_area,policy_subtopic,kind_of_ai,people_helped,global_goals,income_groups,broad_benefits,scsp_example,deepest,reach,duration,distribution,probability,frequency,magnitude,groups,sources,selected_by,echoes,comparator_against,comparator_before,comparator_after,comparator_basis,later_status,later_date,learns_from_data,learns_from_data_source,value_amount,value_what,value_estimate,benefits,collection,collection_reason,collection_details,collection_filters AIBD-0789,2022-01-01,event,month,reported,"FDA finds that the Jewel patch defibrillator converted 8 of 9 dangerous rhythms with few wrong shocks, using machine learning to detect rhythms","In a study at 29 US sites that FDA reviewed, the Jewel patch defibrillator gave 0.357 inappropriate shocks per 100 patient-months. It converted 8 of 9 shockable rhythms with one shock.",*Jewel* patch defibrillator ended eight of nine life-threatening rhythms,0.357 inappropriate shocks per 100 patient-months,,found,Found by a regulator,no comparison,very low,aggregate result,false,Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) with a machine learning VT/VF detection algorithm,,"Element Science, Inc.",United States,Twenty-nine US investigational sites in the Jewel IDE study,United States,"Twenty-nine investigational sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data; Machines that act,Patients,3,High income,physical_health,,5,2,5,,3,5,,personal,4,,0,Pre-specified performance goal for inappropriate shocks,Below 2.0 per 100 patient-months,0.357 per 100 patient-months,measured,scaled,2026-03-24,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230022B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P230022: Jewel Patch Wearable Cardioverter Defibrillator (P-WCD). Approved 2025-04-30."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230022B.pdf""}]","{""kind"": ""Official documents""}" AIBD-1141,2024-01-01,event,year,reported,"Austin's City Auditor finds that APD's license plate readers led to 165 arrests from March to December 2024, with about 133 prosecutions",Austin's City Auditor found that APD's license plate readers led to 165 arrests from March to December 2024. About 133 prosecutions followed. The readers helped recover a missing person.,Austin's *license plate readers* led to 165 arrests in a 2024 trial,"165 arrests, about 133 prosecutions",,found,Found by an auditor,no comparison,very low,aggregate result,false,Automated License Plate Reader (ALPR) program with Flock Safety fixed cameras and Axon vehicle-mounted cameras,,Flock Safety (fixed cameras and ALPR service) and Axon Enterprise (vehicle-mounted cameras),United States,Austin Police Department (APD),United States,"Austin, Texas, United States",United States,Policing,,Safety and rescue,Law and Crime,Police,Images and video,Public servants,16,High income,physical_health,Crime reduction or prevention,4,1,3,,3,5,,organizational; personal; societal,1,,0,,,,,withdrawn,2025-06-30,shown,https://builtin.com/articles/flock-cameras,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Audit report"", ""value"": ""City of Austin Office of the City Auditor. APD License Plate Reader. Audit Report, May 2025. Finding 1, Resolution item C and Exhibit 3, pp. 6-7. The auditor analyzed Flock ALPR data and APD Risk Management's quarterly audits for March to December 2024."", ""url"": ""https://services.austintexas.gov/edims/document.cfm?id=452710""}, {""label"": ""Audit report"", ""value"": ""City of Austin Office of the City Auditor. APD License Plate Reader. Audit Report, May 2025. Finding 1, Resolution item B, p. 6. The auditor reviewed all 286 Hit Stop Forms from the three quarters."", ""url"": ""https://services.austintexas.gov/edims/document.cfm?id=452710""}, {""label"": ""Audit report"", ""value"": ""City of Austin Office of the City Auditor. APD License Plate Reader. Audit Report, May 2025. Finding 1, Resolution item A, p. 5. Because of these gaps, the auditor could not verify the number of Flock scans."", ""url"": ""https://services.austintexas.gov/edims/document.cfm?id=452710""}, {""label"": ""Follow-up"", ""value"": ""Austin's city manager withdrew the plate reader program from the council agenda in June 2025, and APD's program effectively ended on 30 June 2025."", ""url"": ""https://austinmonitor.com/stories/2025/06/council-divided-on-reader-program/""}]","{""kind"": ""Withdrawals""}" AIBD-2312,2021-01-01,source publication,month,reported,"St George's Hospital, London: preterm preeclampsia fell from 0.84% to 0.56% of pregnancies after the hospital began to screen with the Fetal Medicine Foundation's algorithm, and Ontario Health judged that such programs likely reduce the risk","At St George's Hospital in London, preterm preeclampsia fell from 0.84% to 0.56% of pregnancies after the hospital began to screen with an algorithm, and Ontario Health judged the reduction likely.",*FMF screening* cut preterm preeclampsia at a London hospital,0.84% to 0.56%,,found,Found by an assessment body,before and after,very low,aggregate result,false,"Fetal Medicine Foundation (FMF) first-trimester preeclampsia screening algorithm (maternal factors, blood pressure, PAPP-A and uterine artery Doppler)",,Fetal Medicine Foundation,United Kingdom,St George's University Hospitals NHS Foundation Trust,United Kingdom,"London, United Kingdom",United Kingdom,Maternity care (preeclampsia screening),,Other,Health,Disease Prevention,Prediction from data,Women and mothers,3,High income,physical_health,Medical diagnosis,4,3,3,,3,5,,personal,3,,0,Women screened at the same hospital under national guidance before the change,0.84% had preeclampsia with delivery before 37 weeks,0.56%,measured,unknown,,shown,https://pubmed.ncbi.nlm.nih.gov/26297382/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series 22(5):1-118, December 2022. Ontario Health is the agency of the Government of Ontario that assesses health technologies for public funding."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series 22(5):1-118, December 2022. Ontario Health is the agency of the Government of Ontario that assesses health technologies for public funding."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series 22(5):1-118, December 2022. Ontario Health is the agency of the Government of Ontario that assesses health technologies for public funding."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series 22(5):1-118, December 2022. Ontario Health is the agency of the Government of Ontario that assesses health technologies for public funding."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series 22(5):1-118, December 2022. Ontario Health is the agency of the Government of Ontario that assesses health technologies for public funding."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}]","{""kind"": ""Official documents""}" AIBD-2237,2019-02-08,source publication,day,mixed,"ODI Resume, Investigation PE 16-007: Automatic vehicle control systems",The U.S. road safety regulator stated in 2017 that Tesla's rate of airbag-deployment crashes fell by almost 40% after Autosteer. A 2019 reanalysis of the data found a 59% rise.,NHTSA's finding of 40% fewer *Autosteer* crashes is later challenged,fell by almost 40%,,found,Found by a regulator,before and after,very low,harm prevented,false,Tesla Autosteer (part of Autopilot),,Tesla,United States,Owners of Tesla Model S and Model X vehicles of model years 2014 to 2016,United States,United States,United States,Road vehicle crash avoidance,,Safety and rescue,Transportation,Highways,Machines that act,,3; 11,High income,physical_health,Hazard reduction,4,4,,,2,,,personal,2,,0,The same vehicles before Autosteer was installed,The airbag-deployment crash rate before installation,A rate almost 40% lower after installation,measured,challenged,2019-02-08,shown,https://web.archive.org/web/20151016033541/https://www.teslamotors.com/blog/your-autopilot-has-arrived,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""National Highway Traffic Safety Administration, Office of Defects Investigation. Closing report of investigation PE 16-007 into Tesla's Autopilot and automatic emergency braking, closed 19 January 2017. The agency computed the crash rates itself from mileage and airbag data that Tesla supplied."", ""url"": ""https://static.nhtsa.gov/odi/inv/2016/INCLA-PE16007-7876.PDF""}, {""label"": ""Regulatory document"", ""value"": ""National Highway Traffic Safety Administration, Office of Defects Investigation. Closing report of investigation PE 16-007 into Tesla's Autopilot and automatic emergency braking, closed 19 January 2017. The agency computed the crash rates itself from mileage and airbag data that Tesla supplied."", ""url"": ""https://static.nhtsa.gov/odi/inv/2016/INCLA-PE16007-7876.PDF""}, {""label"": ""Follow-up"", ""value"": ""Quality Control Systems reanalyzed the agency's data in February 2019 and found that the crash rate rose by 59% among the vehicles with complete mileage data."", ""url"": ""https://www.safetyresearch.net/Library/NHTSA_Autosteer_Safety_Claim.pdf""}]","{""kind"": ""Challenges""}" AIBD-0788,2026-03-03,source publication,day,reported,FDA finds that the Claire OCT System's AI helped surgeons clear residual breast cancer at lumpectomy margins in 7 of 35 patients,"In a trial that FDA reviewed, surgeons using the Claire OCT System after standard care cleared residual cancer in 7 of 35 patients, a 20.0% relative reduction.",*Claire OCT System* helped surgeons remove cancer left at the margins,a 20.0% relative reduction,,found,Found by a regulator,controlled comparison,low,aggregate result,false,Claire OCT System with the ImgAssist AI detection algorithm,ImgAssist 2.0,"Perimeter Medical Imaging AI, Inc.",Canada,Breast surgeons at the investigational sites of the randomized trial (NCT05113927),United States,"Investigational sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,3,2,1,,3,1,,personal; organizational,2,,0,The same patients' margins after standard care alone,17.0% with at least one unaddressed positive margin,13.6% after use of the device,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf25/P250008B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P250008: Claire OCT System. Approved 2026-03-03."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf25/P250008B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0193,2020-02-20,event,day,reported,"Data from eLocust3m, cleaned by AI, supports FAO's control of locusts in East Africa, which may have averted USD 1.56 billion in losses","PlantVillage's eLocust3m app gathered over 240,000 locust records. AI removed unusable ones for the control operation that FAO credits with averting USD 1.56 billion in losses.",Locust control using eLocust3m data may have averted USD 1.56 billion,protected the food security of 36.6 million people and avoided USD 1.56 billion in losses,,found,Found by an evaluation office,no comparison,very low,harm prevented,false,eLocust3m (PlantVillage) with AI data validation feeding FAO's Desert Locust Information Service,eLocust3M,"PlantVillage, Pennsylvania State University, with FAO",United States,"FAO Desert Locust Information Service and national locust control operations in Kenya, Ethiopia and Somalia",Italy,,,Agriculture / pest early warning,Desert locust control,Agriculture and food,Agriculture,Animal and Crop Disease,Images and video,Public servants; People at risk of disaster,2,,environmental_impact; operational_improvement,Environmental impacts,3,5,4,4,3,5,0.640,societal; organizational; personal,7,,2,no locust control operations in East Africa (FAO's estimate of the losses that the control campaign averted),"loss of 4 million tonnes of cereal and 800 million litres of milk production, USD 1.56 billion in cereal and milk losses",those losses prevented and the food security of 36.6 million people protected,assumed,persisted,2022-06-15,shown,https://www.psu.edu/news/research/story/penn-state-responds-app-aids-un-efforts-control-africas-locust-infestation,USD 1.56 billion,cereal and milk losses avoided by the locust control operations in East Africa that the app and AI data cleaning fed,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""FAO Office of Evaluation (OED) (2020). Real-time evaluation of FAO's response to desert locust upsurge 2020-2021 - Phase I, p. 16 (PDF p. 20), finding 3.5.3, paras 44-46."", ""url"": ""https://www.fao.org/3/cb2437en/cb2437en.pdf""}, {""label"": ""Evaluation report"", ""value"": ""FAO Office of Evaluation (2021). Real-time evaluation of FAO's response to the desert locust upsurge 2020-2021 - Phase II. Programme Evaluation Series 10/2021. Rome: FAO (last updated 23 February 2022). Findings, paragraph 52 (confidence rating: very high); paragraph 25 on Kenya's 3,000 scouts trained on eLocust3g and eLocust3m."", ""url"": ""https://www.fao.org/3/cb6995en/cb6995en.pdf""}]","{""kind"": ""Official documents""}" AIBD-0717,2026-10-31,source access,day,reported,Evidence for ESSA rates DreamBox Math Strong on two randomized studies with math gains for students in kindergarten to grade 2,"Evidence for ESSA rates DreamBox Math Strong. In two randomized studies, users in kindergarten to grade 2 outperformed controls, while gains on state tests in grades 4–5 were not meaningful.",*DreamBox Math* earns a Strong rating for early math gains,the effect size is +0.10,,found,Found by an assessment body,randomized trial,high,aggregate result,false,DreamBox Math (adaptive online mathematics program),,DreamBox Learning,United States,Schools in the two studies: three high-poverty charter schools in the San Francisco Bay Area and 24 schools across North Carolina,United States,"California and North Carolina, United States",United States,Education,,Education,Education,Elementary & Secondary,,Students; Children,4,High income,incentivization,Increased/personalized knowledge,2,,3,4,3,,,personal,1,,0,Control students in the North Carolina randomized study,,"effect size = +0.12 (K-2, Number Knowledge Test), +0.03 (grades 4-5, end-of-grade test)",measured,persisted,2025-01-23,not shown,https://www.evidenceforessa.org/program/dreambox-learning/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. DreamBox Math: program page, rating Strong. Accessed 31 October 2026."", ""url"": ""https://www.evidenceforessa.org/program/dreambox-learning/""}]","{""kind"": ""Official documents""}" AIBD-0720,2026-06-01,source publication,day,reported,The What Works Clearinghouse finds promising evidence that Project LISTEN's Reading Tutor raised literacy scores in a randomized trial,The What Works Clearinghouse found promising (Tier 3) evidence for Project LISTEN's Reading Tutor. Students in grades 1 to 4 who read aloud to it gained more in literacy than peers in silent reading.,A listening *Reading Tutor* beats silent reading in a trial,improvement index 27,,found,Found by an assessment body,randomized trial,high,aggregate result,false,Project LISTEN's Reading Tutor (speech-recognition reading tutor),2000-2001 version,"Project LISTEN, Carnegie Mellon University",United States,Two elementary schools in an affluent suburban school district (not named),United States,"United States (suburban school district, not named)",United States,Education,,Education,Education,Elementary & Secondary,Speech and sound,Children; Students,4,High income,incentivization,Increased/personalized knowledge,2,2,3,2,3,,,personal,3,,0,Sustained silent reading in class during the same daily period,"471.49 (comparison group mean, Woodcock Reading Mastery Test total reading composite)",480.01 (Reading Tutor group mean),measured,scaled,2024-07-24,shown,https://www.cs.cmu.edu/~listen/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""U.S. Department of Education, Institute of Education Sciences, What Works Clearinghouse. Single study review of Mostow, Nelson-Taylor and Beck (2013), Computer-Guided Oral Reading versus Independent Practice. Reviewed June 2026."", ""url"": ""https://ies.ed.gov/ncee/WWC/Study/95240""}]","{""kind"": ""Official documents""}" AIBD-0692,2026-04-01,source publication,month,reported,UNDP's evaluation office finds that tools such as eMonitor+ helped electoral bodies in four Latin American countries monitor hate speech,"UNDP's evaluation office found that tools such as eMonitor+ strengthened monitoring of disinformation by electoral bodies in Chile, Ecuador, Honduras and Peru. Monitoring of hate speech also improved.",*eMonitor+* helps four Latin American election bodies track hate speech,"captured more than 37,000 posts",,found,Found by an evaluation office,no comparison,very low,program,false,"eMonitor+, UNDP's platform for monitoring online content in elections",,"UNDP (Regional Bureau for Arab States), which developed eMonitor in 2018 and upgraded it to eMonitor+ in 2022",,"Electoral management bodies and civil society organizations in Chile, Ecuador, Honduras and Peru, with UNDP","Chile, Ecuador, Honduras and Peru","Chile, Ecuador, Honduras and Peru",Chile | Ecuador | Honduras | Peru,Electoral integrity / information monitoring,,Public sector,Civil Rights,Voting Rights,Text and language,Public servants,16,Lower middle income; Upper middle income; High income,social_improvement,Fact checking,2,2,2,4,3,5,0.400,organizational; societal,3,,0,,,,,scaled,2026-05-01,shown,https://web.archive.org/web/20260112231245/https://www.undp.org/arab-states/press-releases/election-commission-uses-artificial-intelligent-enhance-womens-participation-electoral-processes,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Evaluation of UNDP Support to Strengthening Electoral Capacities and Institutional Processes. April 2026, Finding 17 and footnote 43. The report is an independent publication of the office."", ""url"": ""https://www.unevaluation.org/get-download-file/18820""}, {""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Evaluation of the UNDP Support to Digitalization of Public Services. November 2023. The report is an independent publication of the office. Section on electoral support."", ""url"": ""https://www.unevaluation.org/get-download-file/4444""}]","{""kind"": ""Official documents""}" AIBD-0653,2026-03-19,source publication,day,reported,NICE allows six systems in the NHS after concluding that AI polyp detection raises the adenoma detection rate in colonoscopy,"NICE reviewed 70 studies, most of them randomized trials. It concluded that AI polyp detection systems such as GI Genius improve the adenoma detection rate in colonoscopy.",England's health technology assessor supports AI help in colonoscopy,,,found,Found by an assessment body,randomized trial,high,aggregate result,false,"AI computer-aided detection (CADe) for colonoscopy: CADDIE, CAD EYE, ENDO-AID, EndoScreener, GI Genius and MAGENTIQ-COLO",,"Odin Vision (CADDIE), Fujifilm (CAD EYE), Olympus Medical Systems (ENDO-AID), Wision AI (EndoScreener), Medtronic (GI Genius) and Magentiq Eye (MAGENTIQ-COLO)","Multiple: United Kingdom, Japan, China, Ireland, Israel",Endoscopy services in the trials reviewed by NICE; NHS services in England during the evidence generation period,Multiple,"Multiple countries (trials); England, United Kingdom (guidance)",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,2,4,,2,4,,,personal,5,,1,Standard colonoscopy without AI in randomized trials,Adenoma detection rate with standard colonoscopy,Higher pooled adenoma detection rate with AI for most systems,measured,unknown,,shown,https://www.nice.org.uk/guidance/htg773/chapter/3-Committee-discussion,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps. HealthTech guidance HTG773, section 3: Committee discussion. 19 March 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg773/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps. HealthTech guidance HTG773, section 1: Recommendations. 19 March 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg773/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group (SHTG), Healthcare Improvement Scotland. Artificial intelligence (AI)-assisted lower gastrointestinal (GI) endoscopy (Innovative Medical Technology Overview). Key messages, first bullet (p. 1)"", ""url"": ""https://shtg.scot/media/0hspceqm/2025-01-21-ai-endo-imto-v05.pdf""}, {""label"": ""Assessment report"", ""value"": ""MAGIC Evidence Ecosystem Foundation and The BMJ (BMJ Rapid Recommendations international guideline panel) (2025). Computer aided detection and diagnosis of polyps in adult patients undergoing colonoscopy: a living clinical practice guideline (BMJ 2025;388:e082656), Abstract, Recommendation; doi:10.1136/bmj-2024-082656."", ""url"": ""https://europepmc.org/abstract/MED/40147837""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}]","{""kind"": ""Official documents""}" AIBD-0702,2026-01-05,source publication,day,reported,South Korea's Board of Audit and Inspection finds that a fix raised the accuracy of the Korea Expressway Corporation's pothole detection to 79.6%,"South Korea's Board of Audit and Inspection found that the expressway corporation's pothole detection reached 79.6% average accuracy after a fix, up from 14.7% at seven branches.",Revised pothole detection now guides Korean expressway repairs,79.6% average accuracy,,found,Found by an auditor,tested against a standard,low,aggregate result,false,Pothole detection system (포트홀 감지시스템),,"Korea Expressway Corporation, Road Traffic Research Institute (한국도로공사 도로교통연구원)",South Korea,Korea Expressway Corporation (한국도로공사),South Korea,South Korea (national expressway network),South Korea,Road maintenance,,Energy and infrastructure,Transportation,Highways,Images and video,Other workers,9; 11,High income,operational_improvement,Enhanced productivity,2,1,,,3,,,organizational,1,,0,"The same system at seven branches in March 2024, before the corporation revised its grading",14.7% (76 of 517 detections needed repair),"79.6% on average, 95.5% for the urgent-repair group",measured,unknown,,not shown,https://www.bai.go.kr/api/files/download?fileId=jj20260303%20152833&fileSn=1,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Board of Audit and Inspection of Korea (감사원). 감사보고서 - 인공지능 대비실태 Ⅰ(신뢰성 확보 분야) - [Performance audit report, AI preparedness I: ensuring reliability]. Report dated December 2025, published 5 January 2026. Chapter 3, section 4, printed pp. 49-50."", ""url"": ""https://www.bai.go.kr/api/files/download?fileId=jj20260303%20152833&fileSn=1""}]","{""kind"": ""Official documents""}" AIBD-1145,2026-01-01,source publication,year,reported,India's CAG used e-challans from Bengaluru's AI-camera ITMS to find that 52 of 300 sampled vehicles were on the road after their registration lapsed,India's CAG matched registry samples against e-challans from Bengaluru's AI-camera traffic system. It found that 52 of 300 vehicles with lapsed registration were on the road. That is 17.33%.,*ITMS* e-challans help auditors spot vehicles with lapsed registration,52 vehicles (17.33%),,found,Found by an auditor,no comparison,very low,aggregate result,true,Intelligent Traffic Management System (ITMS) with AI-powered cameras,,Not named in the report,,Bengaluru traffic enforcement through Karnataka's Intelligent Traffic Management System (the report does not name the agency that runs it),India,"Bengaluru, Karnataka, India",India,Motor vehicle registration and tax enforcement,,Public sector,Transportation,Highways,Images and video,Public servants,11,Lower middle income,social_improvement,Transparency and accountability,2,1,1,,3,1,,organizational; societal,1,,0,,,,,unknown,,not shown,https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2026/Report-of-the-Comptroller-and-Auditor-General-of-India-on-State-Revenues-for-the-period-ended-March-2024--Report-No.-3-of-2026-069c60d8a133e16.82085064.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Karnataka, Report No. 3 of 2026. Chapter V, Subject Specific Compliance Audit on Functioning of Regional Transport Offices in Karnataka. Paragraph 5.4.3.2 and footnote 87, report pp. 74-75. The auditors cross-checked the VAHAN sample against ITMS e-challans themselves."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2026/Report-of-the-Comptroller-and-Auditor-General-of-India-on-State-Revenues-for-the-period-ended-March-2024--Report-No.-3-of-2026-069c60d8a133e16.82085064.pdf""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Karnataka, Report No. 3 of 2026. Chapter V, Subject Specific Compliance Audit on Functioning of Regional Transport Offices in Karnataka. Paragraph 5.4.6.4(b) and footnote 119, report p. 90. The sample of 167 vehicles was limited to Bengaluru, where AI cameras capture vehicle movements."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2026/Report-of-the-Comptroller-and-Auditor-General-of-India-on-State-Revenues-for-the-period-ended-March-2024--Report-No.-3-of-2026-069c60d8a133e16.82085064.pdf""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Karnataka, Report No. 3 of 2026. Chapter V, Subject Specific Compliance Audit on Functioning of Regional Transport Offices in Karnataka. Paragraph 5.4.6.4(b), report p. 90. The auditors found that the Transport Department had not used such data with the police."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2026/Report-of-the-Comptroller-and-Auditor-General-of-India-on-State-Revenues-for-the-period-ended-March-2024--Report-No.-3-of-2026-069c60d8a133e16.82085064.pdf""}]","{""kind"": ""Official documents""}" AIBD-1139,2025-08-05,source publication,day,reported,Paraná's Court of Justice upheld a duty to repair Atlantic Forest after its expert dated the clearing with MapBiomas land-cover maps,A court-appointed expert used MapBiomas land-cover maps to date a clearing on a Palmas estate to 2005. In August 2025 Paraná's Court of Justice upheld the duty to repair the damage.,Court expert dates a Paraná forest clearing with *MapBiomas* maps,dated one clearing to 2005,,found,Found by a court,no comparison,very low,benefit created,false,MapBiomas annual land use and land cover maps (MapBiomas Brasil collection),,MapBiomas,Brazil,A court-appointed expert (perito) in the Ministério Público do Paraná's civil action before the Palmas district court,Brazil,"Palmas, Paraná, Brazil",Brazil,Environmental enforcement: Atlantic Forest clearing,,Environment,Environment,Species & Forest,Images and video,Other workers,15; 16,Upper middle income,environmental_impact,Environmental impacts,2,1,1,,3,1,,organizational,2,,0,,,,,unknown,,shown,https://web.archive.org/web/20260217204014/https://brasil.mapbiomas.org/en/visao-geral-da-metodologia/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Apelação Cível nº 0000313-27.2021.8.16.0123 (Palmas), Rel. Des. Wellington Emanuel Coimbra de Moura. Judgment of 5 August 2025, published 11 August 2025. Appeal partly granted: the duty to repair was upheld and collective moral damages were cut to R$70,000."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000032533141/Ac%C3%B3rd%C3%A3o-0000313-27.2021.8.16.0123""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Apelação Cível nº 0000313-27.2021.8.16.0123 (Palmas), Rel. Des. Wellington Emanuel Coimbra de Moura. Judgment of 5 August 2025, published 11 August 2025. Appeal partly granted: the duty to repair was upheld and collective moral damages were cut to R$70,000."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000032533141/Ac%C3%B3rd%C3%A3o-0000313-27.2021.8.16.0123""}]","{""kind"": ""Official documents""}" AIBD-0656,2025-07-24,source publication,day,reported,"NICE allows Limbic Access in NHS Talking Therapies, citing a study in which referrals rose more in services that used the chatbot","NICE cites a study in which NHS services using the Limbic Access referral chatbot saw referrals rise 15% against 6% in control services, with larger rises in minority groups.",NICE lets NHS talking therapies use the *Limbic Access* chatbot,"referrals rise by 15%, against 6% in control services",,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,Limbic Access (AI self-referral chatbot),,Limbic,United Kingdom,NHS Talking Therapies for anxiety and depression services in England,United Kingdom,"England, United Kingdom",United Kingdom,Mental health care access,,Health,Health,Mental Health,Text and language,Patients,3; 10,High income,emotional_health; opportunity_access,,2,4,,5,3,5,,societal,3,,0,NHS Talking Therapies services that did not use the chatbot (control services),6% rise in referrals (control services),15% rise in referrals (services using Limbic Access),measured,persisted,,shown,https://clinicaltrials.gov/study/NCT05495126,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment. HealthTech guidance HTG756, section 3: Committee discussion. 24 July 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg756/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG756, section 1: Recommendations. 24 July 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg756/chapter/1-Recommendations""}]","{""kind"": ""Official documents""}" AIBD-1151,2025-06-01,event,month,reported,"In a trial for the Education Endowment Foundation, NFER finds that pupils given the Maths-Whizz AI tutor made a month's extra progress in math","In an NFER trial for the EEF in 63 English primary schools in 2024/2025, pupils given Maths-Whizz made one additional month's progress in math. Pupils eligible for free school meals made two.",*Maths-Whizz* tutor adds a month of math progress in English schools,one additional month's progress in math,,found,Found by an evaluation office,randomized trial,high,aggregate result,false,Maths-Whizz Intelligent Tutoring Programme (an adaptive virtual tutor),,Whizz Education,United Kingdom,"63 state-funded primary schools in England (Years 2 to 5), in an EEF efficacy trial",United Kingdom,"England, United Kingdom",United Kingdom,Education,,Education,Education,Elementary & Secondary,,Children; Students,4,High income,incentivization,Increased/personalized knowledge,2,3,3,4,3,4,0.420,personal,1,,0,Pupils in the same schools' year groups that were not allocated to Maths-Whizz,Mean Star Maths Unified Scaled Score of 954.6 (control),Mean score of 960.8 (Maths-Whizz),measured,unknown,,not shown,https://www.whizzeducation.com/?p=22,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Aston K, Sahasranaman A, Schwendel G, Welbourne S. Maths-Whizz Intelligent Tutoring Programme: Evaluation report. National Foundation for Educational Research for the Education Endowment Foundation, June 2026. Executive summary, Table 1, p. 4. Trial registration ISRCTN13444898."", ""url"": ""https://d2tic4wvo1iusb.cloudfront.net/production/documents/projects/maths_whizz_-_evaluation_report_v.1.0.0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0699,2025-04-23,source publication,day,reported,"World Bank evaluators find that Lesotho's mobile trucks with AI chest X-rays brought TB screening to remote areas, sparing patients travel costs",World Bank evaluators found that Lesotho's trucks carrying digital chest X-rays with AI took TB services to remote areas. People were spared travel. They were also spared high costs.,Lesotho's mobile trucks bring AI-assisted TB screening to remote areas,,,found,Found by an evaluation office,no comparison,very low,program,false,Digital chest X-ray with artificial intelligence on mobile TB screening trucks (product not named),,Not named in the review,,"Government of Lesotho (Ministry of Health as lead ministry), community-based TB management in three districts under the World Bank-financed regional project",Lesotho,Three districts of Lesotho (not named in the review),Lesotho,Global health: tuberculosis case finding,,Health,Health,Disease Prevention,Images and video,Patients; The public,3,Lower middle income,physical_health,Medical access,2,,,4,3,,,personal; societal,1,,0,,,,,unknown,,not shown,https://documents.worldbank.org/curated/en/099042325122541432/pdf/P155658-ed1a2a0a-d0ca-426b-95f7-477350f6c781.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""World Bank Independent Evaluation Group. Implementation Completion Report (ICR) Review: Southern Africa TB and Health Systems Support Project (P155658), ICRR0024454, 23 April 2025."", ""url"": ""https://documents.worldbank.org/curated/en/099042325122541432/pdf/P155658-ed1a2a0a-d0ca-426b-95f7-477350f6c781.pdf""}]","{""kind"": ""Official documents""}" AIBD-0569,2025-01-02,source publication,day,reported,Wigan Council: QuickAction in adult social care,"Wigan Council reports that Agilisys QuickAction tools saved an estimated 107 staff days on minutes. They made 4,500 tenant survey responses usable for analysis.",Wigan reports staff time saved with AI tools,,,found,Found by a regulator,no comparison,very low,aggregate result,false,"Agilisys Transform QuickAction tools for assessments, minutes, audits, and survey analysis",,Agilisys Transform in co-development with Wigan Council,,Wigan Council,,United Kingdom,United Kingdom,Adult-social-care and housing administration,,Social care,Social Welfare,General,Text and language,Public servants,3,High income,operational_improvement,Enhanced productivity,2,3,4,,3,5,,organizational; personal,5,"Local Government Association, bank of AI case studies",0,Manual minute-taking by council staff,Staff wrote meeting minutes by hand.,The council reports that automation halved the time spent on minutes and saved an estimated 107 days of staff work.,assumed,persisted,2026-03-18,not shown,https://www.agilisys.co.uk/wigan-adult-social-care,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Care Quality Commission, Wigan Council local authority assessment (March 2026), Assessing needs, 18 March 2026. The regulator reviewed case records produced with the AI assessment tool and found that they captured detailed and personalized conversations."", ""url"": ""https://www.cqc.org.uk/care-services/local-authority-assessment-reports/wigan-council/wigan-0326/theme1/needs""}]","{""kind"": ""Official documents""}" AIBD-0719,2025-01-01,event,year,reported,"Evidence for ESSA rates Amira Moderate on two studies, including a Texas study with reading gains for students in kindergarten to first grade","Evidence for ESSA rates the Amira reading tutor Moderate. In a Texas study of 15,424 students in 2024-25, users outscored matched controls by +0.26 in kindergarten. In grade 1 the gain was +0.06.",*Amira* earns a Moderate rating for early reading gains,+0.26 in kindergarten,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,"Amira (AI reading tutor, formerly The Reading Tutor)",,Amira Learning,United States,"A large urban school district in Texas (2024-25), and two suburban schools in the earlier randomized trial",United States,"Texas, United States",United States,Education,,Education,Education,Elementary & Secondary,Speech and sound,Students; Children,4,High income,incentivization,Increased/personalized knowledge,2,,3,,3,,,personal,1,,0,Matched controls on end-of-year DIBELS in the Texas district,,effect size of +0.26 in kindergarten and +0.06 in first grade,measured,scaled,2025-12-04,shown,https://www.evidenceforessa.org/program/amira/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. Amira: program page, rating Moderate. Accessed 31 October 2026."", ""url"": ""https://www.evidenceforessa.org/program/amira/""}]","{""kind"": ""Official documents""}" AIBD-0721,2025-01-01,event,year,reported,Evidence for ESSA rates Coursemojo Moderate after finding that sixth graders using it scored higher on state English tests in two districts,"Evidence for ESSA rates Coursemojo Moderate. In two 2024-25 studies, sixth graders using it scored 8 points higher on Tennessee's TCAP exam. On Texas's STAAR, 68% passed against 59%.",*Coursemojo* lifts sixth-grade English scores in two school districts,scored 8 points higher on the TCAP exam,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,Coursemojo (AI teaching assistant Mojo),,"Coursemojo Education, Inc.",United States,"A large Tennessee district (12 schools) and a large Texas district (12 middle schools), 2024-25 school year",United States,"Tennessee and Texas, United States",United States,Education,,Education,Education,Elementary & Secondary,Text and language,Students,4,High income,incentivization,Increased/personalized knowledge,2,3,3,5,3,,,personal,2,,0,Comparison sixth graders in the Texas district who did not use Coursemojo,59%,68%,measured,scaled,2026-07-14,shown,https://coursemojo.com/llm-usage/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. Coursemojo (Mojo), program page, Program Outcomes. Evidence rating Moderate. Accessed 31 October 2026."", ""url"": ""https://www.evidenceforessa.org/program/mojo/""}]","{""kind"": ""Official documents""}" AIBD-0722,2025-01-01,event,year,reported,Evidence for ESSA rates Learning Genie Promising after finding that children in pre-K to kindergarten classrooms using it grew more in literacy,"Evidence for ESSA rates Learning Genie Promising. In a 2024-25 study of 366 children from pre-K to kindergarten, users grew more on the DRDP in literacy, effect size +0.12. Math showed the same.",*Learning Genie* classrooms show small gains in early literacy,effect sizes of +0.12 in language and literacy and +0.12 in math,,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,Learning Genie (AI-supported instructional planning and documentation platform),,"Learning Genie, Inc.",United States,"Several schools, which the page does not name, with 366 prekindergarten and kindergarten children in the 2024-25 study",United States,"United States (rural communities, schools not named)",United States,Education,,Education,Education,Elementary & Secondary,,Teachers; Children,4,High income,incentivization,Increased/personalized knowledge,2,3,3,4,3,,,personal,2,,0,Children in comparison classrooms that did not use Learning Genie,,"Greater DRDP growth, effect size +0.12 in language and literacy and +0.12 in math",measured,unknown,,not shown,https://www.evidenceforessa.org/program/learning-genie-math/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. Learning Genie - Math, program page, Program Outcomes. Evidence rating Promising. Accessed 31 October 2026."", ""url"": ""https://www.evidenceforessa.org/program/learning-genie-math/""}, {""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. Learning Genie - Reading, program page, Program Outcomes. Evidence rating Promising. Accessed 31 October 2026."", ""url"": ""https://www.evidenceforessa.org/program/learning-genie-reading/""}]","{""kind"": ""Official documents""}" AIBD-0921,2025-01-01,event,year,reported,Hellenic Court of Audit finds that the AI system in the Cadastre's Legal Review Platform markedly sped up the legal review of deeds,"The Hellenic Court of Audit found that AI markedly sped up the Cadastre's legal review of deeds. By the Cadastre's figures, completed deeds were projected to rise 93.15% in 2025.",Greek Cadastre checks deeds faster with its AI *Legal Review Platform*,projected to rise 93.15% in 2025,,found,Found by an auditor,before and after,very low,aggregate result,false,AI system of the Legal Review Platform (Πλατφόρμα Νομικού Ελέγχου) of the Hellenic Cadastre,,"Hellenic Ministry of Digital Governance, with OTE and UBITECH, on Microsoft Azure OpenAI technology",Greece,"Ελληνικό Κτηματολόγιο (Hellenic Cadastre), legal review of deeds at its cadastral offices",Greece,Greece (national),Greece,Public administration (land registration),,Public sector,Government Operations,Property Management,Text and language,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",2,1,4,,3,5,,organizational,3,,0,"Deeds completed in 2024, when the AI system was in use only from October, compared with the Cadastre's projection for 2025",356.287 το 2024,688.153 το Νοέμβριο του 2025,measured,unknown,,shown,https://web.archive.org/web/20251112234305/https://www.mindigital.gr/archives/6507,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Ελεγκτικό Συνέδριο (Hellenic Court of Audit), Eighth Section. Γιατί καθυστερεί η κτηματογράφηση ολόκληρης της Χώρας; Έχει αποδώσει η λειτουργία του Κτηματολογίου, όπου η κτηματογράφηση έχει ολοκληρωθεί; Έκθεση Ελέγχου 5/2025, approved 27 March 2026. Summary finding 4, paragraphs 118-121 (pp. 50-51) and 147."", ""url"": ""https://www.elsyn.gr/sites/default/files/Checks/%CE%95%CE%9A%CE%98%CE%95%CE%A3%CE%97%20%CE%95%CE%9B%CE%95%CE%93%CE%A7%CE%9F%CE%A5%205%20%CE%95%CE%9B%CE%9B%CE%97%CE%9D%CE%99%CE%9A%CE%9F%20%CE%9A%CE%A4%CE%97%CE%9C%CE%91%CE%A4%CE%9F%CE%9B%CE%9F%CE%93%CE%99%CE%9F%20%281%29.pdf""}]","{""kind"": ""Official documents""}" AIBD-1142,2025-01-01,event,year,reported,The Los Angeles Police Commission's Inspector General finds that LAPD's in-car plate readers led to 337 stolen vehicles recovered in two months,The Los Angeles Police Commission's Inspector General found that alerts from LAPD's in-car plate readers led police to 337 stolen vehicles in August and September 2025. They led to 74 arrests.,*Plate reader* alerts led LAPD to 337 stolen vehicles in two months,337 stolen vehicles recovered,,found,Found by an auditor,no comparison,very low,aggregate result,false,ALPR feature of Axon's Digital In-Car Video (DICV) system (Axon Fleet 3 ALPR) in LAPD's Automated License Plate Reader system,,"Axon Enterprise (in-car ALPR whose alerts the OIG reviewed), with Motorola Solutions and Flock Safety supplying other cameras",United States,Los Angeles Police Department (LAPD),United States,"Los Angeles, California, United States",United States,Policing / stolen vehicle recovery,,Safety and rescue,Law and Crime,Police,Images and video,Public servants,16,High income,physical_health,Crime reduction or prevention,2,1,3,,3,5,,organizational; personal; societal,1,,0,,,,,challenged,2026-07-14,not shown,https://www.officer.com/vehicles-fleet/vehicles-equipment/in-car-video/press-release/21229498/axon-axon-fleet-3-has-arrived-next-generation-in-car-video-system-with-alpr-now-shipping-to-public-safety-agencies,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Audit report"", ""value"": ""Office of the Inspector General, Los Angeles Police Commission. Review of the Los Angeles Police Department's Automatic License Plate Reader System and Use in the Field (BPC #26-184), 10 July 2026. Section IV.D, p. 16. The OIG analyzed Axon in-car alert data for 1 August to 30 September 2025."", ""url"": ""https://www.lapdpolicecom.lacity.org/071426/BPC_26-184x.pdf""}, {""label"": ""Audit report"", ""value"": ""Office of the Inspector General, Los Angeles Police Commission. Review of the Los Angeles Police Department's Automatic License Plate Reader System and Use in the Field (BPC #26-184), 10 July 2026. Section IV.E, p. 16. The OIG checked arrest stops against body-worn video, incident details and reports."", ""url"": ""https://www.lapdpolicecom.lacity.org/071426/BPC_26-184x.pdf""}, {""label"": ""Audit report"", ""value"": ""Office of the Inspector General, Los Angeles Police Commission. Review of the Los Angeles Police Department's Automatic License Plate Reader System and Use in the Field (BPC #26-184), 10 July 2026. Section IV.C, p. 16. Officers confirmed these alerts as accurate plate matches, and the vehicles proved not to be stolen."", ""url"": ""https://www.lapdpolicecom.lacity.org/071426/BPC_26-184x.pdf""}, {""label"": ""Follow-up"", ""value"": ""On 14 July 2026 the Los Angeles Police Commission approved the Inspector General's recommendations, which include suspending new plate reader cameras and contracts pending a reassessment of vendors and data practices."", ""url"": ""https://patch.com/california/los-angeles/la-police-commission-oks-suspension-flock-cameras-amid-contract-talks""}]","{""kind"": ""Challenges""}" AIBD-1136,2024-11-01,event,month,reported,Paraná's Court of Justice upheld IAT enforcement against Atlantic Forest clearing flagged by MapBiomas Alerta in nine decisions from 2024 to 2026,Paraná's Court of Justice upheld IAT enforcement in nine decisions from 2024 to 2026 on Atlantic Forest clearing flagged by MapBiomas alerts. None rejected the satellite evidence.,Paraná court upholds nine IAT forest cases built on *MapBiomas Alerta*,upheld IAT enforcement in nine decisions,,found,Found by a court,no comparison,very low,protective response,false,"MapBiomas Alerta, checked in IAT reports with alerts of the federal Brasil MAIS satellite platform (the decisions call it 'Mapbiomas', 'Mapa Biomas' or 'Alerta Mapbiomas')",,"MapBiomas (MapBiomas Alerta), which compiles source alerts from other detection systems. The lead case also names the SCCON web platform of the Programa Brasil Mais, a system of the Ministério da Justiça e Segurança Pública.",Brazil,"Instituto Água e Terra (IAT), Paraná's environmental agency, through its geographic intelligence unit (NGI) and inspectors. The Ministério Público do Paraná brought the civil actions and prosecutions.",Brazil,"Paraná, Brazil (cases from Irati, Rebouças, Dois Vizinhos, Guarapuava, Telêmaco Borba, Cantagalo, Marmeleiro and Bocaiúva do Sul)",Brazil,Environmental enforcement: Atlantic Forest clearing,,Environment,Environment,Species & Forest,Images and video,Public servants,15; 16,Upper middle income,environmental_impact,Environmental impacts,2,1,,,3,,,organizational; societal,12,,0,,,,,persisted,2026-09-04,shown,https://alerta.mapbiomas.org/metodo,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Apelação Cível e Remessa Necessária nº 0000534-55.2025.8.16.0095 (Irati), Rel. Des. Hamilton Rafael Marins Schwartz. Judgment of 15 September 2026, published 18 September 2026. Appeal and mandatory review partly granted: the dismissal was reversed and repair of the damage ordered."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000037190891/Ac%C3%B3rd%C3%A3o-0000534-55.2025.8.16.0095""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Apelação Cível nº 0000385-44.2024.8.16.0079 (Dois Vizinhos), Rel. Des. Carlos Mansur Arida. Judgment of 13 July 2026, published 29 July 2026. Appeal denied: the embargo was upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000036052551/Ac%C3%B3rd%C3%A3o-0000385-44.2024.8.16.0079""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Turma Recursal dos Juizados Especiais. Recurso Inominado nº 0000937-77.2025.8.16.0142 (Rebouças), Rel. Juiz Marco Vinicius Schiebel. Judgment of 5 August 2026, published 7 August 2026. Appeal denied: the fine and embargo were upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/2100000038191841/Ac%C3%B3rd%C3%A3o-0000937-77.2025.8.16.0142""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Apelação Cível nº 0012915-35.2021.8.16.0031 (Guarapuava), Rel. Des. Clayton de Albuquerque Maranhão. Judgment of 7 April 2025. Appeal denied: the repair order was upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000031166311/Ac%C3%B3rd%C3%A3o-0012915-35.2021.8.16.0031""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Agravo de Instrumento nº 0076739-22.2025.8.16.0000 (Bocaiúva do Sul), Rel. Des. Leonel Cunha. Judgment of 2 March 2026, published 4 March 2026. Interlocutory appeal partly granted: the embargo was kept and R$104,000 in fines suspended until judgment."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000034234561/Ac%C3%B3rd%C3%A3o-0076739-22.2025.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Agravo de Instrumento nº 0089425-46.2025.8.16.0000 (Marmeleiro), Rel. Des. Wellington Emanuel Coimbra de Moura. Judgment of 23 March 2026, published 25 March 2026. Interlocutory appeal denied: suspension of four infraction notices was refused."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000034637231/Ac%C3%B3rd%C3%A3o-0089425-46.2025.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Agravo de Instrumento nº 0008450-03.2026.8.16.0000 (Guarapuava), Rel. Des. Carlos Mansur Arida. Judgment of 18 May 2026. Prosecutors' interlocutory appeal denied: the notice is presumed true, and the defendants bear the burden of disproving it."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000036784091/Ac%C3%B3rd%C3%A3o-0008450-03.2026.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Habeas Corpus nº 0046714-89.2026.8.16.0000 (Telêmaco Borba), Rel. Des. Luis Carlos Xavier (majority). Judgment of 21 May 2026, published 22 May 2026. Habeas corpus denied by majority: the prosecution goes on."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000037867071/Ac%C3%B3rd%C3%A3o-0046714-89.2026.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0000526-57.2023.8.16.0060 (Cantagalo), Rel. Des. José Mauricio Pinto de Almeida (majority). Judgment of 11 November 2024, published 27 November 2024. Appeal denied by majority: the convictions were upheld, with the cash penalty reduced by the court of its own motion."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000029424571/Ac%C3%B3rd%C3%A3o-0000526-57.2023.8.16.0060""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Habeas Corpus nº 0046714-89.2026.8.16.0000 (Telêmaco Borba). Dissenting vote (declaração de voto divergente) of Des. Priscilla Placha Sá, 21 May 2026, filed with the judgment of 21 May 2026. She would have halted the prosecution because it rested on satellite-based IAT reports without a forensic exam."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/publico/visualizacao.do?tjpr.url.crypto=8a6c53f8698c7ff76db3047d195cb6a566563aad3816aa8636f005ac05bd8b218a221c700814ffe29e700a71406807007ec2c578fc398929691e0db26d2d9c3355e6ef4bb2df61f11994e1f5e384030026b61062cccf64e874fe4889b209823e4bc58b6185a66ccd3935a8f696c162057ade4aa2d72762fa20d92ab25c18fc21c155f772c191441d7db8b67f77aff75350c92759af5a65ed84b8a9cf74c450a9922feb35e157568c80ad84f8e3aa2f70aa371aabadae4f25""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0000526-57.2023.8.16.0060 (Cantagalo). Dissenting vote (declaração de voto vencido) of Des. Mário Helton Jorge, 11 November 2024, filed with the judgment of 11 November 2024. He would have acquitted for want of a forensic report. The vote is undated, so the judgment date is given."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/publico/visualizacao.do?tjpr.url.crypto=8a6c53f8698c7ff76db3047d195cb6a566563aad3816aa8636f005ac05bd8b218a221c700814ffe226bf5e5edbf78d9af74751032eb55086f7c6f38ff2f265740583d6396171599d7eaf6102f880c2668075a2d7c3445ea091c1ff596fd01576c66e9e391692ae4bea39485647bb729a70b8e9cdefcc2a2d6fb14d68bf42eb0c279ca8bfb9985fa24b6887d38dada5810df3e5bddb1926aebd3796771779f37c80baf2aec13612ff48a640681ced96e65117e94c8fa92850""}]","{""kind"": ""Official documents""}" AIBD-1009,2024-07-01,event,month,reported,ANAO finds that an AI-enabled model helped flag eight potential breaches of Medicare rules before the department dropped it,"The ANAO found that eight potential Medicare fraud or non-compliance matters, estimated at $5,253,601, came in part from an AI-enabled model. The model was not used after December 2025.",Medicare's *AI-enabled model* helps flag eight possible breaches,eight potential Medicare fraud or non-compliance matters,,found,Found by an auditor,no comparison,very low,aggregate result,false,AI-enabled model in the MBS fraud and non-compliance detection system,,"Department of Health, Disability and Ageing (built in-house from August 2023)",Australia,"Department of Health, Disability and Ageing, Benefits Integrity Division",Australia,Australia (national),Australia,Health insurance fraud and improper payments,,Finance,Health,Medical Liability,Prediction from data,,16,High income,privacy_protection,Fraud detection,2,1,4,,3,,,organizational; societal,1,,0,,,,,withdrawn,2025-12-31,shown,https://web.archive.org/web/20261010124600/https://www.anao.gov.au/work/performance-audit/artificial-intelligence-and-medicare-benefits-integrity,"$5,253,601","Estimated value of potential fraud or non-compliance in the eight matters identified in part with the AI-enabled model, whose results also drew on models without AI",True,[],Querist,The system was later withdrawn.,"[{""label"": ""Audit report"", ""value"": ""Australian National Audit Office. Artificial Intelligence and Medicare Benefits Integrity. Auditor-General Report No. 5 of 2026-27, published 21 September 2026. Paragraph 19 and paragraphs 5.5 to 5.14 (archived copy of the report page)."", ""url"": ""https://web.archive.org/web/20261010124600/https://www.anao.gov.au/work/performance-audit/artificial-intelligence-and-medicare-benefits-integrity""}, {""label"": ""Follow-up"", ""value"": ""The department stopped using the AI-enabled model after December 2025 because manual assessment could not keep up with the volume of matters that it generated. Standard statistical modeling replaced it for the same claiming behavior."", ""url"": ""https://web.archive.org/web/20261010124600/https://www.anao.gov.au/work/performance-audit/artificial-intelligence-and-medicare-benefits-integrity""}]","{""kind"": ""Withdrawals""}" AIBD-0747,2024-06-05,source publication,day,mixed,The Peterson Health Technology Institute finds that app-based exercise therapy such as Kaia improves pain compared with no physical therapy,PHTI found that app-based exercise therapy improves pain compared with no physical therapy. It rests on two German Kaia studies. PHTI rated the category no substitute for in-person therapy.,*Kaia*'s exercise app eased back pain in an independent assessment,,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,"Kaia app for app-based exercise therapy, rated with DarioHealth's program in the same category",,Kaia Health,United States,"Kaia Health, through its app, in two studies of people with back pain in Germany",Germany,"Germany (studies), with an assessment for US purchasers",Germany | United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical access,2,3,3,,2,,,personal,2,,0,Standard care for low back pain under German guidelines,,Pain improvements that met the MCID threshold in the app group only,measured,persisted,2026-01-28,shown,https://www.phti.org/wp-content/uploads/2024/10/PHTI-Virtual-MSK-Solutions-Assessment-Report-v1.3.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Peterson Health Technology Institute. Virtual Musculoskeletal Solutions. Health technology assessment, executive summary, 5 June 2024."", ""url"": ""https://www.phti.org/wp-content/uploads/2024/06/PHTI-Virtual-MSK-Solutions-Executive-Summary-1.pdf""}, {""label"": ""Assessment report"", ""value"": ""Peterson Health Technology Institute. Virtual Musculoskeletal Solutions: Assessment Report, version 1.3, updated 10 October 2024, technology context."", ""url"": ""https://www.phti.org/wp-content/uploads/2024/10/PHTI-Virtual-MSK-Solutions-Assessment-Report-v1.3.pdf""}]","{""kind"": ""Official documents""}" AIBD-0232,2024-05-17,event,day,reported,"Cheshire Police facial recognition matches CCTV to an 18-year-old county lines dealer, who gets 28 months while a second dealer gets 34",Cheshire Constabulary's facial recognition system matched CCTV of an unknown Northwich dealer to an 18-year-old. Police stopped him with a 19-year-old on 17 May 2024. Both were jailed on 1 July 2024.,Two men are jailed after face recognition identifies a Northwich dealer,jailed the 18-year-old for 28 months and the 19-year-old for 34 months,,found,Found by an auditor,no comparison,very low,benefit created,false,Cheshire Constabulary facial recognition system (retrospective),,Not named in the sources,,"Cheshire Constabulary, Northwich Proactive Policing Unit",United Kingdom,"Northwich, United Kingdom",United Kingdom,Policing / drug supply,Government,Public sector,Law and Crime,Illegal Drugs,Images and video,Public servants,16,High income,physical_health,Crime reduction or prevention,2,,4,,4,5,,societal,4,,1,conventional identification of a suspect who was not known locally,The 18-year-old was not known in the Northwich area,we were quickly able to identify him as a suspect,assumed,scaled,2026-02-10,not shown,https://assets-hmicfrs.justiceinspectorates.gov.uk/uploads/peel-assessment-2023-25-cheshire.pdf,£990,"crack cocaine seized from the 18-year-old (99 wraps, approximate street value)",False,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2023-2025: An inspection of Cheshire Constabulary. Published 6 February 2025. Section 'Preventing and deterring crime and antisocial behaviour, and reducing vulnerability', innovative practice 'Cheshire Constabulary uses retrospective facial recognition to effectively identify suspects and tackle criminality'. The case counts are the force's own figures, and the inspection does not examine this case."", ""url"": ""https://assets-hmicfrs.justiceinspectorates.gov.uk/uploads/peel-assessment-2023-25-cheshire.pdf""}]","{""kind"": ""Official documents""}" AIBD-0742,2024-04-01,source publication,month,reported,Health Technology Wales supports routine use of AI polyp detection in colonoscopy after estimating that it raised adenoma detection by 23%,Health Technology Wales pooled 36 randomized trials. It estimated that AI-assisted colonoscopy found adenomas in 44.3% of people against 37.1% without it. It supports routine adoption.,Wales supports *CADe* colonoscopy after it found more adenomas in trials,23% higher with CADe than with standard colonoscopy,,found,Found by an assessment body,randomized trial,low,aggregate result,false,"Computer-aided detection (CADe) colonoscopy systems in the trials that HTW pooled, including GI Genius, ENDO-AID, CAD EYE, EndoScreener and EndoAngel",,"Medtronic (GI Genius), Olympus (ENDO-AID), Fujifilm (CAD EYE), Wision AI (EndoScreener), Wuhan EndoAngel Medical Technology Company (EndoAngel) and other makers","Multiple: Ireland, Japan, China",Endoscopy services in the pooled randomized trials,Multiple,"Multiple countries (trials), with guidance for Wales, United Kingdom",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,2,4,1,,3,1,,personal,3,,0,Standard colonoscopy without CADe in the pooled randomized trials,37.1% (standard colonoscopy),"44.3% (CADe), RR: 1.23",measured,unknown,,shown,https://healthtechnology.wales/wp-content/uploads/EAR055-AIAE-WEB.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Health Technology Wales. Artificial Intelligence (AI)-assisted endoscopy in the detection of gastrointestinal cancer and pre-cancerous lesions. Guidance GUI055, April 2024 (topic page, outcome of the appraisal)."", ""url"": ""https://healthtechnology.wales/reports-guidance/ai-assisted-endoscopy-for-gastrointestinal-cancer/""}, {""label"": ""Assessment report"", ""value"": ""Health Technology Wales. Evidence Appraisal Report EAR055: Artificial intelligence assisted endoscopy in the detection of lower gastrointestinal cancer and pre-cancerous lesions. April 2024, section 5.2.1 and Table 2."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/EAR055-AIAE-WEB.pdf""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}]","{""kind"": ""Official documents""}" AIBD-1161,2024-03-28,source publication,day,reported,"Japan's health ministry makes EndoBRAIN-EYE eligible for an insurance add-on, recognizing that it raises the accuracy of specialists in colonoscopy","Japan's health ministry recognized EndoBRAIN-EYE as shown to raise specialists' diagnostic accuracy in colonoscopy, which made it eligible for a new insurance add-on to polyp removal.",*EndoBRAIN-EYE* wins a Japanese insurance add-on for better colonoscopy,tumor detection rate from 21.6% to 31.2%,,found,Found by an assessment body,before and after,very low,aggregate result,false,EndoBRAIN-EYE (内視鏡画像診断支援プログラム),,"Cybernet Systems Co., Ltd. (サイバネットシステム株式会社), with Showa University Northern Yokohama Hospital and Nagoya University",Japan,Japanese hospitals and clinics where colonoscopy specialists use it during polyp removal (not named),Japan,Japan,Japan,Healthcare,,Health,Health,Insurance Providers,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,2,,1,,3,1,,personal,3,,0,Colonoscopy by specialists without the program,21.6% tumor detection rate,31.2% tumor detection rate,measured,unknown,,shown,https://www.cybernet.co.jp/medical-imaging/products/endobrain/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Ministry of Health, Labour and Welfare (MHLW), Health Insurance Bureau, Medical Economics Division, Japan. 疑義解釈資料の送付について(その1)(Q&A on the interpretation of the fiscal 2024 medical fee schedule, part 1), office communication of 28 March 2024. Attachment 1 (medical fee schedule), Question 221, p. 医-58."", ""url"": ""https://www.mhlw.go.jp/content/12404000/001237675.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Pharmaceuticals and Medical Devices Agency (PMDA), Japan. 資料2, PMDA提出資料, 第22回 医療機器・体外診断薬の承認審査や安全対策等に関する定期意見交換会 (Document 2, submitted by PMDA to the 22nd regular exchange meeting on the review and safety of medical devices and in vitro diagnostics), 7 October 2024. Table AIを活用した医療機器(プログラム)の承認状況(R6.9末現在) (approval status of AI-based program devices as of the end of September 2024)."", ""url"": ""https://www.mhlw.go.jp/content/11124500/001329696.pdf""}]","{""kind"": ""Official documents""}" AIBD-0860,2024-02-08,event,day,reported,New Zealand's Privacy Commissioner finds that live facial recognition in 25 Foodstuffs North Island supermarkets reduced serious repeat offending,"New Zealand's Privacy Commissioner concluded that live facial recognition in 25 Foodstuffs North Island supermarkets reduced serious repeat offending, with an estimated 16% fewer serious incidents.",Live *Imagus* face matching cut serious repeat offending in 25 stores,an estimated 16% fewer serious incidents,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Imagus FRT System (live facial recognition),,"Imagus, an Australian-based developer according to the report",Australia,"Foodstuffs North Island, in 25 New World and PAK'nSAVE supermarkets",New Zealand,"North Island, New Zealand",New Zealand,Retail security,,Safety and rescue,Law and Crime,Crime Control,Images and video,,16,High income,physical_health,Crime reduction or prevention,2,3,3,,3,5,,personal; organizational,1,,0,"128 Foodstuffs North Island stores without facial recognition, over the same period",,Estimated 16% reduction in serious harmful behaviors and 21% reduction in shoplifting in the 25 trial stores,measured,persisted,2026-03-25,shown,https://www.privacy.org.nz/assets/DOCUMENTS/20250603-FRT-Inquiry-Report-A1082856.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Office of the Privacy Commissioner, New Zealand. Inquiry into Foodstuffs North Island trial use of facial recognition technology. Report dated May 2025, released 4 June 2025. Executive summary, para 8(b), p. 6. The Commissioner combined the evaluation that Foodstuffs commissioned with his office's own store visits, staff interviews and data requests."", ""url"": ""https://www.privacy.org.nz/assets/DOCUMENTS/20250603-FRT-Inquiry-Report-A1082856.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Office of the Privacy Commissioner, New Zealand. Inquiry into Foodstuffs North Island trial use of facial recognition technology, para 137, p. 39. Released 4 June 2025."", ""url"": ""https://www.privacy.org.nz/assets/DOCUMENTS/20250603-FRT-Inquiry-Report-A1082856.pdf""}]","{""kind"": ""Official documents""}" AIBD-0688,2024-01-01,event,year,mixed,Cour des comptes finds that reassessments from checks suggested by URSSAF data mining rose ninefold in Île-de-France from 2023 to 2024,The Cour des comptes found that reassessments from checks suggested by data mining rose ninefold at URSSAF Île-de-France. They went from €3.7 million in 2023 to €33.5 million in 2024.,URSSAF data mining lifts undeclared-work reassessments ninefold,rose ninefold at URSSAF Île-de-France,,found,Found by an auditor,before and after,very low,aggregate result,false,"ARTIC (Analyse des risques pour le travail d'investigation et le ciblage), the URSSAF data-mining tool",,Agence centrale des organismes de sécurité sociale (ACOSS),France,URSSAF network (figures from URSSAF Île-de-France),France,"Île-de-France, France",France,Social contributions enforcement (undeclared work),,Public sector,Labor,Fair Labor Standards,Prediction from data,Public servants,8; 16,High income,privacy_protection; operational_improvement,Fraud detection,2,1,4,,2,5,,organizational,1,,0,Reassessments from checks suggested by data mining at URSSAF Île-de-France in 2023,"3,7 M€ in 2023","33,5 M€ in 2024",measured,unknown,,not shown,https://program-evaluation.ccomptes.fr/sites/default/files/2026-04/20260416-Lutte-fraude-prelevements-sociaux-et-travail-dissimule.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. La politique de lutte contre la fraude aux prélèvements sociaux liée au travail dissimulé. Évaluation de politique publique, communication au comité d’évaluation et de contrôle des politiques publiques de l’Assemblée nationale, April 2026, pp. 76-77."", ""url"": ""https://program-evaluation.ccomptes.fr/sites/default/files/2026-04/20260416-Lutte-fraude-prelevements-sociaux-et-travail-dissimule.pdf""}]","{""kind"": ""Official documents""}" AIBD-0696,2024-01-01,event,year,reported,UNICEF's Evaluation Office finds that the I-HEAR-U listening platform informed UNICEF's 2024 flood response in Nepal,UNICEF's Evaluation Office found that the AI-powered I-HEAR-U platform informed UNICEF's 2024 flood response in Nepal. It informed HPV vaccine plans there. It cut staff work on reports.,*I-HEAR-U* informs UNICEF's response to Nepal's 2024 floods,,,found,Found by an evaluation office,no comparison,very low,program,false,I-HEAR-U (AI-powered social and community listening platform),,UNICEF Regional Office for South Asia with Research for Purpose,Nepal and Germany,Country offices of UNICEF (at least 5 in South Asia and 11 across UNICEF),,"South Asia, including Nepal and Pakistan",Nepal | Pakistan,Humanitarian response and health communication / social listening,,Humanitarian,International Affairs,Foreign Aid,Text and language,Public servants; Children,3; 13,Lower middle income,operational_improvement,"Faster data management, decision-making",2,3,,2,3,,,organizational; societal,1,,0,,,,,unknown,,not shown,https://evaluationreports.unicef.org/GetDocument?documentID=19824&fileID=59675,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNICEF Evaluation Office. Evaluation of Innovation in UNICEF: South Asia Regional Thematic Case Study Report. New York, December 2025 (imprint November 2025). The case study was carried out between March and October 2025."", ""url"": ""https://evaluationreports.unicef.org/GetDocument?documentID=19824&fileID=59675""}]","{""kind"": ""Official documents""}" AIBD-0707,2024-01-01,event,year,reported,"Brazil's Federal Court of Accounts finds that Ancine's Malha Fina triage, which uses machine learning, cut more than half of its backlog","Brazil's Federal Court of Accounts found that Ancine analyzed 3,634 accountability reports in 2024 with its Malha Fina triage, against 2,400 in 2008-2023. It called the project a good practice.",*Malha Fina* helps Ancine clear a backlog of grant reviews,"3,634 accountability reports in 2024",,found,Found by an auditor,before and after,very low,aggregate result,false,"Projeto Malha Fina: a machine-learning model (PyCaret, LightGBM) in a hybrid triage with an ABC value curve and five automated checks",,"Controladoria-Geral da União (CGU), on Ancine data under a cooperation agreement",Brazil,"Agência Nacional do Cinema (Ancine), Superintendência de Prestação de Contas",Brazil,Brazil,Brazil,Public administration: grant accountability review,,Public sector,Government Operations,Bureaucracy,Prediction from data,,16,Upper middle income,operational_improvement,Enhanced productivity,2,1,,2,3,,,organizational,1,,0,"Ancine's analysis of accountability reports from 2008 to 2023, before Malha Fina",2.400 que haviam sido analisados entre 2008 e 2023,apenas em 2024 foram analisados 3.634 processos,measured,persisted,2026-10-21,shown,https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=905948,"R$ 665.000.000,00","Saving from analyzing accountability reports through Projeto Malha Fina, by Ancine's own calculation",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 726/2026 – TCU – Plenário (TC 014.873/2025-7), relator Ministro Augusto Nardes, session of 25 March 2026. Follow-up report on the management of accountability reports and special audits by the transferring bodies (Ancine and Ministério da Cultura), paragraphs 262-285 and 358-361."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=905948""}]","{""kind"": ""Official documents""}" AIBD-0718,2024-01-01,event,year,reported,The What Works Clearinghouse finds moderate evidence that Amira raised reading scores for K-5 students in 12 Louisiana school districts,The What Works Clearinghouse found moderate (Tier 2) evidence that K-5 students in 12 Louisiana districts who used the Amira reading software in 2023-24 outscored matched non-users.,*Amira* users outscore matched peers across 12 Louisiana districts,+4 in kindergarten and grade 1,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,Amira (Amira Learning reading software),,Amira Learning,United States,12 public school districts in Louisiana,United States,"Louisiana, United States",United States,Education,,Education,Education,Elementary & Secondary,,Students; Children,4,High income,incentivization,Increased/personalized knowledge,2,4,3,4,3,,,personal,2,,0,Matched students in the same districts who did not use Amira,,Improvement indexes of +1 to +4 across six findings,measured,persisted,2025-02-12,shown,https://www.evidenceforessa.org/program/amira/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""U.S. Department of Education, Institute of Education Sciences, What Works Clearinghouse. Single study review of Shah, Scanlan and Wall (2025), Amira Learning® in Louisiana Public Schools: ESSA Level II Study (2023-24). Reviewed June 2026."", ""url"": ""https://ies.ed.gov/ncee/WWC/Study/95242""}]","{""kind"": ""Official documents""}" AIBD-0743,2024-01-01,source publication,year,reported,Evaluators for the Department of Health and Social Care find that DERM safely sorted referrals for suspected skin cancer at four NHS sites,Evaluators of DERM at four NHS sites found that it triaged suspected skin cancer safely. It was accurate. It cut unnecessary referrals. It freed consultant time. Gains in quality of life were unclear.,*DERM* triages suspected skin cancer safely at four NHS sites,"2,600 dermatologist appointments a year",,found,Found by an assessment body,no comparison,very low,aggregate result,false,DERM (Deep Ensemble for the Recognition of Malignancy),,Skin Analytics,United Kingdom,"Chelsea and Westminster, University Hospitals Bristol and Weston, Ashford and St Peter's and University Hospitals Birmingham NHS foundation trusts, with Birmingham primary care networks",United Kingdom,"London, Bristol, Surrey and Birmingham, England, United Kingdom",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,2,2,,3,3,,,organizational; personal,4,,0,"Traditional teledermatology without DERM and the non-digital face-to-face pathway, in the evaluators' cost-benefit model",,42% less time spent reviewing images with DERM than traditional teledermatology,assumed,scaled,2026-10-09,shown,https://www.medicaldevice-network.com/features/ai-skin-cancer/,£1.7 returned for every £1 spent,"Return on each pound spent on DERM in the secondary care model, from the evaluators' cost-benefit analysis",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Unity Insights. Evaluation of Deep Ensemble for the Recognition of Malignancy (DERM). Summary of an evaluation commissioned by the Department of Health and Social Care under phase IV of the AI Awards in Health and Social Care. Hosted by NIHR ARC Kent, Surrey and Sussex. 2024."", ""url"": ""https://www.arc-kss.nihr.ac.uk/resource-library/798-evaluation-of-deep-ensemble-for-the-recognition-of-malignancy-derm/file""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment. HealthTech guidance HTG746, section 3 (Committee discussion), paragraph 3.11. London: NICE, published 1 May 2025, last updated 17 March 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""Walton M, Llewellyn A, Uphoff E, Lord J, Harden M, Hodgson R, Simmonds M. Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment. Health Technology Assessment 2026;30(10):1-96. doi:10.3310/GJMS0317. PubMed 41660864."", ""url"": ""https://doi.org/10.3310/gjms0317""}]","{""kind"": ""Official documents""}" AIBD-0837,2024-01-01,event,year,mixed,"A French evaluation committee found that Wintics analytics helped SNCF spot people on tracks more often, with a quarter of intrusion alerts false",France's evaluation committee found that Wintics video analytics let SNCF detect people on the tracks more regularly. SNCF counted 660 true intrusion alerts. It counted 233 false ones.,*Wintics* video analytics help SNCF spot people on the tracks,660 true and 233 false intrusion alerts,,found,Found by an inquiry,no comparison,very low,aggregate result,false,Algorithmic video processing developed by Wintics,,Wintics,France,"SNCF (rail security services), at stations in the Paris region",France,"Paris region, France",France,Railway safety / trespass detection,,Safety and rescue,Transportation,Railroad Travel,Images and video,Other workers,11,High income,physical_health,Hazard reduction,2,1,2,,2,5,,organizational; societal,3,,0,Video operators watching the camera feeds without the algorithm,,,assumed,persisted,2026-05-26,shown,https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""Comité d'évaluation de l'expérimentation de traitements algorithmiques d'images (chair Christian Vigouroux). Expérimentation de traitements algorithmiques d'images légalement collectées au moyen de systèmes de vidéoprotection, rapport du comité d'évaluation. Ministère de l'Intérieur, January 2025. § 3.2.1, p. 68, and § 2.3.5, p. 59."", ""url"": ""https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf""}, {""label"": ""Inquiry report"", ""value"": ""Sénat, commission des lois. Rapport d'information n° 374 (2024-2025) sur le bilan de la mise en œuvre de la loi du 19 mai 2023 relative aux jeux Olympiques et Paralympiques de 2024 (vidéoprotection intelligente et sécurité privée), by Françoise Dumont and Marie-Pierre de La Gontrie. Registered 19 February 2025."", ""url"": ""https://www.senat.fr/rap/r24-374/r24-3741.pdf""}, {""label"": ""Inquiry report"", ""value"": ""Assemblée nationale, Commission des lois (mission flash; rapporteurs Éric Martineau and Stéphane Peu) (2025). Rapport d'information sur le bilan sécuritaire des Jeux olympiques et paralympiques de 2024 (n° 1156), Quatrième partie, I (pp. 121-138), especially I.D 'Des conditions d'expérimentation insuffisantes' (p. 136)."", ""url"": ""https://www.assemblee-nationale.fr/dyn/17/rapports/cion_lois/l17b1156_rapport-information.pdf""}]","{""kind"": ""Official documents""}" AIBD-0838,2024-01-01,event,year,mixed,"France's evaluation committee found that RATP halved its time to intervene after Wintics video alerts, with 324 false intrusion alerts against 1222 true ones","France's evaluation committee reported that with Wintics video analytics, RATP halved its time to respond to an alert. At the Olympics RATP counted 1222 true intrusion alerts, against 324 false ones.",*Wintics* alerts help RATP halve its time to intervene,1222 true and 324 false intrusion alerts,,found,Found by an inquiry,no comparison,very low,aggregate result,false,Algorithmic video processing developed by Wintics,,Wintics,France,RATP (security services on the Paris metro and RER),France,"Paris, France",France,Public transport security / trespass detection,,Safety and rescue,Transportation,Mass,Images and video,Other workers,11,High income,operational_improvement; physical_health,"Faster data management, decision-making",2,1,2,,2,5,,organizational; societal,3,,0,RATP's intervention time from an alert before the experiment,,divisé par deux,assumed,persisted,2026-08-18,shown,https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""Comité d'évaluation de l'expérimentation de traitements algorithmiques d'images (chair Christian Vigouroux). Expérimentation de traitements algorithmiques d'images légalement collectées au moyen de systèmes de vidéoprotection, rapport du comité d'évaluation. Ministère de l'Intérieur, January 2025. § 3.1.5, p. 67, and § 2.3.5, p. 58."", ""url"": ""https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf""}, {""label"": ""Inquiry report"", ""value"": ""Françoise Dumont and Marie-Pierre de La Gontrie, Rapport d'information n° 374 (2024-2025) fait au nom de la commission des lois du Sénat sur le bilan de la mise en œuvre de la loi du 19 mai 2023 relative aux jeux Olympiques et Paralympiques de 2024 (vidéoprotection intelligente et sécurité privée), Sénat, registered 19 February 2025, p. 34."", ""url"": ""https://www.senat.fr/rap/r24-374/r24-3741.pdf""}, {""label"": ""Inquiry report"", ""value"": ""Assemblée nationale, Commission des lois (mission flash; rapporteurs Éric Martineau and Stéphane Peu) (2025). Rapport d'information sur le bilan sécuritaire des Jeux olympiques et paralympiques de 2024 (n° 1156), Quatrième partie, I (pp. 121-138), especially I.D 'Des conditions d'expérimentation insuffisantes' (p. 136)."", ""url"": ""https://www.assemblee-nationale.fr/dyn/17/rapports/cion_lois/l17b1156_rapport-information.pdf""}]","{""kind"": ""Official documents""}" AIBD-0839,2024-01-01,event,year,mixed,"A French evaluation committee saw real value in Wintics alerts for the Paris police only in some settings, such as the large Vaires-sur-Marne site","France's evaluation committee saw real value in Wintics video alerts for the Paris police only in some settings, such as sites too large to patrol. In the Paralympics 55 detections led to action.",*Wintics* alerts help Paris police watch a large Olympic site,55 of the prefecture's detections had operational value,,found,Found by an inquiry,no comparison,very low,aggregate result,false,"Algorithmic video processing developed by Wintics, on tactical cameras",,Wintics,France,Préfecture de police de Paris,France,"Vaires-sur-Marne and Paris, France",France,Public safety / event security,,Safety and rescue,Law and Crime,Police,Images and video,Public servants,16,High income,operational_improvement; physical_health,Enhanced productivity,2,1,,,2,,,organizational; societal,2,,0,,,,,withdrawn,2025-03-31,shown,https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Inquiry report"", ""value"": ""Comité d'évaluation de l'expérimentation de traitements algorithmiques d'images (chair Christian Vigouroux). Expérimentation de traitements algorithmiques d'images légalement collectées au moyen de systèmes de vidéoprotection, rapport du comité d'évaluation. Ministère de l'Intérieur, January 2025. § 3.1.2, p. 65, § 3.1.1, p. 63, and § 2.3.5, p. 58."", ""url"": ""https://www.interieur.gouv.fr/sites/minint/files/medias/documents/2025-01/Rapport1701_v200125%20avecannexes1a%CC%806.pdf""}, {""label"": ""Inquiry report"", ""value"": ""Françoise Dumont and Marie-Pierre de La Gontrie, Rapport d'information n° 374 (2024-2025) fait au nom de la commission des lois du Sénat sur le bilan de la mise en œuvre de la loi du 19 mai 2023 relative aux jeux Olympiques et Paralympiques de 2024 (vidéoprotection intelligente et sécurité privée), Sénat, Paris, registered 19 February 2025, pp. 30-39."", ""url"": ""https://www.senat.fr/rap/r24-374/r24-3741.pdf""}, {""label"": ""Follow-up"", ""value"": ""France's legal experiment with algorithmic video analysis, under which the Paris police prefecture ran Wintics, ended on 31 March 2025. In July 2025 a bill proposed to restart it. Law no. 2026–798 of 18 August 2026 then reopened the experiment to 31 December 2030. Whether the prefecture resumed Wintics is not reported."", ""url"": ""https://web.archive.org/web/2026/https://reporterre.net/La-videosurveillance-algorithmique-pourrait-etre-reconduite-au-nom-des-JO-2030""}]","{""kind"": ""Withdrawals""}" AIBD-0919,2024-01-01,event,year,reported,Sweden's Social Insurance Inspectorate finds that about 74% of investigations from Försäkringskassan's risk-based selections led to action in 2024,"Sweden's Social Insurance Inspectorate found that about 74% of investigations started by Försäkringskassan's risk-based selections led to action in 2024, against 40% from public tips.",Most investigations from *riskbaserade urval* lead to action,about 74% of investigations started from risk-based selections in 2024 led to action,,found,Found by an auditor,controlled comparison,low,aggregate result,false,Försäkringskassan's risk-based selections (riskbaserade urval) for control investigations: targeted checks (riktade kontroller) and selection profiles (urvalsprofiler),,"Försäkringskassan (Swedish Social Insurance Agency), including a unit of its control function that develops selection profiles",Sweden,"Försäkringskassan (Swedish Social Insurance Agency), control function",Sweden,Sweden,Sweden,Social insurance control,,Finance,Social Welfare,General,Prediction from data,,16,High income,privacy_protection; operational_improvement,Fraud detection,2,1,4,,3,5,,organizational,2,,0,Control investigations started by tips from the public in 2024,40 procent,cirka 74 procent,measured,withdrawn,2025-11-18,shown,https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Audit report"", ""value"": ""Inspektionen för socialförsäkringen (ISF). Kontrollutredningar vid misstänkta bidragsbrott: En granskning av Försäkringskassans och Pensionsmyndighetens arbete vid misstanke om ersättning på felaktiga grunder. ISF Rapport 2025:14, published 17 December 2025. Section 3.3, printed pp. 67-68, and Bilaga 1, Figur B4."", ""url"": ""https://isf.se/download/18.64c0dda619afce1ad7d1cbd5/1768374582621/Rapport%202025-14%20Kontrollutredningar%20vid%20misst%C3%A4nkta%20bidragsbrott.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Integritetsskyddsmyndigheten (IMY). Beslut efter tillsyn enligt dataskyddsförordningen – Försäkringskassan. IMY-2025-11828, 18 November 2025."", ""url"": ""https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf""}, {""label"": ""Follow-up"", ""value"": ""On 18 November 2025 Sweden's data protection authority recorded that Försäkringskassan had taken a machine-learning risk profile out of use and had no plans to use it again."", ""url"": ""https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf""}]","{""kind"": ""Withdrawals""}" AIBD-1095,2024-01-01,source publication,year,reported,Malaysia's MaHTAS finds moderate-quality evidence that Ethos adaptive radiotherapy improves tumor coverage,"In 10 observational studies, Malaysia's MaHTAS found moderate-quality evidence that Ethos adaptive radiotherapy improves tumor coverage in the short term. It found the same for the sparing of organs.",*Ethos* daily replanning improves tumor coverage in Malaysia's review,99.4% with the adapted plans and 86.7% with the scheduled plans,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,Ethos therapy (Varian Ethos online adaptive radiotherapy),,Varian Medical Systems (a Siemens Healthineers company),United States,"Several radiotherapy centers in the 10 studies that MaHTAS reviewed, among them University Hospital Essen, UT Southwestern Medical Center, Rigshospitalet and Medisch Spectrum Twente",Multiple,"Germany, the Netherlands, Denmark, the United States, Australia and China (studies that MaHTAS reviewed)",Germany | Netherlands | Denmark | United States | Australia | China,Healthcare,,Health,Health,Disease Prevention,Images and video; Planning and control,Patients,3,Upper middle income; High income,physical_health,,2,3,1,,3,5,,personal,1,,0,"The scheduled (non-adaptive) plans for the same fractions, in one study of 11 prostate cancer patients in the Netherlands",86.7% ± 6.2% coverage of the PTV60Gy with the scheduled plan,99.4% ± 0.5% with the adapted plan,measured,scaled,2026-06-10,shown,https://web.archive.org/web/20260121155710id_/https://www.moh.gov.my/index.php/database_stores/attach_download/347/421,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia. Ethos Therapy for Cancer Patient. Technology Review (Mini-HTA), Report No. 012/2024. 2024. Executive summary, results and conclusion on effectiveness. Archived copy of 21 January 2026."", ""url"": ""https://web.archive.org/web/20260121155710id_/https://www.moh.gov.my/index.php/database_stores/attach_download/347/421""}, {""label"": ""Assessment report"", ""value"": ""Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia. Ethos Therapy for Cancer Patient. Technology Review (Mini-HTA), Report No. 012/2024. 2024. Section 6.0, Conclusion. Archived copy of 21 January 2026."", ""url"": ""https://web.archive.org/web/20260121155710id_/https://www.moh.gov.my/index.php/database_stores/attach_download/347/421""}]","{""kind"": ""Official documents""}" AIBD-1172,2023-12-31,event,day,mixed,The World Bank's Independent Evaluation Group finds that Bihar's AI tool for roads records defects for repair but is no asset management system,The World Bank's evaluation office found that Bihar's AI-based tool lets the Rural Works Department log road conditions. The department can then rectify defects. The tool captures nothing else.,Bihar's AI tool records the condition of pilot roads,inspected 1000 km of roads in Vaishali district,,found,Found by an evaluation office,no comparison,very low,benefit created,false,Artificial intelligence based road condition monitoring and routine maintenance prioritization tool of the Bihar Rural Works Department (not named in the review),,Not named in the review (the tool was funded by the Government of Bihar),,"Rural Works Department, Government of Bihar",India,"Vaishali district, Bihar, India (pilot)",India,Transport infrastructure / rural road maintenance,,Energy and infrastructure,Transportation,Highways,,,9,Lower middle income,operational_improvement,"Faster data management, decision-making",2,1,,,2,,,organizational,2,,0,,,,,unknown,2024-11-13,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""World Bank Independent Evaluation Group. Implementation Completion Report (ICR) Review: BRRP, Bihar Rural Roads Project (P155522), ICRR0024193, 13 November 2024."", ""url"": ""https://documents.worldbank.org/curated/en/099111324152034071/pdf/P155522-2d4ce70c-53e5-48f1-b151-493c7ddceaa7.pdf""}]","{""kind"": ""Official documents""}" AIBD-1005,2023-09-15,source publication,day,reported,Traficom finds that Nelonen's subtitles for viewers with hearing loss meet the quality requirement once people check every AI-made subtitle,Traficom found in September 2023 that Nelonen's subtitles for viewers with hearing loss met the legal quality requirement once people checked every AI-made subtitle. They corrected them where needed.,Human-checked *AI subtitles* bring Nelonen up to Traficom's standard,,,found,Found by a regulator,tested against a standard,low,aggregate result,false,"AI-based subtitling for the deaf and hard of hearing on Nelonen, with every subtitle checked and corrected by people",,Not named by Traficom (Media Tailor says that it built Nelonen Media's AI subtitling platform with Amberscript),,Sanoma Media Finland Oy (Nelonen channel and Ruutu streaming service),Finland,Finland (Nelonen channel and Ruutu streaming service),Finland,Broadcasting / subtitles for deaf and hard-of-hearing viewers,,Accessibility,Technology,Broadcast,Speech and sound,People with disabilities,10,High income,accessibility,,2,,2,4,3,5,,personal,3,,0,"Nelonen's earlier subtitles, made mostly by the AI-based system without systematic human correction",Failed the requirement of sufficient clarity and ease of understanding (decision of 3 April 2023),"Quality ""now at a sufficient level""",measured,unknown,,shown,https://mediatailor.fi/customer-story/ai-subtitling-advancement-for-nelonen-media/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Finnish Transport and Communications Agency Traficom. The accessibility of media services is a part of equality - now the subtitles of the Nelonen TV channel also fulfil the quality requirements. News release, 15 September 2023."", ""url"": ""https://traficom.fi/en/news/accessibility-media-services-part-equality-now-subtitles-nelonen-tv-channel-also-fulfil-quality-requirements""}, {""label"": ""Regulatory document"", ""value"": ""Liikenne- ja viestintävirasto Traficom. Päätös tekstityspalvelun laadusta Nelonen-kanavalla [Decision on the quality of the subtitling service on the Nelonen channel], Dnro TRAFICOM/16725/11.03.02/2021, 3 April 2023."", ""url"": ""https://www.traficom.fi/sites/default/files/media/regulation/Liikenne-%20ja%20viestint%C3%A4viraston%20p%C3%A4%C3%A4t%C3%B6s%20tekstityspalvelun%20laadusta%20Nelonen-kanavalla.pdf""}]","{""kind"": ""Official documents""}" AIBD-1120,2023-08-01,event,month,reported,Santa Catarina's Court of Justice upheld police enforcement in 15 decisions on Atlantic Forest clearing first flagged by MapBiomas Alerta,Santa Catarina's Court of Justice upheld police enforcement in 15 decisions from 2023 to 2025 on Atlantic Forest clearing that MapBiomas alerts had flagged. None rejected the satellite evidence.,Santa Catarina court upholds 15 forest cases begun by *MapBiomas Alerta*,upheld police enforcement in 15 decisions,,found,Found by a court,no comparison,very low,protective response,false,"MapBiomas Alerta (the decisions call it 'MapBiomas', 'Mapa Biomas' or 'MapBiomas Alerta')",,"MapBiomas (MapBiomas Alerta), which compiles source alerts from other detection systems",Brazil,"Polícia Militar Ambiental de Santa Catarina (Santa Catarina's military environmental police), mostly in the yearly Operação Mata Atlântica em Pé with the Ministério Público de Santa Catarina",Brazil,"Santa Catarina, Brazil (rural properties in Canoinhas, Mafra, Rio Negrinho, Santa Cecília, Lebon Régis and other municipalities)",Brazil,Environmental enforcement: Atlantic Forest clearing,,Environment,Environment,Species & Forest,Images and video,Public servants,15; 16,Upper middle income,environmental_impact,Environmental impacts,2,1,,,3,,,organizational; societal,16,,0,,,,,persisted,2025-09-26,shown,https://alerta.mapbiomas.org/metodo,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5000081-75.2022.8.24.0056 (Santa Cecília), Rel. Des. Subst. Claudio Eduardo Regis de Figueiredo e Silva. Judgment of 29 July 2025. Appeal partly granted: convictions for destroying forest upheld, acquittal on a separate count of cutting hardwood and a lighter sentence."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321753815418910152321008163060&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 1ª Câmara Criminal. Apelação Criminal nº 5000347-03.2021.8.24.0087 (Lauro Müller), Rel. Des. Ariovaldo Rogério Ribeiro da Silva. Judgment of 3 August 2023. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321691427601607386599086295231&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 1ª Câmara de Direito Público. Apelação nº 5001061-23.2022.8.24.0088 (Lebon Régis), Rel. Des. Paulo Henrique Moritz Martins da Silva. Judgment of 22 August 2023. Civil public action. Appeal denied, which upheld a restoration order and R$37,000 in collective moral damages."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321692798014929422042753784286&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5001035-59.2021.8.24.0088 (Lebon Régis), Rel. Des. Ricardo Roesler. Judgment of 10 October 2023. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321697047065169078738324101391&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 4ª Câmara Criminal. Apelação Criminal nº 5002230-89.2022.8.24.0041 (Mafra), Rel. Des. Luiz Antônio Zanini Fornerolli. Judgment of 30 November 2023. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321701992833139316636978036377&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5003232-86.2021.8.24.0055 (Rio Negrinho), Rel. Des. Leopoldo Augusto Brüggemann. Judgment of 25 June 2024. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321719341019680717637033277454&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 2ª Câmara Criminal. Apelação Criminal nº 5002238-81.2021.8.24.0015 (Canoinhas), Rel. Des. Sérgio Rizelo. Judgment of 3 September 2024. Appeal partly granted: conviction upheld, minimum compensation removed and penalty reduced."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321725359065559533759130162021&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 4ª Câmara Criminal. Apelação Criminal nº 5000082-60.2022.8.24.0056 (Santa Cecília), Rel. Des. Alexandre d'Ivanenko. Judgment of 14 November 2024. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321732038079320300167751396358&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 4ª Câmara Criminal. Apelação Criminal nº 5004590-41.2023.8.24.0015 (Canoinhas), Rel. Des. Subst. Mauricio Cavallazzi Povoas. Judgment of 6 February 2025. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321738874366105144634199409167&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5003114-65.2023.8.24.0015 (Canoinhas), Rel. Des. Subst. Claudio Eduardo Regis de Figueiredo e Silva. Judgment of 25 March 2025. Prosecution's appeal partly granted: acquittal reversed and the defendant convicted."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321742950581851167001666370951&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 1ª Câmara Criminal. Apelação Criminal nº 5002168-94.2023.8.24.0047 (Papanduva), Rel. Des. Ana Lia Moura Lisboa Carneiro. Judgment of 24 April 2025. Prosecution's appeal granted: acquittal reversed and the defendant convicted."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321745597636862425119197842272&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5001660-94.2022.8.24.0141 (Presidente Getúlio), Rel. Des. Subst. Claudio Eduardo Regis de Figueiredo e Silva. Judgment of 27 May 2025. Appeal heard in part and denied, which upheld the conviction."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321748346135087232089407031036&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 3ª Câmara Criminal. Apelação Criminal nº 5001534-74.2023.8.24.0055 (Rio Negrinho), Rel. Des. Subst. Claudio Eduardo Regis de Figueiredo e Silva. Judgment of 22 July 2025. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321753211537819148067841934004&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 1ª Câmara Criminal. Apelação Criminal nº 5000316-04.2024.8.24.0143 (Rio do Campo), Rel. Des. Carlos Alberto Civinski. Judgment of 24 July 2025. Appeal denied and conviction upheld."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321753387270245405025990937639&tipo=acordao_eproc""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça de Santa Catarina (TJSC), 1ª Câmara de Direito Público. Agravo Interno em Apelação nº 5001089-98.2023.8.24.0041, Rel. Des. Jairo Fernandes Gonçalves. Judgment of 2 September 2025. Internal appeal denied, which upheld the refusal to annul the infraction notices."", ""url"": ""https://busca.tjsc.jus.br/jurisprudencia/integra.do?rowid=321757005613628867065412393771&tipo=acordao_eproc""}]","{""kind"": ""Official documents""}" AIBD-0852,2023-07-01,event,day,reported,Victoria's Road Safety Camera Commissioner finds that the AI in new roadside cameras can accurately identify offending,"As fines began, Victoria's Road Safety Camera Commissioner wrote on 3 July 2023 that the AI in new roadside cameras can accurately identify illegal phone use.",*Distracted Driving and Seatbelt* cameras pass a Victorian check,"Victoria Police issued 188,493 infringements",,found,Found by an auditor,no comparison,very low,aggregate result,false,Distracted Driving and Seatbelt road safety cameras with AI image recognition,,"Jenoptik Australia, the contractor that manages the AI (named by the Victorian Auditor-General, while the Commissioner names no vendor)",Australia,"Department of Justice and Community Safety (Victoria), with Victoria Police",Australia,"Victoria, Australia",Australia,Traffic enforcement (road safety),,Safety and rescue,Transportation,Highways,Images and video,Public servants,11,High income,physical_health,Crime reduction or prevention,2,,4,,3,,,organizational; societal,2,,0,,,,,persisted,2026-06-10,shown,https://www.audit.vic.gov.au/sites/default/files/2026-06/20260610_Reducing-the-Harm-Caused-by-Distracted-Drivers.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Road Safety Camera Commissioner (Victoria). Enforcement has begun for the new road safety cameras. News item, 3 July 2023 (archived copy of 18 July 2025)."", ""url"": ""https://web.archive.org/web/20250718140240/https://cameracommissioner.vic.gov.au/publications/enforcement-has-begun-new-road-safety-cameras""}, {""label"": ""Audit report"", ""value"": ""Victorian Auditor-General's Office. Reducing the Harm Caused by Distracted Drivers. Independent assurance report to Parliament 2025-26: 23, June 2026."", ""url"": ""https://www.audit.vic.gov.au/sites/default/files/2026-06/20260610_Reducing-the-Harm-Caused-by-Distracted-Drivers.pdf""}, {""label"": ""Audit report"", ""value"": ""Victorian Auditor-General's Office. Reducing the Harm Caused by Distracted Drivers. Independent assurance report to Parliament 2025-26: 23, June 2026."", ""url"": ""https://www.audit.vic.gov.au/sites/default/files/2026-06/20260610_Reducing-the-Harm-Caused-by-Distracted-Drivers.pdf""}, {""label"": ""Audit report"", ""value"": ""Victorian Auditor-General's Office. Reducing the Harm Caused by Distracted Drivers. Independent assurance report to Parliament 2025-26: 23, 10 June 2026, pp. 17-19."", ""url"": ""https://www.audit.vic.gov.au/sites/default/files/2026-06/20260610_Reducing-the-Harm-Caused-by-Distracted-Drivers.pdf""}, {""label"": ""Audit report"", ""value"": ""Victorian Auditor-General's Office. Reducing the Harm Caused by Distracted Drivers. Independent assurance report to Parliament 2025-26: 23, 10 June 2026, key finding 1."", ""url"": ""https://www.audit.vic.gov.au/sites/default/files/2026-06/20260610_Reducing-the-Harm-Caused-by-Distracted-Drivers.pdf""}]","{""kind"": ""Official documents""}" AIBD-1144,2023-06-05,event,day,mixed,"India's CAG finds that Kerala's AI traffic cameras detected offenses carrying ₹351.00 crore in fees, but only 28.69% had been collected","India's CAG found that Kerala's AI traffic cameras detected offenses that carried ₹351.00 crore in compounding fees. Of this, 28.69% had been collected, a sum of ₹100.70 crore.","Kerala's *AI cameras* flagged ₹351.00 crore in fees, 28.69% collected","₹100.70 crore, or 28.69%, had been collected",,found,Found by an auditor,no comparison,very low,aggregate result,false,AI cameras of the Safe Kerala Project (Advanced Automatic Traffic Enforcement System),,"KELTRON (Kerala State Electronics Development Corporation), the implementing agency. The report does not name the camera or software makers.",India,"Motor Vehicles Department, Government of Kerala",India,"Kerala, India",India,Road traffic enforcement,,Safety and rescue,Transportation,Highways,Images and video,,11,Lower middle income,physical_health; operational_improvement,Crime reduction or prevention,2,1,,,2,,,organizational; societal,1,,0,,,,,challenged,2026-04-21,not shown,https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2024/Audit-Report-2024_Full-Report-(1)-06a3a2fe6bab711.92275972.pdf,₹100.70 crore,"Compounding fees collected for offenses that the AI cameras detected, out of ₹351.00 crore collectable",False,[],Querist,The benefit was later disputed.,"[{""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Kerala, Report No. 2 of 2026 (Compliance Audit Report - Civil), countersigned on 5 May 2026. Chapter II, Subject Specific Compliance Audit on Functioning of RTOs and STA in Motor Vehicles Department of Kerala, paragraph 2.4.6.12, Shortfalls in the implementation of Camera Surveillance System. Table 2.24, report p. 58."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2024/Audit-Report-2024_Full-Report-(1)-06a3a2fe6bab711.92275972.pdf""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Kerala, Report No. 2 of 2026 (Compliance Audit Report - Civil), countersigned on 5 May 2026. Chapter II, Subject Specific Compliance Audit on Functioning of RTOs and STA in Motor Vehicles Department of Kerala, paragraph 2.4.6.12, Shortfalls in the implementation of Camera Surveillance System. Report p. 58. The auditors conclude that the uncollected penalties defeated the system's purpose."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2024/Audit-Report-2024_Full-Report-(1)-06a3a2fe6bab711.92275972.pdf""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on State Revenues for the period ended March 2024, Government of Kerala, Report No. 2 of 2026 (Compliance Audit Report - Civil), countersigned on 5 May 2026. Chapter II, Subject Specific Compliance Audit on Functioning of RTOs and STA in Motor Vehicles Department of Kerala, paragraph 2.4.6.12, Shortfalls in the implementation of Camera Surveillance System. Report p. 58. The auditors list concerns about the agreement, revenue collection and the cameras' effectiveness."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2024/Audit-Report-2024_Full-Report-(1)-06a3a2fe6bab711.92275972.pdf""}, {""label"": ""Follow-up"", ""value"": ""Kerala's Road Safety Authority froze ₹34.8 crore of payments to Keltron after Keltron gave no satisfactory explanation for alleged defects in the AI cameras of the Safe Kerala project."", ""url"": ""https://www.onmanorama.com/news/kerala/2026/04/21/road-safety-authority-keltron-payments-frozen-ai-camera-defects.html""}]","{""kind"": ""Challenges""}" AIBD-1137,2023-06-01,event,month,reported,Paraná's Court of Justice upheld police enforcement against Atlantic Forest clearing flagged by MapBiomas Alerta in 10 decisions from 2023 to 2026,"Paraná's Court of Justice upheld police enforcement in 10 decisions from 2023 to 2026 on Atlantic Forest clearing flagged by MapBiomas alerts, three by reversing acquittals.",Paraná court upholds 10 cases that police began with *MapBiomas Alerta*,upheld police enforcement in 10 decisions,,found,Found by a court,no comparison,very low,protective response,false,"MapBiomas Alerta (the decisions call it 'MapBiomas', 'Mapa Biomas', 'MAP BIOMAS' or 'Alerta Biomas')",,"MapBiomas (MapBiomas Alerta), which compiles source alerts from other detection systems",Brazil,"Polícia Militar Ambiental do Paraná (Batalhão de Polícia Ambiental Força Verde), Paraná's military environmental police, often in Operação Mata Atlântica em Pé with the Ministério Público do Paraná, which brought the cases",Brazil,"Paraná, Brazil (cases from Ortigueira, Londrina, Altônia, Prudentópolis, Rio Negro, Guarapuava, Laranjeiras do Sul, Piraí do Sul and Castro)",Brazil,Environmental enforcement: Atlantic Forest clearing,,Environment,Environment,Species & Forest,Images and video,Public servants,15; 16,Upper middle income,environmental_impact,Environmental impacts,2,1,,,3,4,,organizational; societal,15,,0,,,,,persisted,2026-09-04,shown,https://alerta.mapbiomas.org/metodo,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0001119-31.2022.8.16.0122 (Ortigueira), Rel. Des. Kennedy Josue Greca de Mattos. Judgment of 6 February 2025, published 7 February 2025. Appeal denied and conviction upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000030593331/Ac%C3%B3rd%C3%A3o-0001119-31.2022.8.16.0122""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Agravo de Instrumento nº 0096678-56.2023.8.16.0000 (Londrina), Rel. Juíza Subst. Luciani de Lourdes Tesseroli Maronezi. Judgment of 9 December 2024, published 10 December 2024. Interlocutory appeal denied: suspension of the notice and its R$119,000 fine was refused."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000026706161/Ac%C3%B3rd%C3%A3o-0096678-56.2023.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0000180-98.2025.8.16.0040 (Altônia), Rel. Des. José Mauricio Pinto de Almeida (majority). Judgment of 13 July 2026, published 20 July 2026. Prosecution's appeal granted by majority: the acquittal was reversed and the defendant convicted."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000037268841/Ac%C3%B3rd%C3%A3o-0000180-98.2025.8.16.0040""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Turma Recursal dos Juizados Especiais. Apelação Criminal nº 0003414-53.2023.8.16.0139 (Prudentópolis), Rel. Juíza Rafaela Zarpelon. Judgment of 31 May 2026, published 2 June 2026. Appeal denied and conviction upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/2100000034109171/Ac%C3%B3rd%C3%A3o-0003414-53.2023.8.16.0139""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0000539-89.2023.8.16.0146 (Rio Negro), Rel. Des. José Mauricio Pinto de Almeida. Judgment of 8 July 2024, published 9 July 2024. Appeal denied and convictions upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000028322001/Ac%C3%B3rd%C3%A3o-0000539-89.2023.8.16.0146""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 4ª Câmara Cível. Apelação Cível nº 0018802-29.2023.8.16.0031 (Guarapuava), Rel. Des. Clayton de Albuquerque Maranhão. Judgment of 14 April 2025. Appeal denied: the order to stop clearing and restore 29.71 ha was upheld."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000032165871/Ac%C3%B3rd%C3%A3o-0018802-29.2023.8.16.0031""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0001774-40.2020.8.16.0100 (Piraí do Sul), Rel. desig. Des. José Mauricio Pinto de Almeida (majority). Judgment of 26 June 2023, published 6 July 2023. Prosecution's appeal granted by majority: the acquittal was reversed and the defendant convicted."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000024614021/Ac%C3%B3rd%C3%A3o-0001774-40.2020.8.16.0100""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0081926-13.2018.8.16.0014 (Londrina), Rel. Des. Joscelito Giovani Cé (majority). Judgment of 12 May 2025, published 14 May 2025. Prosecution's appeal partly granted by majority: three defendants were convicted and the acquittal of two machine operators was kept."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000028724831/Ac%C3%B3rd%C3%A3o-0081926-13.2018.8.16.0014""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Agravo de Instrumento nº 0016411-63.2024.8.16.0000 (Laranjeiras do Sul), Rel. Juiz Subst. Anderson Ricardo Fogaça. Judgment of 28 October 2024, published 29 October 2024. Interlocutory appeal partly granted: the injunction against further damage was kept and the order to file a recovery plan suspended."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000027872131/Ac%C3%B3rd%C3%A3o-0016411-63.2024.8.16.0000""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 5ª Câmara Cível. Apelação Cível nº 0002442-80.2024.8.16.0064 (Castro), Rel. Des. Ramon de Medeiros Nogueira. Judgment of 17 August 2026. Appeal partly granted: the duty to repair was upheld and collective moral damages were removed."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000037442851/Ac%C3%B3rd%C3%A3o-0002442-80.2024.8.16.0064""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0002174-15.2021.8.16.0134 (Pinhão), Rel. Des. Mario Helton Jorge. Judgment of 14 April 2025. Appeal partly granted: the conviction for destroying Atlantic Forest was upheld, the defendant was acquitted on a separate forest charge and the case was sent back for a possible conditional suspension of proceedings. Kept as context: the inspection took place in September 2018, before the period that MapBiomas Alerta covers, which begins with clearing detected in 2019. The officer quoted described the police's general practice and did not recall the case."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/j/4100000031132761/Ac%C3%B3rd%C3%A3o-0002174-15.2021.8.16.0134""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0000180-98.2025.8.16.0040 (Altônia). Dissenting vote (declaração de voto divergente) of Des. Priscilla Placha Sá, 10 July 2026, filed with the judgment of 13 July 2026. She would have kept the acquittal because no forensic exam proved the vegetation's stage of regeneration."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/publico/visualizacao.do?tjpr.url.crypto=8a6c53f8698c7ff76db3047d195cb6a566563aad3816aa8636f005ac05bd8b218a221c700814ffe29e381fe9289bbfc9f17ed36f42105924691e0db26d2d9c3355e6ef4bb2df61f1f392019ab13a9acd5f0b84445df730318a236d19a26b207d4bc58b6185a66ccd0723778b8f5eb79a18c0350ed3eef569f3d71c13ff804417c155f772c191441d7db8b67f77aff75350c92759af5a65ed84b8a9cf74c450a9922feb35e157568c80ad84f8e3aa2f70aa371aabadae4f25""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0081926-13.2018.8.16.0014 (Londrina). Dissenting vote (declaração de voto vencido) of Des. Mário Helton Jorge, 9 May 2025, filed with the judgment of 12 May 2025. He would have kept the acquittals for want of proof of authorship and of a forensic report."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/publico/visualizacao.do?tjpr.url.crypto=8a6c53f8698c7ff76db3047d195cb6a566563aad3816aa8636f005ac05bd8b218a221c700814ffe2cdd5eff7365b09a2f4ab9391aee8ef09f7c6f38ff2f26574d97851ccf9902d89fed887aa85e4520a3874448d7501485680c78fdb5f0820b2c66e9e391692ae4b34a044395dfb365a93fcf0f96a42184e32503c0f1e0b68c6279ca8bfb9985fa24b6887d38dada5810df3e5bddb1926aebd3796771779f37c80baf2aec13612ff48a640681ced96e65117e94c8fa92850""}, {""label"": ""Court document"", ""value"": ""Tribunal de Justiça do Estado do Paraná (TJPR), 2ª Câmara Criminal. Apelação Criminal nº 0001774-40.2020.8.16.0100 (Piraí do Sul). Dissenting vote (declaração de voto vencido) of Des. Priscilla Placha Sá, 23 June 2023, filed with the judgment of 26 June 2023. She would have kept the acquittal for want of an environmental forensic exam."", ""url"": ""https://portal.tjpr.jus.br/jurisprudencia/publico/visualizacao.do?tjpr.url.crypto=8a6c53f8698c7ff76db3047d195cb6a566563aad3816aa8636f005ac05bd8b218a221c700814ffe24983a26e730c28bb8a72b5ec8995ef14f7c6f38ff2f265740583d6396171599d7fda321b2fee2c9e81724860ac8cde8b91c1ff596fd01576c66e9e391692ae4b148f8dfc0a0230e36c477331adb587971efd1ab6b9f4ebea279ca8bfb9985fa24b6887d38dada5810df3e5bddb1926aebd3796771779f37c80baf2aec13612ff48a640681ced96e65117e94c8fa92850""}]","{""kind"": ""Official documents""}" AIBD-0866,2023-05-01,event,month,mixed,"India's Comptroller and Auditor General finds that ANPR cameras raised Uttarakhand's traffic challans, though only 3.8% of detections were forwarded","India's CAG found that ANPR cameras at Uttarakhand's borders raised traffic challans, with 90,516 challans by March 2024. In September 2024 only 3.8% of detected violations were forwarded.","*ANPR cameras* raised Uttarakhand's challans, but few cases went forward","90,516 challans by March 2024",,found,Found by an auditor,before and after,very low,aggregate result,false,Automatic Number Plate Recognition (ANPR) camera system with ITMS software,,Not named in the report,,"Transport Department, Government of Uttarakhand (Transport Commissioner's control room)",India,"Uttarakhand, India (border entry points)",India,Road traffic enforcement,,Safety and rescue,Transportation,Highways,Images and video,Public servants,11,Lower middle income,physical_health,Crime reduction or prevention,2,1,3,,2,5,,organizational; societal,1,,0,Challans issued in the years before the cameras,,"90,516 challans issued through the cameras by March 2024",measured,unknown,,not shown,https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2025/Report-No.-8-of-2025_PA-on-RTO_UK_English_23-12-2025-signed-069b034a052dc00.75012488.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on Functioning of Regional Transport Offices, Government of Uttarakhand, Report No. 8 of 2025. Executive summary, section D, and paragraph 5.8, Challan through ANPR cameras, pp. 42-43. The auditors analyzed e-challan data from the Transport Commissioner."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2025/Report-No.-8-of-2025_PA-on-RTO_UK_English_23-12-2025-signed-069b034a052dc00.75012488.pdf""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India. Report on Functioning of Regional Transport Offices, Government of Uttarakhand, Report No. 8 of 2025. Executive summary, section D. The auditors found that the low forwarding rate defeats the purpose of the cameras."", ""url"": ""https://d1jmc0u14z2tmp.cloudfront.net/uploads/download_audit_report/2025/Report-No.-8-of-2025_PA-on-RTO_UK_English_23-12-2025-signed-069b034a052dc00.75012488.pdf""}]","{""kind"": ""Official documents""}" AIBD-0859,2023-02-25,event,day,reported,"EU, Commonwealth and IRI/NDI observers find that BVAS facial recognition accredited Nigeria's 2023 voters where fingerprints failed, often faster",Three observer missions found that BVAS facial recognition accredited voters where fingerprints failed in Nigeria's 2023 elections. Two saw it work faster. The EU mission saw fewer rejections.,*BVAS* face matching accredited Nigerian voters when fingerprints failed,,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Bimodal Voter Accreditation System (BVAS), facial recognition function",,"Independent National Electoral Commission (INEC), an in-house design according to the EU mission (the supplier of the face-matching software is not named)",Nigeria,"Independent National Electoral Commission (INEC), Nigeria",Nigeria,Nigeria (polling units nationwide),Nigeria,Elections,,Public sector,Civil Rights,Voting Rights,Images and video,The public,16,Lower middle income,social_improvement; operational_improvement,"Faster data management, decision-making",2,,2,,3,2,,personal; organizational,3,,0,Fingerprint accreditation on the same BVAS devices,Widespread failure of fingerprint scanning (Commonwealth group),Much faster and better results with facial recognition,measured,challenged,2026-09-18,not shown,https://www.ndi.org/sites/default/files/IRI_NDI%20Final%20Report_2023%20Nigeria%20IEOM.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Assessment report"", ""value"": ""European Union Election Observation Mission Nigeria 2023. Final Report: General Elections 25 February and 18 March 2023, section VII (Election technology), b. Implementation, pp. 19-20. Presented 27 June 2023. The mission states that it is independent in its findings and conclusions. It reports its own observers' findings, and it calls BVAS an INEC in-house development."", ""url"": ""https://www.eeas.europa.eu/sites/default/files/documents/2023/EU%20EOM%20NGA%202023%20FR.pdf""}, {""label"": ""Assessment report"", ""value"": ""Commonwealth Secretariat. Nigeria Presidential and National Assembly Elections, 25 February 2023: Report of the Commonwealth Observer Group, chaired by Thabo Mbeki. Chapter 3, Legal Framework and Electoral Administration, p. 25. Letter of transmittal dated 16 February 2024. The Commonwealth Secretary-General constituted the group, which reports its own observers' findings and has no role in BVAS."", ""url"": ""https://comsec-web-static.s3.eu-west-1.amazonaws.com/s3fs-public/2024-03/nigeria-presidential-and-national-assembly-elections_updf.pdf""}, {""label"": ""Assessment report"", ""value"": ""International Republican Institute and National Democratic Institute. IRI/NDI International Election Observation Mission to Nigeria: Final Report of the 2023 General Election, 2023. Executive summary and the section on the presidential and National Assembly election day. A joint mission of two US democracy institutes, with a 40-member delegation that observed in 20 states on 25 February 2023."", ""url"": ""https://www.ndi.org/sites/default/files/IRI_NDI%20Final%20Report_2023%20Nigeria%20IEOM.pdf""}, {""label"": ""Follow-up"", ""value"": ""A September 2026 article reports that after the June 2026 Ekiti election, civil-society observers urged INEC to give elderly voters whom BVAS could not recognize an alternative verification route."", ""url"": ""https://techpolicy.press/when-nigerias-election-technology-cannot-recognize-the-voter""}]","{""kind"": ""Challenges""}" AIBD-0335,2023-01-01,event,year,mixed,"France's tax administration reports that its Foncier innovant tool found 140,000 taxable swimming pools in 2023, but one section of its report gives more than 120,000","Foncier innovant, a tool of France's tax administration, found 140,000 taxable pools in 2023 in aerial photographs. The administration values them at €40 million in local tax.","Foncier innovant finds 140,000 undeclared pools in French aerial photos","140,000 taxable pools in 2023",,found,Found by an auditor,no comparison,very low,aggregate result,false,"Foncier innovant (DGFiP deep-learning detection of pools and buildings on IGN aerial photographs, built with Capgemini and Google)",,Direction générale des Finances publiques (DGFiP) with Capgemini and Google,France,"Direction générale des Finances publiques (DGFiP), ministère de l'Économie et des Finances",France,France (national; Dordogne example),France,Public finance: property-tax base and anti-fraud,Tax administration,Finance,Government Operations,Tax Administration,Images and video,Public servants,16,High income,privacy_protection; operational_improvement,Fraud detection,2,,4,,4,,,personal; organizational; societal,10,,3,a surveyor noticing a new pool in a neighborhood by eye and checking the cadastre,le géomètre qui remarquait une nouvelle piscine dans un quartier et devait vérifier dans le cadastre si elle était déclarée ou pas,"Dans toute la France, 140.000 piscines clandestines ont été repérées, ce qui va rapporter 40 millions d'euros.",assumed,scaled,2026-04-14,shown,https://www.senat.fr/rap/r23-491/r23-4911.pdf,40 millions d’euros,"additional property tax (taxe foncière) to be collected on the 140,000 detected pools",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes, première chambre. L'intelligence artificielle dans les politiques publiques : l'exemple du ministère de l'Économie et des Finances, observations définitives S2024-1165, deliberated 18 July 2024, published 22 October 2024. The national audit office has no stake in the tool. It reports the pool counts and the revenue of the 2022 pilot from DGFiP data. It states that the €40 million for 2023 is the DGFiP's own estimate."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}, {""label"": ""Audit report"", ""value"": ""Cour des comptes. Mieux suivre et valoriser les gains de productivité de l’État issus du numérique. Observations définitives S2024-1570, 21 January 2025, printed p. 60. The audit court calls the benefits telling while finding that the tax administration's projections are unsupported."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2025-01/20250121-S2024-1570_Mieux-suivre-et-valoriser-les-gains-de-productivite-de-lEtat-issus-du-num--rique_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0690,2023-01-01,event,year,reported,Cour des comptes finds that the DGFiP's TAAP software let accountants check 31.9% fewer payment requests while finding more errors,"The Cour des comptes found that the DGFiP's TAAP software let accountants check 31.9% fewer payment requests, while errors found on AI-analyzed requests rose from 1.65% to 8.53%.",*TAAP* points French state accountants to risky payment requests,let accountants check 31.9% fewer payment requests,,found,Found by an auditor,before and after,very low,aggregate result,false,Traitement automatisé de l'analyse prédictive (TAAP),,Direction générale des Finances publiques (DGFiP),France,DGFiP public accountants who control state spending,France,France (national),France,Public finance (control of state payments),,Finance,Government Operations,Bureaucracy,Prediction from data,Public servants,16,High income,operational_improvement,Enhanced productivity,2,1,4,,3,5,,organizational,1,,0,Errors found in the year before TAAP,"1,65 %","8,53 %",measured,unknown,,shown,https://www.ccomptes.fr/sites/default/files/2025-01/20250121-S2024-1570_Mieux-suivre-et-valoriser-les-gains-de-productivite-de-lEtat-issus-du-num--rique_0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. Mieux suivre et valoriser les gains de productivité de l’État issus du numérique. Observations définitives S2024-1570, adopted 5 December 2024 and published 21 January 2025, pp. 60-61."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2025-01/20250121-S2024-1570_Mieux-suivre-et-valoriser-les-gains-de-productivite-de-lEtat-issus-du-num--rique_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0642,2022-12-07,event,day,reported,"MASAI randomized trial in southwest Sweden: Transpara-supported mammography screening finds more cancers with less screen reading, at a non-inferior interval cancer rate","In the MASAI trial of 105,934 women, Transpara-supported screening found 6.4 cancers per 1,000 against 5.0 with standard double reading. It cut screen reading by 44.2%.",*Transpara* helps Swedish breast screening find more cancers,"a detection rate of 6.4 per 1,000 against 5.0 per 1,000","Lund University researchers ran the MASAI trial within the Swedish national screening program. Between 12 April 2021 and 7 December 2022, they randomly assigned 105,934 women in southwest Sweden to Transpara-supported screening or to a control group. In the control group, two radiologists without AI did standard double reading. The AI group had 6.4 screen-detected cancers per 1,000 women against 5.0 in the control group. It needed 44.2% fewer screen readings.[1] Results for the primary outcome, the rate of interval cancers, appeared in The Lancet in 2026. The rate was 1.55 per 1,000 with AI and 1.76 per 1,000 without. That result met the trial's non-inferiority margin. The difference was not statistically significant.[2] The trial tested one product in one region. Its design does not separate the effect of the triage by risk score from that of the marks on suspicious areas.[3]",found,Found by an assessment body,randomized trial,high,aggregate result,false,Transpara,1.7.0,ScreenPoint Medical,Netherlands,"Unilabs Mammography Unit at Skåne University Hospital with Lund University (MASAI trial, Swedish national screening program)",Sweden,"Malmö, Lund, Landskrona and Trelleborg, Skåne, Sweden",Sweden,Healthcare,,Health,Health,Disease Prevention,Images and video,Women and mothers; Health workers,3,High income,physical_health; operational_improvement,Medical diagnosis,2,4,4,3,5,2,0.455,personal; organizational,9,,3,Standard double reading by two radiologists without AI,"5.0 screen-detected cancers per 1,000 women","6.4 screen-detected cancers per 1,000 women",measured,unknown,,shown,https://radboudumc.nl/en/partners/spin-off-companies/screenpoint-medical/about-screenpoint-medical,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""OSTEBA, Servicio de Evaluación de Tecnologías Sanitarias del País Vasco, for the Red Española de Agencias de Evaluación de Tecnologías Sanitarias (RedETS) and the Ministerio de Sanidad. Inteligencia artificial en el programa de cribado de cáncer de mama (Informes de Evaluación de Tecnologías Sanitarias, OSTEBA). III.2.7 (p. 124) and III.5 Conclusiones (p. 136)"", ""url"": ""https://euskadi.eus/contenidos/informacion/osteba_publicacion/eu_def/adjuntos/E-24-09-Inteligencia-Artificial-cancer-mama.pdf""}, {""label"": ""Assessment report"", ""value"": ""HTA syd (Region Skåne, Södra sjukvårdsregionen), with an expert group that included the MASAI trial's principal investigator (2024). Artificiell intelligens vid bröstcancerscreening med mammografi (HTA syd Rapport 2024:1), Sammanfattning (p. 6); Tabell 3, included studies (mostly Transpara, also Lunit INSIGHT MMG)."", ""url"": ""https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2024/hta-syd-rapport-ai-brostcancerscreening.pdf""}]","{""kind"": ""Official documents""}" AIBD-0067,2022-12-06,event,day,reported,An AI eye exam increased screening among young people with diabetes,"In the ACCESS trial, all 81 young people offered IDx-DR completed an eye exam, compared with 18 of 82 controls referred to an eye-care provider.",An AI eye exam increased screening among young people with diabetes,"all 81 young people offered IDx-DR completed an eye exam, compared with 18 of 82 controls",,found,Found by an assessment body,randomized trial,high,aggregate result,false,IDx-DR (now LumineticsCore),,Digital Diagnostics,United States,Johns Hopkins Pediatric Diabetes Center,United States,"Baltimore, United States",United States,Healthcare - diabetic retinopathy screening,Autonomous AI screening in pediatric diabetes care,Health,Health,Disease Prevention,Images and video,Children; Patients,3,High income,physical_health,Medical access,2,2,1,3,4,1,0.200,personal,4,,1,control arm given scripted referral and education with a paper handout,"22%, 95%CI: 14.2%, 32.4%","100%, 95%CI: 95.5%, 100%",measured,persisted,2025-02-14,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC6550188/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""American Diabetes Association (ADA) Professional Practice Committee (2026). 14. Children and Adolescents: Standards of Care in Diabetes-2026 (Diabetes Care 2026;49 Suppl 1), Retinopathy subsection (citing reference 219, the ACCESS randomized trial)."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC12690182/""}]","{""kind"": ""Official documents""}" AIBD-1177,2022-12-01,event,month,reported,ADB's Independent Evaluation Department finds that two AI chatbots brought calls from new survivors of domestic violence in Mongolia,"ADB's Independent Evaluation Department validated in July 2024 that two AI chatbots in Mongolia brought calls from new users. It found that 90% of chatbot users, survivors of violence, were satisfied.",*NCAV and NLI chatbots* bring calls from new survivors in Mongolia,"90% of chatbot users, survivors of violence, were satisfied",,found,Found by an evaluation office,no comparison,very low,aggregate result,false,NCAV and NLI domestic violence chatbots (AI-powered chatbot service on Facebook with mobile texting),,Anduub Lab LLC,Mongolia,"National Center Against Violence and National Legal Institute, Mongolia, under the Ministry of Justice and Home Affairs",Mongolia,Mongolia,Mongolia,Social services,,Social care,Law and Crime,Family Issues,Text and language,Women and mothers; Children,5; 16,Upper middle income,physical_health; opportunity_access,Crime reduction or prevention,2,3,4,4,3,,,personal; organizational,2,,0,The technical assistance's outcome target for chatbot user satisfaction,At least 80% of chatbot users satisfied (target),90% of chatbot users satisfied,measured,persisted,2024-07-01,not shown,https://www.adb.org/sites/default/files/Evaluation%20Document/978856/files/tcrv-6530.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Asian Development Bank, Independent Evaluation Department. Mongolia: Addressing and Preventing Domestic Violence in Mongolia during the COVID-19 Crisis. Technical Assistance Completion Report Validation Report TCRV-2023-085 (TA 6530, Project 54209-001). Manila, July 2024. Section 2, Evidence of Outcomes Achieved. The validators relay the chatbot statistics from the completion report and the project's impact assessment, so on those figures the document is a descriptive report."", ""url"": ""https://www.adb.org/sites/default/files/Evaluation%20Document/978856/files/tcrv-6530.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Asian Development Bank, Independent Evaluation Department. Mongolia: Addressing and Preventing Domestic Violence in Mongolia during the COVID-19 Crisis. Technical Assistance Completion Report Validation Report TCRV-2023-085 (TA 6530, Project 54209-001). Manila, July 2024. Section 4, Sustainability, IED rationale."", ""url"": ""https://www.adb.org/sites/default/files/Evaluation%20Document/978856/files/tcrv-6530.pdf""}]","{""kind"": ""Official documents""}" AIBD-0643,2022-06-09,event,day,reported,"ScreenTrustCAD at Capio Sankt Göran Hospital, Stockholm: Lunit Insight MMG as a third reader leads to 19 more screen-detected breast cancers than two radiologists","In Stockholm, Lunit's Insight MMG read 55,581 mammograms beside two radiologists, and the three together found 269 cancers against 250 by the radiologists alone.",*Insight MMG* as a third reader finds more breast cancers in Stockholm,the three together found 269 cancers against 250 by the radiologists alone,"The ScreenTrustCAD study measured what an AI reader adds where breast screening already uses two radiologists.[1] Karolinska Institutet researchers ran it at Capio Sankt Göran Hospital in Stockholm. From 1 April 2021 to 9 June 2022, Lunit's Insight MMG ran in the background on the screening mammograms of 55,581 women. Two radiologists alone would have found 250 cancers. With the AI as a third reader, 269 were found. In the paired design, two radiologists and the AI read the examinations independently. The 19 extra cancers therefore came from examinations that only the AI flagged.[2] The researchers also found that one radiologist with AI was non-inferior to two radiologists, with 261 cancers against 250. The study ran at one hospital with one mammography vendor. Lunit was among its funders.[3]",found,Found by an assessment body,controlled comparison,low,aggregate result,false,Lunit INSIGHT MMG,1.1.6,Lunit,South Korea,Capio Sankt Göran Hospital with Karolinska Institutet (ScreenTrustCAD study),Sweden,"Stockholm, Sweden",Sweden,Healthcare,,Health,Health,Disease Prevention,Images and video,Women and mothers,3,High income,physical_health,Medical diagnosis,2,4,4,3,5,2,0.455,personal,5,,2,Standard double reading by two radiologists,250 screen-detected cancers,269 screen-detected cancers with AI as a third reader,measured,persisted,2023-09-09,shown,https://pubmed.ncbi.nlm.nih.gov/33334578/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""HTA syd. Artificiell intelligens vid bröstcancerscreening med mammografi [Artificial intelligence in breast cancer screening with mammography]. HTA syd Rapport 2024:1. Lund: Region Skåne, published 5 June 2024. ISBN 978-91-989049-0-1. Summary of conclusions, tables 3, 5 and 6 (ScreenTrustCAD, Dembrower 2023) and section 10 (Diskussion). The assessment pools several AI products and does not single out Lunit as a third reader."", ""url"": ""https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2024/hta-syd-rapport-ai-brostcancerscreening.pdf""}]","{""kind"": ""Official documents""}" AIBD-0084,2022-01-01,event,year,reported,"DGFiP's “Foncier innovant” uses deep learning to detect undeclared swimming pools: 20,000+ pools taxed for 2022, about €10 million for communes","The DGFiP's Foncier innovant tool finds pools in aerial images with deep learning. It led to more than 20,000 pools being taxed for 2022, close to €10 million for communes.","DGFiP's Foncier innovant leads to 20,000+ pools taxed for 2022","more than 20,000 pools being taxed for 2022, close to €10 million of extra revenue",,found,Found by an auditor,no comparison,very low,aggregate result,false,Foncier innovant (DGFiP): open-source deep-learning segmentation of IGN orthophotos cross-checked with cadastral and tax files,,DGFiP (Délégation à la transformation numérique) with Capgemini (assistance à maîtrise d'ouvrage et maîtrise d'œuvre) and Google (cloud infrastructure and AI-model development services),France,Direction générale des Finances publiques (DGFiP),France,France (nine pilot departments in 2022),France,Tax administration: local property tax base,Cadastre and land-tax services,Public sector,Government Operations,Tax Administration,Images and video,Public servants,16,High income,privacy_protection; operational_improvement,Fraud detection,2,,,,4,2,,personal; organizational; societal,7,,2,"the land-tax rolls before the experiment, which rest on owners' own declarations",the pools were not declared and not taxed,"20,000 undeclared pools identified and 10 million euros collected for the communes concerned, according to the tax administration",measured,scaled,2024-04-02,shown,https://www.senat.fr/rap/r23-491/r23-4911.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes, La détection de la fraude fiscale des particuliers, public report, 15 November 2023, pp. 39–40, 59 and 64. France's audit office has no stake in the project. It restates the 2022 results with attribution to the tax administration and puts the cost at 25.9 million euros over three years. It criticizes the absence of deployment in Corsica and overseas. It judges that the main practical effect of the scheme is to demonstrate the detection capacity of the DGFiP."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2023-11/20231115-Detection-fraude-fiscale-des-particuliers.pdf""}, {""label"": ""Audit report"", ""value"": ""Cour des comptes. L’intelligence artificielle dans les politiques publiques : l’exemple du ministère de l’économie et des finances. Observations définitives S2024-1165, 22 October 2024, p. 40. The audit court credits the gain to the system's processing capacity and notes its many false positives."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}]","{""kind"": ""Official documents""}" AIBD-0705,2022-01-01,event,year,reported,Mexico's Superior Audit Office finds that an AI service built on Eviden's AIsaac reduced risk events at CFE in 2022,Mexico's Superior Audit Office checked reports from CFE's AIsaac-based security service. It found that AI correlation of events reduced risk events in 2022. It gave no count.,Mexican auditors find fewer cyber risk events at CFE with *AIsaac*,,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Solución Avanzada de Detección de Amenazas y Respuesta por Inteligencia Artificial, Managed Detection and Response (MDR), delivered with Eviden's AIsaac tool",,"Eviden (Atos Group), maker of AIsaac. The service is supplied under contract 800961753 by Teliko Solutions, S.A.P.I. de C.V. and Grupo Vanguardia en Información y Conocimiento, S.A. de C.V.",France,"Comisión Federal de Electricidad (CFE), corporate office, with its subsidiaries and affiliates",Mexico,Mexico,Mexico,Cybersecurity,,Safety and rescue,Technology,Computers,Prediction from data,,9,Upper middle income,privacy_protection,Sensitive data management,2,1,4,,3,5,,organizational,1,,0,,,,,unknown,,shown,https://www.asf.gob.mx/Trans/Informes/IR2022b/Documentos/Auditorias/2022_0040_a.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Auditoría Superior de la Federación. Informe Individual del Resultado de la Fiscalización Superior de la Cuenta Pública 2022. CFE Corporativo, Auditoría de Cumplimiento a Tecnologías de Información y Comunicaciones 2022-6-90UJB-20-0040-2023 (Auditoría núm. 40), Resultado 5. Opinion issued 13 October 2023."", ""url"": ""https://www.asf.gob.mx/Trans/Informes/IR2022b/Documentos/Auditorias/2022_0040_a.pdf""}]","{""kind"": ""Official documents""}" AIBD-0916,2022-01-01,event,year,reported,Rekenkamer Rotterdam finds that the share of parked cars that paid rose from about 50% to 90% in 2022 after the city's plate-reading scan cars came into use,The Rekenkamer Rotterdam found that the share of parked cars that paid rose from around 50% to 90% in 2022 after the city began checking with plate-reading scan cars.,*Parkeercontrole* scan cars lift Rotterdam's rate of paid parking to 90%,from around 50% to 90% in 2022,,found,Found by an auditor,before and after,very low,aggregate result,false,Parkeercontrole: scan cars (scanauto's) with an Arvoo image-recognition algorithm for license plates and the municipal ISA application,,"Arvoo (cameras and image-recognition software) with the Gemeente Rotterdam (ISA application, built by its ESO team at BCO)",Netherlands,"Gemeente Rotterdam, Stadsbeheer cluster, Parkeervoorzieningen department, Fiscale Handhaving team",Netherlands,"Rotterdam, Netherlands",Netherlands,Municipal parking enforcement,,Public sector,Transportation,Other,Images and video,Public servants,11,High income,operational_improvement,Enhanced productivity,2,1,4,,3,,,organizational,2,,0,The payment rate before the scan cars came into use,rond de 50%,90% in 2022,measured,persisted,2026-02-20,shown,https://rekenkamer.rotterdam.nl/docs/onderzoeken/RO2205-kleur-bekennen-vervolgonderzoek-algoritmes-rekenkamer-rotterdam-casus-bijlagen.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Rekenkamer Rotterdam. Kleur bekennen: vervolgonderzoek algoritmes. Bijlage casusbevindingen, bevindingen casus parkeercontrole, §3-1 sturing en verantwoording and §3-2 model (PDF pp. 20-24). Published 13 May 2024."", ""url"": ""https://rekenkamer.rotterdam.nl/docs/onderzoeken/RO2205-kleur-bekennen-vervolgonderzoek-algoritmes-rekenkamer-rotterdam-casus-bijlagen.pdf""}]","{""kind"": ""Official documents""}" AIBD-0917,2022-01-01,event,year,reported,Netherlands Court of Audit finds that UWV's risk scan flagged files that held three times as much culpable unemployment as random files,The Netherlands Court of Audit found that UWV caseworkers find three times as much culpable unemployment in files flagged by the agency's risk scan as in a random sample.,*Risicoscan Verwijtbare Werkloosheid* triples the hit rate of UWV checks,17% of flagged files against 5.5% of random files,,found,Found by an auditor,controlled comparison,low,aggregate result,false,Risicoscan Verwijtbare Werkloosheid (risk scan for culpable unemployment),,UWV (Uitvoeringsinstituut Werknemersverzekeringen),Netherlands,"UWV, for unemployment benefit (WW) applications",Netherlands,Netherlands (national),Netherlands,Social security (unemployment benefit control),,Safety and rescue,Labor,Employee Benefits,Prediction from data,Public servants,16,High income,operational_improvement; privacy_protection,Enhanced productivity,2,1,4,,3,5,,organizational; personal,2,,0,Unemployment benefit applications drawn at random and handled blind by the same caseworkers,"In 5,5% van de dossiers is verwijtbare werkloosheid gevonden door behandelaren",In 17% van de dossiers is verwijtbare werkloosheid gevonden door behandelaren,measured,persisted,2026-10-14,not shown,https://www.uwv.nl/nl/over-uwv/algoritmeregister-uwv/risicoscan-verwijtbare-werkloosheid,tussen de €29 en €44 miljoen per jaar,"Potential yearly benefits of working with the risk scan, by UWV's estimate",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Algemene Rekenkamer. Resultaten verantwoordingsonderzoek 2024 ministerie van Sociale Zaken en Werkgelegenheid (XV), Rapport bij het Jaarverslag 2024, §5.1 Algoritme Risicoscan Verwijtbare Werkloosheid bij UWV, pp. 56-59, Figuur 8. Published 21 May 2025."", ""url"": ""https://www.rekenkamer.nl/site/binaries/site-content/collections/documents/2025/05/21/vo-2024-szw/XV+SZW+WR.pdf""}]","{""kind"": ""Official documents""}" AIBD-0918,2022-01-01,event,year,mixed,Brazil's Federal Court of Accounts finds that the FNDE's Malha Fina triage approved 27% of school-meal accounts but left the backlog unresolved,"Brazil's Federal Court of Accounts found that the FNDE's Malha Fina triage approved 11,931 school-meal accounts, 27% of those filed. Staff had concluded the analysis of only 3.6%.",*Malha Fina* clears 27% of school-meal accounts at Brazil's FNDE,"11,931 school-meal reports approved, 27% of the 44,386 filed",,found,Found by an auditor,no comparison,very low,aggregate result,false,"Malha Fina FNDE: an ABC value curve, rule-based audit trails and a supervised machine-learning Modelo Preditivo",,"Fundo Nacional de Desenvolvimento da Educação (FNDE), with information, data and technology exchanged with the Controladoria-Geral da União (CGU) under cooperation agreement FNDE-CGU 19/2020",Brazil,"Fundo Nacional de Desenvolvimento da Educação (FNDE), Diretoria Financeira (Difin)",Brazil,Brazil (national),Brazil,Public administration: education grant accountability review,,Public sector,Government Operations,Bureaucracy,Prediction from data,Public servants,16,Upper middle income,operational_improvement,"Faster data management, decision-making",2,1,1,,2,1,,organizational,2,,0,School-meal accountability reports on which FNDE staff had concluded analysis by March 2023,"3,6% (1.369 contas) estavam com análise concluída",27% (11.931 contas) foram homologadas pelo Malha Fina,measured,unknown,,shown,https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=852835,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 743/2025 – TCU – Plenário (TC 020.760/2022-1), relator Ministro Walton Alencar Rodrigues, session of 2 April 2025. Operational audit of the FNDE's internal controls on the financial management of the Programa Nacional de Alimentação Escolar (PNAE), Relatório paragraphs 128-140 and Tabela 1."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=852835""}]","{""kind"": ""Official documents""}" AIBD-1004,2022-01-01,event,year,reported,The Korea Communications Commission finds that the three mobile carriers' intelligent spam filters blocked 97.7% of spam texts in its tests in late 2022,"In tests by Korea's regulator, the three mobile carriers' free intelligent spam filters blocked 97.7% of illegal spam texts in the second half of 2022, up from 89.5% in late 2019.",Korean carriers' *intelligent spam blocking* stops 97.7% of spam tested,blocked 97.7% of illegal spam texts,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"Intelligent spam blocking services (지능형 스팸차단 서비스) of SK Telecom, KT and LG U+",,"SK Telecom, KT and LG Uplus",South Korea,"SK Telecom, KT and LG Uplus (free service for subscribers)",South Korea,South Korea (nationwide mobile networks),South Korea,Telecommunications / spam and fraud prevention,,Finance,Technology,Telecommunications,Text and language,Consumers,16,High income,privacy_protection,Fraud detection,2,,4,,3,,,personal,5,,0,The same services' average blocking rate in the second half of 2019,89.5%,96.2% in the first half of 2020,measured,challenged,2024-04-05,shown,https://m.boannews.com/html/detail.html?idx=73575,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""Korea Communications Commission (방송통신위원회) and Korea Internet & Security Agency. 휴대전화 음성스팸 줄고, 문자스팸 늘어 [Voice spam on mobile phones falls, text spam rises], press release on the survey of spam in the second half of 2022 (「2022년 하반기 스팸 유통현황」), 31 March 2023."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=54820""}, {""label"": ""Regulatory document"", ""value"": ""Korea Communications Commission (방송통신위원회) and Korea Internet & Security Agency. 방통위, 「2020년 상반기 스팸 유통현황」 조사 결과 발표 [The Commission announces its survey of spam in the first half of 2020], press release, 29 September 2020."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=50090""}, {""label"": ""Regulatory document"", ""value"": ""Korea Communications Commission (방송통신위원회). 스팸 10건 중 9건은 막는다...문자스팸 차단율 89.5% [Nine in ten spam texts blocked, text spam blocking rate 89.5%], press release on the survey of spam in the second half of 2019 (「2019년 하반기 스팸 유통현황」), 25 March 2020."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=48691""}, {""label"": ""Regulatory document"", ""value"": ""Korea Communications Commission (방송통신위원회) and Korea Internet & Security Agency. 방통위, 「2023년 하반기 스팸 유통현황」 발표 [The Commission announces its survey of spam in the second half of 2023], press release, 5 April 2024."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=60499""}, {""label"": ""Regulatory document"", ""value"": ""Korea Communications Commission (방송통신위원회). 방통위(이상인 부위원장), 국민생활 불편을 야기하는 불법스팸 차단을 위해 이동통신사(KT) 현장점검 [The Commission's vice chairman inspects KT's blocking of illegal spam], press release, 20 February 2024."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=59778""}, {""label"": ""Follow-up"", ""value"": ""The Commission reported that illegal spam texts received per person rose in the second half of 2023 and wrote that the carriers should strengthen the filtering of their intelligent (AI) spam blocking services."", ""url"": ""https://www.kmcc.go.kr/user.do?mode=view&page=A05030000&dc=K05030000&boardId=1113&boardSeq=60499""}]","{""kind"": ""Challenges""}" AIBD-0691,2021-03-01,event,month,reported,GEF's evaluation office finds that AI monitoring of combustion kept dioxin at two Kunming incinerators well below the 0.1 ng TEQ/m³ target,"GEF's evaluation office found that AI monitoring kept dioxin at two Kunming incinerators far below target, as low as 0.0046 ng TEQ/m³. World Bank reviewers name no AI.",Kunming incinerators keep dioxin far below target with AI monitoring,as low as 0.0046 ng TEQ/m³,,found,Found by an evaluation office,no comparison,very low,benefit created,false,Combustion monitoring automated with artificial intelligence at the Xishan and Konggang incinerators (a SCADA system in the World Bank's review),,Not named in the evaluations,,"Operators of the Xishan and Konggang incinerators in Kunming, under the GEF-financed China Municipal Solid Waste Management Project implemented by the World Bank",China,"Kunming, Yunnan, China",China,Environment and climate,,Environment,Environment,Air Pollution,Prediction from data,,12,Upper middle income,environmental_impact,Environmental impacts,2,2,4,,3,5,,societal,2,,0,The 0.1 ng TEQ/m³ dioxin target,0.1 ng TEQ/m³ target,As low as 0.0046 ng TEQ/m³ at Xishan,measured,scaled,2025-11-19,not shown,https://www.unevaluation.org/get-download-file/18867,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Global Environment Facility Independent Evaluation Office. Evaluation of GEF Support for Technological Innovation. GEF/E/C.70/Inf.02, prepared by the Independent Evaluation Office for the 70th GEF Council Meeting, 19 November 2025. A field mission of the office visited the project."", ""url"": ""https://www.unevaluation.org/get-download-file/18867""}, {""label"": ""Evaluation report"", ""value"": ""World Bank Independent Evaluation Group. Implementation Completion Report (ICR) Review: CH GEF Municipal Solid Waste Management (P126832), ICRR0022775, 14 February 2022. In the review, the Independent Evaluation Group confirms the dioxin results, describes a SCADA system and does not mention artificial intelligence."", ""url"": ""https://documents.worldbank.org/curated/en/099350002142216484/pdf/China000CH0GEF0lid0Waste0Management.pdf""}]","{""kind"": ""Official documents""}" AIBD-0840,2021-02-01,event,month,reported,The UK Covid-19 Inquiry found that QCovid's estimates of risk added 1.7 million people to England's Shielded Patient List in February 2021,"The UK Covid-19 Inquiry reports that QCovid data led to 1.7 million more people on England's Shielded Patient List in February 2021. Of those with ethnicity recorded, 36% were non-white.",*QCovid* adds 1.7 million people to England's shielding list,1.7 million more people on England's Shielded Patient List,,found,Found by an inquiry,no comparison,very low,aggregate result,false,QCovid risk stratification tool,,"Researchers led from the University of Oxford, using the QResearch database of general practice records",United Kingdom,"NHS England with NHS Digital, which kept the Shielded Patient List in England",United Kingdom,"England, United Kingdom",United Kingdom,Public health / pandemic risk stratification,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical access,2,5,2,4,3,1,0.260,personal; societal,2,,0,The adult population,17% non-white ethnicity recorded in the adult population,36% were non-white,measured,persisted,,shown,https://doi.org/10.1136/bmj.m3731,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""UK Covid-19 Inquiry (Chair: The Rt Hon the Baroness Hallett DBE). Module 3: The impact of the Covid-19 pandemic on the healthcare systems of the United Kingdom (HC 1730), ordered to be printed 19 March 2026, paras 3.35-3.38. Accessible PDF with the May 2026 correction slip."", ""url"": ""https://covid19.public-inquiry.uk/wp-content/uploads/2026/03/14162519/14.5.26-E03361629_Covid-Inquiry-M3-Inquiry_accessible-w-Corrslip-2.pdf""}]","{""kind"": ""Official documents""}" AIBD-0094,2021-01-01,event,month,reported,"Nigeria's Rapid Response Register used machine-learning maps of poverty to select 1,163 urban wards for cash transfers in response to COVID-19","Nigeria used machine-learning poverty maps from satellite imagery to select 1,163 of its poorest urban wards for a COVID-19 cash transfer that counted 49,000 beneficiary households by 15 October 2021.",Nigeria uses machine-learning poverty maps to direct COVID-19 cash aid,"49,000 beneficiary households as of 15 October 2021","Nigeria had no urban social registry. Its National Social Safety Nets Coordinating Office therefore built the Rapid Response Register for a government-funded cash transfer during the COVID-19 pandemic. The government used maps of poverty by ward, made by applying machine-learning algorithms to satellite imagery. With them it selected 1,163 of the poorest urban wards, with a population of over 20 million.[1] Their residents then registered by mobile phone and were verified in person. The developers of the maps report that, in targeting the poor, their machine-learning approach raises precision at the ward level to 0.92. A survey-based benchmark reaches 0.79.[2] No source shows how many people the maps helped. A World Bank status report of 29 January 2025 records 49,000 beneficiary households in the cash transfer as of 15 October 2021. The World Bank does not say how many of them had been paid. It also counts over 5 million households supported by the program of direct benefit transfers. It gives no breakdown of the share that the register targeted.[3] Human Rights Watch researchers argued in July 2021 that the targeting methods had in all likelihood excluded, or would exclude, large numbers of people in need.[4]",found,Found by an evaluation office,tested against a standard,low,benefit created,false,"Ward-level poverty maps from supervised machine learning (deep learning) on satellite imagery, used for geographic targeting in the Rapid Response Register",,"Joshua Blumenstock (UC Berkeley) and Isabella Smythe (Columbia University), using wealth estimates by Chi et al. (2021), with World Bank economists Jonathan Lain and Tara Vishwanath, for the Government of Nigeria",,"National Social Safety Nets Coordinating Office (NASSCO), Federal Government of Nigeria",Nigeria,Urban wards across Nigeria,Nigeria,Social protection and cash transfers,Government social assistance,Humanitarian,Social Welfare,Low-Income Assistance,Images and video,The public,1,Lower middle income,opportunity_access,Insurance and benefit access,2,4,3,4,4,3,0.455,personal; organizational; societal,6,,1,survey-based poverty map benchmark (DHS/NLSS data),0.79 precision at the ward level (survey benchmark),0.92 precision at the ward level (ML-based maps),measured,scaled,2025-01-29,shown,https://blogs.worldbank.org/en/opendata/using-big-data-and-machine-learning-locate-poor-nigeria,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""World Bank Independent Evaluation Group. Implementation Completion Report Review: National Social Safety Nets Project (P151488), ICRR0023725, 26 January 2024. The evaluation group reports to the World Bank's Board and validates the results that project teams report."", ""url"": ""https://documents.worldbank.org/curated/en/099012624183017071/pdf/P1514881e50fcd0261bd211ca45ab33dadc.pdf""}]","{""kind"": ""Official documents""}" AIBD-0683,2021-01-01,event,year,reported,"Cour des comptes finds that France Travail's LEGO model catches illegal job offers, cutting checking work by the equivalent of 98 posts",The Cour des comptes found that France Travail's LEGO model catches illegal job offers before publication. It cut advisers' checking work by the equivalent of 98 full-time posts.,*LEGO* catches illegal job offers before France Travail publishes them,93% of offers that LEGO flags are flagged correctly,,found,Found by an auditor,tested against a standard,low,aggregate result,false,"LEGO (Légalité des offres), natural language processing with deep neural networks",,"Pôle emploi, now France Travail",France,France Travail (business advisers in all agencies),France,France (national),France,Public employment services,,Public sector,Labor,General,Text and language,Public servants,8,High income,operational_improvement,Enhanced productivity,2,1,4,,3,5,,organizational; societal,1,,0,"TextKernel, the keyword software used until autumn 2021, run in parallel during 2021",« seulement » 65 % avec l’ancien logiciel,93 % des offres d’emploi signalées par LEGO le sont à raison,measured,unknown,,shown,https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. France Travail et l’intelligence artificielle. Observations définitives S2025-1558, adopted 15 October 2025 and published 8 January 2026, p. 9 and annex 5, pp. 111-112."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0735,2020-12-01,source publication,day,reported,"NICE finds that Zio XT, a 14-day ECG patch analyzed by a deep neural network, diagnoses more people with arrhythmias than 24-hour Holter monitoring","NICE found that Zio XT diagnoses more arrhythmias than 24-hour Holter monitoring, likely at no extra cost. The patch is worn for up to 14 days. A deep neural network analyzes its ECGs.",*Zio XT* patch catches more heart rhythm problems than a 24-hour Holter,"In three of four comparative studies, the yield over total wear time was higher",,found,Found by an assessment body,controlled comparison,low,aggregate result,false,Zio XT (Zio biosensor with ZEUS deep neural network ECG analysis),,iRhythm Technologies,United States,"NHS organizations in England, with studies that included UK NHS sites",United Kingdom,"England, United Kingdom (guidance), with studies in the United Kingdom and United States",United Kingdom | United States,Healthcare (cardiology),,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health,Medical diagnosis,2,3,1,,3,1,,personal,4,,0,24-hour Holter monitoring,,Higher diagnostic yield over total wear time in three of four comparative studies,measured,scaled,2023-07-18,shown,https://www.nice.org.uk/guidance/htg562/chapter/3-Evidence,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Zio XT for detecting cardiac arrhythmias. HealthTech guidance HTG562 (formerly MTG52), section 1: Recommendations. 1 December 2020."", ""url"": ""https://www.nice.org.uk/guidance/htg562/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG562, section 3: Evidence. 1 December 2020."", ""url"": ""https://www.nice.org.uk/guidance/htg562/chapter/3-Evidence""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG562, section 4: Committee discussion. 1 December 2020."", ""url"": ""https://www.nice.org.uk/guidance/htg562/chapter/4-Committee-discussion""}]","{""kind"": ""Official documents""}" AIBD-0093,2020-11-02,event,day,reported,"Togo's Novissi used machine learning on satellite imagery to send emergency cash to rural areas, where phone data identified recipients","Machine-learning models used satellite imagery to rank rural areas for Togo's Novissi cash. In those areas, phone metadata set who got it. From November 2020 to August 2021, 138,531 people were paid.",Togo uses machine learning to send emergency cash to its rural poor,reduced exclusion errors by 4–21% relative to geographic alternatives,,found,Found by an evaluation office,tested against a standard,low,aggregate result,false,Novissi rural targeting pipeline: satellite-imagery poverty maps for canton ranking plus supervised machine learning on anonymized mobile-phone call detail records for individual eligibility,gradient boosting regressor with Microsoft's LightGBM,"Innovations for Poverty Action, CEGA and UC Berkeley (Aiken and Blumenstock, UC Berkeley; Bellue, University of Mannheim; Karlan and Udry, Northwestern University) for the Government of Togo",United States,"Government of Togo, Ministry of Digital Economy and Transformation, with GiveDirectly",Togo,"Rural cantons, Togo",Togo,Social protection and humanitarian cash transfers,Government social assistance,Humanitarian,Social Welfare,Low-Income Assistance,Prediction from data; Images and video,The public,1,Lower middle income,opportunity_access,Insurance and benefit access,2,4,3,4,4,3,0.455,personal; organizational; societal,9,,1,the geographic targeting options considered by the Government of Togo,"errors of exclusion above 53% for the feasible alternatives, by the 4–21% that the authors report","errors of exclusion of 53% for the phone-based approach, a reduction of 4–21%",measured,scaled,2022-01-24,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8967719/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Independent Evaluation Group (IEG), World Bank Group (2023). Togo - Togo Emergency Covid-19 DPO 2021 (P174376): Implementation Completion Report (ICR) Review, Section 12, Lessons, pages 19-20 (lesson 1 on digitalization); results indicator RI3 in Section 4."", ""url"": ""http://documents.worldbank.org/curated/en/099120523130534785/pdf/P1743760994a770790a2420969df01036f2.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Independent Evaluation Group (IEG), World Bank Group (2025). How the World Bank Supports Adaptive Social Protection in Crisis Response - An Independent Evaluation, Chapter 2, box on expanding safety nets in crises, bullet 'Using alternative data sources' (source line: IEG structured literature review)."", ""url"": ""https://documents.worldbank.org/curated/en/099420007082597981/pdf/SECBOS-edce0da9-4c32-4e0a-8a68-8cdf5bea0fee.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Independent Evaluation Group (IEG), World Bank Group (2022). The World Bank's Early Support to Addressing Coronavirus (COVID-19) Health and Social Response - An Early-Stage Evaluation, Chapter 4, box of examples of partnerships in the social response (Togo paragraph)."", ""url"": ""http://documents.worldbank.org/curated/en/099707411152235594/pdf/SECBOS0a7075fa02d096800f25989934099.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Independent Evaluation Group (IEG), World Bank Group (2024). Togo - TG-Safety Nets and Basic Services Project (P157038): Implementation Completion Report (ICR) Review, Section 4, Objective 1 rationale, page 8."", ""url"": ""https://documents.worldbank.org/curated/en/099102424140039295/pdf/P157038-8781f09e-ea59-4a0d-bbd1-e3d699e00992.pdf""}]","{""kind"": ""Official documents""}" AIBD-0651,2020-09-18,source publication,day,reported,CMS approves add-on payments for Viz.ai ContaCT after determining that it is a substantial clinical improvement because it shortens stroke-specialist notification,"CMS found that Viz.ai ContaCT shortens time to specialist notification for large vessel occlusion stroke. In routine use, the median time to notification was 4.31 minutes.",Medicare credits *ContaCT* with faster stroke alerts in a payment review,the median time to notification was 4.31 minutes,,found,Found by a regulator,tested against a standard,low,aggregate result,false,ContaCT (Viz LVO algorithm with Viz Hub and Viz View),,"Viz.ai, Inc.",United States,"US hospitals using ContaCT, including SkyRidge Medical Center, Wellstar, Methodist Le Bonheur Healthcare and Mount Sinai Health System",United States,United States,United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,2,3,3,,5,,,organizational; personal,2,,3,"Usual-care notification time in the retrospective test on past scans that FDA reviewed, as cited by CMS",58.72 minutes mean,7.32 minutes mean,measured,persisted,2021-08-04,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Centers for Medicare & Medicaid Services. Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System; final rule. Federal Register 85 FR 58432, 18 September 2020 (document 2020-19637)."", ""url"": ""https://www.federalregister.gov/documents/2020/09/18/2020-19637/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-and-the-long-term-care-hospital""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. De Novo classification request for ContaCT (DEN170073): decision summary. 13 February 2018."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf""}]","{""kind"": ""Official documents""}" AIBD-0999,2020-07-15,event,day,reported,The CRTC approves Bell Canada's AI-assisted call blocking after it blocked over one billion fraudulent calls with no confirmed false positives,"Bell Canada reported to the CRTC that its AI-assisted system blocked 1,120,372,443 calls in 15 months. The CRTC judged the risk of wrongful blocking minimal. It made the blocking permanent.",Bell uses AI to block over a billion fraudulent calls in Canada,"1,120,372,443 calls",,found,Found by a regulator,no comparison,very low,aggregate result,false,Bell Canada's network-level call-blocking system for fraudulent and scam voice calls (AI anomaly flagging with review),,Bell Canada,Canada,Bell Canada and its affiliates (Bell Canada et al.),Canada,Canada,Canada,Telecommunications / fraud prevention,,Finance,Technology,Telecommunications,Prediction from data,The public,16,High income,privacy_protection,Fraud detection,2,,4,3,3,5,,societal,3,,0,Complaints about fraudulent calls received by Bell and the CRTC before the trial began,,,measured,persisted,2022-09-29,shown,https://business.bell.ca/support/medium-large/mobility/fraudulent-abusive-calls,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Canadian Radio-television and Telecommunications Commission. Compliance and Enforcement and Telecom Decision CRTC 2021-403: Bell Canada - Application to allow Bell Canada and its affiliates to block certain fraudulent and scam voice calls on a permanent basis. Ottawa, 9 December 2021. Archived copy of https://www.crtc.gc.ca/eng/archive/2021/2021-403.htm."", ""url"": ""https://web.archive.org/web/20260520150034id_/https://crtc.gc.ca/eng/archive/2021/2021-403.htm""}, {""label"": ""Regulatory document"", ""value"": ""Canadian Radio-television and Telecommunications Commission. Compliance and Enforcement and Telecom Decision CRTC 2021-403. Ottawa, 9 December 2021. Archived copy of https://www.crtc.gc.ca/eng/archive/2021/2021-403.htm."", ""url"": ""https://web.archive.org/web/20260520150034id_/https://crtc.gc.ca/eng/archive/2021/2021-403.htm""}, {""label"": ""Regulatory document"", ""value"": ""Canadian Radio-television and Telecommunications Commission. Compliance and Enforcement and Telecom Decision CRTC 2021-403. Ottawa, 9 December 2021. Archived copy of https://www.crtc.gc.ca/eng/archive/2021/2021-403.htm."", ""url"": ""https://web.archive.org/web/20260520150034id_/https://crtc.gc.ca/eng/archive/2021/2021-403.htm""}]","{""kind"": ""Official documents""}" AIBD-0297,2020-01-01,event,year,reported,"Nelli, an audiovisual AI monitor for seizures, records 247 nocturnal events missed by carers among 15 people with intellectual disability in Cornwall. In a Danish validation it detected all 11 tonic-clonic seizures","In a Cornwall NHS evaluation of 15 people who could not tolerate EEG, Nelli flagged 707 possible seizure events, 247 unheard or unrecognized by carers. Danish validators reported 93.7% sensitivity.",Nelli flags 247 nocturnal seizure events missed by carers,"Nelli flagged 707 possible seizure events, 247 unheard or unrecognized by carers",,found,Found by an assessment body,controlled comparison,low,aggregate result,false,Nelli audio-video seizure monitoring system (computer vision and AI-based event detection),,"Neuro Event Labs, Tampere, Finland",Finland,"Cornwall Partnership NHS Foundation Trust (community evaluation); Danish Epilepsy Center, Dianalund, and Aarhus University Hospital (validation)",United Kingdom,"Cornwall, United Kingdom; Dianalund and Aarhus, Denmark",United Kingdom | Denmark,Healthcare (epilepsy; nocturnal seizure monitoring),Residential and institutional seizure monitoring for people with intellectual disability,Accessibility,Health,Disease Prevention,Images and video; Speech and sound,Patients; People with disabilities,3,High income,physical_health,Medical diagnosis,2,2,2,4,5,5,0.500,personal; organizational,8,,3,carers' hearing or recognition of night-time events in the same people,247 were not heard or recognised by carers,Nelli recorded 707 possible seizure events across the study cohort,measured,persisted,2025-10-09,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf25/K251506.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, 510(k) premarket notification K251506, Nelli (Version 7.11), decision of 21 November 2025, with the 510(k) summary written by Neuro Event Labs. The summary covers the sponsor's clinical study at three U.S. sites. FDA found the device substantially equivalent to the Empatica Embrace."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf25/K251506.pdf""}, {""label"": ""Assessment report"", ""value"": ""Health Technology Wales (HTW) (2025). HTW Guidance 064: At-home video monitoring for the diagnosis and management of epilepsy, p. 1-2, Evidence summary."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/GUI064-AVME-WEB-ENG.pdf""}, {""label"": ""Assessment report"", ""value"": ""Health Technology Wales, Evidence Appraisal Report EAR064: At-home video monitoring for the diagnosis and management of epilepsy, August 2025, section 5.5.5 (diagnostic accuracy: false positive rate)."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/EAR064-AVME-WEB.pdf""}, {""label"": ""Assessment report"", ""value"": ""Health Technology Wales, Guidance 064 (GUI064): At-home video monitoring for the diagnosis and management of epilepsy, August 2025, headline guidance."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/GUI064-AVME-WEB-ENG.pdf""}]","{""kind"": ""Official documents""}" AIBD-0634,2019-11-27,event,day,reported,"PROSPECT randomized trial in Blantyre, Malawi: HIV testing combined with CAD4TB-read chest X-rays speeds TB treatment for adults with cough","In the PROSPECT trial in Blantyre, TB patients offered HIV testing with chest X-rays read by CAD4TB started treatment a median of 1 day after the visit. Under standard care, they waited 11 days.",Computer-read chest X-rays speed TB treatment at a Malawi clinic,Median time to treatment was 1 day in the X-ray arm and 11 days under standard care,,found,Found by an assessment body,randomized trial,low,aggregate result,false,CAD4TB computer-aided detection software reading digital chest X-rays,CAD4TB v5,Delft Imaging,Netherlands,PROSPECT trial team of the Malawi-Liverpool-Wellcome Trust Clinical Research Programme at Bangwe Health Centre,Malawi,"Bangwe Health Centre, Blantyre, Malawi",Malawi,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,Low income,physical_health,Medical diagnosis,2,2,1,4,3,1,0.180,personal,2,,1,Standard care for adults with cough at the same clinic,0 of 5 TB patients treated on the day of the visit; median 11 days to treatment,6 of 15 TB patients treated on the day of the visit; median 1 day to treatment,measured,unknown,,shown,https://iris.who.int/server/api/core/bitstreams/0d7e8935-879e-4ab6-8c07-e41f7be1465b/content,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia (2024). Computer-aided detection or artificial intelligence for chest X-ray in early detection of tuberculosis: Health Technology Assessment, executive summary, Results, Part A: Diagnostic accuracy and effectiveness (p. 3); Conclusion and Recommendation (p. 5)."", ""url"": ""https://web.archive.org/web/20260118050712id_/https://www.moh.gov.my/moh/resources/Penerbitan/Penilaian%20Teknologi%20Kesihatan%20(HTA)/ES_COMPUTER_AIDED-DETECTION_OR_ARTIFICIAL_INTELLIGENCE_FOR_CHEST_X-RAY_IN_EARLY_DETECTION_OF_TUBERCULOSIS.pdf""}]","{""kind"": ""Official documents""}" AIBD-0623,2019-11-01,event,month,reported,FDA De Novo review of GI Genius: AI-aided colonoscopy detects more adenomas in a randomized trial,"In the randomized Italian trial that FDA reviewed, colonoscopy with GI Genius found adenomas in 55.1% of low-risk patients, against 42.0% with standard colonoscopy.",*GI Genius* helped endoscopists find more adenomas in a randomized trial,an adenoma detection rate of 55.1% with GI Genius against 42.0% with standard colonoscopy,,found,Found by a regulator,randomized trial,high,aggregate result,false,GI Genius,,"Cosmo Artificial Intelligence - AI, Ltd.",Ireland,"Humanitas Research Hospital, Nuovo Regina Margherita Hospital and Valduce Hospital (AID trial)",Italy,"Milan, Rome and Como, Italy",Italy,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,2,3,1,,3,1,,personal; organizational,6,,0,Standard white-light colonoscopy in the same trial,42.0% adenoma detection rate,55.1% adenoma detection rate,measured,persisted,2026-05-29,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200055.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for GI Genius (DEN200055): decision summary. Granted 2021-04-09."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200055.pdf""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), for the Spanish Network of HTA Agencies (RedETS) and the Ministry of Health (2023). Inteligencia artificial para la detección y caracterización de lesiones precancerosas colorrectales en la colonoscopia (Ficha de evaluación de tecnologías sanitarias nuevas y emergentes), Resumen, Resultados (PDF p. 14; repeated p. 52)."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1177""}, {""label"": ""Assessment report"", ""value"": ""Danish Health Technology Council (Behandlingsrådet), expert committee on AI in colonoscopy (2023). Recommendation from the Danish Health Technology Council concerning use of artificial intelligence as clinical decision-support in colonoscopy for the diagnosis of neoplastic disease, Clinical effectiveness (p. 3 of 7); the analysis report (analyserapport_1.pdf) names GI Genius and ENDO-AID as the systems in the evidence."", ""url"": ""https://behandlingsraadet-dk.b-cdn.net/media/35dpf1vw/recommendation.pdf""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), for the Spanish HTA network (RedETS) and Ministry of Health (2023). Inteligencia artificial para la detección y caracterización de lesiones precancerosas colorrectales en la colonoscopia (ficha de evaluación de tecnologías nuevas y emergentes), Resumen, Resultados (p. 13-14)."", ""url"": ""https://scientiasalut.gencat.cat/bitstream/handle/11351/10545/inteligencia_artificial_deteccion_caracterizacion_lesiones_precancerosas_colorrectales_colonoscopia_2023.pdf?sequence=1&isAllowed=y""}]","{""kind"": ""Official documents""}" AIBD-1029,2019-06-11,source publication,day,reported,Netherlands Court of Audit finds that the Belastingdienst's risk model for VAT refunds doubled the hit rate of the selection rules that it replaced,The Netherlands Court of Audit found that the Belastingdienst's risk model for VAT refunds raised the hit rate of checks from 17% to 34%.,*Risicomodel van teruggave btw* doubles the hit rate of VAT checks,from 17% to 34%,,found,Found by an auditor,before and after,very low,aggregate result,false,Risicomodel van teruggave btw (the Belastingdienst's risk model for VAT refund returns),,Belastingdienst (Netherlands Tax and Customs Administration),Netherlands,"Belastingdienst, for the selection of VAT refund returns for checks by tax inspectors",Netherlands,Netherlands (national),Netherlands,Tax compliance,,Public sector,Government Operations,Tax Administration,Prediction from data,Public servants,16,High income,operational_improvement; privacy_protection,Value above replacement,2,1,4,,3,5,,organizational; societal,2,,0,"The old selection rules for VAT refund returns, which the model replaced",De trefkans van het oude model voor btw-teruggave was 17%,met het nieuwe model wordt een trefkans van 34% gehaald,measured,litigated,2026-04-22,shown,https://www.rekenkamer.nl/site/binaries/site-content/collections/documents/2019/06/11/datagedreven-selectie-van-aangiften-door-de-belastingdienst/Dategedreven+selectie+aangiften+door+Belastingdienst+WR.pdf,€ 60 miljoen per jaar,"Extra revenue from the new VAT refund model, by the Belastingdienst's estimate",True,[],Querist,The use of the system was taken to court.,"[{""label"": ""Audit report"", ""value"": ""Algemene Rekenkamer (Netherlands Court of Audit). Datagedreven selectie van aangiften door de Belastingdienst, §2.1.3 Trefkans, p. 10, and Bijlage 1 'Van data naar risicomodel', pp. 28-29. Sent to the House of Representatives on 11 June 2019."", ""url"": ""https://www.rekenkamer.nl/site/binaries/site-content/collections/documents/2019/06/11/datagedreven-selectie-van-aangiften-door-de-belastingdienst/Dategedreven+selectie+aangiften+door+Belastingdienst+WR.pdf""}, {""label"": ""Follow-up"", ""value"": ""The Belastingdienst switched off its OB Negatief model for VAT refund returns in January 2021 over privacy doubts and later restored it. In April 2026 the District Court of The Hague ruled its use in a VAT dispute lawful."", ""url"": ""https://www.accountancyvanmorgen.nl/2026/04/22/risicoselectie-fiscus-via-algoritme-rechtmatig-naheffingen-en-boetes-administratiekantoor/""}]","{""kind"": ""Legal proceedings""}" AIBD-0676,2019-05-20,event,year,mixed,"GAO reports that in a 2019 CBP test, Traveler Verification Service air exit correctly matched 98% of travelers' photos","GAO reports that in a 2019 CBP test, face matching at departure gates correctly matched 98% of travelers' photos, while airlines photographed only about 80% of travelers.",*Traveler Verification Service* met its accuracy goals at airport exits,correctly matched 98% of travelers' photos,,found,Found by an auditor,tested against a standard,low,aggregate result,false,"Traveler Verification Service (TVS), facial recognition for biometric air exit",,U.S. Customs and Border Protection (GAO does not name the algorithm's supplier),United States,U.S. Customs and Border Protection with airline and airport partners,United States,"Detroit, New York JFK and Orlando airports, United States (test sites)",United States,Border control (exit records),,Safety and rescue,Law and Crime,Agencies,Images and video,,16,High income,operational_improvement,"Faster data management, decision-making",2,1,4,3,2,5,0.350,organizational,1,,0,The minimum accuracy requirements in CBP's Operational Requirements Document,At least 90 percent correct matches and at most 0.1 percent false matches,98 percent correct matches and 0.0092 percent false matches,measured,scaled,,not shown,https://www.gao.gov/assets/gao-20-568.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office. Facial Recognition: CBP and TSA are Taking Steps to Implement Programs, but CBP Should Address Privacy and System Performance Issues. GAO-20-568, 2 September 2020, pp. 50-52."", ""url"": ""https://www.gao.gov/assets/gao-20-568.pdf""}]","{""kind"": ""Official documents""}" AIBD-0021,2019-03-29,source publication,day,reported,"Apple Watch alerts about the heart lead doctors to diagnose arrhythmias, which they then treat",Overnight alarms about her heart rate from an Apple Watch Series 2 sent a woman to a hospital in the United Kingdom. An electrocardiogram showed atrial fibrillation. She began an anticoagulant.,Apple Watch heart-rate alarms lead doctors to find atrial fibrillation,her pulse exceeded 120 beats per minute while she was inactive,,found,Found by a regulator,no comparison,very low,benefit created,false,"Apple Watch heart-rate notifications, Irregular Rhythm Notification and ECG app","Apple Watch Series 2 (event); echoes name Series 3, 4, 5, 6 and Ultra; eight reports do not state the model, and in Ahmed et al. the alerting tracker is unnamed (the Series 5 was the authors' post-diagnosis device)",Apple,United States,,,United Kingdom,United Kingdom,Healthcare (cardiology),Consumer wearables,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,2,2,,,5,1,,personal,21,,16,the standard rhythm workup after her transient ischemic attack two months earlier,"Sinus rhythm at the stroke team review and throughout a 24-hour outpatient ECG, with no atrial fibrillation diagnosis and treatment with clopidogrel","Atrial fibrillation with a fast ventricular response on ECG after the watch alarms, followed by rate control and a direct oral anticoagulant",measured,scaled,2024-04-25,not shown,https://www.apple.com/uk/healthcare/docs/site/Apple_Watch_Arrhythmia_Detection.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. De Novo Classification Request for Irregular Rhythm Notification Feature (DEN180042), decision summary, request received 9 August 2018 and granted 11 September 2018. FDA reviewers wrote the summary and its benefit-risk determination. The summary covers the Irregular Rhythm Notification feature and does not cover the alert for a high heart rate in the 2019 index case."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180042.pdf""}]","{""kind"": ""Official documents""}" AIBD-0686,2019-01-01,event,year,reported,"Cour des comptes finds that desk checks picked by the Cnaf data-mining score found overpayments in 26% of files in 2019, up from 6% in 2012","The Cour des comptes found that desk checks picked by the family branch's data-mining score found overpayments in 26% of files in 2019, up from 6% in 2012.",*Datamining* score finds more payment errors in French family benefits,"found overpayments in 26% of files in 2019, up from 6% in 2012",,found,Found by an auditor,before and after,very low,aggregate result,false,Data-mining risk score of the family branch of French social security (le datamining),,Caisse nationale des allocations familiales (Cnaf),France,"Caisses d'allocations familiales (Caf), nationwide",France,France (national),France,Social benefits (family and housing),,Public sector,Social Welfare,Low-Income Assistance,Prediction from data,,16,High income,privacy_protection; operational_improvement,Fraud detection,2,1,4,,3,5,,organizational; personal,3,,0,"Desk checks picked by the score in 2012, its first year of use",6 % et 5 % respectivement en 2012,26 % de dossiers comportant des indus et 22 % des rappels détectés en 2019,measured,litigated,2026-04-27,shown,https://www.ccomptes.fr/system/files/2020-09/20200908-rapport-Lutte-contre-fraudes-prestations-sociales_0.pdf,"218,5 M€",Overpayments detected in 2019 through checks that data mining selected,False,[],Querist,The use of the system was taken to court.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. La lutte contre les fraudes aux prestations sociales. Communication à la commission des affaires sociales de l’Assemblée nationale, September 2020, pp. 48-49."", ""url"": ""https://www.ccomptes.fr/system/files/2020-09/20200908-rapport-Lutte-contre-fraudes-prestations-sociales_0.pdf""}, {""label"": ""Audit report"", ""value"": ""Cour des comptes (France). Sécurité sociale 2025: Rapport sur l'application des lois de financement de la sécurité sociale (RALFSS 2025), chapter on benefits paid in error (indus). Deuxième partie, chapter on indus in the benefit branches, passage on the family branch's controls (around pp. 300-312)"", ""url"": ""https://web.archive.org/web/20251204141332id_/https://www.ccomptes.fr/sites/default/files/2025-05/20250526-RALFSS-2025_0.pdf""}, {""label"": ""Audit report"", ""value"": ""Défenseur des droits (France) (2026). La lutte contre la fraude aux prestations sociales à l'ère de son industrialisation (rapport, version du 27 avril 2026), Part 1, B.2 'Les différents algorithmes utilisés', subsection Cnaf (pp. 12-13); Part 3, C.2 'Une justification approximative du caractère nécessaire et approprié des différences de traitement résultant des algorithmes de ciblage' (pp. 36-37)."", ""url"": ""https://www.defenseurdesdroits.fr/sites/default/files/2026-04/ddd_rapport_fraude-prestations-sociales-2026_20260427.pdf""}, {""label"": ""Follow-up"", ""value"": ""A collective of associations challenged the Cnaf director-general's decision to run the data-mining score before the Conseil d'État. The Défenseur des droits filed observations, and the proceeding was still pending when its April 2026 report closed."", ""url"": ""https://www.defenseurdesdroits.fr/sites/default/files/2026-04/ddd_rapport_fraude-prestations-sociales-2026_20260427.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0779,2019-01-01,event,year,reported,FDA finds that dosing fentanyl by Medasense's NOL index left patients with less pain after abdominal surgery in two randomized trials,"In two randomized trials that FDA reviewed, dosing fentanyl by the PMD-200's NOL index lowered pain scores after abdominal surgery by 30-33% against standard care.",Dosing by *PMD-200* lowered pain scores after abdominal surgery,lowered pain scores after abdominal surgery by 30-33%,,found,Found by a regulator,randomized trial,moderate,aggregate result,false,PMD-200 with the Nociception Level (NOL) index,,Medasense Biometrics Ltd.,Israel,Leiden University Medical Center and Alrijne Hospital (SOLAR trial) and Shaare Zedek Medical Center (Abdomi-NOL trial),Netherlands and Israel,"Leiden and Leiderdorp, Netherlands, and Jerusalem, Israel",Netherlands | Israel,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health,,2,2,1,,3,1,,personal,2,,0,Standard fentanyl dosing guided by blood pressure and heart rate in the randomized control groups,Median pain score 5 after 60 minutes in recovery (Abdomi-NOL),Median pain score 3 after 60 minutes in recovery (Abdomi-NOL),measured,persisted,2026-08-04,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC9869062,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for PMD-200 (NOL index) (DEN210022): decision summary. Granted 2023-02-17."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN210022.pdf""}]","{""kind"": ""Official documents""}" AIBD-0856,2019-01-01,event,month,reported,Australia's Administrative Review Tribunal finds that Bunnings' facial recognition was effective in identifying known offenders in 62 stores,Australia's Administrative Review Tribunal found that facial recognition in 62 Bunnings stores was effective in identifying known offenders. It relied on evidence that theft fell by around 13%.,*Facial recognition* helped Bunnings spot repeat offenders in 62 stores,cut theft by around 13%,,found,Found by a court,controlled comparison,low,aggregate result,false,Hitachi facial recognition system (FRT) on store CCTV,,"Hitachi Kokusai Electric Co Ltd (designed the system, supplied to Bunnings by a third-party supplier)",Japan,"Bunnings Group Limited, 62 stores in New South Wales and Victoria",Australia,"New South Wales and Victoria, Australia",Australia,Retail security,,Safety and rescue,Law and Crime,Crime Control,Images and video,,16,High income,physical_health,Crime reduction or prevention,2,1,4,,3,5,,organizational; personal,2,,0,Bunnings stores without facial recognition over the same period,,reducing theft by around 13%,measured,unknown,,not shown,https://web.archive.org/web/20260728111548/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/ARTA/2026/130.html,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Administrative Review Tribunal of Australia, Guidance and Appeals Panel (Deputy President P Britten-Jones, Senior Members A Murphy and T Simon). Bunnings Group Limited and Privacy Commissioner (Guidance and Appeals Panel) [2026] ARTA 130, 4 February 2026 (archived copy from AustLII)."", ""url"": ""https://web.archive.org/web/20260728111548/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/ARTA/2026/130.html""}, {""label"": ""Regulatory document"", ""value"": ""Office of the Australian Information Commissioner. Commissioner initiated investigation into Bunnings Group Limited (Privacy) [2024] AICmr 230, determination of Privacy Commissioner Carly Kind, 29 October 2024. Findings on APP 3.3, 'Suitability'. AustLII copy in the Wayback Machine."", ""url"": ""https://web.archive.org/web/20260608220010/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/AICmr/2024/230.html""}]","{""kind"": ""Official documents""}" AIBD-0785,2018-08-23,source publication,day,reported,FDA finds that Zephyr's MATRx plus predicted which patients with sleep apnea would respond to an oral appliance with 94.2% sensitivity,"In a home study that FDA reviewed, MATRx plus identified patients with mild to moderate sleep apnea who would respond to an oral appliance with 94.2% sensitivity. Its PPV was 96.1%.",*MATRx plus* identified apnea patients who did well with a mouthpiece,94.2% sensitivity,,found,Found by a regulator,no comparison,very low,aggregate result,false,MATRx plus,,Zephyr Sleep Technologies,Canada,Zephyr Sleep Technologies (home study in adults with mild to moderate obstructive sleep apnea),Canada,,,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,,physical_health,,2,2,1,,3,1,,organizational,3,,0,,,,,withdrawn,2021-07-21,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170090.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for MATRx plus (DEN170090): decision summary. Granted 2018-08-23."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170090.pdf""}, {""label"": ""Follow-up"", ""value"": ""Zephyr Sleep Technologies ceased operations on 25 June 2021, closing manufacturing and support for MATRx plus after failing to raise capital during the pandemic, Sleep Review reported on 21 July 2021."", ""url"": ""https://sleepreviewmag.com/sleep-treatments/therapy-devices/oral-appliances/zephyr-sleep-technologies-ceases-operations/""}]","{""kind"": ""Withdrawals""}" AIBD-0223,2018-08-22,event,day,reported,CBP facial comparison at Dulles flags a French-passport impostor with a Congolese ID in his shoe on day three,On 22 August 2018 CBP's new facial comparison system at Dulles flagged a mismatch for a man presenting a French passport. Officers found a Congolese ID in his shoe. He was returned to Brazil.,CBP facial comparison at Dulles flags a French-passport impostor,the first impostor detected with the technology,,found,Found by an auditor,no comparison,very low,harm prevented,false,"CBP facial comparison biometric system (biometric entry/exit, Traveler Verification Service)",,Not named in the sources,,"U.S. Customs and Border Protection, Office of Field Operations, Washington Dulles International Airport",United States,"Sterling, United States",United States,Border security,Government,Public sector,Immigration,Immigration,Images and video,Public servants,16,High income,privacy_protection; physical_health,Fraud detection,2,1,1,,5,3,,societal; organizational,6,,3,an officer's visual check of the traveler against the passport photo,officials said that the passport may have passed at face value with human inspection,the facial comparison reported a mismatch and the traveler was sent to secondary inspection,assumed,scaled,2022-07-05,not shown,https://www.gao.gov/assets/gao-20-568.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office, Facial Recognition: CBP and TSA are Taking Steps to Implement Programs, but CBP Should Address Privacy and System Performance Issues, GAO-20-568, September 2020. GAO is an independent audit office. On impostors it reports only what CBP officials told it. Its own findings cover privacy notices and photo capture in the exit program."", ""url"": ""https://www.gao.gov/assets/gao-20-568.pdf""}, {""label"": ""Audit report"", ""value"": ""U.S. Department of Homeland Security, Office of Inspector General. CBP Complied with Facial Recognition Policies to Identify International Travelers at Airports. Report OIG-22-48, 5 July 2022. Results of Audit and Appendix B, 'Impostors Identified by CBP at Airports'. The inspector general analysed CBP's own records, and the audit period begins after this case."", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2022-07/OIG-22-48-July22.pdf""}]","{""kind"": ""Official documents""}" AIBD-0920,2018-01-01,event,year,reported,"Cour des comptes finds that when data mining picked very small firms for URSSAF audits, the audits reassessed contributions at twice the rate of all such audits",The Cour des comptes found that URSSAF audits of very small firms picked by data mining reassessed 12.6% of the contributions audited in 2018. The rate across all such audits was 6.1%.,*Datamining* lists double the yield of URSSAF audits of small firms,reassessed 12.6% of the contributions audited in 2018,,found,Found by an auditor,controlled comparison,very low,aggregate result,false,Acoss data-mining risk scores (outils de datamining) that list small and medium firms (since 2015) and very small firms (since 2016) for URSSAF accounting audits,,Agence centrale des organismes de sécurité sociale (Acoss),France,URSSAF network,France,France (national),France,Social contributions enforcement (employer audits),,Public sector,Labor,Fair Labor Standards,Prediction from data,,16,High income,operational_improvement; privacy_protection,Enhanced productivity,2,1,4,,3,,,organizational,1,,0,"All URSSAF accounting audits of very small firms in 2018, including those picked by data mining","6,1 %","12,6 %",measured,scaled,2024-05-28,not shown,https://www.ccomptes.fr/sites/default/files/2023-10/20191202-rapport-fraude-aux-prelevements-obligatoires.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. La fraude aux prélèvements obligatoires: évaluer, prévenir, réprimer. Communication au Premier ministre, November 2019, published 2 December 2019, pp. 128-129, Tableau n° 14."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2023-10/20191202-rapport-fraude-aux-prelevements-obligatoires.pdf""}]","{""kind"": ""Official documents""}" AIBD-0675,2017-08-01,event,year,mixed,DHS Inspector General validates that the Traveler Verification Service matched 98% of gate photos in CBP's 2017 exit pilot at nine airports,"The DHS Inspector General validated a 98% average match rate for CBP's face matching at departure gates from August to December 2017, but only 85% of passengers were confirmed.",*Traveler Verification Service* matched 98% of photographed passengers,a 98% average match rate,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Traveler Verification Service (TVS), CBP's facial recognition matching service",,U.S. Customs and Border Protection (the Inspector General does not name the algorithm's supplier),United States,"U.S. Customs and Border Protection, Biometric Entry-Exit Program, with airlines at nine airports (Sprint 8 pilot)",United States,"Atlanta, Boston, Chicago, Houston (Intercontinental and Hobby), Las Vegas, Miami, New York JFK and Washington Dulles airports, United States",United States,Border control (exit records),,Safety and rescue,Law and Crime,Agencies,Images and video,,16,High income,operational_improvement,"Faster data management, decision-making",2,1,3,2,2,5,0.280,organizational,1,,0,"CBP's objective for full implementation in 2021, a match rate of 97%",97 percent rate objective,"98 percent average technical match rate, August to December 2017",measured,scaled,2026-10-07,not shown,https://www.oig.dhs.gov/sites/default/files/assets/2018-09/OIG-18-80-Sep18.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""U.S. Department of Homeland Security, Office of Inspector General. Progress Made, but CBP Faces Challenges Implementing a Biometric Capability to Track Air Passenger Departures Nationwide. OIG-18-80, 21 September 2018."", ""url"": ""https://www.oig.dhs.gov/sites/default/files/assets/2018-09/OIG-18-80-Sep18.pdf""}]","{""kind"": ""Official documents""}" AIBD-0835,2017-05-01,event,month,reported,The High Court found that South Wales Police's AFR Locate facial recognition led officers to act in 37 cases where other methods had failed,In September 2019 the High Court found that South Wales Police's live facial recognition had led officers to act in 37 cases. Existing methods had not been able to locate those people.,*AFR Locate* led South Wales Police to act in 37 cases,arrests or disposals in 37 cases,,found,Found by a court,no comparison,very low,aggregate result,false,"AFR Locate, using NEC's NeoFace Watch software",,NEC (now North Gate Public Services (UK) Ltd),Japan,South Wales Police,United Kingdom,"Cardiff and South Wales, United Kingdom",United Kingdom,Policing / public protection,,Safety and rescue,Law and Crime,Police,Images and video,Public servants,16,High income,physical_health,Crime reduction or prevention,2,1,4,,3,3,,organizational; societal,1,,0,Existing methods of locating wanted people,had not been capable of location by existing methods,arrests or disposals in 37 cases,assumed,litigated,2020-08-11,shown,https://www.naffco.com/downloads/pdf/neoface-watch-brochure.pdf,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""High Court of Justice, Queen's Bench Division, Divisional Court sitting at Cardiff (Haddon-Cave LJ and Swift J). R (Bridges) v Chief Constable of South Wales Police & Ors [2019] EWHC 2341 (Admin), judgment of 4 September 2019. Find Case Law copy."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/admin/2019/2341""}, {""label"": ""Follow-up"", ""value"": ""The Court of Appeal allowed the claimant's appeal on three grounds, including the legal framework for the use. It rejected the ground on proportionality."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewca/civ/2020/1058""}]","{""kind"": ""Legal proceedings""}" AIBD-0713,2017-01-01,event,year,reported,"Sweden's Social Insurance Inspectorate finds that claims picked by Försäkringskassan's risk model had errors in 55% of checks, against 34% at random","Sweden's Social Insurance Inspectorate found that 55% of parental-benefit claims picked by a risk model in 2017 had errors, against 34% of claims checked at random.",Swedish risk model finds more errors in parental-benefit claims,55% of parental-benefit claims picked by a risk model,,found,Found by an auditor,controlled comparison,low,aggregate result,false,"Försäkringskassan's risk-based selection profile (urvalsprofil) for checks of temporary parental benefit, run through the RaKuR infrastructure",,"Försäkringskassan (Swedish Social Insurance Agency), Urvalsanalys unit",Sweden,Försäkringskassan (Swedish Social Insurance Agency),Sweden,Sweden,Sweden,Social insurance control,,Finance,Social Welfare,Child Care,Prediction from data,,16,High income,operational_improvement,Enhanced productivity,2,1,,2,3,,,organizational,2,,0,Claims picked at random for checks in 2017,34 procent,55 procent,measured,withdrawn,,shown,https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Audit report"", ""value"": ""Inspektionen för socialförsäkringen (ISF). Profilering som urvalsmetod för riktade kontroller: En granskning av träffsäkerheten, effektiviteten och rättssäkerheten i Försäkringskassans modeller för riskbaserade kontroller. ISF Rapport 2018:5, March 2018. Chapter 6, printed pp. 109-110, Tabell 7."", ""url"": ""https://isf.se/download/18.6e75aae16a591304896b99/1565330421562/Profilering%20som%20urvalsmetod%20fo%CC%88r%20riktade%20kontroller-ISF-Rapport%202018-05.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Integritetsskyddsmyndigheten (IMY). Beslut efter tillsyn enligt dataskyddsförordningen – Försäkringskassan. IMY-2025-11828, 18 November 2025."", ""url"": ""https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf""}, {""label"": ""Follow-up"", ""value"": ""Försäkringskassan told the Authority for Privacy Protection that it had taken its machine-learning risk profile for these checks out of use. It did so about a month before its reply of 5 September 2025 and had no plans to bring the profile back."", ""url"": ""https://www.imy.se/globalassets/dokument/beslut/2025/beslut-tillsyn-forsakringskassan.pdf""}]","{""kind"": ""Withdrawals""}" AIBD-0820,2016-01-01,event,month,mixed,New York City's Taxi and Limousine Commission finds that tailgating alerts from Mobileye's system fell in fitted cabs during its safety trial,"In a TLC trial, tailgating alerts from Mobileye's system fell from 100 per 100 miles in July 2015 to between 20 and 40 from January 2016. Crash rates in the trial did not clearly fall.",Tailgating alerts from *Mobileye* fall in New York taxis,fell from 100 per 100 miles in July 2015 to between 20 and 40,,found,Found by a regulator,before and after,very low,aggregate result,false,"Mobileye aftermarket warning system, with a black box recorder added for the trial",,Mobileye,Israel,"A fleet of mostly yellow taxis licensed by the TLC, in the TLC's Vehicle Safety Technology Pilot",United States,"New York City, New York, United States",United States,Road safety / for-hire vehicles,,Safety and rescue,Transportation,Highways,Images and video,Drivers and travelers,11,High income,physical_health,Hazard reduction,2,2,4,,2,5,,personal; societal,1,,0,Alert rates in the same fleet early in the trial,100 alerts for each 100 miles traveled (or one alert per mile) in July 2015,between 20 and 40 alerts per 100 miles starting in January 2016,measured,unknown,,shown,https://ims.mobileye.com/fleets/uk/blog/what-does-ai-have-to-do-with-collision-avoidance-systems/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""New York City Taxi and Limousine Commission. Vehicle Safety Technology Final Report. March 2018."", ""url"": ""https://www.nyc.gov/assets/tlc/downloads/pdf/final_vehicle_safety_technology_report.pdf""}, {""label"": ""Regulatory document"", ""value"": ""New York City Taxi and Limousine Commission. Vehicle Safety Technology Final Report. March 2018."", ""url"": ""https://www.nyc.gov/assets/tlc/downloads/pdf/final_vehicle_safety_technology_report.pdf""}]","{""kind"": ""Official documents""}" AIBD-0635,2015-01-01,event,year,reported,TIGTA finds that the IRS Return Review Program's identity-theft models alone selected $1.88 billion of confirmed identity-theft refunds in the 2015 filing season,"TIGTA found that IRS Return Review Program identity-theft models alone selected $1.88 billion, or 47.8%, of $3.92 billion in confirmed identity-theft refunds in 2015.",*Return Review Program* catches refund fraud that older filters missed,"selected $1.88 billion, or 47.8%, of $3.92 billion in confirmed identity-theft refunds",,found,Found by an auditor,tested against a standard,low,aggregate result,false,IRS Return Review Program (RRP) identity-theft models,,"Internal Revenue Service (Information Technology organization and Office of Research, Applied Analytics, and Statistics)",United States,Internal Revenue Service,United States,United States (national),United States,Tax administration,,Public sector,Government Operations,Tax Administration,Prediction from data,,16,High income,privacy_protection,Fraud detection,2,4,4,,4,5,,organizational; societal,6,,1,The older Electronic Fraud Detection System identity-theft models,$60 million (1.5%) of confirmed identity-theft refunds selected only by the older system,$1.88 billion (47.8%) selected only by the Return Review Program models,measured,persisted,2018-07-24,shown,https://www.tigta.gov/sites/default/files/reports/2022-02/201720080fr.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration. The Return Review Program Increases Fraud Detection; However, Full Retirement of the Electronic Fraud Detection System Will Be Delayed. Reference Number 2017-20-080, 25 September 2017."", ""url"": ""https://www.tigta.gov/sites/default/files/reports/2022-02/201720080fr.pdf""}, {""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office. Tax Fraud and Noncompliance: IRS Could Further Leverage the Return Review Program to Strengthen Tax Enforcement. GAO-18-544, July 2018."", ""url"": ""https://www.gao.gov/assets/gao-18-544.pdf""}, {""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration. The Return Review Program Enhances the Identification of Fraud; However, System Security Needs Improvement. Reference Number 2015-20-060, 2 July 2015, pp. 4–5. The inspector general compared the program's model for identity theft with the older filter in parallel runs."", ""url"": ""https://www.oversight.gov/sites/default/files/oig-reports/201520060fr.pdf""}, {""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration (TIGTA). Constantly Evolving Refund Fraud Patterns Require Continued Refinement and Development of Detection Initiatives (Reference Number 2020-40-040). Highlights, 'What TIGTA Found'"", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2020-07/202040040fr.pdf""}, {""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration (TIGTA). Efforts Continue to Result in Improved Identification of Fraudulent Tax Returns Involving Identity Theft; However, Accuracy of Measures Needs Improvement (Reference Number 2017-40-017). Results of Review, section on the Identity Theft Taxonomy"", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2017-10/201740017fr.pdf""}]","{""kind"": ""Official documents""}" AIBD-1037,2014-12-31,event,day,mixed,"The FDIC Inspector General finds that the SCOR, SCOR-Lag and GMS models flagged 67 of 244 well-rated banks downgraded from 2014 to 2017","The FDIC's Inspector General found that SCOR, SCOR-Lag and GMS had flagged 67 of the 244 banks rated 1 or 2 that were downgraded from late 2014 to late 2017.",Three FDIC models including *SCOR* flag 67 of 244 banks later downgraded,67 of the 244 banks,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Statistical CAMELS Offsite Rating (SCOR), SCOR-Lag and Growth Monitoring System (GMS) offsite monitoring models",,Federal Deposit Insurance Corporation,United States,"Federal Deposit Insurance Corporation, Division of Risk Management Supervision (Case Managers in six Regional Offices)",United States,United States (national),United States,Bank supervision,,Finance,Domestic Commerce,Banking,Prediction from data,,16,High income,operational_improvement,"Faster data management, decision-making",2,1,4,,2,2,,organizational,1,,0,,,,,unknown,,not shown,https://www.oversight.gov/sites/default/files/documents/reports/2023-06/20-002EVAL.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Federal Deposit Insurance Corporation, Office of Inspector General. Offsite Reviews of 1- and 2-Rated Institutions. Evaluation Report EVAL-20-002, 18 December 2019. Background, pp. 2-3, and section 'Downgraded Institutions', pp. 8-9."", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2023-06/20-002EVAL.pdf""}]","{""kind"": ""Official documents""}" AIBD-1150,2013-10-01,event,month,mixed,"Ofcom finds that live TV subtitles in the UK were generally accurate but arrived late, with respeakers using speech recognition alongside stenographers","In Ofcom's sampling of live subtitles from late 2013, accuracy was generally good. For news it was above 98%. But the median delay of 5.6 seconds exceeded Ofcom's 3-second guideline.","UK live subtitles by *respeaking* are accurate but late, Ofcom finds",the average accuracy rate was 98.5%,,found,Found by a regulator,tested against a standard,low,aggregate result,false,"Live subtitling by respeakers using speech recognition software, alongside stenographers",,Not named (speech recognition software used by subtitling providers),,"BBC, ITV, Channel 4, Channel 5 and Sky and their subtitling providers",United Kingdom,United Kingdom,United Kingdom,Broadcasting / live subtitles for deaf and hard-of-hearing viewers,,Accessibility,Technology,Broadcast,Speech and sound,People with disabilities,10,High income,accessibility,,2,,4,4,2,5,,personal,2,,0,The 98% accuracy threshold that Ofcom's external reviewers treat as acceptable,98%,generally higher for news than 98%,measured,persisted,2023-12-13,shown,https://web.archive.org/web/20180424104217id_/https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Ofcom. Measuring live subtitling quality: Results from the first sampling exercise. 30 April 2014, with an external review of the measurements by Pablo Romero-Fresco and Inma Pedregosa (University of Roehampton) in Annex 1. Archived copy of https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf. Section 1, para. 1.10."", ""url"": ""https://web.archive.org/web/20180424104217id_/https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Ofcom. Measuring live subtitling quality: Results from the first sampling exercise. 30 April 2014, with an external review of the measurements by Pablo Romero-Fresco and Inma Pedregosa (University of Roehampton) in Annex 1. Archived copy of https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf. Annex 1, section 2."", ""url"": ""https://web.archive.org/web/20180424104217id_/https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Ofcom. Measuring live subtitling quality: Results from the first sampling exercise. 30 April 2014, with an external review of the measurements by Pablo Romero-Fresco and Inma Pedregosa (University of Roehampton) in Annex 1. Archived copy of https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf. Section 1, para. 1.11."", ""url"": ""https://web.archive.org/web/20180424104217id_/https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Ofcom. Measuring live subtitling quality: Results from the first sampling exercise. 30 April 2014, with an external review of the measurements by Pablo Romero-Fresco and Inma Pedregosa (University of Roehampton) in Annex 1. Archived copy of https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf. Annex 1, section 2."", ""url"": ""https://web.archive.org/web/20180424104217id_/https://www.ofcom.org.uk/__data/assets/pdf_file/0019/45136/sampling-report.pdf""}]","{""kind"": ""Official documents""}" AIBD-1201,2012-10-01,event,month,mixed,"An NIJ-funded evaluation shows that ShotSpotter alerts brought Kansas City police to gunfire sooner and raised evidence recovery in both cities, with no gain in crime control","In an NIJ-funded evaluation, Kansas City officers reached ShotSpotter alerts in 266.82 s against 390.87 s for citizen calls. NIBIN collection ran 30.4% above control. Crime did not fall.","*ShotSpotter* got police to gunfire sooner, but crime did not fall",266.82 s against 390.87 s,,found,Found by an evaluation office,controlled comparison,low,aggregate result,false,"ShotSpotter gunshot detection technology (GDT), with alerts confirmed at the Real-Time Incident Review Center",,"ShotSpotter, Inc. (renamed SoundThinking, Inc. in 2023)",United States,Kansas City Police Department and Chicago Police Department,United States,"Kansas City, Missouri and Chicago, Illinois, United States",United States,Policing (gunfire detection),,Safety and rescue,Law and Crime,Police,Speech and sound,Public servants,16,High income,physical_health; operational_improvement,Crime reduction or prevention,2,2,4,4,2,5,0.420,organizational; societal,2,,0,Citizen calls for service about shots fired in Kansas City,"390.87 s to arrive on scene, stopping 54.62 m from the gunfire","266.82 s to arrive on scene, stopping 35.66 m from the gunfire",measured,withdrawn,2026-11-02,shown,https://www.soundthinking.com/law-enforcement/gunshot-detection-technology/,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Evaluation report"", ""value"": ""Piza, Eric L., George O. Mohler, Jeremy G. Carter, David N. Hatten, Nathan T. Connealy, Rachael Arietti, Jisoo Cho and Emily Castillo. The Impact of Gunshot Detection Technology on Gun Violence in Kansas City and Chicago: A Multi-Pronged Evaluation. Final report to the National Institute of Justice, award 2019-R2-CX-0004, document 308357, January 2024."", ""url"": ""https://www.ojp.gov/pdffiles1/nij/grants/308357.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Piza, Eric L., George O. Mohler, Jeremy G. Carter, David N. Hatten, Nathan T. Connealy, Rachael Arietti, Jisoo Cho and Emily Castillo. The Impact of Gunshot Detection Technology on Gun Violence in Kansas City and Chicago: A Multi-Pronged Evaluation. Final report to the National Institute of Justice, award 2019-R2-CX-0004, document 308357, January 2024."", ""url"": ""https://www.ojp.gov/pdffiles1/nij/grants/308357.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Piza, Eric L., George O. Mohler, Jeremy G. Carter, David N. Hatten, Nathan T. Connealy, Rachael Arietti, Jisoo Cho and Emily Castillo. The Impact of Gunshot Detection Technology on Gun Violence in Kansas City and Chicago: A Multi-Pronged Evaluation. Final report to the National Institute of Justice, award 2019-R2-CX-0004, document 308357, January 2024."", ""url"": ""https://www.ojp.gov/pdffiles1/nij/grants/308357.pdf""}, {""label"": ""Follow-up"", ""value"": ""Chicago took ShotSpotter offline in 2024, as The Center Square reported in November 2026 while the city weighed a new pilot. No report was found on whether Kansas City kept its contract."", ""url"": ""https://www.thecentersquare.com/illinois/article_f3cae6f6-c6fd-4685-8f62-41379238db4b.html""}]","{""kind"": ""Withdrawals""}" AIBD-0725,2012-01-01,event,year,reported,"CrimeSolutions finds that patrols guided by the ETAS crime-forecasting model, later sold as PredPol, cut crime volume in a Los Angeles trial","In a 2011-2013 LAPD trial rated Promising by CrimeSolutions, patrols sent by the ETAS model saw 7.4 percent less crime per 1,000 patrol minutes than patrols sent by analysts.",*PredPol* maps cut property crime per patrol minute in an LAPD trial,an average 7.4 percent reduction in crime volume per thousand minutes of patrol time,,found,Found by an assessment body,randomized trial,high,aggregate result,false,"Epidemic-type aftershock sequence (ETAS) crime forecasting model, known as PredPol (later Geolitica)",,"PredPol (later Geolitica), from the ETAS model of George Mohler and colleagues",United States,"Los Angeles Police Department (Foothill, North Hollywood and Southwest divisions)",United States,"Los Angeles, California, United States",United States,Policing,,Safety and rescue,Law and Crime,Police,Prediction from data,Public servants,16,High income,physical_health,Crime reduction or prevention,2,,3,,3,5,,societal,2,,0,Patrols sent to boxes chosen by LAPD crime analysts,,An average 7.4 percent reduction in crime volume per thousand minutes of patrol time,measured,withdrawn,,shown,https://crimesolutions.ojp.gov/ratedprograms/predictive-policing-model-los-angeles-calif,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Assessment report"", ""value"": ""CrimeSolutions, National Institute of Justice, U.S. Department of Justice. Program Profile: Predictive Policing Model in Los Angeles, Calif. Rated Promising. Posted 28 November 2022."", ""url"": ""https://crimesolutions.ojp.gov/ratedprograms/predictive-policing-model-los-angeles-calif""}, {""label"": ""Audit report"", ""value"": ""Office of the Inspector General, Los Angeles Police Commission (2019). Review of Selected Los Angeles Police Department Data-Driven Policing Strategies, Section III.D.3, Conclusions and Next Steps (PredPol), pp. 29-30."", ""url"": ""https://www.oig.lacity.org/_files/ugd/b2dd23_21f6fe20f1b84c179abf440d4c049219.pdf""}, {""label"": ""Follow-up"", ""value"": ""CrimeSolutions notes that the LAPD no longer has a contract with PredPol, citing a Guardian report of 8 November 2021 on the end of the LAPD's predictive policing programs."", ""url"": ""https://crimesolutions.ojp.gov/ratedprograms/predictive-policing-model-los-angeles-calif""}]","{""kind"": ""Withdrawals""}" AIBD-0716,2011-02-01,event,month,reported,The What Works Clearinghouse finds that DreamBox Learning had potentially positive effects on math for students from kindergarten to first grade,"The What Works Clearinghouse rated DreamBox Learning as having potentially positive effects on math, an improvement index of +4, in a trial with 557 students from kindergarten to first grade.",*DreamBox Learning* lifts early math scores in a San Jose trial,an improvement index of +4,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,DreamBox Learning (adaptive online K-5 mathematics program),,"DreamBox Learning, Inc.",United States,"Rocketship Education (three charter elementary schools in San Jose, California)",United States,"San Jose, California, United States",United States,Education,,Education,Education,Elementary & Secondary,,Students; Children,4,High income,incentivization,Increased/personalized knowledge,2,3,3,4,3,5,0.480,personal,1,,0,Students randomly assigned to an online literacy program during the same lab time,"156.20 (comparison group mean, MAP overall math score)",159.00 (DreamBox group mean),measured,persisted,2023-10-12,not shown,https://ies.ed.gov/ncee/WWC/Docs/InterventionReports/wwc_dreambox_121013.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""U.S. Department of Education, Institute of Education Sciences, What Works Clearinghouse. Elementary School Mathematics intervention report: DreamBox Learning. December 2013, modified 5 February 2014. Pages 1 and 3."", ""url"": ""https://ies.ed.gov/ncee/WWC/Docs/InterventionReports/wwc_dreambox_121013.pdf""}]","{""kind"": ""Official documents""}" AIBD-0724,2010-01-01,event,year,reported,"The What Works Clearinghouse finds that the ITSS tutor has positive effects on reading comprehension in two randomized trials with 6,724 students","The What Works Clearinghouse rates ITSS as having positive effects on comprehension. Across two randomized studies with 6,724 students in grades 4, 5 and 7, the improvement index was +9.",*ITSS* tutoring software raises reading comprehension in two trials,The improvement index was +9 percentile points,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,Web-Based Intelligent Tutoring for the Structure Strategy (ITSS),,ITSS developers led by Kausalai Wijekumar (contact at Texas A&M University),United States,"Rural and suburban schools in two US states (grades 4, 5 and 7) in the two rated studies",United States,United States (two states that the report does not name),United States,Education,,Education,Education,Elementary & Secondary,,Students,4,High income,incentivization,Increased/personalized knowledge,2,3,3,4,3,4,0.420,personal,2,,0,Classrooms using the usual language arts curriculum,,Improvement index of +9 percentile points,measured,persisted,2015-08-01,not shown,https://ies.ed.gov/ncee/WWC/Docs/InterventionReports/wwc_ALitss_IR_apr2020.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""What Works Clearinghouse, Institute of Education Sciences, U.S. Department of Education. Web-Based Intelligent Tutoring for the Structure Strategy (ITSS). Intervention Report, Adolescent Literacy Topic Area, NCEE 2020-009. April 2020, revised April 2021."", ""url"": ""https://ies.ed.gov/ncee/WWC/Docs/InterventionReports/wwc_ALitss_IR_apr2020.pdf""}]","{""kind"": ""Official documents""}" AIBD-0214,2009-01-01,event,year,mixed,U.S. high schools using Cognitive Tutor Algebra I see a second-year gain that loses significance after correction,"Students using Cognitive Tutor Algebra I scored 0.21 standard deviations higher in the second year, with no statistically significant difference after correction for multiple comparisons.",Algebra software shows an uncertain gain in a trial's second year,scored 0.21 standard deviations higher in the second year,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,"Cognitive Tutor Algebra I, with an ACT-R-based cognitive model, classroom instruction, and curriculum materials",,Carnegie Learning,United States,Participating public and Catholic parochial schools in 51 districts across seven states (study sites),,"Seven states (147 schools), United States",United States,Education,Secondary-school algebra,Education,Education,Excellence,Prediction from data,Students,4,High income,incentivization,Increased/personalized knowledge,2,3,3,,2,4,,personal,9,,0,Schools using their usual algebra curriculum,Comparison schools in the same implementation year,"Second high-school cohort: +0.21 standard deviations; p = .04 before correction, not significant at the Clearinghouse’s corrected threshold of .025",measured,challenged,2016-12-21,not shown,https://doi.org/10.3758/BF03194060,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Assessment report"", ""value"": ""What Works Clearinghouse. Cognitive Tutor® Algebra I. June 2016, revised 21 December 2016."", ""url"": ""https://ies.ed.gov/ncee/wwc/Docs/InterventionReports/wwc_cognitivetutor_122116.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evidence for ESSA, Center for Research and Reform in Education, Johns Hopkins University. Carnegie Learning High School Math Solution Algebra I, program rating Strong, program outcomes (read 31 October 2026). The rating rests on the same trial. The What Works Clearinghouse rates its results as mixed."", ""url"": ""https://www.evidenceforessa.org/program/carnegie-learning-high-school-math-solution/""}, {""label"": ""Follow-up"", ""value"": ""The revised What Works Clearinghouse review rated the wider algebra evidence as mixed. It found that this trial's second-year estimate was not statistically significant after correction for multiple comparisons."", ""url"": ""https://ies.ed.gov/ncee/wwc/Docs/InterventionReports/wwc_cognitivetutor_122116.pdf""}]","{""kind"": ""Challenges""}" AIBD-0794,2008-09-01,event,month,mixed,"FDA finds that surgeons using the MarginProbe System removed more cancer at lumpectomy margins, with 5 percentage points fewer re-operations","In a randomized trial that FDA reviewed, MarginProbe raised complete re-excision of positive margins from 22.4% to 71.8%. A 5-point drop in re-operations was not statistically significant.",*MarginProbe* helped surgeons remove cancer left at lumpectomy margins,from 22.4% to 71.8%,,found,Found by a regulator,randomized trial,moderate,aggregate result,false,MarginProbe System,,"Dune Medical Devices, Inc.",United States,Surgical sites in the randomized trial in Israel and the United States (596 women undergoing lumpectomy),Israel and United States,Israel and United States,Israel | United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Women and mothers; Health workers,3,High income,physical_health,Medical diagnosis,2,3,1,2,2,1,0.120,organizational; personal,2,,0,Standard care in the randomized control arm,25.8% of patients had a further excision,20.8%,measured,persisted,2018-07-31,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110014B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P110014: Dune Medical Devices MarginProbe System. Approved 2012-12-27."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110014B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0796,2006-03-16,source publication,day,mixed,"FDA finds that adding the LUMA Cervical Imaging System after colposcopy found 22.0% more women with high-grade lesions, with extra biopsies","In a study of 193 women that FDA reviewed, biopsies directed by LUMA after colposcopy found high-grade lesions in 9 more women, a 22.0% relative gain.",*LUMA* imaging found more high-grade cervical lesions after colposcopy,a 22.0% relative gain,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,LUMA Cervical Imaging System,,"MediSpectra, Inc.",United States,Seven colposcopy centers with 16 colposcopists in the intended use study,,,,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Women and mothers,3,,physical_health,Medical diagnosis,2,2,1,,2,1,,personal,2,,0,Colposcopy alone in the same women,"41 women with CIN 2,3+ found by colposcopy (21.2%)",9 more women found with LUMA (4.7%),measured,withdrawn,,not shown,https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040028B.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P040028: LUMA Cervical Imaging System. Approved 2006-03-16."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040028B.pdf""}, {""label"": ""Follow-up"", ""value"": ""The post-approval study of LUMA that FDA required, led by SpectraScience after MediSpectra, is listed as terminated after enrolling 10 of 950 planned patients."", ""url"": ""https://ctv.veeva.com/study/study-of-luma-cervical-imaging-system-as-adjunct-to-colposcopy""}]","{""kind"": ""Withdrawals""}" AIBD-0679,2005-01-01,event,year,reported,ANAO finds that the Passport Office's facial recognition matching caught many identity frauds that would otherwise have gone undetected,"The ANAO found that facial recognition matching of passport applications detected many identity frauds that would not otherwise have been found, about 22 recorded a year.",Passport photo *FR matching* exposes otherwise hidden identity fraud,about 22 recorded a year,,found,Found by an auditor,no comparison,very low,aggregate result,false,Australian Passport Office facial recognition (FR) matching of applicants' photos against its image database (one-to-many),,A commercial supplier of the biometric algorithm (not named in the report),,"Australian Passport Office, Department of Foreign Affairs and Trade",Australia,Australia (national),Australia,Identity documents (passport issuing),,Public sector,International Affairs,Diplomats,Images and video,Public servants,16,High income,privacy_protection,Fraud detection,2,1,4,,3,3,,organizational; societal,1,,0,,,,,persisted,2025-11-18,not shown,https://www.anao.gov.au/sites/default/files/201112%20Audit%20Report%20No%2033.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Australian National Audit Office. Management of ePassports, Department of Foreign Affairs and Trade. Audit Report No.33 2011–12, 22 May 2012, paragraphs 4.16 to 4.20."", ""url"": ""https://www.anao.gov.au/sites/default/files/201112%20Audit%20Report%20No%2033.pdf""}]","{""kind"": ""Official documents""}" AIBD-2305,1998-09-25,source publication,day,reported,FDA approval review of the Logicon Caries Detector: dentists' sensitivity for decay in the dentin rose from 70.3% to 90.5% with a neural network's reading of X-rays,"In the clinical study that FDA reviewed, 18 dentists found decay that had reached the dentin with 90.5% sensitivity after running the Logicon Caries Detector, against 70.3% before.",*Logicon Caries Detector* helped dentists find more decay on X-rays,90.5%,,found,Found by a regulator,before and after,very low,aggregate result,false,Logicon Caries Detector,,"Logicon RDA, a Northrop Grumman company (Carestream Dental is the applicant in FDA's database today)",United States,18 dentists in 16 private practice offices in the United States,United States,United States,United States,Healthcare (dentistry),,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,2,3,1,,3,1,,organizational,2,,0,The same dentists' diagnoses of the same surfaces before they ran the software,"Mean sensitivity 70.3%, specificity 88.6%","Mean sensitivity 90.5%, specificity 88.3%",measured,persisted,2011-03-01,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the Logicon Caries Detector (P980025). Approved 1998-09-25. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P980025.pdf""}]","{""kind"": ""Official documents""}" AIBD-1184,2026-10-09,source publication,day,reported,HMICFRS finds that Dyfed-Powys Police's integration of artificial intelligence with other digital tools is improving productivity,"In its PEEL report of 9 October 2026, HMICFRS found that Dyfed-Powys Police is improving productivity by integrating AI with other digital tools. It found the same for decision-making.",*Artificial intelligence tools* and others lift Dyfed-Powys productivity,,,found,Found by an auditor,no comparison,very low,program,false,Artificial intelligence tools within Dyfed-Powys Police's digital transformation program (not named in the report),,,,Dyfed-Powys Police,United Kingdom,"Carmarthenshire, Ceredigion, Pembrokeshire and Powys, Wales, United Kingdom",United Kingdom,Policing,,Safety and rescue,Law and Crime,Police,,,16,High income,operational_improvement,Enhanced productivity,1,1,,,3,,,organizational,1,,0,,,,,unknown,,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2025-27: An inspection of Dyfed-Powys Police. 9 October 2026. Original address: https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/dyfed-powys-2025-27/ (Wayback copy cited)."", ""url"": ""https://web.archive.org/web/20261009134848id_/https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/dyfed-powys-2025-27/""}, {""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2025-27: An inspection of Dyfed-Powys Police. 9 October 2026. Leadership and force management."", ""url"": ""https://web.archive.org/web/20261009134848id_/https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/dyfed-powys-2025-27/""}]","{""kind"": ""Official documents""}" AIBD-0868,2026-09-08,source publication,day,reported,HM Inspectorate of Constabulary finds that Thames Valley Police's Bobbi chatbot helped manage non-emergency demand by guiding the public,HM Inspectorate of Constabulary found that Thames Valley Police's Bobbi chatbot helped manage non-emergency demand. It directed people to the most appropriate service early.,*Bobbi* chatbot helps Thames Valley Police handle non-emergency contact,,,found,Found by an auditor,no comparison,very low,aggregate result,false,Bobbi (AI agent built on Salesforce Agentforce),,"Thames Valley Police and Hampshire and Isle of Wight Constabulary, on Salesforce's Agentforce platform",United Kingdom,Thames Valley Police (shared with Hampshire and Isle of Wight Constabulary),United Kingdom,"Thames Valley, England",United Kingdom,Policing,,Safety and rescue,Law and Crime,Police,Text and language,The public; Public servants,16,High income,operational_improvement,Enhanced productivity,1,,3,4,3,5,,organizational; personal,2,,0,,,,,unknown,,shown,https://www.salesforce.com/blog/atlas-reasoning-engine/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. State of Policing: The Annual Assessment of Policing in England and Wales 2025-26. Published 8 September 2026. Section 2, overview of the PEEL 2025-27 inspections, response to calls for service (archived copy). The inspectorate inspects police forces and has no role in building or running Bobbi."", ""url"": ""https://web.archive.org/web/20261012112357/https://hmicfrs.justiceinspectorates.gov.uk/publication-html/state-of-policing-the-annual-assessment-of-policing-in-england-and-wales-2025-26/""}]","{""kind"": ""Official documents""}" AIBD-1166,2026-08-01,source publication,month,reported,"WFP's Office of Evaluation finds that WFP could use limited assessment data with the help of AI tools that forecast food consumption, built with Google Research Africa",WFP built AI tools with Google Research Africa to forecast household food consumption weeks ahead. Its Office of Evaluation found that these tools helped WFP use its reduced assessment data.,AI forecasts help WFP use its shrinking data from food assessments,,,found,Found by an evaluation office,no comparison,very low,benefit created,false,AI-driven tools for forecasting household food consumption several weeks in advance (not named),,World Food Programme (WFP) with Google Research Africa,Italy and United States,"World Food Programme (WFP), for food security analysis",Italy,"Global (WFP operations, countries not named)",,Humanitarian food security analysis,,Agriculture and food,International Affairs,Developing Countries,Prediction from data,,2,,operational_improvement,"Faster data management, decision-making",1,1,,,3,,,organizational; societal,1,,0,,,,,unknown,,not shown,https://docs.wfp.org/api/documents/WFP-0000176693/download/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""WFP Office of Evaluation. Strategic evaluation of WFP's adaptation to the evolving partnership landscape. Centralized evaluation report OEV/2025/016, August 2026. Conducted by an external evaluation team between October 2025 and June 2026."", ""url"": ""https://docs.wfp.org/api/documents/WFP-0000176693/download/""}]","{""kind"": ""Official documents""}" AIBD-0909,2026-07-02,source publication,day,reported,"Singapore's Auditor-General observes that IPOS's trade mark system recommends classes from uploads, which cuts errors in fees","Singapore's Auditor-General observed that IPOS's system for trademark applications recommends classes from uploaded material. It calculates fees, so fewer fees are wrong. Fewer applicants refile.",IPOS's trade mark system recommends classes from what applicants upload,,,found,Found by an auditor,no comparison,very low,program,false,IPOS trade mark application system (recommends trade mark classes from uploaded images or text descriptions),,Intellectual Property Office of Singapore (IPOS) (vendor not named),Singapore,Intellectual Property Office of Singapore (IPOS),Singapore,Singapore,Singapore,Intellectual property administration,,Public sector,Domestic Commerce,Copyrights and Patents,Images and video; Text and language,Consumers,16,High income,operational_improvement,Enhanced productivity,1,,1,,3,,,personal,1,,0,,,,,unknown,,not shown,https://isomer-user-content.by.gov.sg/357/4f8ec87d-3c06-4ada-bc7c-80214c49cfd9/Report%20of%20the%20Auditor-General%20for%20FY2025-26.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Auditor-General's Office, Singapore. Report of the Auditor-General for the Financial Year 2025/26, 2 July 2026. Overview, Selective Audits."", ""url"": ""https://isomer-user-content.by.gov.sg/357/4f8ec87d-3c06-4ada-bc7c-80214c49cfd9/Report%20of%20the%20Auditor-General%20for%20FY2025-26.pdf""}]","{""kind"": ""Official documents""}" AIBD-0817,2026-06-17,source publication,day,reported,"The RDW reports that almost 40,000 Teslas drove about 24 million km with FSD Supervised in the Netherlands without relevant incidents","The Dutch vehicle authority reported in June 2026 that almost 40,000 Teslas had driven about 24 million km with FSD Supervised since its approval without relevant incidents.",Teslas on *FSD Supervised* drive 24 million km in the Netherlands,"almost 40,000 Teslas had driven about 24 million km",,found,Found by a regulator,no comparison,very low,aggregate result,false,FSD Supervised (Full Self Driving Supervised),,Tesla,United States,"Tesla, in owners' cars in the Netherlands after the EU type approval",United States,Netherlands,Netherlands,Road transport / driver assistance,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,High income,physical_health,Hazard reduction,1,4,,,3,,,personal; societal,1,,0,Other driving aids,,"At least as safe, in the RDW's judgment",assumed,unknown,,shown,https://en.wikipedia.org/wiki/Tesla_Autopilot,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""RDW (Rijksdienst voor het Wegverkeer, Netherlands Vehicle Authority). Toelichting typegoedkeuring FSD Supervised. News item, 17 June 2026 (in Dutch)."", ""url"": ""https://www.rdw.nl/nieuws/2026/toelichting-typegoedkeuring-fsd-supervised""}, {""label"": ""Regulatory document"", ""value"": ""RDW (Rijksdienst voor het Wegverkeer, Netherlands Vehicle Authority). Toelichting typegoedkeuring FSD Supervised. News item, 17 June 2026 (in Dutch)."", ""url"": ""https://www.rdw.nl/nieuws/2026/toelichting-typegoedkeuring-fsd-supervised""}]","{""kind"": ""Official documents""}" AIBD-1047,2026-06-16,source publication,day,reported,Care Inspectorate Wales and Healthcare Inspectorate Wales find that AI-enabled recording tools accurately record people's own words in Conwy,Care Inspectorate Wales and Healthcare Inspectorate Wales found that Conwy's learning disability practitioners use AI-enabled recording tools to accurately record people's own words.,*AI-enabled recording tools* keep people's own words in Conwy records,,,found,Found by an assessment body,no comparison,very low,program,false,AI-enabled recording tools used by community learning disability practitioners (not named in the letter),,Not named in the letter,,"Conwy County Borough Council and Betsi Cadwaladr University Health Board, Community Learning Disability Team",United Kingdom,"Conwy, Wales, United Kingdom",United Kingdom,Learning disability services (social care and health),,Accessibility,Social Welfare,Disabled Assistance,Speech and sound; Text and language,Public servants; People with disabilities,3; 10,High income,operational_improvement,,1,1,,4,3,,,organizational; personal,1,,0,,,,,unknown,,not shown,https://www.careinspectorate.wales/sites/default/files/2026-06/260616-conwy-cldt-letter-en.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Care Inspectorate Wales and Healthcare Inspectorate Wales. Joint assurance check letter: Community Learning Disability Team in Conwy (Conwy County Borough Council and Betsi Cadwaladr University Health Board). Assurance check 9 to 11 February 2026, letter published 16 June 2026. Section 3, People, Strengths, paragraph 3.1. The sentence begins 'Practitioners use AI-enabled' on page 2 and ends on page 3. The inspectorates state it as their own finding and do not attribute it to staff."", ""url"": ""https://www.careinspectorate.wales/sites/default/files/2026-06/260616-conwy-cldt-letter-en.pdf""}, {""label"": ""Assessment report"", ""value"": ""Care Inspectorate Wales and Healthcare Inspectorate Wales. Joint assurance check letter: Community Learning Disability Team in Conwy. Section 5, Methodology, paragraph 5.1."", ""url"": ""https://www.careinspectorate.wales/sites/default/files/2026-06/260616-conwy-cldt-letter-en.pdf""}]","{""kind"": ""Official documents""}" AIBD-0706,2026-06-10,event,day,reported,"Brazil's Federal Court of Accounts finds that Galileu's drafts cover 93.3% of claims in labor cases, with hallucinations in 7.3% of topics","Brazil's Federal Court of Accounts tested the Galileu judgment-drafting tool on 50 real cases. Its drafts covered 93.3% of the parties' claims, with hallucinations in 7.3% of topics.",Brazil's audit court finds *Galileu* drafts reliable in labor cases,93.3% of the parties' claims,,found,Found by an auditor,no comparison,very low,aggregate result,false,Galileu (generative AI drafting assistant on Google Gemini Flash models),,"Tribunal Regional do Trabalho da 4ª Região (TRT-4), using Google Gemini models through the cloud contract of the Conselho Superior da Justiça do Trabalho (CSJT)",Brazil,"TRT-4 (Rio Grande do Sul), with a national rollout to the Labor Justice coordinated by the CSJT",Brazil,"Rio Grande do Sul, Brazil",Brazil,Justice administration: labor court drafting,,Public sector,Law and Crime,Court Administration,Text and language,Public servants,16,Upper middle income,operational_improvement,Enhanced productivity,1,3,4,3,3,,,organizational,1,,0,,,,,scaled,,shown,https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=919995,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 2836/2026 – TCU – Plenário (TC 001.458/2026-4), relator Ministro Odair Cunha, session of 14 October 2026. Operational audit of the Galileu system at TRT-4, report by the Unidade de Auditoria Especializada em Tecnologia da Informação (AudTI), items 2.2, 2.6 and 155."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=919995""}]","{""kind"": ""Official documents""}" AIBD-1165,2026-03-01,source publication,month,reported,UNICEF's Evaluation Office finds that AI analysis of complaint narratives gave insights that appeared specific enough for UNICEF programs to use,"UNICEF's Evaluation Office found that two UNICEF teams used AI to analyze narratives of feedback, including complaints. The analysis gave insights that appeared specific enough for programs to use.",AI analysis of complaint narratives yields trends for UNICEF programs,,,found,Found by an evaluation office,no comparison,very low,benefit created,false,AI analysis of feedback and complaint narratives used by UNICEF's GRM and SBC teams (unnamed tool),,Not named in the report,,"UNICEF's grievance redress mechanism (GRM) and social and behavior change (SBC) teams, in a country office that the passage does not name (the report's GRM and SBC examples are from UNICEF Afghanistan)",,Country office not named in the passage (the report's GRM and SBC examples are from Afghanistan),Afghanistan,Humanitarian accountability and community feedback,,Humanitarian,International Affairs,Organizations,Text and language,Public servants,16,Low income,operational_improvement,"Faster data management, decision-making",1,1,,,3,,,organizational,1,,0,,,,,unknown,,not shown,https://evaluationreports.unicef.org/GetDocument?documentID=20750&fileID=60839,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNICEF Evaluation Office. Evaluation of UNICEF's Accountability to Affected Populations: Evaluation report. Carried out by Itad. New York, March 2026. The evaluation covers 2020 to 2025."", ""url"": ""https://evaluationreports.unicef.org/GetDocument?documentID=20750&fileID=60839""}]","{""kind"": ""Official documents""}" AIBD-0891,2026-01-01,source publication,month,mixed,"The Austrian Institute for Health Technology Assessment found that clinicians felt less burdened by documentation with AI scribes, but time savings varied","In a review of seven reviews covering 36 studies, AIHTA found that clinicians were generally satisfied with AI scribes. They felt less burdened by documentation. Time savings were inconsistent.",Clinicians feel less burdened by documentation with *AI scribes*,from a 19-92% decrease to a 13-50% increase,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"AI scribes (ambient scribes), including Dragon Ambient eXperience, Abridge, Nabla Copilot, Sunoh.ai and Amazon HealthScribe",,"Several makers, including Nuance (Dragon Ambient eXperience), Abridge, Nabla, Sunoh.ai and Amazon","Multiple: United States, France","Hospitals, clinics and other services in the studies that AIHTA reviewed",Multiple,"Multiple countries (studies), mostly the United States",United States,Healthcare (clinical documentation),,Health,Health,Medical Facilities,Speech and sound; Text and language,Health workers,3,High income,operational_improvement,Enhanced productivity,1,,,,2,,,personal; organizational,2,,0,"Typing and dictation, in one randomized trial",,"2.7x faster than typing, 2x faster than dictation for patient history sections",measured,persisted,2026-05-01,shown,https://eprints.aihta.at/1597/1/HTA-Projektbericht_Nr.171a.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Erdös J, Grabenhofer L. Artificial Intelligence for Hospital Documentation Support: A Scoping Review of Current Use Cases. AIHTA Project Report No. 171a. Vienna: Austrian Institute for Health Technology Assessment, January 2026. Executive summary and Table 3-3."", ""url"": ""https://eprints.aihta.at/1597/1/HTA-Projektbericht_Nr.171a.pdf""}, {""label"": ""Assessment report"", ""value"": ""Centre for Assessment of Medical Technology in Örebro (CAMTÖ), Region Örebro län (2026). A Systematic Review Comparing Ambient Scribes and Conventional Documentation Methods in Outpatient Care (HTA-rapport 2026:86), Abstract, Conclusion (p. 5)."", ""url"": ""https://www.regionorebrolan.se/siteassets/media/forskning/hta-camto/rapporter/rapporter-2026/2026.86-a-systematic-review-comparing-ambient-scribes-and-conventional-documentation-methods-in-outpatient-care.pdf""}]","{""kind"": ""Official documents""}" AIBD-1179,2026-01-01,event,year,mixed,New Zealand's Education Review Office finds that teachers using generative AI report less time tailoring resources,"In ERO's 2026 survey, 61 percent of New Zealand secondary teachers report less time tailoring resources. For planning lessons, 44 percent do. Checking student work often offsets these savings.",New Zealand teachers say *generative AI* saves time tailoring resources,61 percent of New Zealand secondary teachers report less time tailoring resources,,found,Found by an auditor,no comparison,very low,aggregate result,false,Generative AI tools used by teachers (the report names no product),,,,Teachers in New Zealand English-medium state and state-integrated schools with students in Year 5 and above,New Zealand,New Zealand (national),New Zealand,Education,,Education,Education,Elementary & Secondary,Text and language,Teachers,4,High income,operational_improvement,Enhanced productivity,1,3,1,2,2,,,personal; organizational,1,,0,,,,,unknown,,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Education Review Office (Te Tari Arotake Mātauranga), Education Evaluation Centre (Te Ihuwaka). Ready or not: How are schools responding to Artificial Intelligence? Research report, 2026."", ""url"": ""https://www.evidence.ero.govt.nz/media/bz2b144q/ready-or-not-how-are-schools-responding-to-artificial-intelligence-research-report.pdf""}, {""label"": ""Audit report"", ""value"": ""Education Review Office (Te Tari Arotake Mātauranga), Education Evaluation Centre (Te Ihuwaka). Ready or not: How are schools responding to Artificial Intelligence? Research report, 2026. Section on primary schools."", ""url"": ""https://www.evidence.ero.govt.nz/media/bz2b144q/ready-or-not-how-are-schools-responding-to-artificial-intelligence-research-report.pdf""}, {""label"": ""Audit report"", ""value"": ""Education Review Office (Te Tari Arotake Mātauranga), Education Evaluation Centre (Te Ihuwaka). Ready or not: How are schools responding to Artificial Intelligence? Research report, 2026. Section on secondary schools."", ""url"": ""https://www.evidence.ero.govt.nz/media/bz2b144q/ready-or-not-how-are-schools-responding-to-artificial-intelligence-research-report.pdf""}]","{""kind"": ""Official documents""}" AIBD-0183,2025-12-16,source publication,day,mixed,Data mining grows from a third to half of French tax controls. The Cour des comptes finds efficiency gains. It also finds a 13.8% share of recovered tax,"The Cour des comptes found that data mining, with machine learning in the tax administration's CFVR program, came to start half of tax controls and made their programming more efficient.","Data mining grows to half of French tax controls, with efficiency gains",originated half of tax controls but accounted for 13.8% of the tax and penalties recovered in 2023,,found,Found by an auditor,before and after,very low,aggregate result,false,"DGFiP Ciblage de la fraude et valorisations des requêtes (CFVR), including machine-learning models for tax-risk analysis",,Direction générale des Finances publiques (DGFiP),France,Direction générale des Finances publiques (DGFiP),France,France (national),France,Tax compliance,Audit targeting and fraud detection,Finance,Government Operations,Tax Administration,Prediction from data,Public servants,16,High income,operational_improvement; privacy_protection,Enhanced productivity,1,1,4,,3,,,organizational; societal,5,,1,tax controls initiated by DGFiP agents' own analysis,,,measured,scaled,2026-07-21,shown,https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes, 'La détection de la fraude fiscale des particuliers', 15 November 2023"", ""url"": ""https://www.ccomptes.fr/fr/publications/la-detection-de-la-fraude-fiscale-des-particuliers""}, {""label"": ""Audit report"", ""value"": ""Cour des comptes, “La lutte contre la fraude fiscale”, 16 December 2025. The French public audit court has no stake in the DGFiP systems. At the end of a cycle of audits it found that mass data cross-matching originates half of tax controls. By its count, cross-matching accounted for 13.8% of the tax and penalties recovered in 2023."", ""url"": ""https://www.ccomptes.fr/fr/publications/la-lutte-contre-la-fraude-fiscale""}, {""label"": ""Audit report"", ""value"": ""Cour des comptes. L’intelligence artificielle dans les politiques publiques : l’exemple du ministère de l’économie et des finances. Observations définitives S2024-1165, 22 October 2024, p. 34. France's audit court has no stake in the tax administration's systems."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}]","{""kind"": ""Official documents""}" AIBD-0991,2025-07-07,source publication,day,mixed,The Supreme Court of British Columbia refused to make Acciona redo its machine-learning review of about 7 million documents,In July 2025 a British Columbia court refused to make Acciona redo its TAR 1.0 review of about 7 million documents. It found that a TAR 2.0 review would have cost more than $10.6 million.,BC court declines to make Acciona redo its *TAR 1.0* review,about 7 million documents,,found,Found by a court,no comparison,very low,benefit created,false,"TAR 1.0 predictive coding models (one English, one Spanish)",,"TransPerfect Legal, which built and ran the models (the judgment does not name the TAR software)",United States,"Acciona Wastewater Solutions LP, with its counsel Dentons",Canada,"Vancouver, British Columbia, Canada",Canada,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,1,1,,2,1,,organizational,1,,0,"A TAR 2.0 (continuous active learning) review, with more manual review",more than $10.6 million,,assumed,unknown,,shown,https://web.archive.org/web/20250806185330id_/https://www.bccourts.ca/jdb-txt/sc/25/12/2025BCSC1256.htm,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Supreme Court of British Columbia (Justice Elwood). Acciona Wastewater Solutions LP v. Greater Vancouver Sewerage and Drainage District, 2025 BCSC 1256, Reasons for Judgment, 7 July 2025, paras 13-16, 24-36 and 96-103. BC Courts text, read through the Internet Archive."", ""url"": ""https://web.archive.org/web/20250806185330id_/https://www.bccourts.ca/jdb-txt/sc/25/12/2025BCSC1256.htm""}]","{""kind"": ""Official documents""}" AIBD-0842,2025-03-20,source publication,day,mixed,Jonathan Fisher KC's review says that OpenText Axcelerate lets the Serious Fraud Office find disclosable material much faster than a human,Jonathan Fisher KC's independent review says that OpenText Axcelerate helps the Serious Fraud Office find disclosable material much faster than a human. It reports a fault in the tool's setup.,*Axcelerate* speeds the Serious Fraud Office's review for disclosure,,,found,Found by an auditor,no comparison,very low,program,false,OpenText Axcelerate,,OpenText,Canada,Serious Fraud Office (SFO),United Kingdom,United Kingdom,United Kingdom,Criminal justice / disclosure in fraud cases,,Finance,Law and Crime,White Collar Crime,Text and language,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",1,1,4,,2,,,organizational,3,,0,A human reviewer,,at much faster rates,assumed,unknown,,shown,https://cdn.websitebuilder.service.justice.gov.uk/uploads/sites/24/2024/08/SFO-Disclosure-Report-2.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""Jonathan Fisher KC, Independent Review of Disclosure and Fraud Offences. Disclosure in the Digital Age: Independent Review of Disclosure and Fraud Offences, Part 1 (CP 1285), published 20 March 2025, paras 231-233."", ""url"": ""https://assets.publishing.service.gov.uk/media/67e279b64fed20c7f559f558/Disclosure_in_the_Digital_Age_-_Independent_Review_Report_CP1285_WEB_0.1.pdf""}, {""label"": ""Audit report"", ""value"": ""HM Crown Prosecution Service Inspectorate (HMCPSI). An inspection of the handling and management of disclosure in the Serious Fraud Office. Chapter 9, para 9.42 (also para 4.16 for the AI features)"", ""url"": ""https://cdn.websitebuilder.service.justice.gov.uk/uploads/sites/24/2024/08/SFO-Disclosure-Report-2.pdf""}, {""label"": ""Audit report"", ""value"": ""HM Crown Prosecution Service Inspectorate (HMCPSI). Serious Fraud Office: case progression follow-up inspection. Para 10.27 (also para 7.33)"", ""url"": ""https://cdn.websitebuilder.service.justice.gov.uk/uploads/sites/24/2024/08/SFO-case-progression-follow-up.pdf""}]","{""kind"": ""Official documents""}" AIBD-1044,2025-03-11,source publication,day,reported,Ofsted finds that AI pilots in Sunderland's children's services let managers spend more time in reflective supervision that is well recorded,Ofsted found in March 2025 that AI pilots in Sunderland's children's services let managers spend more time in reflective conversations with social workers. It found that these were well recorded.,Piloted *AI tools* free Sunderland managers for reflective supervision,,,found,Found by an assessment body,no comparison,very low,program,false,AI tools piloted in family meetings and supervision sessions (not named in the report),,Not named in the report,,"Together for Children, which delivers Sunderland City Council's children's services",United Kingdom,"Sunderland, England, United Kingdom",United Kingdom,Children's social care,,Social care,Law and Crime,Family Issues,,Public servants,16,High income,operational_improvement,Enhanced productivity,1,1,,,3,,,organizational; personal,1,,0,,,,,unknown,,not shown,https://files.ofsted.gov.uk/v1/file/50271150,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Ofsted. Inspection of Sunderland City Council local authority children's services, inspection dates 27 to 31 January 2025. Published 11 March 2025. Paragraph 62, on the impact of leaders on social work practice, with the pilots described in paragraph 12. Ofsted's judgment that the conversations are well captured in recording comes from inspectors' reading of the records (see paragraph 8)."", ""url"": ""https://files.ofsted.gov.uk/v1/file/50271150""}, {""label"": ""Assessment report"", ""value"": ""Ofsted. Inspection of Sunderland City Council local authority children's services, inspection dates 27 to 31 January 2025. Published 11 March 2025. Paragraph 8, on what inspectors found in children's records."", ""url"": ""https://files.ofsted.gov.uk/v1/file/50271150""}]","{""kind"": ""Official documents""}" AIBD-1182,2025-01-29,source publication,day,reported,HMICFRS finds that Bedfordshire Police's AI tool that brings databases together saves the force considerable time,"In its PEEL inspection of 29 January 2025, HMICFRS found that Bedfordshire Police is developing an AI tool that brings databases together and saves officers and staff considerable time.",*AI database tool* saves Bedfordshire officers considerable time,,,found,Found by an auditor,no comparison,very low,benefit created,false,Bedfordshire Police tool that uses artificial intelligence to bring together a range of databases (not named in the report),,Bedfordshire Police (the report lists the tool among projects from the force's relationship with Amazon Web Services),United Kingdom,"Bedfordshire Police, in use in the Eastern Region Special Operations Unit",United Kingdom,"Bedfordshire, England, United Kingdom",United Kingdom,Policing,,Safety and rescue,Law and Crime,Police,,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",1,1,1,,3,,,organizational,1,,0,,,,,unknown,,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2023-25: An inspection of Bedfordshire Police. 29 January 2025. Original address: https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/bedfordshire-2023-25/ (Wayback copy cited)."", ""url"": ""https://web.archive.org/web/20250517163134id_/https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/bedfordshire-2023-25/""}, {""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2023-25: An inspection of Bedfordshire Police. 29 January 2025. Leadership and force management."", ""url"": ""https://web.archive.org/web/20250517163134id_/https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/bedfordshire-2023-25/""}]","{""kind"": ""Official documents""}" AIBD-0723,2025-01-01,event,year,reported,NFER finds that primary teachers given Oak National Academy's Aila in an EEF trial spent 76% as much time on lesson preparation,"In a 2025 trial in 108 English primary schools, teachers given Aila spent about 2.5 hours a week preparing lessons against 3.3 hours for others. Reviewers judged that quality was no worse.",*Aila* cuts primary teachers' lesson preparation time by about a quarter,"a saving of 0.8 hours, or 48.6 minutes, a week",,found,Found by an assessment body,randomized trial,high,aggregate result,false,"Aila, Oak National Academy's AI lesson assistant",GPT-4o,Oak National Academy (built on OpenAI's GPT-4o),United Kingdom,"Teachers of Years 3 to 6 in 108 primary schools in England, in a trial funded by the Education Endowment Foundation and evaluated by NFER",United Kingdom,"England, United Kingdom",United Kingdom,Education,,Education,Education,Elementary & Secondary,Text and language,Teachers,4,High income,operational_improvement,Enhanced productivity,1,3,3,,3,4,,personal; organizational,2,,0,Teachers in schools assigned not to use Aila,3.3 hours a week,About 2.5 hours a week,measured,persisted,2026-10-07,shown,https://d2tic4wvo1iusb.cloudfront.net/production/documents/projects/aila-lesson-planning_teacher-choices_evaluation-report.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Roy P, Poet H, Staunton R, Aston K, Thomas D, Styles B. Lesson planning using AI lesson assistant, Aila. A Teacher Choices Trial, evaluation report. National Foundation for Educational Research for the Education Endowment Foundation, October 2026."", ""url"": ""https://d2tic4wvo1iusb.cloudfront.net/production/documents/projects/aila-lesson-planning_teacher-choices_evaluation-report.pdf""}]","{""kind"": ""Official documents""}" AIBD-0890,2024-11-01,source publication,month,mixed,Canada's Drug Agency found low-certainty evidence that RapidAI's Rapid LVO cut the time to report CT angiography for stroke by 8.6 minutes,"From one US cohort study, Canada's Drug Agency found low-certainty evidence that Rapid LVO cut the turnaround of radiology reports on CT angiography for stroke by 8.6 minutes.",*Rapid LVO* may cut the time to report stroke scans by 8.6 minutes,8.6 minutes sooner on average,,found,Found by an assessment body,before and after,very low,aggregate result,false,Rapid LVO (RapidAI),RAPID 4.9,iSchemaView (RapidAI),United States,"Stroke center at the University of California, Irvine (cohort study by Soun and colleagues)",United States,"Orange, California, United States",United States,Healthcare (acute stroke care),,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,1,3,1,2,2,1,0.105,organizational; personal,3,,0,"Clinicians' interpretation of CT angiography without Rapid LVO, before the tool was introduced",30.6 minutes (SD 29.9),22 minutes (SD 35.1),measured,unknown,,not shown,https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221248.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Canada's Drug Agency (CDA-AMC). RapidAI for Stroke Detection: Main Report. Health Technology Review OP0556, Canadian Journal of Health Technologies 4(11), November 2024. Summary of Evidence, pp. 24-25, and Table 3."", ""url"": ""https://canjhealthtechnol.ca/index.php/cjht/article/download/OP0556/OP0556/8815""}]","{""kind"": ""Official documents""}" AIBD-0682,2024-10-22,source publication,day,reported,Cour des comptes finds that AI routing of reports of financial crime freed 25 agents of a French ministry service for investigations,The Cour des comptes found that AI labels reports from professionals with reporting duties before routing them. This let a service of the finance ministry move 25 agents to investigations.,*Orientations de déclarations* frees 25 agents for investigations,move 25 agents to investigations,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Intégration de déclarations and Orientations de déclarations (automatic correction, labeling and routing of reports)",,A service of the French economy and finance ministry (listed in the Cour's annex as another service and not named),France,"The same ministry service, which receives reports from professionals with reporting duties (probably Tracfin, which the Cour does not name)",France,France (national),France,Financial intelligence (money laundering and tax fraud),,Finance,Law and Crime,White Collar Crime,Text and language,Public servants,16,High income,operational_improvement,Enhanced productivity,1,1,,,3,5,,organizational,1,,0,Handling the rising number of reports with additional staff,,,assumed,unknown,,not shown,https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. L’intelligence artificielle dans les politiques publiques : l’exemple du ministère de l’économie et des finances. Observations définitives S2024-1165, adopted 18 July 2024 and published 22 October 2024, p. 35 and annex 2, p. 81."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}]","{""kind"": ""Official documents""}" AIBD-0708,2024-05-01,event,month,reported,Brazil's Federal Court of Accounts confirms that the Ministry of Sport closed 149 accountability reports on grants with a machine-learning risk score,"Brazil's Federal Court of Accounts checked the Ministry of Sport's technical notes. It confirmed that computerized review, using a CGU machine-learning risk score, closed 149 accountability reports.",Brazil's sport ministry clears grant reviews with a risk score,149 accountability reports,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Análise informatizada de prestação de contas: a risk score (nota de risco) from a CGU supervised machine-learning model, combined with audit trails and value-band risk tolerances",,Controladoria-Geral da União (CGU),Brazil,Ministério do Esporte (Coordenação de Prestação de Contas),Brazil,Brazil,Brazil,Public administration: grant accountability review,,Public sector,Government Operations,Bureaucracy,Prediction from data,,16,Upper middle income,operational_improvement,Enhanced productivity,1,1,,,3,,,organizational,1,,0,,,,,unknown,,shown,https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=899639,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 2551/2025 – TCU – Plenário (TC 040.043/2023-1), relator Ministro-Substituto Marcos Bemquerer Costa, session of 29 October 2025. Monitoring of the orders to the Ministério do Esporte in Acórdão 2234/2023 – TCU – Plenário, report section D, paragraphs 56-71."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=899639""}, {""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 2551/2025 – TCU – Plenário (TC 040.043/2023-1), relator Ministro-Substituto Marcos Bemquerer Costa, session of 29 October 2025. Monitoring of the orders to the Ministério do Esporte in Acórdão 2234/2023 – TCU – Plenário, report section D, paragraphs 56-71."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=899639""}]","{""kind"": ""Official documents""}" AIBD-0229,2024-01-25,event,day,reported,Pindrop's deepfake detector traces a fake Biden robocall in New Hampshire to ElevenLabs. A Berkeley team agrees. The FCC cites the finding,Pindrop ran its deepfake audio analysis against more than 120 voice engines. It traced a fake Biden robocall before New Hampshire's January 2024 primary to ElevenLabs. The FCC later cited it.,Pindrop traces a fake Biden robocall in New Hampshire to ElevenLabs,the result came back well north of 99 percent for ElevenLabs,,found,Found by a regulator,no comparison,very low,benefit created,false,Pindrop deepfake audio analysis (voice-engine attribution),,Pindrop,United States,Pindrop (developer and deployer are the same company); independent corroboration by Hany Farid's UC Berkeley model,United States,"New Hampshire, United States",United States,Election integrity / deepfake detection,Technology,Public sector,Government Operations,Political Campaigns,Speech and sound,The public,16,High income,social_improvement; privacy_protection,Transparency and accountability,1,1,,,3,1,,societal,4,,0,,,,,litigated,2025-06-13,shown,https://www.pindrop.com/resources/article/pindrop-reveals-tts-engine-behind-biden-ai-robocall,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Notice of Apparent Liability for Forfeiture, In the Matter of Steve Kramer, FCC 24-59, adopted 23 May 2024, released 24 May 2024. The FCC has no stake in Pindrop. It states as fact that the deepfake was made with Eleven Labs software. In footnote 27 it cites only Pindrop's post and an NBC News report on the magician for that statement."", ""url"": ""https://docs.fcc.gov/public/attachments/FCC-24-59A1.pdf""}, {""label"": ""Follow-up"", ""value"": ""A New Hampshire jury acquitted Steven Kramer of all state voter suppression and impersonation charges on 13 June 2025, according to the Associated Press. He still faced the FCC's $6 million fine, which he told AP that he would not pay. Lingo Telecom had settled with the FCC for $1 million."", ""url"": ""https://web.archive.org/web/2026/https://apnews.com/article/ai-robocalls-new-hampshire-biden-kramer-e87ef8848a2a6515202535a6e800da07""}]","{""kind"": ""Legal proceedings""}" AIBD-0677,2024-01-01,event,year,reported,Queensland Audit Office reports that the MPST camera AI cut the photo assessments needing human review by 98.7% in 2024,"The Queensland Audit Office reports that in 2024 the MPST image-recognition AI cut the assessments needing human review at its vendor by 98.7%, to 2.7 million.",*Mobile Phone and Seatbelt Technology* screens out most camera photos,cut the assessments needing human review at its vendor by 98.7%,,found,Found by an auditor,no comparison,very low,aggregate result,false,Mobile Phone and Seatbelt Technology (MPST) image-recognition AI,,"Acusensus, the external vendor that owns and manages the AI (named as TMR's contractor in a ministerial answer, while the audit names no vendor)",Australia,"Queensland Department of Transport and Main Roads, with the Queensland Revenue Office reviewing possible offenses",Australia,"Queensland, Australia",Australia,Traffic enforcement (road safety),,Safety and rescue,Transportation,Highways,Images and video,,11,High income,operational_improvement,Enhanced productivity,1,1,4,,3,5,,organizational; societal,2,,0,Human review of every assessment that the AI made,208.4 million assessments performed by the AI in 2024,2.7 million assessments reviewed by the external vendor,assumed,persisted,2026-07-27,shown,https://web.archive.org/web/20260713131003/https://www.qao.qld.gov.au/reports-resources/reports-parliament/managing-ethical-risks-artificial-intelligence,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Queensland Audit Office. Managing the ethical risks of artificial intelligence. Report 2: 2025–26, tabled 24 September 2025, chapter 5 (archived copy of the report page)."", ""url"": ""https://web.archive.org/web/20260713131003/https://www.qao.qld.gov.au/reports-resources/reports-parliament/managing-ethical-risks-artificial-intelligence""}]","{""kind"": ""Official documents""}" AIBD-0689,2024-01-01,event,year,reported,Cour des comptes finds that Panoptes document recognition in France Travail's Upload simplifié avoided about €5 million of contractor costs,The Cour des comptes estimates that automatic document recognition in France Travail's Upload simplifié avoided about €5 million of contractor costs in 2024 and in 2025.,*Upload simplifié* document recognition cuts France Travail's costs,avoided about €5 million of contractor costs in 2024 and in 2025,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Upload simplifié, built on Panoptes (deep-learning computer vision)",,France Travail,France,France Travail,France,France (national),France,Public employment services (document processing),,Public sector,Government Operations,Bureaucracy,Images and video,,16,High income,operational_improvement,Enhanced productivity,1,1,4,,3,5,,organizational,1,,0,Contractors recognizing the types of uploaded documents,,,assumed,unknown,,shown,https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf,environ 5 M€,Contractor costs avoided in 2024 and in 2025 through automatic document recognition,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. France Travail et l’intelligence artificielle. Observations définitives S2025-1558, adopted 15 October 2025 and published 8 January 2026, p. 58 and annex 5, p. 115."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-1038,2023-12-01,source publication,month,mixed,FATF and GAFILAT assessors find that COAF's AI predictive model allows rapid analysis of suspicious transaction reports but sends only 5% to analysts,"FATF and GAFILAT assessors found that COAF's AI predictive model allows rapid analysis of the 4.8 million suspicious transaction reports received in 2018–2022, but that only 5% go to analysts.",*COAF predictive model* speeds triage of Brazil's suspicious reports,4.8 million suspicious transaction reports,,found,Found by an assessment body,no comparison,very low,aggregate result,false,COAF predictive model for scoring suspicious transaction reports,,Conselho de Controle de Atividades Financeiras (COAF) (the report names no other developer),Brazil,"Conselho de Controle de Atividades Financeiras (COAF), Brazil's financial intelligence unit",Brazil,Brazil (national),Brazil,Anti-money laundering: financial intelligence,,Finance,Law and Crime,White Collar Crime,Prediction from data,Public servants,16,Upper middle income,operational_improvement,"Faster data management, decision-making",1,1,4,,2,5,,organizational,1,,0,,,,,persisted,2025-10-21,shown,https://web.archive.org/web/20250903135451id_/https://www.fatf-gafi.org/content/dam/fatf-gafi/mer/Brazil-Mutual-Evaluation-2023.pdf.coredownload.inline.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""FATF and GAFILAT. Anti-money laundering and counter-terrorist financing measures – Brazil. Fourth Round Mutual Evaluation Report, December 2023, adopted at the FATF Plenary of October 2023. Chapter 3, Immediate Outcome 6, paras 180-184 and 196-198."", ""url"": ""https://web.archive.org/web/20250903135451id_/https://www.fatf-gafi.org/content/dam/fatf-gafi/mer/Brazil-Mutual-Evaluation-2023.pdf.coredownload.inline.pdf""}]","{""kind"": ""Official documents""}" AIBD-0654,2023-09-27,source publication,day,reported,NICE allows nine systems in the NHS after concluding that AI autocontouring is quicker than manual contouring for radiotherapy planning,"NICE reviewed 79 studies of clinician-reviewed AI autocontouring by systems such as MVision and Limbus Contour. It found reviewed autocontouring likely equivalent to manual contouring, and quicker.",NICE finds AI outlining quicker for radiotherapy planning,Reported time savings ranged from 3 to 80 minutes,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,"AI autocontouring software: AI-Rad Companion Organs RT, ART-Plan, DLCExpert, INTContour, Limbus Contour, MIM Contour ProtégéAI, MRCAT Prostate plus Auto-contouring, MVision Segmentation Service and RayStation",,"Siemens Healthineers, TheraPanacea, Mirada Medical, Carina Medical, Limbus AI, MIM Software, Philips, MVision AI and RaySearch","Multiple: Germany, France, United Kingdom, United States, Canada, Netherlands, Finland, Sweden",Radiotherapy centers in the studies reviewed by NICE; NHS radiotherapy services in England,Multiple,"Multiple countries (studies); England, United Kingdom (guidance)",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,1,2,1,,3,,,organizational,3,,0,Manual contouring by radiotherapy staff,Manual contouring time,3 to 80 minutes saved in studies; experts estimated 10 to 30 minutes,measured,persisted,2026-05-15,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC13389072/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessment. HealthTech guidance HTG695 (formerly HTE11), section 3: Committee discussion. 27 September 2023."", ""url"": ""https://www.nice.org.uk/guidance/htg695/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG695, section 1: Recommendations. 27 September 2023."", ""url"": ""https://www.nice.org.uk/guidance/htg695/chapter/1-Recommendations""}, {""label"": ""Evaluation report"", ""value"": ""King's Technology Evaluation Centre (KiTEC), King's College London, for NHS England's AI in Health and Care Award (2026). A multi-centre real-world evaluation of AI-assisted organ at risk contouring on radiotherapy treatment planning workflows (British Journal of Radiology 2026), Abstract, Results and Conclusions."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC13389072/""}]","{""kind"": ""Official documents""}" AIBD-0883,2023-07-01,event,month,reported,"Together with the police inspectorate, Scotland's Biometrics Commissioner finds that CAID facial matching aided investigations of child abuse","With the police inspectorate, Scotland's Biometrics Commissioner found that CAID facial matching made some contribution to investigations of child abuse. It did the same for the wellbeing of staff.",*CAID* facial matching helps Scottish investigators of child abuse,up to three days to review can now be processed in about an hour,,found,Found by an auditor,no comparison,very low,aggregate result,false,Facial matching function of the UK Child Abuse Image Database (CAID),,"NEC (face recognition technology, per the review), within the Home Office's Child Abuse Image Database, which West Yorkshire Police manages",Japan,"Police Scotland (Cybercrime Investigations, Digital Forensics and the Victim ID Unit)",United Kingdom,"Scotland, United Kingdom",United Kingdom,Policing,,Safety and rescue,Law and Crime,Child Abuse,Images and video,Public servants; Children,16,High income,operational_improvement; physical_health,Enhanced productivity,1,1,4,,3,4,,organizational; personal; societal,1,,0,Manual review of a seized device's images before facial matching,up to three days to review,about an hour,assumed,unknown,,shown,https://www.naffco.com/downloads/pdf/neoface-watch-brochure.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Scottish Biometrics Commissioner and HM Inspectorate of Constabulary in Scotland. Joint Assurance Review of the use of retrospective facial search technologies for criminal justice and police purposes in Scotland (SBC/2025/02). Laid before the Scottish Parliament in March 2025. Summary of findings, section on effectiveness."", ""url"": ""https://www.biometricscommissioner.scot/media/vobnmsze/joint-assurance-review-retrospective-facial-search.pdf""}, {""label"": ""Audit report"", ""value"": ""Scottish Biometrics Commissioner and HM Inspectorate of Constabulary in Scotland. Joint Assurance Review (SBC/2025/02), March 2025, chapter 4, CAID findings. It adds the time saving that operators and managers reported to the reviewers."", ""url"": ""https://www.biometricscommissioner.scot/media/vobnmsze/joint-assurance-review-retrospective-facial-search.pdf""}]","{""kind"": ""Official documents""}" AIBD-0678,2023-06-01,event,month,mixed,"In an audit, the NYC Comptroller finds that police reached ShotSpotter alerts 1 minute 38 seconds faster than 911 reports of outdoor shots in June 2023",New York City's Comptroller found that in June 2023 police reached ShotSpotter alerts 1 minute 38 seconds faster on average than 911 reports of outdoor shots.,Police reached *ShotSpotter* alerts faster than 911 shot reports,1 minute 38 seconds faster,,found,Found by an auditor,controlled comparison,very low,aggregate result,false,ShotSpotter Gunshot Detection and Location System,,"ShotSpotter, Inc. (renamed SoundThinking, Inc. on 10 April 2023)",United States,New York City Police Department (NYPD),United States,"New York City, United States",United States,Policing (gunfire detection),,Safety and rescue,Law and Crime,Police,Speech and sound,Public servants,16,High income,physical_health; operational_improvement,Crime reduction or prevention,1,1,1,,2,5,,organizational; societal,1,,0,NYPD response to 911 calls about outdoor gunfire in June 2023,5 minutes 28 seconds for 911,3 minutes 50 seconds for ShotSpotter,measured,challenged,2025-02-05,shown,https://www.soundthinking.com/blog/soundthinkings-approach-to-fourth-of-july-safety/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Audit report"", ""value"": ""Office of the New York City Comptroller, Bureau of Audit. Audit Report on the New York City Police Department's Oversight of Its Agreement with ShotSpotter Inc. for the Gunshot Detection and Location System. FP23-074A, 20 June 2024."", ""url"": ""https://comptroller.nyc.gov/reports/audit-report-on-the-new-york-city-police-departments-oversight-of-its-agreement-with-shotspotter-inc-for-the-gunshot-detection-and-location-system/""}, {""label"": ""Follow-up"", ""value"": ""On 5 February 2025 the city Comptroller declined to register NYPD's renewal of the ShotSpotter contract for December 2024 to December 2027, citing violations of procurement rules."", ""url"": ""https://comptroller.nyc.gov/newsroom/comptroller-lander-declines-to-register-shotspotter-contract-renewal""}]","{""kind"": ""Challenges""}" AIBD-1183,2023-06-01,event,month,reported,HMICFRS finds that Bedfordshire Police's automatic redaction technology cuts the time taken to prepare files for court,"In its PEEL inspection published on 29 January 2025, HMICFRS found that Bedfordshire Police's automatic redaction technology improves the time taken to prepare files for court.",*Automatic redaction* speeds court files at Bedfordshire Police,,,found,Found by an auditor,no comparison,very low,benefit created,false,Automatic redaction technology (identified by Police Professional as Riven DocDefender),,"Riven, with Amazon Web Services, according to Police Professional (HMICFRS names no product)",,Bedfordshire Police,United Kingdom,"Bedfordshire, England, United Kingdom",United Kingdom,Policing,,Safety and rescue,Law and Crime,Police,Text and language; Images and video,Public servants,16,High income,operational_improvement,Enhanced productivity,1,1,1,,3,,,organizational,2,,0,,,,,persisted,2025-03-11,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""His Majesty's Inspectorate of Constabulary and Fire & Rescue Services. PEEL 2023-25: An inspection of Bedfordshire Police. 29 January 2025. Original address: https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/bedfordshire-2023-25/ (Wayback copy cited)."", ""url"": ""https://web.archive.org/web/20250517163134id_/https://hmicfrs.justiceinspectorates.gov.uk/peel-reports/bedfordshire-2023-25/""}]","{""kind"": ""Official documents""}" AIBD-0887,2023-05-01,event,month,mixed,The Scottish Health Technologies Group found that NHS Grampian patients got CT scans six days sooner once Annalise Enterprise CXR triaged X-rays,SHTG found that NHS Grampian patients got CT scans six days sooner once Annalise Enterprise CXR triaged chest X-rays. NHS Grampian also added capacity. Other gains were not statistically significant.,CT scans came six days sooner after *Annalise Enterprise CXR* arrived,received a CT scan six days more quickly,,found,Found by an assessment body,before and after,very low,aggregate result,false,Annalise Enterprise CXR,,Annalise.ai,Australia,NHS Grampian,United Kingdom,"Grampian, Scotland, United Kingdom",United Kingdom,Healthcare (lung cancer diagnosis),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,1,2,1,,2,1,,personal; organizational,3,,0,A 2019 baseline of clinical review without the software (n=113),,received a CT scan six days more quickly following a CXR report,measured,persisted,2025-08-21,shown,https://shtg.scot/media/2526/2024-07-18-chest-x-ray-assessment-v14.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group, Healthcare Improvement Scotland. Artificial intelligence-assisted clinician review of chest X-rays for suspected lung cancer. SHTG Assessment in response to an enquiry from the Accelerated National Innovation Adoption (ANIA) partnership, February 2025, pp. 3 and 18-20."", ""url"": ""https://shtg.scot/media/2526/2024-07-18-chest-x-ray-assessment-v14.pdf""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence (NICE) (2023). Artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HealthTech guidance 696, updated February 2025), 1 Recommendations; What this means in practice."", ""url"": ""https://www.nice.org.uk/guidance/htg696/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""Austrian Institute for Health Technology Assessment (AIHTA). AI-supported Chest X-Ray Analysis for Lung Cancer Detection: Systematic Review of clinical outcomes and organisational implications. AIHTA Project Report No. 171b. Vienna, February 2026."", ""url"": ""https://eprints.aihta.at/1598/1/HTA-Projektbericht_Nr.171b.pdf""}, {""label"": ""Assessment report"", ""value"": ""Austrian Institute for Health Technology Assessment (AIHTA). AI-supported Chest X-Ray Analysis for Lung Cancer Detection: Systematic Review of clinical outcomes and organisational implications. AIHTA Project Report No. 171b. Vienna, February 2026."", ""url"": ""https://eprints.aihta.at/1598/1/HTA-Projektbericht_Nr.171b.pdf""}]","{""kind"": ""Official documents""}" AIBD-0932,2023-01-01,event,year,reported,"In a rapid assessment, IIPH Gandhinagar finds that qXR saved money on reading X-rays from TB screening in India, while Genki was cost-effective","Using 2023 screening records from Tamil Nadu and Maharashtra, researchers costed AI reading at INR 30 per case with qXR. With Genki it was INR 22, against INR 100 for a radiologist.",*qXR* and *Genki* cut the cost of reading X-rays for TB in India,INR 30 with qXR and INR 22 with Genki,,found,Found by an assessment body,before and after,very low,aggregate result,false,qXR and Genki (AI-assisted chest X-ray interpretation for TB screening),,Qure.ai (qXR) and DeepTek (Genki),India,"Public health facilities in Chennai, Tamil Nadu (Genki) and Maharashtra (qXR) screening for TB under India's National Tuberculosis Elimination Program",India,"Chennai, Tamil Nadu, and Maharashtra, India",India,Healthcare (tuberculosis screening),,Health,Health,Disease Prevention,Images and video,Patients,3,Lower middle income,operational_improvement; physical_health,Enhanced productivity,1,4,1,4,3,,,organizational,2,,0,Digital chest X-ray reading by a radiologist,INR 100 (USD 1.2) per case,INR 30 (USD 0.36) for qXR and INR 22 (USD 0.26) for Genki,measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC12715009/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Health Technology Assessment in India (HTAIn), Department of Health Research, Ministry of Health and Family Welfare; assessment by its resource hub at the Indian Institute of Public Health Gandhinagar (2024). Health Technology Assessment of AI-Assisted CXR for Interpretation for Tuberculosis: A Rapid Health Technology Assessment (Policy Brief, study 77), Executive Summary; Results; Conclusion (pp. 1-2)."", ""url"": ""https://htain.dhr.gov.in/images/pdf/Policy_Briefs/77.AI_based_cXR_Interpreation_Policy_Brief.pdf""}]","{""kind"": ""Official documents""}" AIBD-0998,2023-01-01,event,year,reported,"The FCC finds that fully automatic phone captions cost providers about $0.60 per minute in 2023, against $1.04 with human assistants","The FCC found that providers' allowable expenses averaged about $0.60 per minute for fully automatic captions in 2023, against $1.04 with assistants. Automatic captions carried 74.6% of minutes.",Automatic phone captions cost $0.44 per minute less than assisted ones,about $0.60 per minute for fully automatic captions in 2023,,found,Found by a regulator,controlled comparison,low,aggregate result,false,"ASR-only (fully automatic) Internet Protocol Captioned Telephone Service (IP CTS), as provided by FCC-certified providers",,The certified IP CTS providers and their speech recognition vendors (not named in the order),,FCC-certified IP CTS providers paid from the Interstate TRS Fund (five were paid for IP CTS in 2023),,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,operational_improvement,Enhanced productivity,1,2,4,,3,5,,organizational; societal,1,,0,"CA-assisted IP CTS, captioned with communications assistants, in 2023",$1.04 per minute,$0.60 per minute,measured,persisted,2026-06-30,shown,https://docs.fcc.gov/public/attachments/FCC-24-81A1.pdf,$0.44 per minute,Lower average allowable expense per minute of ASR-only IP CTS than of CA-assisted IP CTS in 2023,False,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission. Report and Order and Order, FCC 24-81, CG Docket Nos. 22-408, 03-123 and 13-24 (Internet Protocol Captioned Telephone Service compensation). Adopted and released 31 July 2024. Public version, para. 20."", ""url"": ""https://docs.fcc.gov/public/attachments/FCC-24-81A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission. Report and Order and Order, FCC 24-81, CG Docket Nos. 22-408, 03-123 and 13-24 (Internet Protocol Captioned Telephone Service compensation). Adopted and released 31 July 2024. Public version, n. 58."", ""url"": ""https://docs.fcc.gov/public/attachments/FCC-24-81A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission. Report and Order and Order, FCC 24-81, CG Docket Nos. 22-408, 03-123 and 13-24 (Internet Protocol Captioned Telephone Service compensation). Adopted and released 31 July 2024. Public version, para. 2."", ""url"": ""https://docs.fcc.gov/public/attachments/FCC-24-81A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-1010,2022-12-01,event,month,mixed,ANAO finds that 64.7% of the classifications made by IP Australia's Patent Auto Classifier were correct on average as of November 2025,"From IP Australia's data, the ANAO found that 64.7% of the Patent Auto Classifier's classifications were correct as of November 2025. Missing ones made up 27.5%. The other 7.8% were incorrect.",*Patent Auto Classifier* gets about two in three classifications right,64.7% of the Patent Auto Classifier's classifications were correct,,found,Found by an auditor,no comparison,very low,aggregate result,false,Patent Auto Classifier (PAC),,IP Australia (built in-house and retrained every year),Australia,IP Australia (patent examination),Australia,Australia (national),Australia,Intellectual property administration (patent examination),,Education,Domestic Commerce,Copyrights and Patents,Text and language,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",1,1,4,,2,5,,organizational,1,,0,,,,,unknown,,shown,https://web.archive.org/web/20260712121955/https://www.anao.gov.au/work/performance-audit/artificial-intelligence-use-ip-australia,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Australian National Audit Office. Artificial Intelligence Use in IP Australia. Auditor-General Report No. 43 of 2025-26, published 29 June 2026. Paragraphs 3.25 and 3.26 and Figure 3.3 (archived copy of the report page)."", ""url"": ""https://web.archive.org/web/20260712121955/https://www.anao.gov.au/work/performance-audit/artificial-intelligence-use-ip-australia""}]","{""kind"": ""Official documents""}" AIBD-0994,2022-10-21,source publication,day,reported,A special master for e-discovery in a US court found that Huntsman's TAR review had already met his benchmark for a presumptively reasonable search,"In October 2022 a US special master found that Huntsman's TAR review had met his benchmark for a reasonable search, with 9.1% responsive documents in its last two batches.",Huntsman's *TAR* review meets a special master's benchmark,9.1% responsive documents in its last two batches,,found,Found by a court,no comparison,very low,benefit created,false,TAR (technology-assisted review),,Not named in the report,,Huntsman Corporation (defendant),United States,"Pittsburgh, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,1,1,,3,1,,organizational,1,,0,"The special master's benchmark for a presumptively reasonable search, no more than 10% responsive documents in the last two batches reviewed",no more than 10%,9.1%,measured,litigated,2023-11-07,not shown,https://storage.courtlistener.com/recap/gov.uscourts.pawd.250109/gov.uscourts.pawd.250109.800.0.pdf,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Western District of Pennsylvania, E-Discovery Special Master James C. Francis IV (Ret.). In re Diisocyanates Antitrust Litigation, Master Docket Misc. No. 18-1001, MDL No. 2862, Supplemental Report and Recommendation (ECF No. 800), 21 October 2022, pp. 1-2. CourtListener RECAP copy."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.pawd.250109/gov.uscourts.pawd.250109.800.0.pdf""}, {""label"": ""Follow-up"", ""value"": ""The plaintiffs filed limited objections to the 19 October 2022 report. On 7 November 2023 the district court overruled them, adopted both reports as its opinion and required only Wanhua Chemical (America) and Covestro to resume their TAR review."", ""url"": ""https://www.courtlistener.com/docket/8042096/in-re-diisocyanates-antitrust-litigation/?entry_gte=968&entry_lte=968""}]","{""kind"": ""Legal proceedings""}" AIBD-0680,2022-06-01,event,month,reported,"Cour des comptes finds that LLaMandement let teams at France's finance ministry absorb 85,345 parliamentary amendments without extra staff","The Cour des comptes found that the DGFiP's LLaMandement sorts amendments for staff. It summarizes them. It let teams absorb 85,345 amendments without extra staff.",*LLaMandement* summarizes amendments for French officials,"85,345 amendments tabled between June 2022 and January 2024",,found,Found by an auditor,no comparison,very low,aggregate result,false,"LLaMendements (LLaMandement), the DGFiP's tool for sorting and summarizing parliamentary amendments",,Direction générale des Finances publiques (DGFiP),France,DGFiP teams handling parliamentary amendments for the economy and finance ministry,France,France (national),France,Public administration (legislative work),,Public sector,Government Operations,Bureaucracy,Text and language,Public servants,16,High income,operational_improvement,Enhanced productivity,1,1,4,,3,5,,organizational,2,,0,,,,,unknown,,shown,https://arxiv.org/abs/2401.16182,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. L’intelligence artificielle dans les politiques publiques : l’exemple du ministère de l’économie et des finances. Observations définitives S2024-1165, adopted 18 July 2024 and published 22 October 2024, p. 35."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}]","{""kind"": ""Official documents""}" AIBD-0685,2022-01-01,event,year,mixed,"Cour des comptes finds that France Travail's Contact via mail matches 98% of jobseekers' emails to their senders, though its reply tool goes unused",The Cour des comptes found that France Travail's machine-learning email tool matches 98% of jobseekers' emails to their senders. It found that the tool's sorting saves advisers time.,*Contact via mail* sorts jobseekers' emails for France Travail advisers,matches 98% of jobseekers' emails to their senders,,found,Found by an auditor,no comparison,very low,aggregate result,false,Contact via mail (CVM),,"Pôle emploi, now France Travail (Intelligence emploi program)",France,France Travail (advisers and managers nationwide),France,France (national),France,Public employment services,,Public sector,Labor,General,Text and language,Public servants,16,High income,operational_improvement,Enhanced productivity,1,1,4,,2,5,,organizational,1,,0,,,,,unknown,,shown,https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. France Travail et l’intelligence artificielle. Observations définitives S2025-1558, adopted 15 October 2025 and published 8 January 2026, annex 5, p. 114 and p. 24."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0684,2021-11-01,event,month,reported,"Cour des comptes finds that 75% of jobseekers use France Travail's automatic CV analysis, which cuts profile filling from 45 to 15 minutes","The Cour des comptes found that 75% of jobseekers use France Travail's automatic CV analysis to fill in their skills profile, which then takes 15 minutes against 45.",*Analyse automatique de CV* fills in jobseekers' skills profiles,75% of jobseekers use France Travail's automatic CV analysis,,found,Found by an auditor,no comparison,very low,aggregate result,false,Analyse automatique de CV (CV discovery),,"Pôle emploi, now France Travail",France,France Travail (jobseekers' online personal space),France,France (national),France,Public employment services,,Public sector,Labor,General,Text and language,Other workers,8,High income,opportunity_access,Employment access,1,4,1,2,3,1,0.160,personal,1,,0,Filling in the skills profile without the tool,45 minutes,15 minutes,assumed,unknown,,not shown,https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. France Travail et l’intelligence artificielle. Observations définitives S2025-1558, adopted 15 October 2025 and published 8 January 2026, pp. 38-39, footnote 19 on p. 23 and annex 5, p. 113."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2026-01/20260108-S2025-1558-France-Travail-et-intelligence-artificielle_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0704,2021-09-29,event,day,reported,Taiwan's Control Yuan finds in a site test that face recognition at the Chiayi Detention Center identifies inmates within 3 seconds,Taiwan's Control Yuan tested face recognition at the Chiayi Detention Center on 29 September 2021. It found that recognition finished within 3 seconds with a high recognition rate.,Face recognition at a Chiayi jail works within 3 seconds in a test,within 3 seconds,,found,Found by an auditor,no comparison,very low,program,false,Smart prison face recognition (人臉辨識) at the Chiayi Detention Center,,Not named in the report,,"Agency of Corrections, Ministry of Justice (法務部矯正署), Chiayi Detention Center (嘉義看守所)",Taiwan,"Chiayi, Taiwan",Taiwan,Prisons,,Public sector,Law and Crime,Prisons,Images and video,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",1,1,,,3,,,organizational,1,,0,"Face recognition as described in a December 2020 press report, which the Minister of Justice said referred to the old 2016 project",數十秒 (tens of seconds),3秒內 (within 3 seconds),assumed,unknown,,not shown,https://cybsbox.cy.gov.tw/CYBSBoxSSL/edoc/download/72532,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Control Yuan (監察院), Taiwan. 調查報告(公布版)111司調0010 [Investigation report, public version] on whether the Agency of Corrections' smart surveillance and smart prison projects met their goals. Investigating members 高涌誠 and 王幼玲. Approved 13 April 2022. Investigation opinion 5, p. 14."", ""url"": ""https://cybsbox.cy.gov.tw/CYBSBoxSSL/edoc/download/72532""}]","{""kind"": ""Official documents""}" AIBD-0823,2020-07-01,event,month,reported,The FCC certifies InnoCaption's automatic captions after its test lab measured better accuracy than in human-assisted captions in all five scenarios,"In the FCC's National Test Lab, InnoCaption's automatic captions had average error rates of 4.2% to 12.0%, against 8.0% to 19.7% for human-assisted providers. They arrived seconds sooner.",*InnoCaption*'s automatic captions top assisted ones in the FCC's tests,average error rates of 4.2% to 12.0%,,found,Found by a regulator,tested against a standard,low,aggregate result,false,InnoCaption ASR Calling Feature (fully automatic IP CTS on Google Cloud Speech-to-Text),,"Mezmo Corporation d/b/a InnoCaption, with Google Cloud Speech-to-Text",,Mezmo Corporation d/b/a InnoCaption,,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,1,,4,4,3,5,,personal,5,,0,"Average error rates of CA-assisted providers other than InnoCaption, on the same call scenarios",8.0% to 19.7%,4.2% to 12.0%,measured,persisted,2024-12-23,shown,https://cloud.google.com/speech-to-text,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 20-1476, CG Docket Nos. 13-24 and 03-123 (conditional certification of Mezmo Corporation d/b/a InnoCaption to provide fully automatic IP CTS). Released 11 December 2020."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-20-1476A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau (2022). Order, DA 22-1283, CG Docket Nos. 03-123 and 13-24 (full certification of Mezmo Corporation d/b/a InnoCaption to provide IP CTS), para. 7."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-22-1283A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau (2024). Order, DA 24-1291, CG Docket No. 03-123 (conditional certification of Mezmo Corporation d/b/a InnoCaption to provide IP Relay with an ASR-only option), paras. 10-12 and the speech-to-text speed and accuracy paragraphs."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-1291A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0989,2020-04-22,source publication,day,reported,"The High Court in London declined to revisit Musst's technology assisted review of 175,723 documents, seeing no likely basis to object to its cost","In April 2020 the High Court in London faulted Musst for not announcing its technology assisted review of 175,723 documents but found no likely basis to object to its cost.","London court declines to revisit Musst's *TAR* of 175,723 documents","175,723 documents",,found,Found by a court,no comparison,very low,benefit created,false,Technology assisted review by predictive coding and clustering analytics,,Not named in the judgment,,"Musst, with its then solicitors Bird & Bird",British Virgin Islands,"London, United Kingdom",United Kingdom,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,1,1,,3,1,,organizational,1,,0,,,,,unknown,,shown,https://caselaw.nationalarchives.gov.uk/ewhc/ch/2020/1871,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""High Court of Justice, Business and Property Courts of England and Wales, Business List (ChD) (Chief Master Marsh). Astra Asset Management UK Ltd & Anor v MUSST Investments LLB & Ors [2020] EWHC 1871 (Ch), judgment of 22 April 2020, paras 32 to 38. Find Case Law copy."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/ch/2020/1871""}]","{""kind"": ""Official documents""}" AIBD-0985,2020-04-09,source publication,day,reported,"A Kansas federal court found that it was reasonable for Spirit AeroSystems to stop its Predict review at 85% recall, denying a demand for more documents","In April 2020 a US magistrate judge found that Spirit AeroSystems could reasonably stop its Predict review of 322,000 documents at 85% recall. The judge found that more was not proportional.",Court accepts Spirit's *Predict* review stopped at 85% recall,85% recall,,found,Found by a court,no comparison,very low,benefit created,false,"Predict, a technology-assisted review tool that uses continuous active learning",,"Not named in the orders, which say that Spirit's e-discovery vendor Legility offers the tool",,"Spirit AeroSystems, Inc. (defendant), with its e-discovery vendor Legility and its law firm",United States,"Kansas, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Value above replacement,1,1,1,,3,1,,organizational,1,,0,Any other form of review,,,assumed,litigated,2020-06-18,shown,https://storage.courtlistener.com/recap/gov.uscourts.ksd.120882/gov.uscourts.ksd.120882.335.0.pdf,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the District of Kansas (Magistrate Judge Angel D. Mitchell). Lawson v. Spirit AeroSystems, Inc., No. 18-1100-EFM-ADM, Memorandum and Order (Doc. 335), 9 April 2020. CourtListener RECAP copy of the filed order."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.ksd.120882/gov.uscourts.ksd.120882.335.0.pdf""}, {""label"": ""Follow-up"", ""value"": ""On 18 June 2020 the court granted Spirit's motion to shift its TAR expenses, reported at about $600,000, to the plaintiff. It found that review of a largely non-responsive data set had become disproportionate to the needs of the case."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.ksd.120882/gov.uscourts.ksd.120882.372.0.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0697,2020-01-01,event,year,reported,"UNDP's evaluation office reports that Ecuador's Catalina chatbot answered over 164,900 COVID-19 chats in four months to relieve a government hotline","UNDP's evaluation office found that the Catalina chatbot, set up to unblock Ecuador's COVID-19 hotline, answered over 164,900 chats between May and August 2020.","*Catalina* chatbot answers over 164,900 COVID-19 chats in Ecuador","over 164,900 chats",,found,Found by an evaluation office,no comparison,very low,program,false,Catalina COVID-19 chatbot on Government of Ecuador webpages,,1MillionBot (One Million Bot S.L.),Spain,"Government of Ecuador (Ministry of Telecommunications and the Information Society, MINTEL) with UNDP, which led the initiative, and other UN agencies",Ecuador,Ecuador (national government websites),Ecuador,Public health / government services,,Public sector,Health,Disease Prevention,Text and language,The public,3,Upper middle income,operational_improvement,Enhanced productivity,1,4,3,,3,,,personal; organizational,3,,0,,,,,unknown,,not shown,https://1millionbot.com/en/chatbot-coronavirus-ecuador/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Independent Country Programme Evaluation: Ecuador. December 2021, Finding 14 (COVID-19). The evaluation covers UNDP's program in Ecuador from 2019 to June 2021."", ""url"": ""https://www.unevaluation.org/get-download-file/5211""}]","{""kind"": ""Official documents""}" AIBD-1034,2019-01-01,event,year,reported,"European Court of Auditors finds that the Flemish paying agency prevented overpayments with checks by monitoring, using data from Sentinel satellites","The European Court of Auditors found that the paying agency of Flanders, like Malta's, used satellite checks by monitoring to prevent a number of overpayments of EU farm aid.",*Checks by monitoring* help Flanders prevent overpayments of farm aid,,,found,Found by an auditor,no comparison,very low,program,false,"Checks by monitoring of the paying agency of Belgium (Flanders), with an artificial intelligence algorithm trained on Sentinel 1 and 2 image time series",,"The paying agency of Belgium (Flanders), following technical guidelines from the European Commission's Joint Research Centre",Belgium,"The paying agency of Belgium (Flanders), for the basic payment scheme",Belgium,"Flanders, Belgium",Belgium,Agriculture (control of EU farm aid claims),,Agriculture and food,Agriculture,Subsidies to Farmers,Images and video,,16,High income,privacy_protection; operational_improvement,Fraud detection,1,1,4,,3,5,,organizational,2,,0,,,,,scaled,2023-01-01,shown,https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""European Court of Auditors. 2020 annual reports on the implementation of the EU budget for the 2020 financial year, Chapter 6 'Natural resources', paragraph 6.20 and Box 6.3. Published 26 October 2021."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/annualreports-2020/annualreports-2020_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. Box 1 and Table 3. Published 28 January 2020."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}]","{""kind"": ""Official documents""}" AIBD-2316,2019-01-01,event,year,reported,"The paying agency of Castile and Leon inspected 0.2% of the parcels that its satellite checks monitored in 2019, and the European Court of Auditors reported the result","In 2019 the paying agency of Castile and Leon in Spain checked 128,479 farm parcels with a machine learning classifier and inspected 0.2% in the field, the European Court of Auditors reported.",*Checks by monitoring* kept Castile and Leon field visits to 0.2%,0.2% in the field,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Checks by monitoring of the paying agency of Castile and Leon, with a machine learning classifier that was trained on farmers' declarations and Sentinel 2 image series",,The paying agency of Castile and Leon,Spain,"The paying agency of Castile and Leon, for the basic payment scheme",Spain,"Castile and Leon, Spain",Spain,Agriculture (control of EU farm aid claims),,Agriculture and food,Agriculture,Subsidies to Farmers,,,,High income,operational_improvement,"Faster data management, decision-making",1,,4,,3,5,,organizational,1,,0,,,,,unknown,,shown,https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}]","{""kind"": ""Official documents""}" AIBD-2317,2019-01-01,event,year,reported,"Denmark's paying agency inspected 0.1% of the parcels that its satellite checks monitored in 2019, and the European Court of Auditors reported the result","In 2019 Denmark's paying agency checked 506,717 farm parcels by satellite and machine learning and inspected 0.1% in the field, the European Court of Auditors reported.",*Checks by monitoring* kept Danish field visits to 0.1% of parcels,0.1% in the field,,found,Found by an auditor,no comparison,very low,aggregate result,false,"Checks by monitoring of Denmark's paying agency, with machine learning algorithms that process Sentinel 1 and 2 satellite images",,Denmark's paying agency,Denmark,"Denmark's paying agency, for the basic payment scheme",Denmark,Denmark,Denmark,Agriculture (control of EU farm aid claims),,Agriculture and food,Agriculture,Subsidies to Farmers,,,,High income,operational_improvement,"Faster data management, decision-making",1,,4,,3,5,,organizational,1,,0,,,,,unknown,,shown,https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}, {""label"": ""Audit report"", ""value"": ""European Court of Auditors. Special report 04/2020: Using new imaging technologies to monitor the Common Agricultural Policy: steady progress overall, but slower for climate and environment monitoring. 28 January 2020. The Court is the external auditor of the European Union."", ""url"": ""https://www.eca.europa.eu/Lists/ECADocuments/SR20_04/SR_New_technologies_in_agri-monitoring_EN.pdf""}]","{""kind"": ""Official documents""}" AIBD-0674,2018-01-01,event,year,mixed,"Most staff surveyed by SSA's Inspector General found Insight useful in reviewing hearing decisions, though 71 reported problems with its flags","About 74% of 302 staff who answered a survey by SSA's Inspector General found Insight useful in reviewing hearing decisions. Still, 71 users reported problems with its flags.",Most staff found *Insight* useful for reviewing hearing decisions,About 74% agreed that it was useful and valuable,,found,Found by an auditor,no comparison,very low,aggregate result,false,Insight (SSA quality-review software for disability hearing decisions),,Staff of SSA's Office of Appellate Operations (SSA's Office of Analytics and Improvements took over the program after its release),United States,SSA Office of Appellate Operations and Office of Hearings Operations,United States,United States (national),United States,Social security (disability appeals),,Accessibility,Social Welfare,Disabled Assistance,Text and language,Public servants,16,High income,operational_improvement,Enhanced productivity,1,3,4,,2,5,,organizational,1,,0,"Cases of appellate analysts who did not use Insight, in the appellate office's own study",21.5 percent of non-Insight users' cases returned for quality issues,12.6 percent for Insight users' cases,measured,persisted,,not shown,https://web.archive.org/web/20251010181932id_/https://oig-files.ssa.gov/audits/full/A-12-18-50353.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Social Security Administration, Office of the Inspector General. The Social Security Administration's Use of Insight Software to Identify Potential Anomalies in Hearing Decisions. Audit report A-12-18-50353, 19 April 2019 (archived copy of the report at oig-files.ssa.gov)."", ""url"": ""https://web.archive.org/web/20251010181932id_/https://oig-files.ssa.gov/audits/full/A-12-18-50353.pdf""}]","{""kind"": ""Official documents""}" AIBD-0986,2017-11-27,source publication,day,reported,"After examining New York City's TAR training in camera, a New York federal court found that the City had trained the system appropriately",In November 2017 a US magistrate judge examined New York City's TAR training in camera. She found that the City had handled the system appropriately. She found its process reliable.,Judge clears New York City's *TAR* system after in camera review,"5 documents wrongly marked non-responsive out of the 100,000 reviewed",,found,Found by a court,no comparison,very low,benefit created,false,"The City of New York's technology assisted review (predictive coding) software, not named in the opinion",,Not named in the opinion,,City of New York (defendant) and its document review team,United States,"New York, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,1,1,,3,1,,organizational,1,,0,Manual review,,,assumed,unknown,,shown,https://storage.courtlistener.com/recap/gov.uscourts.nysd.444418/gov.uscourts.nysd.444418.217.0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Southern District of New York (Magistrate Judge Katharine H. Parker). Winfield v. City of New York, No. 15-CV-05236 (LTS) (KHP), Opinion and Order (Doc. 217), 27 November 2017. CourtListener RECAP copy of the filed opinion."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.nysd.444418/gov.uscourts.nysd.444418.217.0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0681,2017-01-01,event,year,reported,Cour des comptes finds that the ClaudIA chatbot absorbed a fivefold rise in Chorus Pro user requests without extra staff,"The Cour des comptes found that the ClaudIA chatbot absorbed Chorus Pro user requests without extra staff. Requests rose from 20,000 to 100,000 a month.",*ClaudIA* chatbot absorbs a fivefold rise in e-invoicing questions,"from 20,000 to 100,000 a month",,found,Found by an auditor,no comparison,very low,aggregate result,false,"ClaudIA, the Chorus Pro chatbot",,"Agence pour l'informatique financière de l'État (AIFE), using IBM Watson technology according to a 2018 trade report",France,"AIFE, for suppliers using the Chorus Pro e-invoicing portal",France,France (national),France,Public finance (e-invoicing support),,Finance,Government Operations,Bureaucracy,Text and language,Consumers,16,High income,operational_improvement,Enhanced productivity,1,1,4,,3,5,,organizational,2,,0,,,,,unknown,,shown,https://www.lemondeinformatique.fr/actualites/lire-chorus-pro-active-un-chatbot-sous-ibm-watson-71287.html,"1,3 M€","Annual savings planned under the transformation contract for ClaudIA, of which the AIFE reports 55% achieved",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. L’intelligence artificielle dans les politiques publiques : l’exemple du ministère de l’économie et des finances. Observations définitives S2024-1165, adopted 18 July 2024 and published 22 October 2024, p. 35 and table 1, p. 16."", ""url"": ""https://www.ccomptes.fr/sites/default/files/2024-10/20241022-S2024-1165-L-intelligence-artificielle-dans-les-poltiques-publiques-exemple-du-MEF.pdf""}]","{""kind"": ""Official documents""}" AIBD-2318,2017-01-01,event,year,reported,"Lånekassen's machine learning model for the residence check let the Fund find almost as many wrong residence statuses with 25,000 checks in 2017 as with nearly 50,000 in 2016, as Riksrevisjonen wrote","Norway's audit office reports that the Loan Fund's model chose 15,000 of 25,000 residence checks in 2017, and the Fund found almost as many wrong statuses as in 2016 with nearly 50,000 checks.",*Lånekassen's model* cut residence checks nearly in half,"25,000 people in 2017 instead of nearly 50,000 in 2016",,found,Found by an auditor,before and after,very low,aggregate result,false,Catboost gradient boosting model that selects student loan recipients for the residence check,,Statens lånekasse for utdanning (the Norwegian State Educational Loan Fund),Norway,Statens lånekasse for utdanning (the Norwegian State Educational Loan Fund),Norway,Norway,Norway,Public administration (student loan residence checks),,Public sector,Education,Higher,,,,High income,operational_improvement,"Faster data management, decision-making",1,,,,3,5,,organizational,1,,0,The full-scale residence check of 2016,"Nearly 50,000 people checked","25,000 people checked",measured,unknown,,shown,https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Riksrevisjonen (the Office of the Auditor General of Norway), in cooperation with the Norwegian State Educational Loan Fund. Report on residence checks based on machine learning. 26 March 2020. Riksrevisjonen is Norway's public audit office, and the report gives its own assessment of the model."", ""url"": ""https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf""}, {""label"": ""Audit report"", ""value"": ""Riksrevisjonen (the Office of the Auditor General of Norway), in cooperation with the Norwegian State Educational Loan Fund. Report on residence checks based on machine learning. 26 March 2020. Riksrevisjonen is Norway's public audit office, and the report gives its own assessment of the model."", ""url"": ""https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf""}, {""label"": ""Audit report"", ""value"": ""Riksrevisjonen (the Office of the Auditor General of Norway), in cooperation with the Norwegian State Educational Loan Fund. Report on residence checks based on machine learning. 26 March 2020. Riksrevisjonen is Norway's public audit office, and the report gives its own assessment of the model."", ""url"": ""https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf""}, {""label"": ""Audit report"", ""value"": ""Riksrevisjonen (the Office of the Auditor General of Norway), in cooperation with the Norwegian State Educational Loan Fund. Report on residence checks based on machine learning. 26 March 2020. Riksrevisjonen is Norway's public audit office, and the report gives its own assessment of the model."", ""url"": ""https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf""}, {""label"": ""Audit report"", ""value"": ""Riksrevisjonen (the Office of the Auditor General of Norway), in cooperation with the Norwegian State Educational Loan Fund. Report on residence checks based on machine learning. 26 March 2020. Riksrevisjonen is Norway's public audit office, and the report gives its own assessment of the model."", ""url"": ""https://lg.fo/download/file/29e0507a0efcbeb376300856054bae966995472c.pdf""}]","{""kind"": ""Official documents""}" AIBD-0834,2016-01-01,event,month,mixed,"The US Tax Court held that predictive coding of about 406,000 documents gave the IRS a complete response, at a precision of 3%","In July 2016 the US Tax Court held that a response to the IRS by predictive coding was complete. The model sorted about 406,000 documents into a production set of about 180,000, at 3% precision.",Tax Court finds a response to the IRS by *predictive coding* complete,"about 406,000 documents into a production set of about 180,000",,found,Found by a court,no comparison,very low,benefit created,false,Predictive coding algorithm,,Not named in the order,,"Dynamo Holdings Limited Partnership and Beekman Vista, Inc. (petitioners)",United States,United States,United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,,16,High income,operational_improvement,Enhanced productivity,1,2,1,,2,1,,organizational,1,,0,,,,,unknown,,shown,https://www.ediscoverylaw.com/wp-content/uploads/2016/08/Dynamo-II-Order.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States Tax Court (Judge Ronald L. Buch). Dynamo Holdings Limited Partnership v. Commissioner, Docket Nos. 2685-11 and 8393-12, order of 13 July 2016 denying the Commissioner's motion to compel. Copy of the signed order on the eDiscovery Law blog of K&L Gates."", ""url"": ""https://www.ediscoverylaw.com/wp-content/uploads/2016/08/Dynamo-II-Order.pdf""}]","{""kind"": ""Official documents""}" AIBD-0186,2015-01-01,event,year,reported,Medicare's Fraud Prevention System helps catch $654.8 million in inappropriate payments in 2015,The Centers for Medicare and Medicaid Services count $654.8 million in inappropriate Medicare payments identified or prevented in 2015 with help from their Fraud Prevention System.,Screening Medicare claims helps catch $654.8 million in 2015,$654.8 million in inappropriate Medicare payments identified or prevented in 2015,,found,Found by an auditor,no comparison,very low,aggregate result,false,Fraud Prevention System (FPS),,Contractors engaged by CMS (the report lists 'Developing Contractor Costs' and 'Modeling Contractor Costs' without naming firms),,Centers for Medicare and Medicaid Services (CMS),United States,United States (national),United States,Health insurance fraud and improper payments,Medicare program integrity,Finance,Health,Medical Liability,Prediction from data,,16,High income,privacy_protection,Fraud detection,1,1,4,,5,5,,organizational; societal,4,,3,"the FPS's identified savings in the previous year, 2014",identified savings from the previous year ($454.0 million in Table 1),$654.8 million,measured,persisted,2017-08-30,not shown,https://web.archive.org/web/20260831112755/https://www.gao.gov/products/gao-17-710,$654.8 million,inappropriate Medicare payments identified or prevented in calendar year 2015,False,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office, Medicare: CMS Fraud Prevention System Uses Claims Analysis to Address Fraud, GAO-17-710, 30 August 2017. The congressional audit office has no stake in the system. Its own analysis found that FPS leads started about a fifth of fraud investigations by contractors, while the savings figures that it reports come from CMS."", ""url"": ""https://web.archive.org/web/20260831112755/https://www.gao.gov/products/gao-17-710""}, {""label"": ""Audit report"", ""value"": ""U.S. Department of Health and Human Services, Office of Inspector General. The Fraud Prevention System Increased Recovery and Prevention of Improper Medicare Payments, but Updated Procedures Would Improve Reported Savings. Report A-01-14-00503, June 2015, executive summary. The inspector general certifies the system's savings by law and has no stake in it."", ""url"": ""https://oig.hhs.gov/oas/reports/region1/11400503.pdf""}, {""label"": ""Audit report"", ""value"": ""U.S. Department of Health and Human Services, Office of Inspector General. The Fraud Prevention System Identified Millions in Medicare Savings, but the Department Could Strengthen Savings Data by Improving Its Procedures. Report A-01-13-00510, June 2014, executive summary."", ""url"": ""https://oig.hhs.gov/oas/reports/region1/11300510.pdf""}]","{""kind"": ""Official documents""}" AIBD-0982,2013-04-18,source publication,day,reported,"An Indiana federal court found that Biomet's review complied fully with the discovery rules, using predictive coding after keyword culling",In April 2013 a US district judge found that Biomet's review fully met the discovery rules. Biomet culled by keyword before predictive coding of 2.5 million documents. He refused to order a restart.,Court upholds Biomet's *predictive coding* review under discovery rules,2.5 million documents,,found,Found by a court,no comparison,very low,benefit created,false,Axelerate predictive coding service (the order's spelling of Axcelerate),,"Recommind, maker of Axcelerate (the order names the service as Axelerate and names no company)",United States,"Biomet (defendant), with its e-discovery vendor and eight contract attorneys",United States,"South Bend, Indiana, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,1,1,,3,1,,organizational,1,,0,,,,,litigated,2013-08-21,shown,https://storage.courtlistener.com/recap/gov.uscourts.innd.71286/gov.uscourts.innd.71286.396.0.pdf,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Northern District of Indiana (Judge Robert L. Miller, Jr.). In re Biomet M2a Magnum Hip Implant Products Liability Litigation (MDL 2391), No. 3:12-MD-2391, Order Regarding Discovery of ESI (Doc. 396), 18 April 2013. CourtListener RECAP copy of the filed order."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.innd.71286/gov.uscourts.innd.71286.396.0.pdf""}, {""label"": ""Follow-up"", ""value"": ""On 21 August 2013 the court refused to order Biomet to identify which produced documents were in its seed set. It found that Biomet's cooperation fell below what the Sedona Conference endorses and urged it to reconsider."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.innd.71286/gov.uscourts.innd.71286.763.0.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0987,2013-02-01,source publication,day,reported,"A California federal court found that H5's algorithm-driven review of almost 12 million records was more efficient, holding its fees reasonable","In February 2013 a US district judge found that H5's algorithm-driven review of almost 12 million records was a more efficient method. The judge held its $2,829,349.10 cost reasonable.",Court credits *H5* review of almost 12 million records as efficient,almost 12 million records,,found,Found by a court,no comparison,very low,benefit created,false,"H5's computer-assisted, algorithm-driven document review (proprietary technology)",,H5,United States,"Qualcomm Incorporated and its co-defendants, through their counsel Cooley LLP, with contract reviewers from Black Letter Discovery",United States,"San Diego, California, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,1,2,1,,3,1,,organizational,1,,0,Manual review of the records,,,assumed,litigated,2014-03-18,not shown,https://www.govinfo.gov/content/pkg/USCOURTS-casd-3_08-cv-01992/pdf/USCOURTS-casd-3_08-cv-01992-9.pdf,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Southern District of California (Judge Anthony J. Battaglia). Gabriel Technologies Corp. v. Qualcomm Inc., No. 08cv1992 AJB (MDD), Order Granting in Part and Denying in Part Defendants' Motion for Attorneys' Fees (Doc. 371), 1 February 2013. GovInfo copy of the filed order."", ""url"": ""https://www.govinfo.gov/content/pkg/USCOURTS-casd-3_08-cv-01992/pdf/USCOURTS-casd-3_08-cv-01992-9.pdf""}, {""label"": ""Follow-up"", ""value"": ""The plaintiffs did not appeal the amount of the fee award, and the Federal Circuit affirmed the award on 18 March 2014."", ""url"": ""https://www.cafc.uscourts.gov/opinions-orders/13-1205.opinion.3-14-2014.1.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0673,2008-03-01,event,year,reported,SSA's Inspector General finds that 93% of claims picked by the Quick Disability Determinations model were allowed. Decisions took 18 days on average,"SSA's Inspector General found that 537 of 575 sampled claims picked by the QDD model, about 93%, were allowed. It found that decisions took 18 days on average.",*Quick Disability Determinations* speed up likely disability claims,"537 claims, about 93%, were allowed",,found,Found by an auditor,no comparison,very low,aggregate result,false,Quick Disability Determination (QDD) predictive model,,"IBM, which originally designed the model according to SSA, with later changes by the Social Security Administration",United States,Social Security Administration with state Disability Determination Services,United States,United States (national),United States,Social security (disability benefits),,Accessibility,Social Welfare,Disabled Assistance,Prediction from data,People with disabilities,1; 10,High income,opportunity_access,Insurance and benefit access,1,4,1,2,3,1,0.160,personal,2,,0,SSA's recommended timeframe for QDD claims,20 days or fewer,18 days on average for all sampled claims and 15 days for allowed claims,measured,persisted,2026-05-18,not shown,https://web.archive.org/web/20250718071131id_/https://oig-files.ssa.gov/audits/full/A-01-10-21080.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Social Security Administration, Office of the Inspector General. National Rollout of Quick Disability Determinations. Audit report A-01-09-19030, 13 May 2009 (archived copy of the report at oig-files.ssa.gov)."", ""url"": ""https://web.archive.org/web/20250524182533id_/https://oig-files.ssa.gov/audits/full/A-01-09-19030.pdf""}]","{""kind"": ""Official documents""}" AIBD-0726,2008-01-01,event,year,reported,CrimeSolutions finds that Philadelphia probationers forecast as low risk by a random forests model did no worse in caseloads of about 400,"In a 2007-08 Philadelphia trial rated Promising by CrimeSolutions, people whom a random forests model forecast as low risk were supervised in caseloads of about 400 with no rise in reoffending.",A risk model lets Philadelphia supervise low-risk probationers lightly,a caseload of about 400 people,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,Random forests risk forecasting model (modified from Berk et al. 2009),,"Richard Berk and colleagues (Berk et al. 2009), with the Philadelphia Adult Probation and Parole Department",United States,"Philadelphia Adult Probation and Parole Department, First Judicial District of Pennsylvania",United States,"Philadelphia, Pennsylvania, United States (western and northeastern regions)",United States,Criminal justice (probation and parole),,Public sector,Law and Crime,Prisons,Prediction from data,Public servants,16,High income,operational_improvement,Enhanced productivity,1,3,4,,3,,,organizational; personal,1,,0,Standard regional supervision of people forecast as low risk,Almost the same contact as in the previous year,Contacts reduced by about 45 percent,measured,persisted,,shown,https://crimesolutions.ojp.gov/ratedprograms/philadelphia-pa-low-intensity-community-supervision-experiment,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""CrimeSolutions, National Institute of Justice, U.S. Department of Justice. Program Profile: Philadelphia (Pa.) Low-Intensity Community Supervision Experiment. Rated Promising. Posted 15 June 2011."", ""url"": ""https://crimesolutions.ojp.gov/ratedprograms/philadelphia-pa-low-intensity-community-supervision-experiment""}]","{""kind"": ""Official documents""}" AIBD-0844,2007-05-01,event,month,reported,"EPA finds that SmartCEM-75 software matched a NOx analyzer on Great River Energy's Cambridge Station turbine, including startups","EPA found that SmartCEM-75 software, trained on a Minnesota turbine's own data, matched a certified NOx analyzer over 720 hours, including startups and shutdowns. EPA approved it on 2 June 2009.",*SmartCEM-75* matches a NOx analyzer on a Minnesota turbine,matched a certified NOx analyzer over 720 hours,,found,Found by a regulator,tested against a standard,low,aggregate result,false,SmartCEM-75 predictive emission monitoring system (PEMS),,CMC Solutions,United States,"Great River Energy, Cambridge Station Unit 2",United States,"Cambridge, Minnesota, United States",United States,Environment and climate,,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,,1,1,,,3,5,,organizational,1,,0,"Hourly readings from the unit's certified NOx analyzer over the same 720 operating hours, judged by EPA's three statistical tests",A linear correlation coefficient (r) above 0.8 required,r = 0.9521 over all 720 hours and r = 0.8541 over the 542 non-DLN startup and shutdown hours,measured,unknown,,shown,https://www.epa.gov/sites/default/files/2015-05/documents/cambridge_station.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Approval of the Predictive Emission Monitoring System Installed on Unit 2 at Great River Energy's Cambridge Station (Facility ID (ORISPL) 2038). Letter to Great River Energy, 2 June 2009."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/cambridge_station.pdf""}]","{""kind"": ""Official documents""}" AIBD-0845,2007-01-01,event,year,reported,"EPA finds that SmartCEM-75 models matched NOx analyzers on all eight T.H. Wharton turbines, where NRG has reported emissions with them since 2009",EPA found that SmartCEM-75 models matched NOx analyzers over 720 hours each on eight NRG turbines in Houston. NRG has reported NOx with them since 2009 for six units. Two more followed in 2011.,*SmartCEM-75* models match NOx analyzers on eight Houston turbines,matched NOx analyzers over 720 hours each,,found,Found by a regulator,tested against a standard,low,aggregate result,false,"SmartCEM-75 predictive emission monitoring systems (PEMS), one model per turbine",,CMC Solutions,United States,"NRG Texas Power (NRG Energy), T.H. Wharton Generating Station Units THW31 to THW34 and THW41 to THW44",United States,"Houston, Texas, United States",United States,Environment and climate,,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,,1,1,4,,3,5,,organizational,2,,0,"Hourly readings from certified NOx analyzers on the same units over 720 operating hours each, judged by EPA's three statistical tests",A linear correlation coefficient (r) above 0.8 required,r = 0.936 to r = 0.999 across the eight units,measured,persisted,2025-05-21,shown,https://www.epa.gov/sites/default/files/2015-05/documents/t.h._wharton.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Updated Approval of the Predictive Emission Monitoring Systems Installed on Units THW31 through THW34 and Units THW41 through THW44 at NRG Texas Power's T.H. Wharton Generating Station [Facility ID (ORISPL) 3469]. Letter to NRG Texas Power, 27 September 2010."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/t.h._wharton.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air and Radiation. Request for Changes to the PEMS Approval for Units THW31 through THW34 and THW41 through THW44 at T.H. Wharton (Facility ID (ORISPL) 3469). Letter to NRG Energy, 21 May 2025."", ""url"": ""https://www.epa.gov/system/files/documents/2025-05/t_h_wharton_petition_response.pdf""}]","{""kind"": ""Official documents""}" AIBD-0895,2006-04-05,source publication,day,reported,EPA approved a neural-network model of emissions at the Mahrt Paper Mill after its NOx output passed all three federal statistical tests,EPA found that a neural network's NOx estimates for a mill turbine passed all three federal statistical tests. It estimated that two such systems cost less than half as much as hardware monitors.,EPA approves *Software CEM* to monitor NOx from a paper mill's turbine,less than half the cost,,found,Found by a regulator,no comparison,very low,aggregate result,false,Pavilion Technologies Software CEM predictive emission monitoring system (PEMS),,Pavilion Technologies,United States,"MeadWestvaco Coated Board, Inc. (Mahrt Mill)",United States,"Cottonton, Alabama, United States",United States,Air emissions monitoring,,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,Value above replacement,1,1,4,,3,5,,organizational,1,,0,"Two continuous emission monitoring systems (CEMS), the next least costly option under EPA's cost model","$125,400 a year for two CEMS","approximately $51,700 a year for two PEMS with in-house audits",assumed,unknown,,shown,https://www.epa.gov/sites/default/files/2015-05/documents/meadwestvaco_coated_board_inc.pdf,"$36,650","Estimated yearly saving of two PEMS over two CEMS at the mill, even if outside contractors run the audits",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Final Approval of the Predictive Emission Monitoring Systems Installed on Units X022 and Z008 at the Mahrt Paper Mill (Facility ID (ORISPL) 54802). Letter to MeadWestvaco Coated Board, Inc., 5 April 2006, with Attachments A to C."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/meadwestvaco_coated_board_inc.pdf""}]","{""kind"": ""Official documents""}" AIBD-0843,2004-07-01,event,month,reported,EPA finds that SmartCEM-75 software tracked NOx at Dearborn Industrial Generation closely enough to stand in for hardware analyzers,EPA found that SmartCEM-75 software matched a NOx analyzer on a Dearborn boiler over 720 hours. It estimated that on a turbine there the software would cost under half as much as an analyzer.,*SmartCEM-75* stands in for NOx analyzers at a Dearborn plant,matched a NOx analyzer on a Dearborn boiler over 720 hours,,found,Found by a regulator,tested against a standard,low,aggregate result,false,SmartCEM-75 predictive emission monitoring system (PEMS),,"CMC Solutions, L.L.C.",United States,"Dearborn Industrial Generation (DIG), on boiler Unit BL1100 and turbine Unit GTP1",United States,"Dearborn, Michigan, United States",United States,Environment and climate,,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,Value above replacement,1,1,4,,3,5,,organizational,2,,0,"Hourly readings from the unit's certified NOx analyzer over the same 720 operating hours, judged by EPA's three statistical tests",A linear correlation coefficient (r) above 0.8 required,r = 0.9678 over all 720 hours and r = 0.9286 over 98 startup and shutdown hours,measured,unknown,,shown,https://www.epa.gov/system/files/documents/2024-09/dig-55088-original-petition-response-bl1100-2006.9.6.pdf,"$12,950",Estimated yearly saving of the PEMS on Unit GTP1 over an analyzer even if outside contractors run the extra audits,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Approval of the Predictive Emission Monitoring System Installed on Unit BL1100 at Dearborn Industrial Generation (Facility ID (ORISPL) 55088). Letter to Dearborn Industrial Generation, 6 September 2006."", ""url"": ""https://www.epa.gov/system/files/documents/2024-09/dig-55088-original-petition-response-bl1100-2006.9.6.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Final Approval of the Predictive Emission Monitoring System (PEMS) Installed on Unit GTP1 at Dearborn Industrial Generation (Facility ID (ORISPL) 55088). Letter with attachments, 5 April 2006 (scanned copy)."", ""url"": ""https://www.epa.gov/system/files/documents/2024-09/dig-55088-original-petition-response-gtp1-2006.4.5.pdf""}]","{""kind"": ""Official documents""}" AIBD-1036,2004-01-01,event,year,reported,GAO finds that FHA's TOTAL Scorecard gave lenders more consistent underwriting decisions than the scorecards that it replaced,In April 2006 GAO found that FHA's TOTAL Scorecard gave lenders less paperwork than the two scorecards that it replaced. Borrowers had less. Underwriting decisions were more consistent.,*TOTAL Scorecard* makes FHA's underwriting more consistent,,,found,Found by an auditor,no comparison,very low,program,false,Technology Open to Approved Lenders (TOTAL) Scorecard,,"Federal Housing Administration (HUD), with contractor Unicon Research Corporation and subcontractor Fair Isaac Corporation",United States,Federal Housing Administration and its direct endorsement lenders,United States,United States (national),United States,Housing finance: mortgage insurance underwriting,,Finance,Domestic Commerce,Consumer Finance,Prediction from data,Consumers,10; 11,High income,operational_improvement,Value above replacement,1,,4,4,3,5,,organizational; personal,1,,0,"The FHA versions of Freddie Mac's Loan Prospector and Fannie Mae's Desktop Underwriter scorecards, used before 2004","at times the results of their assessments differed, which resulted in the same loan being accepted by one scorecard and referred by the other",TOTAL limits the number of loans that need to be approved manually because it provides consistent automatic underwriting decisions,assumed,persisted,2022-09-27,shown,https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-06-435/pdf/GAOREPORTS-GAO-06-435.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office. Mortgage Financing: HUD Could Realize Additional Benefits from Its Mortgage Scorecard. GAO-06-435, report to the Chairman, Subcommittee on Housing and Community Opportunity, House Committee on Financial Services, 13 April 2006. Section 'HUD Could Benefit Significantly More from TOTAL', pp. 15-16, and Table 1."", ""url"": ""https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-06-435/pdf/GAOREPORTS-GAO-06-435.pdf""}]","{""kind"": ""Official documents""}" AIBD-0846,2002-05-01,event,month,reported,EPA approves a software monitor for NOx on Braintree's Potter II Unit 3 after finding that it matched reference measurements on both of its fuels,EPA found that a predictive emission monitor on Braintree's Potter II Unit 3 matched reference NOx measurements on gas and oil. It estimated that it would cost less than half as much as an analyzer.,Braintree's *predictive emission monitor* passes EPA's tests for NOx,cost less than half as much as an analyzer,,found,Found by a regulator,tested against a standard,low,aggregate result,false,Predictive emission monitoring system (PEMS) on Potter II Unit 3,,Not named in the letter,,"Braintree Electric Light Department (BELD), Norton P. Potter II Station Unit 3",United States,"Braintree, Massachusetts, United States",United States,Environment and climate,,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,Value above replacement,1,1,4,,3,5,,organizational,1,,0,"Hourly NOx readings from a temporary reference method system over the same hours, judged by EPA's three statistical tests",A linear correlation coefficient (r) above 0.8 required,r = 0.8524 on natural gas and r = 0.9211 on fuel oil,measured,unknown,,shown,https://www.epa.gov/sites/default/files/2015-05/documents/potter.pdf,"$12,950",Estimated yearly saving of the PEMS over an analyzer even if outside contractors run the extra audits,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Approval of the Predictive Emission Monitoring System Installed on Unit 3 at Braintree Electric Light Department's Norton P. Potter II Station (ORISPL 01660). Letter to Braintree Electric Light Department, 31 May 2006."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/potter.pdf""}]","{""kind"": ""Official documents""}" AIBD-1160,2026-10-23,source publication,day,tested,China's CMDE finds that the BMP-10 monitor's sedation index matched sedation scores more often than BIS in the maker's trial,"In the maker's trial of 140 patients that China's CMDE reviewed, the BMP-10 monitor's NSI agreed with sedation scores 90.62% of the time, more often than the BIS index.",*BMP-10* sedation index tracked sedation scores better than BIS,agreed with sedation scores 90.62% of the time,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"BMP-10 anesthesia depth monitor (麻醉深度监护仪), with its sedation depth index (NSI)",Software release 1 (full version 1.0.0.143),"Sichuan Xinyuan Bioelectronics Technology Co., Ltd. (四川新源生物电子科技有限公司)",China,Sichuan Xinyuan Bioelectronics Technology (registration trial with 140 patients at four clinical institutions),China,Four clinical institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,Upper middle income,physical_health,,,,,,,,,organizational,1,,0,"The BIS index, scored against the same MOAA/S sedation assessments in the trial",Lower agreement of the BIS value with MOAA/S (figure not given),"Higher agreement of the NSI with MOAA/S, a statistically significant difference",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1792720030064015380.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:麻醉深度监护仪 (technical review report for the registration of an anesthesia depth monitor), acceptance no. CQZ2500601, applicant 四川新源生物电子科技有限公司. Undated report, posted on CMDE's website on 23 October 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1792720030064015380.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:麻醉深度监护仪 (technical review report for the registration of an anesthesia depth monitor), acceptance no. CQZ2500601, applicant 四川新源生物电子科技有限公司. Undated report, posted on CMDE's website on 23 October 2026. Section 三、临床评价概述 (clinical evaluation), CMDE's closing judgment on the clinical evidence. The report has no benefit-risk section."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1792720030064015380.pdf""}]","{""kind"": ""Official documents""}" AIBD-0990,2026-10-05,source publication,day,intended,A federal court in Arizona found insufficient evidence that a 70-80% recall target for technology assisted review is deficient,In October 2026 a federal court in Arizona declined to require a 90-95% recall for technology assisted review. It found insufficient evidence that the defendants' 70-80% target was deficient.,Arizona court declines to raise a 70-80% recall target for *TAR*,a recall rate of 70-80%,,found,Found by a court,,very low,benefit created,false,Technology Assisted Review (TAR),,Not named in the order,,J.E.T. Limousines & Transportation LLC and the other defendants,United States,"Phoenix, Arizona, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,,,,,unknown,,shown,https://storage.courtlistener.com/recap/gov.uscourts.azd.1414720/gov.uscourts.azd.1414720.323.0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the District of Arizona (Magistrate Judge John Z. Boyle). McGhee v. J.E.T. Limousines & Transportation LLC, No. CV-24-03394-PHX-DJH, Order (Doc. 323), dated 2 October 2026 and filed 5 October 2026, pp. 3-4 and 8-9. CourtListener RECAP copy."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.azd.1414720/gov.uscourts.azd.1414720.323.0.pdf""}]","{""kind"": ""Official documents""}" AIBD-1159,2026-08-12,source publication,day,tested,China's CMDE finds that the GluRing ring estimated blood glucose without a needle within 9.20% of venous values on average in the maker's trial,"In the maker's trial that China's CMDE reviewed, the GluRing ring's needle-free glucose estimates differed from venous values by 9.20% on average, with 99.32% in Clarke zones A and B.",*GluRing* estimated blood glucose without a needle in China's review,differed from venous values by 9.20% on average,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,GluRing and GluRing s non-invasive glucose meter (无创血糖仪),Release 1 of the GluRing apps and server (full version 1.1.0),"Beijing Lepu Diagnostics Technology Co., Ltd. (北京乐普诊断科技股份有限公司)",China,Beijing Lepu Diagnostics Technology (registration trial with 96 subjects at three clinical institutions),China,Three clinical institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,Upper middle income,physical_health,,,,,,,,,personal,1,,0,"Venous blood glucose of the same subjects, measured in pairs as the reference standard",,MARD 9.20% (95% CI 8.65% to 9.74%),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1786495243657085501.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:无创血糖仪 (technical review report for the registration of a non-invasive blood glucose meter), acceptance no. CQZ2500265, applicant 北京乐普诊断科技股份有限公司. Undated report, posted on CMDE's website on 12 August 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1786495243657085501.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:无创血糖仪 (technical review report for the registration of a non-invasive blood glucose meter), acceptance no. CQZ2500265, applicant 北京乐普诊断科技股份有限公司. Undated report, posted on CMDE's website on 12 August 2026. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1786495243657085501.pdf""}]","{""kind"": ""Official documents""}" AIBD-1031,2026-08-06,source publication,day,tested,Canary Islands assessment service SESCS finds that the G-STRIDE gait sensor may detect fall risk better than the Timed Up and Go test,"SESCS found that in one study, the G-STRIDE gait sensor identified more older people at risk of falling than the Timed Up and Go test. It identified about as many as a gait-speed test.",*G-STRIDE* spots more older people at risk of falls than the TUG test,sensitivity of 77%,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,G-STRIDE (shoe-mounted inertial sensor with a machine-learning gait algorithm),,Academic consortium of Universidad Rey Juan Carlos and collaborators,Spain,"The Spanish validation study that SESCS used, with 157 people over 70",Spain,Spain,Spain,Healthcare (fall prevention in older people),,Health,Health,Disease Prevention,Prediction from data,Older people,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,The Timed Up and Go test and a gait-speed test in the same people,"test TUG, que tuvo una sensibilidad de 51% (IC95%: 39, 62)","el dispositivo portátil G-STRIDE obtuvo una sensibilidad de 77% (IC95%: 55, 85)",measured,unknown,,shown,https://sescs.es/wp-content/uploads/2026/08/114_2025_SESCS_Telemonitorizacion_Caidas_DEF_NIPO.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Sistemas de telemonitorización portátiles para la evaluación del riesgo de caídas y la detección de caídas en personas de 65 o más años. Informes de Evaluación de Tecnologías Sanitarias, Ministerio de Sanidad, 2026. Resumen ejecutivo (Resultados, Coste-efectividad y análisis económico)."", ""url"": ""https://sescs.es/wp-content/uploads/2026/08/114_2025_SESCS_Telemonitorizacion_Caidas_DEF_NIPO.pdf""}]","{""kind"": ""Official documents""}" AIBD-2308,2026-05-22,source publication,day,tested,FDA De Novo review of PCWP Analysis Software: a machine learning estimate of heart filling pressure met its accuracy goals against catheter measurements,"In the study that FDA reviewed, Cardiosense's PCWP Analysis Software identified elevated heart filling pressure with 78% sensitivity and 80% specificity against catheter measurements in 119 patients.",*PCWP Analysis Software* gauges heart pressure without a catheter,78%,,found,Found by a regulator,tested against a standard,very low,program,false,PCWP Analysis Software (with the CardioTag sensor),,"Cardiosense, Inc.",United States,Cardiosense (clinical validation study at U.S. centers),United States,United States,United States,Healthcare (cardiology),,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Pulmonary capillary wedge pressure measured with a Swan-Ganz catheter during right heart catheterization,Reference standard,Sensitivity 78% and specificity 80% for a pressure of 18 mmHg or more,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for PCWP Analysis Software (DEN250057): decision summary. Granted 2026-05-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250057.pdf""}]","{""kind"": ""Official documents""}" AIBD-0956,2026-05-14,source publication,day,tested,China's CMDE finds that investigators using AI Local AutoVision analyzed karyotypes 23.23 minutes faster in the maker's trial,"In the maker's trial that China's CMDE reviewed, investigators using AI Local AutoVision took 11.19 minutes on average per karyotype, against 34.42 minutes by hand.",*AI Local AutoVision* cut time to analyze karyotypes in China's review,"11.19 minutes on average per karyotype, against 34.42 minutes by hand",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,AI Local AutoVision (染色体核型图像辅助诊断软件),Release 2 (full version 2.0.0.0),"Hangzhou Diagens Biotechnology Co., Ltd. (杭州德适生物科技股份有限公司)",China,"Hangzhou Diagens Biotechnology (registration trial with 1,734 subjects at three hospitals)",China,"First People's Hospital of Yunnan Province, Third Affiliated Hospital of Zhengzhou University and Reproductive Hospital Affiliated to Shandong University, China",China,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,Upper middle income,operational_improvement,Enhanced productivity,,,1,,,1,,organizational,2,,0,"Traditional manual karyotype analysis of the same cases, with an expert panel's analysis as the reference",34.42±11.48min on average by traditional manual analysis,11.19±5.48min on average with the software,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1783924708399056481.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:染色体核型图像辅助诊断软件 (technical review report for the registration of chromosome karyotype image diagnosis-aid software), acceptance no. CQZ2501137, applicant 杭州德适生物科技股份有限公司. 14 May 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1783924708399056481.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:染色体核型图像辅助诊断软件 (technical review report for the registration of chromosome karyotype image diagnosis-aid software), acceptance no. CQZ2501137, applicant 杭州德适生物科技股份有限公司. 14 May 2026. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1783924708399056481.pdf""}]","{""kind"": ""Official documents""}" AIBD-1092,2026-05-08,source publication,day,tested,China's CMDE finds that uAI MI Onco flagged focal FDG uptake in the chest on PET/CT with 90.97% sensitivity in the maker's trial,"In the maker's retrospective trial that China's CMDE reviewed, uAI MI Onco flagged focal FDG uptake in the chest with 90.97% sensitivity and 94.98% specificity against an expert panel.",*uAI MI Onco* flagged chest uptake on PET/CT scans in China's review,90.97% sensitivity and 94.98% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,uAI MI Onco (胸部核医学图像辅助分诊软件),Release 1.0 (full version 1.00-2-24),"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective registration trial with 596 cases at two sites),China,"Two trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"A target of 80% for the lower 95% confidence bounds of sensitivity and specificity, with an expert panel's reading as the reference",Target of 80% for the lower confidence bounds,Sensitivity 90.97% (87.60%,94.35%) and specificity 94.98% (92.59%,97.38%),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1783924291455047433.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:胸部核医学图像辅助分诊软件 (technical review report for the registration of chest nuclear medicine image triage-aid software), acceptance no. CQZ2402165, applicant 上海联影智能医疗科技有限公司. 8 May 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1783924291455047433.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:胸部核医学图像辅助分诊软件 (technical review report for the registration of chest nuclear medicine image triage-aid software), acceptance no. CQZ2402165, applicant 上海联影智能医疗科技有限公司. 8 May 2026. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1783924291455047433.pdf""}]","{""kind"": ""Official documents""}" AIBD-0799,2026-05-04,source publication,day,tested,"FDA found that ArteraAI Breast's high risk group had an 8.7% risk of metastasis within five years, against 0.9% in its low risk group, in 1,271 patients","In FDA's review of ArteraAI Breast, five-year distant metastasis risk was 8.7% in its high risk group and 0.9% in its low risk group, against 3.6% across 1,271 patients.",*ArteraAI Breast* sorted patients with breast cancer by risk of spread,five-year distant metastasis risk was 8.7% in its high risk group,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,ArteraAI Breast,,"Artera, Inc.",United States,"Artera (retrospective clinical validation on archived slides from 1,271 patients at three US sites)",United States,"Three sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational,2,,0,"Five-year distant metastasis risk across all 1,271 patients",3.6%,8.7% in the high risk group and 0.9% in the low risk group,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K254115.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for ArteraAI Breast (K254115). Cleared 2026-05-04."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K254115.pdf""}]","{""kind"": ""Official documents""}" AIBD-1126,2026-05-01,source publication,month,tested,"SHTG finds that AI-estimated CT-FFR agrees well with invasive FFR, so it could spare some patients invasive testing, though no outcome studies exist","SHTG found that machine-learning CT-FFR agrees well with invasive FFR, with pooled sensitivity of 0.86 and specificity of 0.87 per patient. No study followed patients or costs.","*AI-estimated CT-FFR* agrees well with invasive heart tests, SHTG finds",pooled sensitivity of 0.86 and specificity of 0.87,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"Machine-learning CT-FFR software in the meta-analyses that SHTG reviewed: cFFR, DEEPVESSEL-FFR, skCT-FFR and XFFR",cFFR versions 1.4 to 3.2 in one meta-analysis,"Siemens Healthineers (cFFR), Keya Medical (DEEPVESSEL-FFR) and other makers","Multiple: Germany, China","Study sites in the meta-analyses that SHTG reviewed, with NHSScotland cardiology services as prospective users",Multiple,"Multiple countries (studies), with an overview for Scotland, United Kingdom",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,personal,2,,0,"Invasive FFR measurement, the reference test (per patient, 17 studies)",,Pooled sensitivity 0.86 and specificity 0.87,measured,unknown,,shown,https://admin.shtg.scot/media/udwcvr0v/2026-05-18-ct-ffr-imto-v10.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group, Healthcare Improvement Scotland. Innovative Medical Technology Overview: Artificial intelligence (AI) estimated computed tomography fractional flow reserve (CT-FFR). May 2026, Key messages."", ""url"": ""https://admin.shtg.scot/media/udwcvr0v/2026-05-18-ct-ffr-imto-v10.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}]","{""kind"": ""Official documents""}" AIBD-0714,2026-04-22,source publication,day,reported,The Swiss Federal Audit Office finds that COMCO's machine-learning screen for bid rigging in construction gave encouraging results in real cases,"The Swiss Federal Audit Office found that COMCO's machine-learning screen for bid rigging in construction gave concrete, encouraging results in real cases. COMCO spends under CHF 10,000 a year on it.",Swiss auditors find that COMCO's bid-rigging screen works at low cost,,,found,Found by an auditor,no comparison,very low,program,false,"COMCO bid-rigging screen for construction tenders (statistical screens combined with machine learning, run as a script)",,"Secretariat of the Swiss Competition Commission (COMCO/WEKO), with the University of Fribourg from 2019",Switzerland,Swiss Competition Commission (COMCO/WEKO),Switzerland,Switzerland,Switzerland,Competition enforcement / public procurement,,Public sector,Domestic Commerce,Corporate Management,Prediction from data,Public servants,16,High income,privacy_protection,Fraud detection,,1,4,,3,2,,organizational,1,,0,,,,,unknown,,shown,https://www.efk.admin.ch/wp-content/uploads/publikationen/berichte/wirtschaft_und_verwaltung/informatikprojekte/25407/25407be-comco-rapport-utilisation-application-avec-ia.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Contrôle fédéral des finances / Eidgenössische Finanzkontrolle (CDF/EFK). Audit de l'utilisation d'une application avec intelligence artificielle: Commission de la concurrence (COMCO). CDF-25407, version with responses dated 11 February 2026, published 22 April 2026. Section 2.1, p. 11."", ""url"": ""https://www.efk.admin.ch/wp-content/uploads/publikationen/berichte/wirtschaft_und_verwaltung/informatikprojekte/25407/25407be-comco-rapport-utilisation-application-avec-ia.pdf""}]","{""kind"": ""Official documents""}" AIBD-1124,2026-04-22,source publication,day,intended,"Region Skåne's priority council backs AI grading of eye photos in diabetes screening, expecting about 1,400 staff hours a year to be freed","Region Skåne's council backed AI grading of eye photos for people with diabetes but no known retinopathy. It judged the AI as precise as manual review. It expected it to free about 1,400 hours a year.",Skåne backs *AI fundus grading* to free hours in diabetic eye screening,"about 1,400 hours a year",,found,Found by an assessment body,,very low,aggregate result,false,"AI-developed automated image analysis of fundus photographs, including DAIRET (Retmarker) and Aireen in the studies behind the main finding",,"Retmarker (DAIRET), Aireen and other makers, with an in-house model in one study","Multiple: Portugal, Czech Republic, Pakistan","Screening services in the studies that HTA South reviewed, with prospective use at Region Skåne's eye clinics",Multiple,"Multiple countries (studies), with a recommendation for Skåne, Sweden",Sweden,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,"Grading of the same photos by human graders, used as the reference standard",,Sensitivity around 89% and specificity 84% for any retinopathy,measured,unknown,,shown,https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2025/ai-baserad-bildanalys-vid-screening-for-diabetesretinopati.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Region Skåne, Metod- och prioriteringsrådet. Yttrande: AI-utvecklad automatiserad bildanalys av ögonbottenfotografier vid screening för diabetesretinopati. Dnr 2026-O000003, 22 April 2026. Metod- och prioriteringsrådets ställningstagande."", ""url"": ""https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/metod-och-prioriteringsradet/yttranden/yttrande-ai-bildanalys-retinopati-2026-04-22_jp.pdf""}, {""label"": ""Assessment report"", ""value"": ""HTA syd (HTA South), Region Skåne. AI-baserad bildanalys vid screening för diabetesretinopati: en systematisk översikt och utvärdering av medicinska, hälsoekonomiska, etiska och organisatoriska aspekter. Rapport 2025:4, Lund, 17 December 2025. English abstract, Key Message."", ""url"": ""https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2025/ai-baserad-bildanalys-vid-screening-for-diabetesretinopati.pdf""}]","{""kind"": ""Official documents""}" AIBD-0816,2026-04-10,source publication,day,tested,"The RDW approves Tesla's FSD Supervised for the Netherlands after more than a year and a half of tests, judging it safer than other driving aids","After more than a year and a half of tests, the Dutch vehicle authority approved Tesla's FSD Supervised. It judged the system safer than other driving aids because it strictly monitors the driver.",Dutch regulator approves *FSD Supervised* after tests on the road,,,found,Found by a regulator,no comparison,very low,aggregate result,false,FSD Supervised (Full Self Driving Supervised),,Tesla,United States,"Tesla, under an EU type approval valid for now only in the Netherlands",United States,Netherlands,Netherlands,Road transport / driver assistance,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,High income,physical_health,Hazard reduction,,,,,,,,personal; societal,1,,0,Other driving aids,,"Safer than other driving aids, in the RDW's judgment",assumed,persisted,2026-06-17,shown,https://en.wikipedia.org/wiki/Tesla_Autopilot,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""RDW (Rijksdienst voor het Wegverkeer, Netherlands Vehicle Authority). Toelichting RDW op Europese typegoedkeuring Tesla met voorlopige geldigheid in Nederland. News item, 10 April 2026 (in Dutch)."", ""url"": ""https://www.rdw.nl/nieuws/2026/toelichting-rdw-op-europese-typegoedkeuring-tesla-met-voorlopige-geldigheid-in-nederland""}]","{""kind"": ""Official documents""}" AIBD-0741,2026-04-02,source publication,day,tested,"NICE allows ArtiQ.Spiro in NHS primary care while evidence is gathered, citing higher sensitivity for airway diseases such as COPD in a UK trial","NICE allowed ArtiQ.Spiro in NHS primary care while evidence is gathered. In the SPIRO-AID trial, it raised professionals' sensitivity for asthma. The same held for COPD. Specificity was similar.",*ArtiQ.Spiro* raised sensitivity for COPD in a UK trial,,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,ArtiQ.Spiro,,Clario,United States,SPIRO-AID trial with 133 UK primary care professionals reviewing past spirometry records,United Kingdom,United Kingdom,United Kingdom,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Health workers,3,High income,physical_health,Medical diagnosis,,3,1,,,1,,organizational; personal,2,,0,Primary care professionals reviewing the same kind of records without the software (SPIRO-AID control arm),,sensitivity was higher,measured,unknown,,shown,https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/ai-in-primary-care-spirometry-for-diagnosis-of-lung-disease-april/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment. HealthTech guidance HTG776, section 1: Recommendations. 2 April 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg776/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HealthTech guidance HTG776, section 3: Committee discussion (diagnostic accuracy of initial diagnosis). 2 April 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg776/chapter/3-Committee-discussion""}]","{""kind"": ""Official documents""}" AIBD-1214,2026-03-25,source publication,day,intended,Japan's Kanto District Transport Bureau approves Macnica's NAVYA EVO shuttle in Hitachiota as a Level 4 automated vehicle that needs no driver,On 25 March 2026 the Kanto District Transport Bureau confirmed that the EVO's automated operation device met the safety standards. It approved the shuttle as a Level 4 vehicle on about 200 m of road.,Macnica's *EVO* shuttle may run with no driver on a Hitachiota road,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (自動運行装置) on a NAVYA EVO shuttle,,"Navya Mobility (NAVYA), maker of the EVO shuttle",France,"Macnica, Inc. (株式会社マクニカ), the applicant and operator",Japan,"Hitachiota, Ibaraki Prefecture, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,physical_health; operational_improvement,,,,,,,,,societal,3,,0,,,,,unknown,,shown,https://web.archive.org/web/20231109122136id_/https://www.navya.tech/?p=827,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 自動運転車(レベル4)の認可を行いました (Approval of a Level 4 automated vehicle). Press release, 25 March 2026."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000370411.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 自動運転車(レベル4)の認可を行いました (Approval of a Level 4 automated vehicle). Press release, 25 March 2026."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000370411.pdf""}]","{""kind"": ""Official documents""}" AIBD-0767,2026-03-17,source publication,day,tested,"In FDA's De Novo review, Tyto Insights detected eardrum bulging in otoscope videos more accurately than three non-ENT clinicians","In the study that FDA reviewed, Tyto Insights detected eardrum bulging in 857 otoscope recordings with 0.9231 sensitivity, against 0.7242 for three non-ENT clinicians.",*Tyto Insights* detects bulging eardrums better than non-ENT doctors,a sensitivity of 0.9231,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Tyto Insights for Eardrum Bulging Detection,,Tyto Care Ltd.,Israel,Tyto Care (retrospective validation on 857 otoscope recordings from real-world use),Israel,Recording sites not stated in the decision summary,,Healthcare,,Health,Health,Disease Prevention,Images and video,Children,3,,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Two pediatricians and one general practitioner reading the same recordings,"Sensitivity 0.7242, specificity 0.7325","Sensitivity 0.9231, specificity 0.9463",measured,persisted,2026-04-27,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250014.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Tyto Insights for Eardrum Bulging Detection (DEN250014): decision summary. Granted 2026-03-17."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN250014.pdf""}]","{""kind"": ""Official documents""}" AIBD-1020,2026-03-01,event,month,tested,"CATARC found in C-ICAP tests that Xiaomi's assisted driving on the YU7 scored 97.9% for basic driving assistance, with 100% for car following","In CATARC's C-ICAP tests, published on 4 June 2026, Xiaomi's assisted driving on a YU7 scored 97.9% for basic driving assistance. It scored 100% for car following, as it did for combined control.",*Hyper OS 1.12.0* assisted driving scores 97.9% in basic tests on a YU7,97.9% for basic driving assistance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Xiaomi assisted driving in Hyper OS 1.12.0, as fitted to the Xiaomi YU7 (小米YU7) long-range rear-wheel-drive version",Hyper OS 1.12.0 (software version tested),Xiaomi Auto (小米汽车),China,"Xiaomi Auto (小米汽车科技有限公司), factory-fitted on the YU7",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,persisted,2026-08-08,shown,https://tech.ifeng.com/c/8oacqKAfyiF,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 小米YU7 超长续航后驱版 (Xiaomi YU7 long-range rear-wheel drive), protocol version 2024 revised, test year 2026. Result page published 4 June 2026, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/eefd45c3d383aac4ca0e2dc36f20636a""}]","{""kind"": ""Official documents""}" AIBD-0957,2026-02-13,source publication,day,tested,China's CMDE finds that doctors using uAI-BreastTomoCare detected more breast masses on tomosynthesis in the maker's trial,"In the maker's trial that China's CMDE reviewed, doctors using uAI-BreastTomoCare found 62.17% of breast mass lesions on tomosynthesis, against 50.42% without it.",*uAI-BreastTomoCare* helped doctors find more breast masses,"62.17% of breast mass lesions on tomosynthesis, against 50.42% without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,uAI-BreastTomoCare (乳腺X射线断层图像辅助检测软件),Release 1.1 (full version 1.1-1-1-45),"United Imaging Intelligence (Beijing) Co., Ltd. (联影智能医疗科技(北京)有限公司)",China,United Imaging Intelligence (Beijing) (retrospective reader trial on images of 432 subjects from three centers),China,"Three trial centers that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Women and mothers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,The same doctors reading the same tomosynthesis cases without the software,50.42% lesion-level sensitivity,62.17% lesion-level sensitivity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1775030830626008899.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺X射线断层图像辅助检测软件 (technical review report for the registration of breast X-ray tomosynthesis image detection-aid software), acceptance no. CQZ2500562, applicant 联影智能医疗科技(北京)有限公司. 13 February 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1775030830626008899.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺X射线断层图像辅助检测软件 (technical review report for the registration of breast X-ray tomosynthesis image detection-aid software), acceptance no. CQZ2500562, applicant 联影智能医疗科技(北京)有限公司. 13 February 2026. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1775030830626008899.pdf""}]","{""kind"": ""Official documents""}" AIBD-0958,2026-01-27,source publication,day,tested,China's CMDE finds that readers using EA PC-UGI identified more gastric lesions on magnified endoscopy images in the maker's trial,"In the maker's trial that China's CMDE reviewed, readers using EA PC-UGI reached a lesion-level sensitivity of 85.80% for gastric lesions, against 79.94% alone.",*EA PC-UGI* helped readers spot more stomach lesions in a trial,"a lesion-level sensitivity of 85.80% for gastric lesions, against 79.94% alone",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,EA PC-UGI (胃部病变电子内窥镜图像辅助分诊软件),Release V1,"Wuhan EndoAngel Medical Technology Co., Ltd. (武汉楚精灵医疗科技有限公司)",China,Wuhan EndoAngel Medical Technology (retrospective reader trial with 340 cases at four sites),China,Four trial sites in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"The same readers reading the same images without the software, with pathology as the reference",79.94%(75.70%,84.18%) lesion-level sensitivity,85.80%(82.45%,89.15%) lesion-level sensitivity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1773816067239059668.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:胃部病变电子内窥镜图像辅助分诊软件 (technical review report for the registration of gastric lesion electronic endoscopy image triage-aid software), acceptance no. CQZ2400681, applicant 武汉楚精灵医疗科技有限公司. 27 January 2026. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1773816067239059668.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:胃部病变电子内窥镜图像辅助分诊软件 (technical review report for the registration of gastric lesion electronic endoscopy image triage-aid software), acceptance no. CQZ2400681, applicant 武汉楚精灵医疗科技有限公司. 27 January 2026. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1773816067239059668.pdf""}]","{""kind"": ""Official documents""}" AIBD-0800,2026-01-22,source publication,day,tested,FDA found that PhenoMATRIX read images of culture plates at three US laboratories with false negative rates of 0.1-0.5% against technicians,"In clinical studies at three US laboratories that FDA reviewed, PhenoMATRIX had false positive rates of 1.0-1.3% and false negative rates of 0.1-0.5% against technicians.",*PhenoMATRIX* sorted images of culture plates with few missed growths,false negative rates of 0.1-0.5%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,PhenoMATRIX,,Copan WASP S.r.l.,Italy,Three US clinical microbiology laboratories in the clinical study,United States,"Three clinical laboratories, United States",United States,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Experienced technicians reading the same digital plate images,Technician reads (reference),Positive percent agreement for growth of 99.5% to 100% at Site A,measured,scaled,2026-02-17,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K251511.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for PhenoMATRIX (K251511). Cleared 2026-01-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K251511.pdf""}]","{""kind"": ""Official documents""}" AIBD-1013,2026-01-13,source publication,day,reported,"Japan's Kanto District Transport Bureau approves a bus in Kashiwa, Chiba Prefecture, as a Level 4 automated vehicle that needs no driver",On 29 August 2025 a Japanese transport bureau confirmed that a Kashiwa bus's automated operation device met the safety standards. It approved the bus as a Level 4 vehicle with no driver.,*Automated operation device* lets a Kashiwa bus run with no driver,,,found,Found by a regulator,no comparison,very low,benefit created,false,Automated operation device (自動運行装置) on an Isuzu Erga Mio bus,,"Advanced Smart Mobility Co., Ltd. (先進モビリティ株式会社), the applicant, which converted the bus",Japan,"Tobu Bus Central Co., Ltd. (東武バスセントラル株式会社), the operator",Japan,"Kashiwa, Chiba Prefecture, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,physical_health; operational_improvement,,,1,,,3,,,societal,2,,0,,,,,persisted,2026-01-13,not shown,https://wwwtb.mlit.go.jp/kanto/content/000356771.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Kanto District Transport Bureau, Automotive Technology and Safety Department. 千葉県初!自動運転車(レベル4)の認可を行いました (First in Chiba Prefecture: approval of a Level 4 automated vehicle). Press release, 29 August 2025, paragraphs 1 and 2 and table."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000356771.pdf""}]","{""kind"": ""Official documents""}" AIBD-0715,2026-01-07,source publication,day,reported,The Swiss Federal Audit Office finds that two FINMA machine-learning systems help supervisors prepare analyses,The Swiss Federal Audit Office examined two FINMA systems. One handles press coverage. The other estimates risk for small banks. It found that such AI methods help with specific supervisory tasks.,Swiss auditors find that FINMA's AI tools lighten supervisory work,,,found,Found by an auditor,no comparison,very low,program,false,FINMA Pressespiegel Report (press-review clustering) and Vorhersage von Risikokennzahlen bei Kleinbanken (risk-weighted asset estimates for small banks),,"FINMA Data Innovation Lab (DIL), in-house",Switzerland,"Eidgenössische Finanzmarktaufsicht (FINMA, Swiss Financial Market Supervisory Authority)",Switzerland,Switzerland,Switzerland,Financial supervision,,Finance,Domestic Commerce,Banking,Text and language; Prediction from data,Public servants,16,High income,operational_improvement,Enhanced productivity,,1,,,3,5,,organizational,1,,0,,,,,persisted,,shown,https://www.efk.admin.ch/wp-content/uploads/publikationen/berichte/wirtschaft_und_verwaltung/informatikprojekte/25551/d/25551_endgueltige_fassung_v04.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Eidgenössische Finanzkontrolle (EFK). Prüfung des Einsatzes Künstlicher Intelligenz in der Aufsichtstätigkeit: Eidgenössische Finanzmarktaufsicht. EFK-25551, version with responses dated 14 October 2025, published 7 January 2026. Section 3.2, pp. 15-16."", ""url"": ""https://www.efk.admin.ch/wp-content/uploads/publikationen/berichte/wirtschaft_und_verwaltung/informatikprojekte/25551/d/25551_endgueltige_fassung_v04.pdf""}]","{""kind"": ""Official documents""}" AIBD-1033,2025-12-17,source publication,day,tested,"HTA syd finds that AI analysis of fundus photographs detects referable diabetic retinopathy with about 92% sensitivity, at 91% specificity","HTA syd pooled 13 studies and found, with moderate certainty, that AI grading of retinal photographs detects referable diabetic retinopathy with about 92% sensitivity and 91% specificity.",*AI-based image analysis* detects referable diabetic retinopathy,about 92% sensitivity and 91% specificity,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"AI-based image analysis of fundus photographs for diabetic retinopathy screening (products in the included studies such as EyeArt, IDx-DR, SELENA, RetCAD and Aireen)",,"Several vendors, among them Eyenuk (EyeArt), Digital Diagnostics (IDx-DR) and EyRIS (SELENA)","Multiple: United States, Singapore",Clinics and screening programs in the comparative studies that HTA syd reviewed,"Multiple: Italy, Norway, Czech Republic, United States, Pakistan, India, Thailand, Taiwan, China, Philippines, Rwanda, New Zealand","Studies in Europe, Asia, Africa, Oceania and North America, assessed for Sweden's Southern Healthcare Region",Sweden,Healthcare (diabetic retinopathy screening),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,Human graders reading the same fundus photographs,,sensitivitet på cirka 92% och en specificitet på cirka 91%,measured,persisted,2026-04-22,shown,https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2025/ai-baserad-bildanalys-vid-screening-for-diabetesretinopati.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""HTA syd, Region Skåne. AI-baserad bildanalys vid screening för diabetesretinopati: en systematisk översikt och utvärdering av medicinska, hälsoekonomiska, etiska och organisatoriska aspekter. HTA syd Rapport 2025:4, published 17 December 2025. Abstract (Results), p. 2."", ""url"": ""https://vardgivare.skane.se/siteassets/3.-kompetens-och-utveckling/sakkunniggrupper/hta/rapporter/2025/ai-baserad-bildanalys-vid-screening-for-diabetesretinopati.pdf""}]","{""kind"": ""Official documents""}" AIBD-0693,2025-12-01,source publication,month,reported,UNDP's evaluation office finds that Libya's election commission uses eMonitor+ to respond to violent content against women politicians,UNDP's evaluation office found that Libya's election commission now uses eMonitor+ to respond with targeted communications. The tool finds violent content directed at women politicians.,*eMonitor+* finds violent posts aimed at Libya's women politicians,,,found,Found by an evaluation office,no comparison,very low,protective response,false,"eMonitor+, UNDP's platform for monitoring online media",,UNDP Regional Bureau for Arab States,,"High National Elections Commission (HNEC), Libya, with UNDP and the UN Support Mission in Libya",Libya,Libya,Libya,Electoral integrity / online violence against women,,Public sector,Civil Rights,Voting Rights,Text and language,Women and mothers; Public servants,5; 16,Upper middle income,social_improvement,,,1,4,4,3,5,,organizational; societal,3,,0,,,,,unknown,,shown,https://web.archive.org/web/20260112231245/https://www.undp.org/arab-states/press-releases/election-commission-uses-artificial-intelligent-enhance-womens-participation-electoral-processes,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Independent Country Programme Evaluation: Libya. December 2025, Chapter 2 (Findings). The evaluation team visited Libya in November 2024."", ""url"": ""https://www.undp.org/sites/g/files/zskgke326/files/2025-12/icpe_libya-report.pdf""}, {""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Evaluation of the UNDP Support to Digitalization of Public Services. November 2023. The report is an independent publication of the office. Section on electoral support."", ""url"": ""https://www.unevaluation.org/get-download-file/4444""}]","{""kind"": ""Official documents""}" AIBD-1158,2025-11-21,source publication,day,tested,China's CMDE finds that HB-AI-T1 met its targets for triaging breast thermal images against senior sonographers in the maker's trial,"In the maker's trial of 743 women that China's CMDE reviewed, HB-AI-T1's triage of breast thermal images met its target for sensitivity against senior sonographers. The same held for specificity.",*HB-AI-T1* met its targets for triage of breast images in China's review,,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,HB-AI-T1 (乳腺热层析影像辅助分诊软件),Release 1,"Wuhan Haobo Technology Co., Ltd. (武汉昊博科技有限公司)",China,Wuhan Haobo Technology (registration trial with 743 women at three clinical institutions),China,Three clinical institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Women and mothers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Preset targets for sensitivity and specificity, with a panel of senior sonographers' diagnoses as the reference standard",Preset targets that the report does not state,Sensitivity and specificity reached the targets (no figures given),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1765437352894073517.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺热层析影像辅助分诊软件 (technical review report for the registration of breast thermal tomography image triage-aid software), acceptance no. CQZ2400541, applicant 武汉昊博科技有限公司. 21 November 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1765437352894073517.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺热层析影像辅助分诊软件 (technical review report for the registration of breast thermal tomography image triage-aid software), acceptance no. CQZ2400541, applicant 武汉昊博科技有限公司. 21 November 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1765437352894073517.pdf""}]","{""kind"": ""Official documents""}" AIBD-0959,2025-10-29,source publication,day,tested,"China's CMDE finds that with AI-Rad Companion Prostate MR, doctors diagnosed lesions on prostate MRI slightly better in the maker's trial","In the maker's trial that China's CMDE reviewed, doctors reading prostate MRI with AI-Rad Companion Prostate MR reached an AUROC of 0.7010, against 0.6758 without it.",*AI-Rad Companion Prostate MR* lifted readers' accuracy slightly,"an AUROC of 0.7010, against 0.6758 without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,AI-Rad Companion Prostate MR (前列腺癌磁共振图像辅助检测软件),"Release VA11 (full version VA11B), algorithm release VA1 (full version VA10A)","Siemens Healthineers, with 上海西门子医疗器械有限公司 (Siemens Shanghai Medical Equipment Ltd.) as the applicant in China",Germany,"上海西门子医疗器械有限公司 (Siemens Shanghai Medical Equipment Ltd.), the applicant (retrospective reader trial with 12 doctors and 340 subjects)",China,"Trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,2,,0,Doctors reading the same cases without the software,AUROC 0.6758,AUROC 0.7010,measured,scaled,2025-11-07,shown,https://www.cmde.org.cn/directory/web/cmde/images/1765243681648031434.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:前列腺癌磁共振图像辅助检测软件 (technical review report for the registration of prostate cancer MR image detection-aid software), acceptance no. CQZ2401376, applicant 上海西门子医疗器械有限公司. 29 October 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1765243681648031434.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:前列腺癌磁共振图像辅助检测软件 (technical review report for the registration of prostate cancer MR image detection-aid software), acceptance no. CQZ2401376, applicant 上海西门子医疗器械有限公司. 29 October 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1765243681648031434.pdf""}]","{""kind"": ""Official documents""}" AIBD-0739,2025-10-14,source publication,day,tested,"NICE allows five AI tools, such as HealthVCF, in the NHS after finding that they detect spinal fragility fractures missed in radiology reports","NICE found that AI tools detect moderate to severe vertebral fragility fractures missed in original radiology reports, generally with specificity above 90%. It allowed five in the NHS in 2025.",AI tools find spinal fractures missed in routine scan reports,a specificity above 90%,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"AI tools for opportunistic detection of vertebral fragility fractures on CT: BriefCase-Triage, CINA-VCF Quantix, HealthVCF, HealthOST and IB Lab FLAMINGO",,"Aidoc Medical (BriefCase-Triage), Avicenna.AI (CINA-VCF Quantix), Nanox AI (HealthVCF and HealthOST) and IB Lab (IB Lab FLAMINGO)","Multiple: Israel, France, Austria",Hospitals in the studies reviewed by NICE and NHS radiology services in England during the evidence generation period,Multiple,"England, United Kingdom (guidance), with studies in several countries",United Kingdom,Healthcare (radiology and osteoporosis),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Original radiology reports (standard care),,Additional moderate to severe fractures detected,measured,persisted,,shown,https://www.nice.org.uk/guidance/htg760/chapter/3-Committee-discussion,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies to aid opportunistic detection of vertebral fragility fractures: early value assessment. HealthTech guidance HTG760 (formerly HTE34), section 3: Committee discussion. 14 October 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg760/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG760, section 1: Recommendations. 14 October 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg760/chapter/1-Recommendations""}]","{""kind"": ""Official documents""}" AIBD-1091,2025-10-09,source publication,day,tested,China's CMDE finds that MIAS-3000 flagged intermediate or later macular degeneration on OCT with 95.5% sensitivity in the maker's trial,"In the maker's trial that China's CMDE reviewed, MIAS-3000 flagged intermediate or later age-related macular degeneration on OCT with 95.5% sensitivity and 92.1% specificity per eye.",*MIAS-3000* flagged macular degeneration on OCT scans in China's review,95.5% sensitivity and 92.1% specificity per eye,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,MIAS-3000 (眼科OCT图像辅助诊断软件),Release V1,"Suzhou Bigvision Medical Technology Co., Ltd. (苏州比格威医疗科技有限公司)",China,Suzhou Bigvision Medical Technology (prospective multicenter registration trial with 908 subjects),China,Trial sites in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,A target of 85% for the lower 95% confidence bounds of sensitivity and specificity,Target of 85% for the lower confidence bounds,"Sensitivity 95.5%, 95%CI(92.5%,97.5%) and specificity 92.1%, 95%CI(89.6%,94.2%) per eye",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1761699620880017467.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:眼科OCT图像辅助诊断软件 (technical review report for the registration of ophthalmic OCT image diagnosis-aid software), acceptance no. CQZ2400999, applicant 苏州比格威医疗科技有限公司. 9 October 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1761699620880017467.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:眼科OCT图像辅助诊断软件 (technical review report for the registration of ophthalmic OCT image diagnosis-aid software), acceptance no. CQZ2400999, applicant 苏州比格威医疗科技有限公司. 9 October 2025. Section 综合评价意见 (concluding evaluation), CMDE's own conclusion and recommendation to approve."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1761699620880017467.pdf""}]","{""kind"": ""Official documents""}" AIBD-0633,2025-07-31,source publication,day,tested,FDA De Novo review of ArteraAI Prostate: AI risk categories from biopsy slides separate 10-year metastasis risk in 886 patients,"In FDA's review of ArteraAI Prostate, among 886 patients, 10-year metastasis risk was 28.1% in its high risk category, against 8.1% overall. In its low category it was 3.3%.",*ArteraAI Prostate* sorted prostate cancer patients by risk of spread,10-year metastasis risk was 28.1% in its high risk category,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,ArteraAI Prostate,,"Artera, Inc.",United States,Artera (clinical validation at three US sites),United States,"Three sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,,,,,2,,,,organizational,2,,0,Overall 10-year distant metastasis risk in the validation cohort,8.1% overall,28.1% in the high risk category; 3.3% in the low risk category,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN240068.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for ArteraAI Prostate (DEN240068): decision summary. Granted 2025-07-31."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN240068.pdf""}]","{""kind"": ""Official documents""}" AIBD-1025,2025-06-26,source publication,day,tested,"CATARC found in its C-ICAP tests that the Onvo L60's assisted driving scored 99.4% for basic driving assistance, with 96.3% for navigation","In C-ICAP results that CATARC published on 26 June 2025, the Onvo L60's assisted driving scored 99.4% for basic driving assistance. It scored 96.3% for navigation pilot assistance.",*Onvo L60 assisted driving* scores 99.4% for basic driving assistance,99.4% for basic driving assistance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Assisted driving (辅助驾驶), as fitted to the Onvo (乐道) L60 60kWh rear-wheel drive",1.1.1CN (assisted-driving software version tested),"NIO (蔚来汽车科技(安徽)有限公司), for its Onvo brand",China,NIO (factory-fitted on the Onvo L60),China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,2,,0,,,,,persisted,2026-06-11,not shown,https://www.c-ncap.org.cn/evaluation/ecb71725a7c11d895ff271bc2cdab4b8,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Testing & Assessment Management Center (中汽测评). 乐道L60 [Onvo L60 60kWh 后驱], C-ICAP results page, protocol 2024 edition, test year 2025. Published 26 June 2025. Section 辅助驾驶 > 行车辅助 [assisted driving > driving assistance]."", ""url"": ""https://www.c-ncap.org.cn/evaluation/ecb71725a7c11d895ff271bc2cdab4b8""}]","{""kind"": ""Official documents""}" AIBD-1093,2025-06-26,source publication,day,tested,China's CMDE finds that uAI-CT_CerebralPerfusion measured stroke volumes in close agreement with a marketed product in the maker's trial,"In the maker's trial that China's CMDE reviewed, uAI-CT_CerebralPerfusion measured infarct core and penumbra volumes with ICCs of 0.96 and 0.83 against an already-marketed product.",*uAI-CT_CerebralPerfusion* agreed with a marketed tool on stroke scans,ICCs of 0.96 and 0.83,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,uAI-CT_CerebralPerfusion (脑缺血CT灌注图像辅助评估软件),Release 1.1 (full version 1.1-0-0-56),"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective registration trial with 446 cases at six institutions),China,"Six trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"An already-marketed cerebral ischemia image assessment software of the same kind on the same cases, with a target ICC of 0.75 for the lower 95% confidence bound",Target ICC of 0.75,"ICC 0.96 (95%CI: 0.95, 0.97) for the infarct core and 0.83 (95%CI: 0.79, 0.86) for the penumbra",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1751851972285059301.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:脑缺血CT灌注图像辅助评估软件 (technical review report for the registration of cerebral ischemia CT perfusion image assessment-aid software), acceptance no. CQZ2401663, applicant 上海联影智能医疗科技有限公司. 26 June 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1751851972285059301.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:脑缺血CT灌注图像辅助评估软件 (technical review report for the registration of cerebral ischemia CT perfusion image assessment-aid software), acceptance no. CQZ2401663, applicant 上海联影智能医疗科技有限公司. 26 June 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1751851972285059301.pdf""}]","{""kind"": ""Official documents""}" AIBD-0733,2025-06-10,source publication,day,tested,"WHO finds that six AI chest X-ray programs, including qXR v4.0 and CAD4TB v7, meet its standards for TB screening of people aged 15 and older","WHO found that six of eight AI programs tested on 3,915 archived chest X-rays met its accuracy standards for TB screening of people aged 15 and older.",Six AI chest X-ray readers meet WHO's standard for TB screening,ranged from 45% to 56%,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"CAD4TB, DrAid for TB screening, Genki Edge, InferRead DR Chest, Insight CXR and qXR (computer-aided detection software for TB)","CAD4TB v7, DrAid for TB screening v2.4.4–6, Genki Edge v3.4.2, InferRead DR Chest v1.0.1.1, Insight CXR v3.1 and qXR v4.0","Delft Imaging (CAD4TB), VinBrain (DrAid), DeepTek (Genki Edge), Infervision (InferRead DR Chest), Lunit (Insight CXR) and Qure.ai (qXR)","Multiple: Netherlands, Vietnam, India, China, South Korea","FIND's independent validation platform in Geneva, for WHO (archived chest X-ray libraries)",Switzerland,"Global (evaluation in Geneva, Switzerland)",Switzerland,Healthcare (tuberculosis screening),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,2,,,,organizational,1,,0,WHO's minimum of 40% specificity at 90% sensitivity,40%,45% to 56% for the six products in community screening,measured,persisted,2026-03-17,shown,https://iris.who.int/server/api/core/bitstreams/0d7e8935-879e-4ab6-8c07-e41f7be1465b/content,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""World Health Organization, Global Programme on Tuberculosis & Lung Health. Use of computer-aided detection software for tuberculosis screening: WHO policy statement. Geneva, 10 June 2025. ISBN 978-92-4-011037-3."", ""url"": ""https://iris.who.int/server/api/core/bitstreams/0d7e8935-879e-4ab6-8c07-e41f7be1465b/content""}]","{""kind"": ""Official documents""}" AIBD-0632,2025-05-30,source publication,day,tested,FDA De Novo review of Clairity Allix5: AI predicts five-year breast cancer risk from screening mammograms at five US sites,"In FDA's review of Clairity Allix5, the software predicted five-year breast cancer risk from 77,511 screening mammograms with an AUC of 0.70, above a goal of 0.64.",*Allix5* read five-year breast cancer risk from a mammogram,"an AUC of 0.70, above a goal of 0.64",,found,Found by a regulator,no comparison,very low,aggregate result,false,Allix5,,"Clairity, Inc.",United States,Clairity (retrospective study on mammograms from five US screening sites),United States,"Atlanta, Georgia; Fort Worth and Bedford, Texas; Sacramento and Folsom, California, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,,,,,2,,,,organizational,2,,0,A performance goal based on the discrimination of traditional risk models,AUC goal of 0.64,AUC 0.70 (95% CI 0.69 to 0.72),assumed,scaled,2026-10-02,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN240047.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Allix5 (DEN240047): decision summary. Granted 2025-05-30."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN240047.pdf""}]","{""kind"": ""Official documents""}" AIBD-0738,2025-05-01,source publication,day,tested,"NICE allows DERM in NHS teledermatology while evidence is gathered, finding that it detects skin cancer about as accurately as dermatology review",NICE found that DERM detects skin cancer about as accurately as review by dermatologists. Its assessors estimated that automated DERM could about halve urgent dermatologist referrals.,NICE assessors estimate that *DERM* could halve urgent skin referrals,could about halve urgent referrals to a dermatologist,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,DERM (Deep Ensemble for Recognition of Malignancy),,Skin Analytics,United Kingdom,"NHS teledermatology services in England, including sites already using DERM",United Kingdom,"England, United Kingdom",United Kingdom,Healthcare (dermatology),,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,,2,,2,,,,organizational,2,,0,Face-to-face dermatologist review (DERM-003 study),93.8% sensitivity for cancer,96.0% sensitivity for cancer,measured,scaled,2026-10-09,shown,https://www.medicaldevice-network.com/features/ai-skin-cancer/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment. HealthTech guidance HTG746, section 1: Recommendations. 1 May 2025, last updated 17 March 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG746, section 3: Committee discussion. 1 May 2025, last updated 17 March 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion""}]","{""kind"": ""Official documents""}" AIBD-1017,2025-04-07,event,day,tested,Australia's Age Assurance Technology Trial measured Persona's facial age estimation within 2 years of true age on average for ages 11 to 20,"In Australia's government-commissioned trial, Persona's facial age estimation had a mean absolute error of less than 2 years for ages 11 to 20. Testers rated this good for commercial systems.",Testers find *Persona* age estimates within 2 years for ages 11 to 20,a mean absolute error of less than 2 years for ages 11 to 20,,found,Found by an assessment body,no comparison,very low,aggregate result,false,Persona age assurance (facial age estimation),,Persona,United States,"Online services that use Persona for age checks (tested in Australia's Age Assurance Technology Trial, 2025)",,Australia (Age Assurance Technology Trial),Australia,Online safety (age assurance),,Safety and rescue,Technology,Computers,Images and video,Children,16,High income,physical_health,,,,,,,,,personal,2,,0,"Human accuracy at judging whether a person is above an age threshold, as the testers cite it",approximately 60-70%,"False negative rates between 25%-36% for 18–20-year-olds at the 18+ gate, which the testers call similar to human accuracy",assumed,unknown,,shown,https://web.archive.org/web/20260618134510id_/https://ageassurance.com.au/wp-content/uploads/2025/08/IndividualTestReport-Persona_AE.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Age Check Certification Scheme for the Age Assurance Technology Trial. Age Estimation Test Report: Persona. Dated 10 June 2025, version 1.2 of 21 July 2025 (archived copy). Evaluation Results, Table 2 and accompanying text."", ""url"": ""https://web.archive.org/web/20260618134510id_/https://ageassurance.com.au/wp-content/uploads/2025/08/IndividualTestReport-Persona_AE.pdf""}, {""label"": ""Assessment report"", ""value"": ""Age Check Certification Scheme. Age Assurance Technology Trial, Part D: Age Estimation. August 2025 (archived copy). Its back cover names the department that commissioned the Trial. In section D.7.3 and Figure D.4.1 the Trial team describes the trained facial analysis models that age estimation providers use."", ""url"": ""https://web.archive.org/web/20250831133639id_/https://ageassurance.com.au/wp-content/uploads/2025/08/AATT_Part_D_DIGITAL.pdf""}]","{""kind"": ""Official documents""}" AIBD-1016,2025-03-24,event,day,tested,Australia's Age Assurance Technology Trial measured Yoti's facial age estimation within 2 years of true age on average for ages 13 to 20,"In Australia's government-commissioned trial, Yoti's facial age estimation had a mean absolute error of less than 2 years for ages 13 to 20. Testers rated this strong for commercial systems.",Testers find *Yoti* age estimates within 2 years for ages 13 to 20,a mean absolute error of less than 2 years for ages 13 to 20,,found,Found by an assessment body,no comparison,very low,aggregate result,false,Yoti facial age estimation,,Yoti,United Kingdom,"Online services that use Yoti for age checks (tested in Australia's Age Assurance Technology Trial, 2025)",,Australia (Age Assurance Technology Trial),Australia,Online safety (age assurance),,Safety and rescue,Technology,Computers,Images and video,Children,16,High income,physical_health,,,,,,,,,personal,2,,0,"Human accuracy at judging whether a person is above an age threshold, as the testers cite it",approximately 60-70%,"False negative rate of 55% for 18-year-olds at the 18+ gate, which the testers call slightly worse than human accuracy",assumed,scaled,,shown,https://www.yoti.com/blog/anonymous-facial-age-estimation/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Age Check Certification Scheme for the Age Assurance Technology Trial. Age Estimation Test Report: YOTI. Dated 10 June 2025, version 1.1 of 21 July 2025 (archived copy). Evaluation Results, Table 2 and accompanying text."", ""url"": ""https://web.archive.org/web/20260904094239id_/https://ageassurance.com.au/wp-content/uploads/2025/08/IndividualTestReport-YOTI_AE.pdf""}, {""label"": ""Assessment report"", ""value"": ""Age Check Certification Scheme. Age Assurance Technology Trial, Part D: Age Estimation. August 2025 (archived copy). Its back cover names the department that commissioned the Trial. In section D.7.3 and Figure D.4.1 the Trial team describes the trained facial analysis models that age estimation providers use."", ""url"": ""https://web.archive.org/web/20250831133639id_/https://ageassurance.com.au/wp-content/uploads/2025/08/AATT_Part_D_DIGITAL.pdf""}]","{""kind"": ""Official documents""}" AIBD-0960,2025-03-06,source publication,day,tested,China's CMDE finds that sonographers using ITS-200 identified more malignant thyroid nodules in the maker's randomized trial,"In the maker's randomized trial that China's CMDE reviewed, sonographers using ITS-200 identified malignant thyroid nodules with 97.33% sensitivity, against 79.30% without it.",*ITS-200* helped sonographers spot more malignant thyroid nodules,"97.33% sensitivity, against 79.30% without it",,found,Found by a regulator,randomized trial,moderate,aggregate result,false,ITS-200 (甲状腺结节超声影像辅助诊断软件),Release 1,"Maide Intelligent Technology (Wuxi) Co., Ltd. (脉得智能科技(无锡)有限公司)",China,Maide Intelligent Technology (Wuxi) (prospective randomized trial with 931 subjects at five sites),China,"Five trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"Sonographers assessing nodules without the software in the same randomized trial, with surgical pathology as the reference",79.30% nodule-level sensitivity,97.33% nodule-level sensitivity,measured,persisted,2026-07-22,shown,https://www.cmde.org.cn/directory/web/cmde/images/1742452535587010664.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:甲状腺结节超声影像辅助诊断软件 (technical review report for the registration of thyroid nodule ultrasound image diagnosis-aid software), acceptance no. CQZ2400633, applicant 脉得智能科技(无锡)有限公司. 6 March 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742452535587010664.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:甲状腺结节超声影像辅助诊断软件 (technical review report for the registration of thyroid nodule ultrasound image diagnosis-aid software), acceptance no. CQZ2400633, applicant 脉得智能科技(无锡)有限公司. 6 March 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742452535587010664.pdf""}]","{""kind"": ""Official documents""}" AIBD-0652,2025-02-27,source publication,day,tested,EMA qualifies AIM-NASH after AI-assisted pathologists scored MASH liver biopsies more accurately than pathologists reading alone,"EMA qualified PathAI's AIM-NASH after a 1,481-case validation in which AI-assisted pathologists agreed better with expert panels on lobular inflammation and on hepatocellular ballooning.",Europe's medicines regulator accepts *AIM-NASH* for biopsy scoring,hepatocellular ballooning (0.563 against 0.414),,found,Found by a regulator,controlled comparison,very low,aggregate result,false,AIM-NASH (Artificial Intelligence-Based Measurement of NASH histology; also called AIM-MASH),,PathAI,United States,"PathAI with sponsors of MASH drug trials (validation on archived biopsies from trials of obeticholic acid, pegbelfermin and semaglutide)",United States,Multinational MASH clinical trials (central pathology reading),,Drug development / pathology,,Science,Health,Drug Industry,Images and video,Health workers,3,,physical_health,Medical diagnosis,,,,,,,,organizational,4,,0,"Individual pathologists reading without the tool, scored against the same expert panel",Mean weighted kappa of unassisted reads,Weighted kappa higher by 0.15 for ballooning and 0.12 for lobular inflammation,measured,scaled,2025-12-08,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC11750710/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""European Medicines Agency, Committee for Medicinal Products for Human Use. Qualification opinion for Artificial Intelligence-Based Measurement of Non-alcoholic Steatohepatitis Histology in Liver Biopsies to Determine Disease Activity in NASH/MASH Clinical Trials. Adopted 27 February 2025 (EMADOC-1700519818-1761332 Corr.1)."", ""url"": ""https://www.ema.europa.eu/en/documents/other/qualification-opinion-artificial-intelligence-based-measurement-non-alcoholic-steatohepatitis-histology-liver-biopsies-determine-disease-activity-nash-mash-clinical-trials_en.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Drug Evaluation and Research. FDA Qualifies First AI Drug Development Tool, Will Be Used in 'MASH' Clinical Trials. 8 December 2025."", ""url"": ""https://www.fda.gov/drugs/drug-safety-and-availability/fda-qualifies-first-ai-drug-development-tool-will-be-used-mash-clinical-trials""}]","{""kind"": ""Official documents""}" AIBD-0961,2025-02-25,source publication,day,tested,China's CMDE finds that less senior readers detected breast lesions more accurately with Yizhun-DBU in the maker's trial,"In the maker's trial that China's CMDE reviewed, six less senior readers detected breast lesions with an AFROC-AUC of 0.8785 using Yizhun-DBU, against 0.6500 alone.",*Yizhun-DBU* helped less senior readers find breast lesions,"an AFROC-AUC of 0.8785 using Yizhun-DBU, against 0.6500 alone",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Yizhun-DBU (乳腺超声影像辅助检测软件),Release 4,"Beijing Yizhun Medical Technology Co., Ltd. (北京医准医疗科技有限公司)",China,Beijing Yizhun Medical Technology (prospective reader trial with 176 subjects at three sites),China,"Three trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,1,,0,"The same six readers reading the same cases without the software, with three senior readers as the reference","AFROC-AUC 0.6500(0.6268, 0.6733)","AFROC-AUC 0.8785 (0.8471, 0.9100)",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1741742380821028657.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺超声影像辅助检测软件 (technical review report for the registration of breast ultrasound image detection-aid software), acceptance no. CQZ2400392, applicant 北京医准医疗科技有限公司. 25 February 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1741742380821028657.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺超声影像辅助检测软件 (technical review report for the registration of breast ultrasound image detection-aid software), acceptance no. CQZ2400392, applicant 北京医准医疗科技有限公司. 25 February 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1741742380821028657.pdf""}]","{""kind"": ""Official documents""}" AIBD-1086,2025-02-19,source publication,day,tested,China's CMDE finds that Infervision's IR-CT-PE flagged pulmonary embolism with 92.27% sensitivity at 96.91% specificity in the maker's trial,"In the maker's two-site trial that China's CMDE reviewed, Infervision's IR-CT-PE flagged pulmonary embolism with 92.27% sensitivity and 96.91% specificity, above 80% targets.",*IR-CT-PE* flagged pulmonary embolism in a two-site trial in China,92.27% sensitivity and 96.91% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"IR-CT-PE (肺栓塞CT血管造影图像辅助分诊软件), models IR-CT-PE(A) and IR-CT-PE(B)",Release 1 (full version 1.0.3.0),"Infervision Medical Technology Co., Ltd. (推想医疗科技股份有限公司)",China,Infervision Medical Technology (trial with 485 cases at two institutions),China,Two trial institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Preset targets of 80%, with an expert panel's case judgments as the reference",Targets of 80% for sensitivity and for specificity,92.27% sensitivity and 96.91% specificity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1740618990620049428.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺栓塞CT血管造影图像辅助分诊软件 (technical review report for the registration of pulmonary embolism CT angiography image triage-aid software), acceptance no. CQZ2400926, applicant 推想医疗科技股份有限公司. 19 February 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1740618990620049428.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺栓塞CT血管造影图像辅助分诊软件 (technical review report for the registration of pulmonary embolism CT angiography image triage-aid software), acceptance no. CQZ2400926, applicant 推想医疗科技股份有限公司. 19 February 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1740618990620049428.pdf""}]","{""kind"": ""Official documents""}" AIBD-1014,2025-02-18,source publication,day,intended,Japan's Kinki District Transport Bureau approves Osaka Metro's Expo park-and-ride bus as a Level 4 automated vehicle that needs no driver,On 18 February 2025 a Japanese transport bureau approved Osaka Metro's Expo park-and-ride bus for Level 4. It confirmed that the bus's automated operation device met the safety standards.,*ASM-AD* lets Osaka Metro run an Expo bus with no driver,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (ASM-AD by Advanced Smart Mobility) on an EV Motors Japan F8 series2-City Bus 10.5m,,"Advanced Smart Mobility Co., Ltd. (先進モビリティ株式会社), maker of the ASM-AD system, with the bus built by EV Motors Japan",Japan,"Osaka Metro (大阪市高速電気軌道株式会社), the applicant and operator",Japan,"Maishima, Osaka, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,Drivers and travelers,11,High income,physical_health; operational_improvement,,,,,,,,,societal,2,,0,,,,,withdrawn,2025-04-28,not shown,https://jidounten-lab.com/u_52872,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Kinki District Transport Bureau, Automotive Technology and Safety Department. 近畿初!自動運転車(レベル4)認可 ~ 万博来場者向け自動運転を実現 ~ (First in Kinki: Level 4 automated vehicle approved for Expo visitors). News release, 18 February 2025, first paragraph and table."", ""url"": ""https://wwwtb.mlit.go.jp/kinki/content/000343237.pdf""}, {""label"": ""Follow-up"", ""value"": ""After a bus with Advanced Smart Mobility's system hit a wall on 28 April 2025, Osaka Metro stopped running its self-driving Expo buses, blamed a setting error, and planned test runs before resuming."", ""url"": ""https://www.netdenjd.com/articles/-/318720""}]","{""kind"": ""Withdrawals""}" AIBD-0962,2025-02-13,source publication,day,tested,"China's CMDE finds that with DC-OPGAI-01, dentists found more decayed teeth on panoramic X-rays in the maker's trial","In the maker's trial that China's CMDE reviewed, 12 dentists using DC-OPGAI-01 detected caries with a tooth-level sensitivity of 82.40%, against 67.43% without it.",*DC-OPGAI-01* helped dentists find more tooth decay on X-rays,"a tooth-level sensitivity of 82.40%, against 67.43% without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,DC-OPGAI-01 (龋病口腔曲面体层图像辅助检测软件),Release 1 (full version 1.0.0),"Beijing Yuyi Ganlan Information Technology Co., Ltd. (北京羽医甘蓝信息技术有限公司)",China,Beijing Yuyi Ganlan Information Technology (retrospective reader trial with 12 dentists and 402 subjects at three sites),China,"Three trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,1,,0,The same 12 dentists reading the same radiographs without the software,67.43% tooth-level sensitivity,82.40% tooth-level sensitivity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1740036818606034537.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:龋病口腔曲面体层图像辅助检测软件 (technical review report for the registration of dental caries panoramic radiograph detection-aid software), acceptance no. CQZ2400448, applicant 北京羽医甘蓝信息技术有限公司. 13 February 2025. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1740036818606034537.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:龋病口腔曲面体层图像辅助检测软件 (technical review report for the registration of dental caries panoramic radiograph detection-aid software), acceptance no. CQZ2400448, applicant 北京羽医甘蓝信息技术有限公司. 13 February 2025. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1740036818606034537.pdf""}]","{""kind"": ""Official documents""}" AIBD-0801,2025-01-24,source publication,day,tested,"FDA found a 3.5% rise in pathologists' sensitivity for prostate cancer with Galen Second Read, which flagged 202 of 347 cases called benign, of which experts confirmed 46","In FDA's review of Galen Second Read, pathologists' sensitivity rose from 90.5% to 93.9%. Their specificity fell from 91.1% to 87.9%. Of 347 cases called benign, it flagged 202. Experts confirmed 46.",*Galen Second Read* caught prostate cancers missed on a first read,pathologists' sensitivity rose from 90.5% to 93.9%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Galen Second Read,3.1-US,Ibex Medical Analytics Ltd.,Israel,Ibex Medical Analytics (AIDER-2 study at three sites and AIDER-1 reader study with 12 pathologists at four sites),Israel,"Pathology sites in the United States, with one site outside the US in each study",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,2,,0,The same 12 pathologists reading the same cases without the software,"Sensitivity 90.5%, specificity 91.1%","Sensitivity 93.9%, specificity 87.9%",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K241232.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for Galen Second Read (K241232). Cleared 2025-01-24."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K241232.pdf""}]","{""kind"": ""Official documents""}" AIBD-0655,2025-01-14,source publication,day,tested,NICE allows four systems in NHS urgent care after finding that AI fracture-detection software raised clinicians' sensitivity on X-rays,"NICE reviewed 16 studies of AI fracture software such as BoneView. It found that readers' sensitivity rose without lost specificity, from 61% to 74% in one study.",NICE supports AI help to find fractures on X-rays,from 61% to 74%,,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,"AI fracture detection software: BoneView, RBfracture, Rayvolve and TechCare Alert",,"Gleamer (BoneView), Radiobotics (RBfracture), AZmed (Rayvolve) and Milvue (TechCare Alert)","Multiple: France, Denmark",Hospitals in the reader studies reviewed by NICE; NHS urgent care services in England during the evidence generation period,Multiple,"Multiple countries (studies); England, United Kingdom (guidance)",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational,3,,1,Emergency physicians reading mixed fracture types without BoneView,61% sensitivity,74% sensitivity,measured,persisted,2026-10-23,shown,https://www.nice.org.uk/guidance/htg739/chapter/3-Committee-discussion,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessment. HealthTech guidance HTG739, section 3: Committee discussion. 14 January 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg739/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG739, section 1: Recommendations. 14 January 2025."", ""url"": ""https://www.nice.org.uk/guidance/htg739/chapter/1-Recommendations""}]","{""kind"": ""Official documents""}" AIBD-1024,2025-01-13,source publication,day,tested,"CATARC found in its C-ICAP tests that Coffee OS 3.1 assisted driving on the Wey Lanshan scored 94.4% for emergency avoidance, with 92.8% for navigation","In C-ICAP results that CATARC published on 13 January 2025, the Wey Lanshan's assisted driving scored 94.4% for collision avoidance. It scored 92.8% for navigation pilot assistance.",*Coffee OS 3.1* on the Wey Lanshan scores 94.4% for collision avoidance,94.4% for collision avoidance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Assisted driving (辅助驾驶) with Coffee OS 3.1, as fitted to the Wey Lanshan 四驱智驾 Ultra",Coffee OS 3.1.E110701 (assisted-driving software version tested),Great Wall Motor (长城汽车股份有限公司),China,Great Wall Motor (factory-fitted on the Wey Lanshan),China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,2,,0,,,,,unknown,,shown,https://autonews.gasgoo.com/articles/icv/gwms-cto-confirms-no-tie-up-with-huawei-on-advanced-intelligent-driving-business-70035195,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Testing & Assessment Management Center (中汽测评). 魏牌蓝山 [Wey Lanshan 四驱智驾 Ultra], C-ICAP results page, protocol 2024 edition, test year 2024. Published 13 January 2025. Section 辅助驾驶 > 行车辅助 [assisted driving > driving assistance]."", ""url"": ""https://www.c-ncap.org.cn/evaluation/cba3d04f72ebbfdfa5e922cd3511f2a8""}]","{""kind"": ""Official documents""}" AIBD-0802,2025-01-10,source publication,day,tested,FDA found that TriVerity sorted most emergency patients with suspected infection into actionable bands for bacterial infection,"In FDA's review of TriVerity, 80.4% of bacterial results fell in actionable bands. Severe illness within seven days followed in 58.1% of patients with Very High results, against 2.7% with Very Low.",*TriVerity* sorted emergency patients with suspected infection by risk,80.4% of bacterial results fell in actionable bands,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,TriVerity,IMX-BVN-4 and IMX-SEV-4 classifiers,"Inflammatix, Inc.",United States,Inflammatix (non-interventional SEPSIS-SHIELD study at 22 emergency departments and academic hospitals in the United States and Europe),United States,22 sites in the United States and Europe,United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,"Prevalence of severe illness across the 1,120 patients",10.9%,58.1% in the Very High band and 2.7% in the Very Low band,measured,scaled,2026-03-10,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K241676.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for TriVerity (K241676). Cleared 2025-01-10."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K241676.pdf""}]","{""kind"": ""Official documents""}" AIBD-0926,2025-01-01,source publication,year,tested,"Avalia-t finds that the Willem, Cardiologs and ILR-ECG-A algorithms removed 60.3% to 98% of false alerts from insertable heart monitors","In three studies, Avalia-t found that AI algorithms removed 60.3% to 98% of false-positive alerts from insertable heart monitors by re-reading their recordings. It rated them at high risk of bias.","*Willem*, *Cardiologs* and *ILR-ECG-A* cut heart monitors' false alerts",removed between 60.3% and 98% of the monitors' false positives,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"Willem (IDOVEN), Cardiologs and ILR-ECG-A (Implicity), AI algorithms that re-read insertable cardiac monitor recordings",,"Idoven (Willem), Cardiologs and Implicity (ILR-ECG-A)","Multiple: Spain, France","Remote monitoring centers in the studies that Avalia-t reviewed: Valley Hospital in the United States (Cardiologs), one center in Italy (IDOVEN) and 31 US and French centers on the Implicity platform","Multiple: United States, Italy, France","Spain (assessment), with studies in the United States, Italy and France",Spain | United States | Italy | France,Healthcare (cardiology),,Health,Health,Disease Prevention,Prediction from data,Health workers,3,High income,physical_health; operational_improvement,Medical diagnosis,,,,,,,,organizational,1,,0,Alerts from the Medtronic Reveal LINQ monitor without the AI filter (Mittal et al. study),"53,9% (IC 95%: 51.4%-56.5%) positive predictive value","74,5% (IC 95%: 71,8%-77%) with the Cardiologs algorithm",measured,persisted,2026-04-15,shown,https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1284,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Unidad de Asesoramiento Científico-técnico, Avalia-t, Agencia Gallega para la Gestión del Conocimiento en Salud (ACIS), for the Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del SNS. López Loureiro I, Puñal-Rioboo J, Mejuto Martí T. Evaluación del rendimiento diagnóstico y la seguridad de la inteligencia artificial en la monitorización cardíaca con dispositivos insertables. Informes de Evaluación de Tecnologías Sanitarias. Madrid: Ministerio de Sanidad, 2025. NIPO 133-25-043-1. Resumen, Conclusiones."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1284""}, {""label"": ""Assessment report"", ""value"": ""Avalia-t (ACIS). Assessment of artificial intelligence's diagnostic yield and security in cardiac monitoring using insertable cardiac monitors. English summary, Conclusions. Madrid: Ministerio de Sanidad, 2025."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1284""}]","{""kind"": ""Official documents""}" AIBD-2310,2025-01-01,source publication,year,tested,SESCS's assessment: machine learning on FT-Raman spectra told platinum-resistant ovarian cancer from platinum-sensitive cancer with 95% to 100% accuracy in one small study,"In the one study that SESCS found, machine learning sorted FT-Raman spectra from 21 women by resistance to platinum with 95% to 100% accuracy. SESCS adds that the evidence is thin.",*FT-Raman* spectra with machine learning flag resistant ovarian cancer,95% to 100%,,found,Found by an assessment body,tested against a standard,very low,program,false,FT-Raman spectroscopy of blood serum or ovarian tissue with machine learning classifiers (a research method without a product name),,A research group in Poland (the authors of the study that SESCS reviewed),Poland,The research group in Poland that ran the study (no clinical use),Poland,Poland,Poland,Healthcare (ovarian cancer diagnosis),,Health,Health,Disease Prevention,Prediction from data,Women and mothers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,personal,1,,0,,,,,unknown,,shown,https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}, {""label"": ""Assessment report"", ""value"": ""Servicio de Evaluación del Servicio Canario de la Salud (SESCS). Espectroscopía FT-Raman con análisis de datos mediante aprendizaje automático para el diagnóstico de cáncer de ovario resistente al platino. Ficha de Evaluación de Tecnologías Sanitarias Nuevas y Emergentes. Ministerio de Sanidad and Servicio Canario de la Salud, 2025. SESCS is the evaluation service of the Canary Islands Health Service, and Spain's Ministry of Health funded the report. The report states that its conclusions are those of the service. The quotations are in Spanish."", ""url"": ""https://sescs.es/wp-content/uploads/2025/05/TE_2023SSTE40_2024_SESCS_FT-raman_cancer_ovario_DEF_NIPO.pdf""}]","{""kind"": ""Official documents""}" AIBD-1060,2024-12-16,source publication,day,tested,China's CMDE finds that endoscopists using HW-ES missed fewer colon polyps in the maker's randomized trial,"In the maker's randomized trial that China's CMDE reviewed, endoscopists using HW-ES missed 12.41% of polyps, against 50.80% without it.",*HW-ES* helped endoscopists miss fewer colon polyps in a trial,"missed 12.41% of polyps, against 50.80% without it",,found,Found by a regulator,randomized trial,moderate,aggregate result,false,HW-ES (肠息肉电子下消化道内窥镜图像辅助检测软件),Release V1,"Changsha Huiwei Intelligent Medical Technology Co., Ltd. (长沙慧维智能医疗科技有限公司)",China,Changsha Huiwei Intelligent Medical Technology (prospective randomized trial with 354 patients at three sites),China,"Three trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,3,1,,,1,,organizational,1,,0,Endoscopists examining without the software in the same randomized trial,50.80% lesion-level polyp miss rate,12.41% lesion-level polyp miss rate,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1742969333809034777.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道内窥镜图像辅助检测软件 (technical review report for the registration of colon polyp detection-aid software for electronic lower gastrointestinal endoscope images), acceptance no. CQZ2302046, applicant 长沙慧维智能医疗科技有限公司. 16 December 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742969333809034777.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道内窥镜图像辅助检测软件 (technical review report for the registration of colon polyp detection-aid software for electronic lower gastrointestinal endoscope images), acceptance no. CQZ2302046, applicant 长沙慧维智能医疗科技有限公司. 16 December 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742969333809034777.pdf""}]","{""kind"": ""Official documents""}" AIBD-0744,2024-12-01,source publication,month,mixed,"CADTH, now Canada's Drug Agency, finds that AI-assisted colonoscopy, which is likely cost-effective, may detect more adenomas","CADTH reviewed five studies, mostly systematic reviews. It found that AI-assisted colonoscopy may detect more adenomas. It may also miss fewer. CADTH found that it is likely cost-effective.",CADTH finds that *AI-assisted colonoscopy* may detect more adenomas,,,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,"AI-assisted (computer-aided detection) colonoscopy systems, including Deep-GI and CAD EYE in the included trial",,"Several makers, including Fujifilm (CAD EYE)",Multiple countries (makers not named),Endoscopy services in the studies that CADTH reviewed,Multiple,"Multiple countries (studies), with guidance for Canada",Canada,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,2,,,personal,2,,0,Conventional colonoscopy,,,measured,challenged,2025-08-12,shown,https://healthtechnology.wales/wp-content/uploads/EAR055-AIAE-WEB.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Assessment report"", ""value"": ""Canadian Agency for Drugs and Technologies in Health. Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer. CADTH Health Technology Review, Report No. RC1559, December 2024. NCBI Bookshelf NBK611312, PMID 39869728 (key messages)."", ""url"": ""https://europepmc.org/abstract/MED/39869728""}, {""label"": ""Assessment report"", ""value"": ""Canadian Agency for Drugs and Technologies in Health. CADTH Health Technology Review RC1559, December 2024, key messages (economic evidence)."", ""url"": ""https://europepmc.org/abstract/MED/39869728""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Follow-up"", ""value"": ""Polish researchers reported in August 2025 that endoscopists' unassisted adenoma detection fell from 28.4% to 22.4% after three months of routine AI use, raising a deskilling concern. The study was observational."", ""url"": ""https://wrap.warwick.ac.uk/id/eprint/191005""}]","{""kind"": ""Challenges""}" AIBD-1212,2024-11-26,source publication,day,intended,Japan's Kanto District Transport Bureau approves an Ibaraki Kotsu bus on the Hitachi BRT as a Level 4 automated vehicle that needs no driver,On 26 November 2024 a Japanese transport bureau confirmed that a Hitachi BRT bus's automated operation device met the safety standards. It approved the bus as a Level 4 vehicle on about 6.1 km.,*Automated operation device* lets a Hitachi BRT bus run with no driver,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (自動運行装置) on an Isuzu Erga Mio bus for the Hitachi BRT,,"Advanced Smart Mobility Co., Ltd. (先進モビリティ株式会社), the applicant",Japan,"Ibaraki Kotsu Co., Ltd. (茨城交通株式会社), the operator",Japan,"Hitachi, Ibaraki Prefecture, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,physical_health; operational_improvement,,,,,,,,,societal,4,,0,,,,,persisted,2025-01-24,not shown,https://www.soumu.go.jp/main_content/001034209.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 茨城県初!自動運転車(レベル4)の認可を行いました (Ibaraki's first approval of a Level 4 automated vehicle). Press release, 26 November 2024."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000336532.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 茨城県初!自動運転車(レベル4)の認可を行いました (Ibaraki's first approval of a Level 4 automated vehicle). Press release, 26 November 2024."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000336532.pdf""}]","{""kind"": ""Official documents""}" AIBD-0745,2024-11-24,event,day,reported,"Medicare contractor Palmetto GBA covers AI coronary plaque analysis for stable chest pain, citing better diagnosis","Palmetto GBA found AI coronary plaque analysis reasonable and necessary for chest pain without known coronary disease. In a cited study, physicians changed plans for 57.1% of patients.",Medicare contractor covers *AI-QCT* plaque analysis for chest pain,changed management plans for 57.1% of 750 patients,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,"AI-enabled CT-based quantitative coronary topography and coronary plaque analysis (AI-QCT/AI-CPA), chiefly Cleerly's platform, with HeartFlow plaque analysis also in the evidence",,"Cleerly, Inc. and HeartFlow, Inc.",United States,Medicare providers performing coronary CT angiography in Palmetto GBA's jurisdictions,United States,"Alabama, Georgia, Tennessee, South Carolina, North Carolina, Virginia and West Virginia, United States",United States,Healthcare (cardiology),,Health,Health,Disease Prevention,Images and video,Patients; Health workers,3,High income,physical_health,Medical diagnosis,,3,1,,3,1,,organizational; personal,9,,0,Physicians' management plans for the same patients based on CT angiography alone (CERTAIN study),Management plans made from the CT angiography results,a change in management for 57.1% (428/750) of patients,measured,persisted,2026-10-15,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf20/K202280.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Palmetto GBA. Local Coverage Determination L39851: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA). Original effective date 24 November 2024, revision effective 15 October 2026. CMS Medicare Coverage Database, Analysis of Evidence."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39851&ver=18""}, {""label"": ""Assessment report"", ""value"": ""Wellpoint Federal (formerly National Government Services), Medicare Administrative Contractor for CMS. LCD L39863: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA). Analysis of Evidence (Rationale for Determination)"", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39863&ver=10""}, {""label"": ""Assessment report"", ""value"": ""UnitedHealthcare (commercial and exchange plans), Cardiovascular and Radiology Imaging Guidelines (2026). Cardiovascular and Radiology Imaging Guidelines V6.0.2026, Cardiac Imaging: Coronary CTA plaque quantification (CPT 75577) (effective 1 October 2026), Cardiac Imaging Guidelines, 'Coronary CTA plaque quantification CPT 75577' (indications and non-indications); references 50-51."", ""url"": ""https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/r-c/COMM-Exchange-Rad-Card-Guidelines-10-2026.pdf""}, {""label"": ""Assessment report"", ""value"": ""Noridian Healthcare Solutions (Medicare Administrative Contractor, Jurisdictions E and F) (2024). LCD L39881: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA), Summary of Evidence and Analysis of Evidence (Rationale for Determination)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39881""}, {""label"": ""Assessment report"", ""value"": ""Wisconsin Physicians Service Insurance Corporation (WPS, Medicare Administrative Contractor, Jurisdictions 5 and 8) (2024). LCD L39913: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA), Summary of Evidence and Analysis of Evidence (Rationale for Determination)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39913""}, {""label"": ""Assessment report"", ""value"": ""CGS Administrators (Medicare Administrative Contractor, Jurisdiction 15) (2024). LCD L39840: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA), Summary of Evidence and Analysis of Evidence (Rationale for Determination)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39840""}, {""label"": ""Assessment report"", ""value"": ""UnitedHealthcare Community Plan (Medicaid managed care), Cardiovascular and Radiology Imaging Guidelines (2026). UnitedHealthcare Community Plan Cardiovascular and Radiology Imaging Guidelines V6.0.2026, Coronary CTA plaque quantification (effective 1 October 2026), Cardiac Imaging Guidelines, 'Coronary CTA plaque quantification' (indications and non-indications)."", ""url"": ""https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/r-c/UHCCP-Rad-Card-Guidelines-Oct-2026.pdf""}, {""label"": ""Assessment report"", ""value"": ""Oregon Health Evidence Review Commission (HERC), Oregon Health Authority, Value-based Benefits Subcommittee (VbBS) (2025). HERC/VbBS meeting materials, 9 October 2025: 2026 CPT Code Review, AI Coronary Atherosclerotic Plaque Assessment (CPT 75577, replacing 0623T-0626T), 2026 CPT Code Review: AI Coronary Atherosclerotic Plaque Assessment, evidence and HERC staff summary."", ""url"": ""https://www.oregon.gov/oha/HPA/DSI-HERC/MeetingDocuments/HERC-VBBS-Materials-10-9-2025.pdf""}, {""label"": ""Assessment report"", ""value"": ""Kaiser Foundation Health Plan of Washington (Kaiser Permanente), Medical Policy Committee, Clinical Review Criteria (2026). Clinical Review Criteria: Cardiac CT, Coronary CT Angiography, Calcium Scoring and CT Fractional Flow Reserve, including AI-QCT/AI-CPA (reviewed 5 May 2026, revised 10 July 2026), Criteria, 'For Non-Medicare Members', row for Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) (CPT 75577)."", ""url"": ""https://wa-provider.kaiserpermanente.org/static/pdf/hosting/clinical/criteria/pdf/ct_angiography_diagnostic.pdf""}]","{""kind"": ""Official documents""}" AIBD-1084,2024-11-04,source publication,day,tested,China's CMDE finds that uAI-AorticDissection flagged aortic dissection on CT angiography with 99.46% sensitivity in the maker's trial,"In the maker's retrospective trial that China's CMDE reviewed, uAI-AorticDissection flagged aortic dissection with 99.46% sensitivity and 98.45% specificity against an expert panel.",*uAI-AorticDissection* flagged aortic dissections in China's review,99.46% sensitivity and 98.45% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,uAI-AorticDissection (主动脉夹层CT血管造影图像辅助分诊软件),Release 1.0 (full version 1.0.0.0.18),"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective trial with 380 subjects at three institutions),China,Three trial institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Targets set in the trial protocol, with an expert panel's reading as the reference",Protocol targets that the report does not state,99.46% sensitivity and 98.45% specificity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1732498238794063154.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:主动脉夹层CT血管造影图像辅助分诊软件 (technical review report for the registration of aortic dissection CT angiography image triage-aid software), acceptance no. CQZ2400640, applicant 上海联影智能医疗科技有限公司. 4 November 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1732498238794063154.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:主动脉夹层CT血管造影图像辅助分诊软件 (technical review report for the registration of aortic dissection CT angiography image triage-aid software), acceptance no. CQZ2400640, applicant 上海联影智能医疗科技有限公司. 4 November 2024. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1732498238794063154.pdf""}]","{""kind"": ""Official documents""}" AIBD-0951,2024-10-31,source publication,day,intended,Japan's Hokuriku-Shinetsu District Transport Bureau approves TIER IV's automated minibus in Shiojiri as a Level 4 vehicle that needs no driver,On 31 October 2024 a Japanese transport bureau confirmed that TIER IV's automated operation device met the safety standards. It approved a Shiojiri minibus as a Level 4 vehicle with no driver.,Japan approves *AI Pilot* to drive a Shiojiri minibus with no driver,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (TIER IV's AI Pilot) on the TIER IV Minibus,,"TIER IV, Inc.",Japan,"Shiojiri City Promotion Corporation (一般財団法人塩尻市振興公社), the operator",Japan,"Shiojiri, Nagano Prefecture, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,operational_improvement; physical_health,Enhanced productivity,,,,,,,,societal,4,,0,,,,,persisted,2026-11-02,not shown,https://web.archive.org/web/20260209202144id_/https://technode.global/prnasia/tier-ivs-ai-pilot-system-certified-for-level-4-autonomous-bus-service-in-nagano-prefecture/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Hokuriku-Shinetsu District Transport Bureau, Automotive Technology and Safety Department. 北陸信越運輸局管内初!!自動運転車(レベル4)の認可について (First in the bureau's area: approval of a Level 4 automated vehicle). Press release, 31 October 2024, paragraphs 1 to 3 and table."", ""url"": ""https://wwwtb.mlit.go.jp/hokushin/content/000335753.pdf""}]","{""kind"": ""Official documents""}" AIBD-0992,2024-10-21,source publication,day,intended,"The Delaware Court of Chancery let defendants review 125,000 documents with technology assisted review over a demand for manual review","In October 2024 the Delaware Court of Chancery let defendants review 125,000 documents with technology assisted review over the plaintiff's demand for manual review. The review had not run.",Delaware court lets defendants use *TAR* over a demand for manual review,"125,000 documents",,found,Found by a court,,very low,benefit created,false,"Technology assisted review (TAR), or predictive coding",,Not named in the opinion,,The former directors and officers of Graf Industrial Corp. (defendants),United States,"Wilmington, Delaware, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,Manual review of all the documents captured by the plaintiff's search terms,,,assumed,unknown,,shown,https://courts.delaware.gov/Opinions/Download.aspx?id=371000,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Court of Chancery of the State of Delaware (Vice Chancellor Lori W. Will). Berger v. Graf Acquisition, LLC, et al., C.A. No. 2023-0873-LWW, letter opinion of 21 October 2024 on the plaintiff's motion to compel, pp. 4-9 and 12."", ""url"": ""https://courts.delaware.gov/Opinions/Download.aspx?id=371000""}]","{""kind"": ""Official documents""}" AIBD-1063,2024-09-29,source publication,day,tested,China's CMDE finds that doctors using Dr.Wise AI Lung Cancer judged the malignancy of lung nodules more accurately in the maker's trial,"In the maker's trial that China's CMDE reviewed, doctors' area under the ROC curve for suspected malignant lung nodules rose from 0.7325 to 0.8397 with Dr.Wise AI Lung Cancer.",*Dr.Wise AI Lung Cancer* helped doctors rate risk of lung nodules on CT,area under the ROC curve for suspected malignant lung nodules rose from 0.7325 to 0.8397,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Dr.Wise AI Lung Cancer (肺结节CT图像辅助诊断软件),Release 1 (full version 1.1.0.1),Beijing Deepwise (北京深睿博联科技有限责任公司),China,Beijing Deepwise (multi-reader trial with 400 subjects at three sites),China,"Three trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"The same doctors reading the same CT cases without the software, with imaging, thoracic surgery and pathology experts as the reference",Subject-level area under the ROC curve 0.7325±0.0234,Subject-level area under the ROC curve 0.8397±0.0165,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1729664104391037246.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺结节CT图像辅助诊断软件 (technical review report for the registration of lung nodule diagnosis-aid software for CT images), acceptance no. CQZ2302309, applicant 北京深睿博联科技有限责任公司. 29 September 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1729664104391037246.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺结节CT图像辅助诊断软件 (technical review report for the registration of lung nodule diagnosis-aid software for CT images), acceptance no. CQZ2302309, applicant 北京深睿博联科技有限责任公司. 29 September 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1729664104391037246.pdf""}]","{""kind"": ""Official documents""}" AIBD-1018,2024-09-23,source publication,day,tested,"CATARC found in C-ICAP tests that ADS Pro V2.0 on the AITO M9 scored 100.0% for emergency avoidance, with 95.8% for navigation-guided driving","In CATARC's C-ICAP tests, published on 23 September 2024, ADS Pro V2.0 on an AITO M9 scored 100.0% for emergency avoidance. It scored 95.8% for navigation-guided driving assistance.",*ADS Pro V2.0* scores 100.0% for emergency avoidance on an AITO M9,100.0% for emergency avoidance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"ADS Pro V2.0 with the ADS high-level function pack (ADS高阶功能包), as fitted to the AITO M9 (问界M9) Ultra BEV",ADS Pro V2.0(2024.24.1eAcK8T3K0Ye) (software version tested),"Huawei (ADS), fitted by Seres on the AITO M9",China,"Seres (重庆赛力斯汽车有限公司), factory-fitted on the AITO M9",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,unknown,,shown,https://carnewschina.com/2024/04/24/huawei-qiankun-ads-3-0-announced-brings-intelligent-driving-upgrade/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 赛力斯问界M9 Ultra纯电版 (AITO M9 Ultra BEV), protocol version 1.1, test year 2024. Result page published 23 September 2024, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/e45fb38aacbd2f6e4afd9f24728b0a14""}]","{""kind"": ""Official documents""}" AIBD-1019,2024-09-23,source publication,day,tested,CATARC found in C-ICAP tests that XPeng's assisted driving on the X9 scored 100.0% for emergency avoidance but had no minimal risk maneuver,"In CATARC's C-ICAP tests, published on 23 September 2024, XPeng's assisted driving on an X9 scored 100.0% for emergency avoidance. It had no minimal risk maneuver.",*XOS 5.0.5* scores 100.0% for emergency avoidance on an XPeng X9,100.0% for emergency avoidance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"XPeng assisted driving in XOS 5.0.5, as fitted to the XPeng X9 (小鹏X9) 702 Max",XOS 5.0.5 (software version tested),XPeng (小鹏),China,"XPeng (肇庆小鹏新能源投资有限公司), factory-fitted on the X9",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,unknown,,shown,https://cnevpost.com/2022/10/24/xpeng-tech-day-2022/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 小鹏X9 702 超长续航Max (XPeng X9 702 Max), protocol version 1.1, test year 2024. Result page published 23 September 2024, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/8fef19bc48306f3d021dd3c7479b9bbb""}]","{""kind"": ""Official documents""}" AIBD-1022,2024-09-23,source publication,day,tested,CATARC found in C-ICAP tests that DiPilot300 on the Denza N7 scored 100.0% for emergency avoidance but collided when a car ahead moved aside,"In CATARC's C-ICAP tests, published on 23 September 2024, DiPilot300 on a Denza N7 scored 100.0% for emergency avoidance. It collided when a car ahead moved aside to reveal a stopped car.",*DiPilot300* scores 100.0% for emergency avoidance on a Denza N7,100.0% for emergency avoidance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"DiPilot300, as fitted to the Denza N7 (腾势N7) 630 AWD Ultra",DiPilot300 (listed as the software version),"BYD (比亚迪), for its Denza brand",China,"BYD (比亚迪汽车工业有限公司), factory-fitted on the Denza N7",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,unknown,,not shown,https://www.c-ncap.org.cn/evaluation/287c71b4d9ab738ecc3b147fd5bc70b2,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 腾势N7 630 四驱智驾 Ultra (Denza N7 630 AWD Ultra), protocol version 1.1, test year 2024. Result page published 23 September 2024, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/287c71b4d9ab738ecc3b147fd5bc70b2""}]","{""kind"": ""Official documents""}" AIBD-1064,2024-09-20,source publication,day,tested,China's CMDE finds that doctors using uAI-CTA-HeadNeckVessels detected more brain aneurysms on CT angiograms in the maker's trial,"In the maker's trial that China's CMDE reviewed, doctors using uAI-CTA-HeadNeckVessels detected 90.00% of intracranial aneurysms on CT angiograms, against 81.97% without it.",*uAI-CTA-HeadNeckVessels* helped doctors find more brain aneurysms,"detected 90.00% of intracranial aneurysms on CT angiograms, against 81.97% without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,uAI-CTA-HeadNeckVessels (颅内动脉瘤CT造影图像辅助检测软件),Release 2.2 (full version 2.2-0-0-72),"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective reader trial on 484 cases at three institutions),China,"Three trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,2,,0,"The same doctors reading the same CT angiograms without the software, with imaging experts' readings as the reference",81.97% lesion-level sensitivity,90.00% lesion-level sensitivity,measured,persisted,2025-02-19,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743990436956096747.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT造影图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for CT angiography images), acceptance no. CQZ2302223, applicant 上海联影智能医疗科技有限公司. 20 September 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990436956096747.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT造影图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for CT angiography images), acceptance no. CQZ2302223, applicant 上海联影智能医疗科技有限公司. 20 September 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990436956096747.pdf""}, {""label"": ""Regulatory document"", ""value"": ""National Medical Products Administration (NMPA), China. CT Angiography Image-aided Detection Software for Intracranial Aneurysms Approved for Marketing. English-language notice, posted 19 February 2025. The notice names the maker as Shanghai United Imaging Healthcare Co., Ltd."", ""url"": ""https://english.nmpa.gov.cn/2025-02/19/c_1073672.htm""}]","{""kind"": ""Official documents""}" AIBD-1085,2024-09-13,source publication,day,tested,China's CMDE finds that uAI-PulmonaryEmbolism flagged pulmonary embolism on CT angiography with 95.09% sensitivity in the maker's trial,"In the maker's retrospective trial that China's CMDE reviewed, uAI-PulmonaryEmbolism flagged pulmonary embolism with 95.09% sensitivity and 88.24% specificity, above 80% targets.",*uAI-PulmonaryEmbolism* flagged pulmonary embolism in China's review,95.09% sensitivity and 88.24% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,uAI-PulmonaryEmbolism (肺栓塞CT血管造影图像辅助分诊软件),Release 1.0 (full version 1.0-0-2-27),"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective trial with 496 cases at three institutions),China,Three trial institutions in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Preset targets, with an expert panel's reading as the reference",Targets of 80% for sensitivity and for specificity,95.09% sensitivity and 88.24% specificity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743990790208002773.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺栓塞CT血管造影图像辅助分诊软件 (technical review report for the registration of pulmonary embolism CT angiography image triage-aid software), acceptance no. CQZ2400084, applicant 上海联影智能医疗科技有限公司. 13 September 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990790208002773.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺栓塞CT血管造影图像辅助分诊软件 (technical review report for the registration of pulmonary embolism CT angiography image triage-aid software), acceptance no. CQZ2400084, applicant 上海联影智能医疗科技有限公司. 13 September 2024. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990790208002773.pdf""}]","{""kind"": ""Official documents""}" AIBD-1061,2024-08-13,source publication,day,tested,"China's CMDE finds that with AIneurysm, doctors detected more aneurysms on brain MR angiograms in the maker's trial","In the maker's trial that China's CMDE reviewed, AIneurysm raised doctors' lesion-level sensitivity for brain aneurysms on MR angiograms by 0.0698.",*AIneurysm* helped doctors find more brain aneurysms on MR scans,lesion-level sensitivity for brain aneurysms on MR angiograms by 0.0698,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,AIneurysm (颅内动脉瘤磁共振图像辅助检测软件),Release 1 (full version 1.0.0.20240116),"Fuying (Shanghai) Medical Technology Co., Ltd. (复影(上海)医疗科技有限公司). The Paper reports that a Fudan University team led by Professor Geng Daoying developed the software.",China,Fuying (Shanghai) Medical Technology (retrospective reader trial on 484 analyzed cases from three centers),China,"Three trial centers that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,2,,0,"The same doctors reading the same MR angiograms without the software, with an expert panel's marks as the reference",,Lesion-level sensitivity 0.0698 higher (95% CI 0.0358 to 0.1037),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1724824253132010762.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤磁共振图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for magnetic resonance images), acceptance no. CQZ2301701, applicant 复影(上海)医疗科技有限公司. 13 August 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1724824253132010762.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤磁共振图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for magnetic resonance images), acceptance no. CQZ2301701, applicant 复影(上海)医疗科技有限公司. 13 August 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1724824253132010762.pdf""}]","{""kind"": ""Official documents""}" AIBD-1087,2024-08-05,source publication,day,tested,China's CMDE finds that Infervision's IR-CT-AO flagged aortic dissection with 87.83% sensitivity at 97.64% specificity in the maker's trial,"In the maker's prospective trial of 485 subjects that China's CMDE reviewed, Infervision's IR-CT-AO flagged aortic dissection with 87.83% sensitivity and 97.64% specificity.",*IR-CT-AO* flagged aortic dissections in a prospective trial in China,87.83% sensitivity and 97.64% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"IR-CT-AO (主动脉夹层CT造影图像辅助评估软件), models IR-CT-AO (A) and IR-CT-AO (B)",Release 1 (full version 1.0.3.0),"Infervision Medical Technology Co., Ltd. (推想医疗科技股份有限公司)",China,Infervision Medical Technology (prospective trial with 485 subjects),China,Trial centers in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Preset targets, with a three-physician expert panel's reading as the reference",Targets of 80% for sensitivity and for specificity,87.83% sensitivity and 97.64% specificity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743990567461064830.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:主动脉夹层CT造影图像辅助评估软件 (technical review report for the registration of aortic dissection CT angiography image assessment-aid software), acceptance no. CQZ2302385, applicant 推想医疗科技股份有限公司. 5 August 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990567461064830.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:主动脉夹层CT造影图像辅助评估软件 (technical review report for the registration of aortic dissection CT angiography image assessment-aid software), acceptance no. CQZ2302385, applicant 推想医疗科技股份有限公司. 5 August 2024. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743990567461064830.pdf""}]","{""kind"": ""Official documents""}" AIBD-0811,2024-07-26,source publication,day,tested,"FDA found that the Guardant Shield blood test detected 83.1% of colorectal cancers but only 13.2% of advanced adenomas in 7,861 average-risk adults","In FDA's review of Guardant Shield, the blood test detected 83.1% of colorectal cancers in 7,861 average-risk adults, with 89.6% specificity. It detected 13.2% of advanced adenomas.",*Shield* blood test found most colorectal cancers but few precancers,detected 83.1% of colorectal cancers,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Shield,,"Guardant Health, Inc.",United States,Guardant Health (ECLIPSE study at 265 US sites),United States,"265 sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational,2,,0,Screening colonoscopy with histopathology in the same adults,Colonoscopy findings (reference),"Sensitivity 83.1% for colorectal cancer and 13.2% for advanced adenomas, specificity 89.6%",measured,scaled,2026-05-27,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230009B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for Shield (P230009). Approved 2024-07-26."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230009B.pdf""}]","{""kind"": ""Official documents""}" AIBD-1062,2024-07-18,source publication,day,tested,China's CMDE finds that doctors using LiverMRDoc Pro detected more focal liver lesions on MRI in the maker's trial,"In the maker's trial that China's CMDE reviewed, doctors using LiverMRDoc Pro had lesion-level sensitivity for focal liver lesions 0.0969 higher than without it.",*LiverMRDoc Pro* helped doctors find more liver lesions on MRI,lesion-level sensitivity for focal liver lesions 0.0969 higher,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,LiverMRDoc Pro (肝脏局灶性病变MR图像辅助评估软件),Release 2 (full version 2.0.0.001),"Yukun (Beijing) Network Technology Co., Ltd. (语坤(北京)网络科技有限公司)",China,Yukun (Beijing) Network Technology (retrospective reader trial on 392 cases at five hospitals),China,"Beijing Friendship Hospital of Capital Medical University, Ningbo Hwa Mei Hospital of the University of Chinese Academy of Sciences, Affiliated Hospital of Hebei University, First Affiliated Hospital of Xi'an Jiaotong University and Huazhong University of Science and Technology Union Shenzhen Hospital, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"The same doctors reading the same liver MRI cases without the software, with an expert consensus as the reference",,Lesion-level sensitivity 0.0969 higher (95% CI 0.0840 to 0.1099),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1731393706297054265.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肝脏局灶性病变MR图像辅助评估软件 (technical review report for the registration of focal liver lesion assessment-aid software for MR images), acceptance no. CQZ2301004, applicant 语坤(北京)网络科技有限公司. 18 July 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1731393706297054265.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肝脏局灶性病变MR图像辅助评估软件 (technical review report for the registration of focal liver lesion assessment-aid software for MR images), acceptance no. CQZ2301004, applicant 语坤(北京)网络科技有限公司. 18 July 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1731393706297054265.pdf""}]","{""kind"": ""Official documents""}" AIBD-1023,2024-06-19,source publication,day,tested,CATARC found in C-ICAP tests that the Jiyue 01's assisted driving scored 100.0% for emergency avoidance but collided when a car ahead moved aside,"In CATARC's C-ICAP tests, published on 19 June 2024, the Jiyue 01 Max scored 100.0% for emergency avoidance. It collided when a car ahead moved aside to reveal a stopped car.",*Jiyue 01 assisted driving* scores 100.0% for emergency avoidance,100.0% for emergency avoidance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Jiyue 01 assisted driving, software V1.3.1, as fitted to the Jiyue 01 (极越01) Max (the page does not name the system)",V1.3.1 (software version tested),"Jiyue (上海集度汽车), with Baidu Apollo (not named on the page)",China,"Jiyue (上海集度汽车有限公司), factory-fitted on the Jiyue 01",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,withdrawn,2024-12-11,shown,https://autonews.gasgoo.com/articles/news/ji-yue-introduces-pure-vision-based-intelligent-driving-solution-70028988,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 极越01 Max (Jiyue 01 Max), protocol version 1.1, test year 2024. Result page published 19 June 2024, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/b71f517eb3fede6f2bfbcf03f466a43d""}, {""label"": ""Follow-up"", ""value"": ""On 11 December 2024 Jiyue Auto, the carmaker backed by Baidu and Geely that made the Jiyue 01, told employees that it was shutting down entirely."", ""url"": ""https://en.jiemian.com/article/12189660.html""}]","{""kind"": ""Withdrawals""}" AIBD-1094,2024-06-11,source publication,day,tested,China's CMDE finds that the MCS fundus software met its targets for accuracy on 11 eye diseases in the maker's trial,"In the maker's trial that China's CMDE reviewed, the MCS fundus software met its targets for 11 eye diseases, with 91.18% sensitivity and 91.56% specificity for diabetic retinopathy.",*MCS* flagged 11 eye diseases on fundus photos in China's review,91.18% sensitivity and 91.56% specificity for diabetic retinopathy,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,MCS / MCSLocal (眼底病变眼底图像辅助诊断软件),Release V2 (MCS cloud server version and MCSLocal local server version),"Beijing Zhiyuan Huitu Technology Co., Ltd. (北京致远慧图科技有限公司)",China,"Beijing Zhiyuan Huitu Technology (registration trial with 2,778 fundus photographs at four institutions)",China,"Four trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Targets set for each disease from a pilot trial and the literature, with central reading as the gold standard",Target of 82.0% sensitivity for diabetic retinopathy,"91.18% [86.48%,94.35%] sensitivity for diabetic retinopathy",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1742968101004034249.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:眼底病变眼底图像辅助诊断软件 (technical review report for the registration of fundus disease fundus image diagnosis-aid software), acceptance no. CQZ2200072, applicant 北京致远慧图科技有限公司. 11 June 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742968101004034249.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:眼底病变眼底图像辅助诊断软件 (technical review report for the registration of fundus disease fundus image diagnosis-aid software), acceptance no. CQZ2200072, applicant 北京致远慧图科技有限公司. 11 June 2024. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742968101004034249.pdf""}]","{""kind"": ""Official documents""}" AIBD-0827,2024-06-01,event,month,tested,EPA approves SENSIA's RedLook System for compliance after finding that it meets the 1 kg per hour threshold for screening methane leaks,EPA found in June 2026 that SENSIA's RedLook System meets the 1 kg/hr threshold for periodic screening for methane. It uses machine learning to analyze camera video.,*RedLook* software meets EPA's threshold of 1 kg per hour for methane,meets the 1 kg/hr threshold,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"RedLook System, with the Caroline FY and Mileva cameras for optical gas imaging",,"SENSIA (Leganés, Madrid)",Spain,Oil and gas owners and operators at affected facilities (approved use),United States,United States,United States,Climate change mitigation / methane emissions monitoring,,Environment,Environment,Air Pollution,Images and video,,13,High income,environmental_impact,Environmental impacts,,,,,,,,societal,3,,0,The 1 kg/hr threshold for periodic screening,1 kg/hr,"90% probability of detection at 0.84 kg/hr, without wind correction",measured,unknown,,shown,https://www.epa.gov/system/files/documents/2026-08/sensia-mileva-approval-letter.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air and Radiation. Approval letter for the SENSIA RedLook System Caroline FY as Methane Alternative Test Method MATM-017. 12 June 2026."", ""url"": ""https://www.epa.gov/system/files/documents/2026-08/sensia-caroline-approval-letter.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air and Radiation. Approval letter for the SENSIA RedLook System Mileva as Methane Alternative Test Method MATM-018. 12 June 2026."", ""url"": ""https://www.epa.gov/system/files/documents/2026-08/sensia-mileva-approval-letter.pdf""}]","{""kind"": ""Official documents""}" AIBD-1015,2024-05-31,source publication,day,intended,Japan's Hokkaido District Transport Bureau approves a NAVYA ARMA shuttle in Kamishihoro as a Level 4 automated vehicle that needs no driver,On 31 May 2024 a Japanese transport bureau approved a NAVYA ARMA shuttle in Kamishihoro for Level 4. It confirmed that the shuttle's automated operation device met the safety standards.,NAVYA's *ARMA* gets approval to run with no driver in Kamishihoro,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device on a NAVYA ARMA shuttle,,NAVYA (maker of the ARMA shuttle),France,"BOLDLY Inc. (BOLDLY株式会社), the applicant and operator, in the town of Kamishihoro",Japan,"Kamishihoro, Hokkaido, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,physical_health; operational_improvement,,,,,,,,,societal,2,,0,,,,,persisted,2024-10-25,shown,https://www.anyauto.com.au/?p=16136,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Hokkaido District Transport Bureau, Automotive Technology and Safety Department. 北海道初! 自動運転車(レベル4)の認可について ~バス運転手不足の解決に一歩前進~ (First in Hokkaido: approval of a Level 4 automated vehicle, a step toward solving the bus driver shortage). Press release, 31 May 2024, paragraphs 1 and 2, table and attachment."", ""url"": ""https://wwwtb.mlit.go.jp/hokkaido/content/000325959.pdf""}]","{""kind"": ""Official documents""}" AIBD-0772,2024-05-17,source publication,day,tested,"In FDA's De Novo review of DentalMonitoring, its AI read orthodontic photos taken by phone in agreement with panels of orthodontists","In studies that FDA reviewed, DentalMonitoring's analysis of patients' phone scans matched orthodontist panels. For black triangles, for example, sensitivity was 81.0%. Specificity was 98.4%.",*DentalMonitoring* reads phone photos of braces for orthodontists,sensitivity was 81.0% and specificity 98.4%,,found,Found by a regulator,no comparison,very low,aggregate result,false,DentalMonitoring,,Dental Monitoring SAS,France,Dental Monitoring (retrospective and prospective studies with US orthodontists),France,United States (retrospective review with 15 US orthodontists and prospective studies at US sites),United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,,,,,persisted,2025-06-20,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230035.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for DentalMonitoring (DEN230035): decision summary. Granted 2024-05-17."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230035.pdf""}]","{""kind"": ""Official documents""}" AIBD-0768,2024-05-15,source publication,day,tested,"In FDA's De Novo review of the Notal Vision Home OCT, patients' home retinal scans agreed with clinic scans on fluid in most pairs","In the five-week study that FDA reviewed, patients' home OCT scans agreed with clinic scans on retinal fluid, with a PPA of 0.864. The NPA was 0.849. No gain in vision was shown.",*Notal Vision Home OCT* lets patients scan their own retinas at home,a positive percent agreement of 0.864,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Notal Vision Home Optical Coherence Tomography (OCT) System with the Notal OCT Analyzer (NOA),,"Notal Vision, Inc.",United States,"Notal Vision (001 Study at seven US sites, with patients imaging themselves at home, and 006 Study at six US sites)",United States,Patients' homes and seven US clinical sites (001 Study) and six US sites (006 Study),United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical access,,3,2,,,5,,personal,2,,0,Clinic OCT scans graded by the reading center within 24 hours,Fluid status on clinic OCT,PPA 0.864 and NPA 0.849 for home scans,measured,persisted,2026-01-01,shown,https://www.ophthalmologytimes.com/view/notal-vision-shares-data-on-novel-home-oct-device,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Notal Vision Home Optical Coherence Tomography (OCT) System (DEN230043): decision summary. Granted 2024-05-15."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230043.pdf""}]","{""kind"": ""Official documents""}" AIBD-0814,2024-05-03,source publication,day,tested,"FDA found that the ColoSense stool RNA test detected 92.6% of colorectal cancers in 7,763 average-risk adults, more than its FIT component alone","In FDA's review of ColoSense, the stool RNA test detected 92.6% of colorectal cancers in 7,763 adults, with 85.6% specificity. It detected 41.3% of advanced precancerous lesions.",*ColoSense* stool RNA test found 25 of 27 colorectal cancers,detected 92.6% of colorectal cancers,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,ColoSense,,"Geneoscopy, Inc.",United States,Geneoscopy (CRC-PREVENT study with participants from 48 US states),United States,United States (48 contiguous states),United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,"The FIT component of ColoSense alone, in the same adults",Cancer sensitivity 77.8%,Cancer sensitivity 92.6%,measured,scaled,2026-06-09,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230001B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for ColoSense (P230001). Approved 2024-05-03."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf23/P230001B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0810,2024-05-01,source publication,month,tested,FDA qualified Apple's AFib History Feature for trials of ablation devices after finding that its weekly estimates of AFib burden were clinically acceptable,"FDA qualified Apple's AFib History Feature as a tool for trials of cardiac ablation devices. In 280 subjects, its weekly estimate of AFib burden differed from an ECG patch by 0.67% on average.",FDA qualified the *AFib History Feature* for trials of ablation devices,differed from an ECG patch by 0.67% on average,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Apple Atrial Fibrillation History Feature,,Apple Inc.,United States,Apple (prospective AFib History clinical study of 280 subjects),United States,,,Healthcare,,Health,Health,Drug Industry,Prediction from data,Patients,3,,physical_health,Medical diagnosis,,,,3,,,,organizational,1,,0,A Cardea SOLO wireless ECG patch worn by the same subjects,Reference weekly AFib burden,"Average difference of 0.67%, with 92.9% of subjects within ±5%",measured,persisted,2025-06-02,not shown,https://www.apple.com/uk/healthcare/docs/site/Apple_Watch_Arrhythmia_Detection.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Medical Device Development Tool (MDDT) summary of evidence and basis of qualification: Apple Atrial Fibrillation History Feature (U230116). 2024-05-01."", ""url"": ""https://www.fda.gov/media/178230/download""}]","{""kind"": ""Official documents""}" AIBD-1121,2024-05-01,source publication,month,tested,Health Technology Wales finds that AI help raised pathologists' sensitivity for prostate cancer but judges the evidence insufficient for routine use,Health Technology Wales found that pathologists' sensitivity for prostate cancer rose from 91.6% to 96% with AI help in four pooled studies. It judged the evidence insufficient for routine use.,*AI biopsy review* catches more prostate cancers in HTW's pooled studies,from 91.6% to 96%,,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,"AI-assisted review of prostate biopsies: Galen Prostate, Paige Prostate and DeepDx Prostate",,"Ibex Medical Analytics (Galen Prostate), Paige AI (Paige Prostate) and Deep Bio (DeepDx Prostate)","Multiple: Israel, United States, South Korea","Pathology services in the studies that HTW reviewed, with Galen Prostate introduced across NHS Wales through a Welsh Government innovation fund pilot",Multiple,"Multiple countries (studies), with guidance for Wales, United Kingdom",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,"Pathologists reviewing the same biopsy slides without AI, pooled across four studies",91.6%,96%,measured,scaled,,shown,https://healthtechnology.wales/wp-content/uploads/EAR057-AIPB-WEB.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Health Technology Wales. HTW Guidance 057: Artificial Intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer. May 2024, Evidence summary."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/GUI057-AIPB-ENG-WEB.pdf""}, {""label"": ""Assessment report"", ""value"": ""Health Technology Wales. Evidence Appraisal Report EAR057: Artificial Intelligence (AI) assisted review of prostate biopsies in the detection and diagnosis of prostate cancer. May 2024, section 5.2 and Table 2."", ""url"": ""https://healthtechnology.wales/wp-content/uploads/EAR057-AIPB-WEB.pdf""}]","{""kind"": ""Official documents""}" AIBD-0769,2024-04-09,source publication,day,tested,"In FDA's De Novo review of Rho, the software detected low bone density on routine x-rays with high specificity but low sensitivity","In FDA's review of Rho, the software met its specificity goal on x-rays from three datasets. Its AUC reached its goal. Its sensitivity was 0.36 to 0.67. FDA saw a small probable benefit.",*Rho* detects low bone density on routine x-rays but misses many cases,Specificity was 0.90 to 0.94,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Rho,,16 Bit Inc.,Canada,"16 Bit (retrospective study on x-rays from True North Imaging, OneMedNet and the Osteoarthritis Initiative)",Canada,"Six True North Imaging centers in Ontario, Canada, and US sites of OneMedNet and the Osteoarthritis Initiative",Canada | United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,2,,,,organizational,2,,0,"Pre-specified goals for specificity and AUC, with DXA as the reference",Specificity goal of a lower 95% bound above 0.775,"Specificity 0.90 (TNI), 0.93 (OMN) and 0.94 (OAI)",measured,persisted,2024-07-25,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230023.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Rho (DEN230023): decision summary. Granted 2024-04-09."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230023.pdf""}]","{""kind"": ""Official documents""}" AIBD-0626,2024-04-02,source publication,day,tested,FDA De Novo review of Prenosis Sepsis ImmunoScore: AI risk categories track sepsis risk in data from three hospitals,"In FDA's review of the Prenosis Sepsis ImmunoScore, sepsis within 24 hours rose from 3.02% in its low risk category to 69.70% in its very high category. The AUROC was 0.81.",*Sepsis ImmunoScore* sorted patients by sepsis risk in FDA's review,an area under the ROC curve of 0.81,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Sepsis ImmunoScore,,"Prenosis, Inc.",United States,Prenosis (retrospective validation on data from three US hospitals),United States,"Boston, Massachusetts; Chicago, Illinois; Royal Oak, Michigan, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Pre-specified AUROC performance goal,Goal of 0.75,0.81 (forced majority adjudication),measured,scaled,2026-07-28,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230036.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Sepsis ImmunoScore (DEN230036): decision summary. Granted 2024-04-02."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230036.pdf""}]","{""kind"": ""Official documents""}" AIBD-1065,2024-02-26,source publication,day,tested,China's CMDE finds that doctors using Dr.Wise-AADS detected more brain aneurysms on CT angiograms in the maker's trial,"In the maker's trial that China's CMDE reviewed, doctors using Dr.Wise-AADS had lesion-level sensitivity for brain aneurysms on CT angiograms 10.85% higher than without it.",*Dr.Wise-AADS* helped doctors find more brain aneurysms on CT,lesion-level sensitivity for brain aneurysms on CT angiograms 10.85% higher,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Dr.Wise-AADS (颅内动脉瘤CT造影图像辅助检测软件),Release 1 (full version 1.1.0.1),Hangzhou Deepwise (杭州深睿博联科技有限公司),China,Hangzhou Deepwise (retrospective crossover reader trial on 965 cases at four institutions),China,"Four trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,2,,0,"The same doctors reading the same CT angiograms without the software, with imaging experts' readings as the reference",,Lesion-level sensitivity 10.85% higher (95% CI 7.77% to 13.94%),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1714024440043003676.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT造影图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for CT angiography images), acceptance no. CQZ2301114, applicant 杭州深睿博联科技有限公司. 26 February 2024. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1714024440043003676.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT造影图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for CT angiography images), acceptance no. CQZ2301114, applicant 杭州深睿博联科技有限公司. 26 February 2024. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1714024440043003676.pdf""}, {""label"": ""Regulatory document"", ""value"": ""National Medical Products Administration (NMPA), China. CT Image-aided Detection Software for Intracranial Aneurysms Approved for Marketing. English-language notice, 1 March 2024."", ""url"": ""https://english.nmpa.gov.cn/2024-03/01/c_1049695.htm""}]","{""kind"": ""Official documents""}" AIBD-0770,2024-02-06,source publication,day,tested,"In FDA's De Novo review of Samsung's Sleep Apnea Feature, the watch detected 82.7% of people with moderate to severe sleep apnea","In the study that FDA reviewed, Samsung's watch feature detected 82.7% of people with moderate to severe obstructive sleep apnea. Its specificity, 87.7%, missed the preset criterion.",Samsung's *Sleep Apnea Feature* caught most moderate to severe cases,sensitivity was 82.7%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Sleep Apnea Feature (Samsung Galaxy Watch and Phone),,"Samsung Electronics Co., Ltd.",South Korea,Samsung (multi-center clinical validation against polysomnography run by an accredited sleep lab),South Korea,Sites not named in the decision summary,,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,,physical_health,Medical diagnosis,,,,2,,,,personal,2,,0,Polysomnography scored by physicians and preset acceptance criteria,Preset criteria for sensitivity and specificity,"Sensitivity 82.7% passed, specificity 87.7% did not",measured,scaled,2025-06-05,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230041.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Sleep Apnea Feature (Samsung) (DEN230041): decision summary. Granted 2024-02-06."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230041.pdf""}]","{""kind"": ""Official documents""}" AIBD-0826,2024-02-01,event,month,tested,EPA approves SLB's SOOFIE sensor network for methane screening after finding a 90% probability of detection at about 0.6 kg per hour,EPA found that SLB's SOOFIE network reached 90% probability of detection at about 0.6 kg/hr in controlled tests. It uses an AI-based algorithm to detect methane events.,*SOOFIE* sensors detect methane well under EPA's limit of 5 kg per hour,90% probability of detection at about 0.6 kg/hr,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,SOOFIE (Systematic Observation of Facility Intermittent Emissions) emissions monitoring system,,"SLB (application first filed by ChampionX, LLC)",United States,Oil and gas operators (approved use),United States,"Colorado, United States",United States,Climate change mitigation / methane emissions monitoring,,Environment,Environment,Air Pollution,Prediction from data,,13,High income,environmental_impact,Environmental impacts,,,,,,,,societal,1,,0,The reference limit of 5 kg/hr for detection,5 kg/hr,About 0.6 kg/hr at 90% probability of detection,measured,unknown,,shown,https://www.epa.gov/system/files/documents/2025-09/slb-soofie-approval-letter-and-justification-memo.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency. Approval letter for the SLB SOOFIE emissions monitoring system as Methane Alternative Test Method MATM-013, with the Acceptance Justification memorandum, 23 September 2025 (docket EPA-HQ-OAR-2024-0619)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-09/slb-soofie-approval-letter-and-justification-memo.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency. Approval letter for the SLB SOOFIE emissions monitoring system as Methane Alternative Test Method MATM-013, with the Acceptance Justification memorandum, 23 September 2025 (docket EPA-HQ-OAR-2024-0619)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-09/slb-soofie-approval-letter-and-justification-memo.pdf""}]","{""kind"": ""Official documents""}" AIBD-1133,2024-02-01,event,month,tested,"EPA approves Earthview's BluBird sensor network for compliance after finding that it meets its thresholds for methane screening of 5, 10 and 15 kg per hour","EPA found that Earthview's BluBird network of methane sensors meets the 5, 10 and 15 kg/hr thresholds for periodic screening. It approved the network on 30 September 2025.",*BluBird* sensors meet EPA's threshold of 5 kg per hour for methane,"meets the 5, 10 and 15 kg/hr thresholds",,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"BluBird Continuous Monitoring System (BluBird CMS), with the Gridded Pad Analysis and Quantification System (GPAQS) cloud software",,"Earthview Corporation (Dallas, Texas)",United States,Oil and gas owners and operators at affected facilities (approved use),United States,Contiguous United States,United States,Climate change mitigation / methane emissions monitoring,,Environment,Environment,Air Pollution,Prediction from data,,13,High income,environmental_impact,Environmental impacts,,,,,,,,societal,2,,0,The 5 kg/hr detection threshold for periodic screening,5 kg/hr,a 90% probability of detection (POD) of approximately 2.4 kg/hr for the single release,measured,persisted,2026-10-22,shown,https://www.epa.gov/system/files/documents/2025-09/earthview-formal-atm-10kg_hr-2025.08.29-508_ns-sd-for-pdf.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards, Measurement Technology Group. Approval letter for the Earthview BluBird Continuous Monitoring System as Methane Alternative Test Method MATM-015, with the Acceptance Justification memorandum, 30 September 2025 (docket EPA-HQ-OAR-2024-0619)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-10/earthview-approval-letter_v1b.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency. Acceptance Justification: BluBird CMS, memorandum to docket EPA-HQ-OAR-2024-0619, 30 September 2025, attached to the approval letter (Method Sensitivity)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-10/earthview-approval-letter_v1b.pdf""}]","{""kind"": ""Official documents""}" AIBD-0771,2024-01-31,source publication,day,tested,"In FDA's De Novo review of Hologic's Genius Cervical AI, cytology teams caught more precancerous lesions than with a microscope","In the study that FDA reviewed, cytology teams using Genius Cervical AI found HSIL+ lesions with 81.5% sensitivity, against 74.0% by microscope. Specificity fell by 1.3% to 2.9%.",*Genius Cervical AI* helped cytology teams catch more precancers,sensitivity rose from 74.0% to 81.5%,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Genius Digital Diagnostics System with the Genius Cervical AI algorithm,,"Hologic, Inc.",United States,Four US cytology laboratories in Hologic's multi-center clinical study,United States,"Four cytology laboratories, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,The same cytology teams reading the glass slides by light microscope,HSIL+ sensitivity 74.0%,HSIL+ sensitivity 81.5%,measured,scaled,2025-03-05,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN210035.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of automatic class III designation for the Genius Digital Diagnostics System with the Genius Cervical AI algorithm (DEN210035): decision summary. Granted 2024-01-31."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN210035.pdf""}]","{""kind"": ""Official documents""}" AIBD-1002,2024-01-17,source publication,day,tested,The FCC conditionally certifies Rogervoice's automatic phone captions after its test lab measured shorter delays than other providers',"In the FCC's test lab, Rogervoice's automatic captions arrived in 1.2 to 1.3 seconds, against 1.8 to 2.4 for other providers. Its word error rates were higher but comparable.",*Rogervoice*'s automatic captions arrive faster in the FCC's lab tests,arrived in 1.2 to 1.3 seconds,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Rogervoice ASR-only Internet Protocol Captioned Telephone Service (IP CTS) app,,Rogervoice SAS (the FCC does not name the speech recognition engine),France,Rogervoice SAS,France,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,,,personal,2,,0,Aggregate average caption delay of other IP CTS providers on the same two call scenarios,1.8 to 2.4 seconds,1.2 to 1.3 seconds,measured,persisted,2026-07-13,shown,https://rogervoice.com/blog/news/how-ai-powered-captioning-is-changing-communication/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-48, CG Docket No. 03-123 (conditional certification of Rogervoice to provide IP CTS on a fully automatic basis). Adopted and released 17 January 2024. Paragraph 9, a sentence split by a page break."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-48A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Public Notice, DA 26-728, CG Docket No. 03-123: Extension of Conditional Certification of Rogervoice SAS, to Provide Internet Protocol Captioned Telephone Service. Released 13 July 2026."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-26-728A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-1003,2024-01-17,source publication,day,tested,The FCC conditionally certifies NexTalk's automatic SpeechPath captions after its test lab measured shorter delays with comparable accuracy,"In the FCC's test lab, NexTalk's automatic SpeechPath captions arrived faster than other providers' captions. Their median word error rates of 0.8% to 7.6% were comparable to the others' 2.0% to 7.4%.",*SpeechPath* captions come faster at similar accuracy in the FCC's tests,median word error rates of 0.8% to 7.6%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,NexTalk SpeechPath ASR-only Internet Protocol Captioned Telephone Service (IP CTS),,"NexTalk, Inc. (SpeechPath, ""developed by and exclusively for NexTalk"")",United States,"NexTalk, Inc. (NexTalk Software, Inc. after Solen Ventures acquired control in December 2024)",United States,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,,,,,,personal,3,,0,Other IP CTS providers' aggregated word error rates on the same three call scenarios,2.0% to 7.4%,0.8% to 7.6%,measured,unknown,2025-01-17,shown,https://docs.fcc.gov/public/attachments/DA-24-49A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-49, CG Docket No. 03-123 (conditional certification of NexTalk, Inc. to provide IP CTS on a fully automatic basis). Adopted and released 17 January 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-49A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Public Notice, DA 25-73, CG Docket No. 03-123: Comment Sought on Application of Solen Ventures and NexTalk for Conditional Certification as a Provider of Internet Protocol Captioned Telephone Service. Released 17 January 2025."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-25-73A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0630,2024-01-12,source publication,day,tested,FDA De Novo review of DermaSensor: Primary care physicians refer more skin cancers with an AI spectroscopy device,"In FDA's review of DermaSensor, primary care physicians aided by the device referred skin cancers with 91.4% sensitivity, against 82.0% unaided. The device alone reached 95.5%.",*DermaSensor* raised primary care sensitivity for skin cancer,Their sensitivity rose from 82.0% to 91.4%,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,DermaSensor,,"DermaSensor, Inc.",United States,Primary care sites in the DERM-SUCCESS study,United States; Australia,Twenty-two sites in the United States and Australia,United States | Australia,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Health workers,3,High income,physical_health,Medical diagnosis,,3,1,2,,1,,organizational,4,,0,The same primary care physicians judging the same lesion images without the device output,"Sensitivity 82.0%, specificity 44.2%","Sensitivity 91.4%, specificity 32.4%",measured,scaled,2026-09-09,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230008.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for DermaSensor (DEN230008): decision summary. Granted 2024-01-12."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230008.pdf""}]","{""kind"": ""Official documents""}" AIBD-0773,2024-01-12,source publication,day,tested,"FDA's De Novo review of Fibresolve shows that it caught more idiopathic pulmonary fibrosis on CT than experts did, at a cost in false positives","In FDA's review, Fibresolve flagged idiopathic pulmonary fibrosis on chest CT with 55% sensitivity, against 20% for an expert panel. Its specificity was 82%, against 95%.",*Fibresolve* flagged more lung fibrosis than experts in FDA's review,a sensitivity of 55%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Fibresolve,,"Imvaria, Inc.",United States,Imvaria (retrospective study on 300 CT cases from the Lung Tissue Research Consortium),United States,Lung Tissue Research Consortium sites (not named in the decision summary),,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,,physical_health,Medical diagnosis,,,,,,,,organizational,3,,0,An expert panel of five pulmonologists and thoracic radiologists reviewing the same cases,"Panel sensitivity 20%, specificity 95%","Device sensitivity 55%, specificity 82%",measured,persisted,2025-11-07,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220040.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Fibresolve (DEN220040): decision summary. Granted 2024-01-12."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220040.pdf""}]","{""kind"": ""Official documents""}" AIBD-0774,2024-01-11,source publication,day,tested,FDA's De Novo review of BrainSee shows that it predicted which patients with mild cognitive impairment developed Alzheimer's dementia in five years,"In FDA's review, BrainSee predicted which of 198 patients with amnestic mild cognitive impairment developed Alzheimer's dementia within five years. Its specificity was 96%. Its sensitivity was 73%.",*BrainSee* predicted which patients with memory loss would get dementia,a specificity of 96%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,BrainSee,,"Darmiyan, Inc.",United States,Darmiyan (retrospective validation on 198 patients from 27 North American sites),United States,27 North American sites,,Healthcare,,Health,Health,Disease Prevention,Images and video; Prediction from data,Patients; Health workers,3,,physical_health,Medical diagnosis,,,,2,,,,organizational,2,,0,Pre-defined goals of sensitivity and specificity above 70%,Goals above 70%,"Specificity 96%, sensitivity 73% with a lower bound of 65%",measured,persisted,2025-05-29,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220066.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for BrainSee (DEN220066): decision summary. Granted 2024-01-11."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220066.pdf""}]","{""kind"": ""Official documents""}" AIBD-0997,2024-01-04,source publication,day,tested,The FCC certifies Nagish's fully automatic captions after its test lab measured shorter delays than for other providers,"In the FCC's National Test Lab, Nagish's automatic captions had a median delay of 1.0 seconds, against 1.8-2.4 seconds for other providers, with comparable word error rates.",*Nagish* captions calls faster than other providers in the FCC's tests,a median delay of 1.0 seconds,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"Nagish fully automatic IP CTS (automatic speech recognition) and IP Relay (speech recognition with text-to-speech), delivered by smartphone app",,"Nagish, Inc., on speech recognition and text-to-speech from unnamed vendors",,"Nagish, Inc.",,United States,United States,"Telecommunications relay services / accessibility for people who are deaf, hard of hearing or speech disabled",,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,5,,personal,3,,0,Aggregate average caption delay of other IP CTS providers in the same two call scenarios,1.8-2.4 seconds,1.0 seconds,measured,persisted,2026-06-09,shown,https://docs.fcc.gov/public/attachments/DA-26-566A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-12, CG Docket No. 03-123 (conditional certification of Nagish, Inc. to provide IP CTS on a fully automatic basis). Adopted and released 4 January 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-12A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-12, CG Docket No. 03-123 (conditional certification of Nagish, Inc. to provide IP CTS on a fully automatic basis). Adopted and released 4 January 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-12A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-1292, CG Docket No. 03-123 (conditional certification of Nagish, Inc. to provide fully automatic Internet Protocol Relay Service). Adopted and released 23 December 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-1292A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-1292, CG Docket No. 03-123 (conditional certification of Nagish, Inc. to provide fully automatic Internet Protocol Relay Service). Adopted and released 23 December 2024. The finding rests on test results from Cositics, LLC, which Nagish filed with its application."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-1292A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Public Notice, DA 26-566, CG Docket No. 03-123: Grant of Certification for Nagish, Inc., to Provide Internet Protocol Captioned Telephone Service and Internet Protocol Relay Service. Released 9 June 2026."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-26-566A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-1001,2024-01-04,source publication,day,tested,The FCC conditionally certifies Global Caption's automatic captions for people in custody after its lab measured shorter delays than other providers',"In the FCC's test lab, Global Caption's automatic captions for incarcerated callers arrived in 1.0 to 1.1 seconds, against 1.8 to 2.4 for other providers. Word error rates were higher but comparable.",*Global Caption*'s captions for people in custody arrive faster in tests,arrived in 1.0 to 1.1 seconds,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Global Caption ASR-only Internet Protocol Captioned Telephone Service (IP CTS) for carceral facilities,,"Global Caption, Inc., with a speech recognition vendor that the FCC does not name",,"Global Caption, Inc., in carceral facilities, through technology firms that work with incarcerated people's calling service providers",,United States (carceral facilities),United States,Telecommunications relay services / accessibility for incarcerated people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,5,,personal,2,,0,Other IP CTS providers' average caption delay on the same two call scenarios,1.8 to 2.4 seconds,1.0 to 1.1 seconds,measured,persisted,2026-06-16,shown,https://docs.fcc.gov/public/attachments/DA-24-11A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-11, CG Docket No. 03-123 (conditional certification of Global Caption, Inc. to provide IP CTS on a fully automatic basis in carceral facilities). Adopted and released 4 January 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-11A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Public Notice, DA 26-593, CG Docket No. 03-123: Extension of Conditional Certification of Global Caption, Inc., to Provide Internet Protocol Captioned Telephone Service. Released 16 June 2026."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-26-593A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0929,2024-01-01,source publication,year,tested,"AQuAS finds that readers were at least as accurate with Koios DS Breast on breast ultrasound, in studies at high risk of bias",AQuAS found in four retrospective studies that readers' sensitivity was at least as high with Koios DS Breast. So was their area under the ROC curve. Selection bias may have inflated the results.,*Koios DS Breast* helped readers classify breast lumps on ultrasound,0.87 with it and 0.83 without,,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,Koios DS Breast,,Koios Medical,United States,"Readers in the four retrospective studies that AQuAS reviewed, three in the United States and one in Spain","Multiple: United States, Spain","Spain (assessment), with studies in the United States and Spain",Spain | United States,Healthcare (breast imaging),,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,The same readers without Koios DS Breast (Mango et al. 2020),"0,83 (95 % IC 0,78 – 0,89) area under the ROC curve","0,87 [95 % IC 0,84 – 0,90] with Koios DS Breast",measured,persisted,,shown,https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1360,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), for the Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del SNS. Llinàs-Mallol L, Guzmán Aroca F, Estrada Sabadell MD, Vivanco-Hidalgo RM. Herramienta de apoyo en el diagnóstico ecográfico para la clasificación de nódulos mamarios. Ficha de evaluación de tecnologías sanitarias nuevas y emergentes. Barcelona: AQuAS, 2024. NIPO 133-24-102-2. Puntos clave."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1360""}]","{""kind"": ""Official documents""}" AIBD-1021,2024-01-01,event,year,tested,"CATARC found in C-ICAP tests that Li Auto's assisted driving on the L6 Max scored 99.4% for basic driving assistance, with 98.5% for navigation","In CATARC's C-ICAP tests, published on 3 January 2025, Li Auto's assisted driving on an L6 Max scored 99.4% for basic driving assistance. It scored 98.5% for navigation-guided driving assistance.",*Li Auto assisted driving* scores 99.4% in basic tests on an L6 Max,99.4% for basic driving assistance,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Li Auto assisted driving, software version 6.3.0, as fitted to the Li L6 (理想L6) Max",6.3.0 (software version tested),Li Auto (理想汽车),China,"Li Auto (北京理想汽车有限公司), factory-fitted on the L6",China,China,China,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,Upper middle income,physical_health,Hazard reduction,,,,,,,,personal,1,,0,,,,,persisted,2026-09-10,not shown,https://www.c-ncap.org.cn/evaluation/76cc4a6cc90d6e7cc4a4695e00e5298d,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""China Automotive Technology and Research Center (CATARC), Automotive Test & Assessment Management Center. C-ICAP result for the 理想L6 Max (Li L6 Max), protocol version 2024, test year 2024. Result page published 3 January 2025, with CATARC's rating report linked from it."", ""url"": ""https://www.c-ncap.org.cn/evaluation/76cc4a6cc90d6e7cc4a4695e00e5298d""}]","{""kind"": ""Official documents""}" AIBD-1030,2024-01-01,source publication,year,tested,Andalusia's assessment agency AETSA finds that ejection fractions from four AI echocardiography assistants agree with expert measurement,"AETSA reviewed five studies of four AI echocardiography assistants. It found that their ejection fractions agreed with manual expert measurement, with no systematic error identified.",*AI echocardiography assistants* match experts' ejection fractions,intraclass correlation was 0.84 for Caption Guidance,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"AI echocardiography assistants: Caption Guidance, Real-Time EF, LVivo Seamless and AI TRIO",,"Caption Health (Caption Guidance), GE HealthCare (Real-Time EF), DIA Imaging Analysis (LVivo Seamless) and EchoNous (AI TRIO)","Multiple: United States, Israel","Hospitals in the five validation studies that AETSA reviewed, in the United States, Germany, Tunisia and Portugal","Multiple: United States, Germany, Tunisia, Portugal","United States, Germany, Tunisia and Portugal (studies), assessed for Spain",United States | Germany | Tunisia | Portugal | Spain,Healthcare (cardiology),,Health,Health,Disease Prevention,Images and video,Health workers,3,Lower middle income; High income,physical_health,Medical diagnosis,,,,,,,,organizational; societal,1,,0,Manual measurement of the ejection fraction by expert echocardiographers or cardiologists with the modified Simpson method,,concordancia entre la FEVI determinada por los cuatro sistemas de IA y las obtenidas manualmente por el método de referencia,measured,unknown,,shown,https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1268,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""AETSA, Evaluación de Tecnologías Sanitarias de Andalucía (Maesa Márquez JM, Isabel Gómez R). Sistema de identificación de enfermedades cardiacas basado en ecografía e inteligencia artificial. Ficha de evaluación de tecnologías sanitarias nuevas y emergentes, RedETS and Ministerio de Sanidad, Sevilla, 2024. Puntos clave, p. 53."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1268""}]","{""kind"": ""Official documents""}" AIBD-1075,2023-11-22,source publication,day,tested,"China's CMDE finds that LiverMRDoc met its targets for accuracy on liver MRI, reaching judgments faster than an expert panel in the maker's trial","In the maker's trial that China's CMDE reviewed, judgments on liver MRI took a median of 7.47 minutes with LiverMRDoc, against 9.45 minutes for an expert panel.",*LiverMRDoc* reached judgments on liver MRI faster in China's review,"a median of 7.47 minutes with LiverMRDoc, against 9.45 minutes for an expert panel",,found,Found by a regulator,tested against a standard,very low,aggregate result,false,LiverMRDoc (肝脏局灶性病变MR图像辅助分诊软件),Release 2.0 (full version 2.0.1.001),"Yukun (Beijing) Network Technology Co., Ltd. (语坤(北京)网络科技有限公司)",China,Yukun (Beijing) Network Technology (retrospective registration trial with 490 cases at two hospitals),China,"Beijing Friendship Hospital of Capital Medical University in Beijing and Ningbo Hwa Mei Hospital of the University of Chinese Academy of Sciences in Ningbo, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,operational_improvement; physical_health,Enhanced productivity,,,,,,,,organizational,1,,0,"The expert panel that set the reference standard, reading the same 490 cases",median 9.45min for the expert panel,median 7.47min with the software,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743664577098001803.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肝脏局灶性病变MR图像辅助分诊软件 (technical review report for the registration of focal liver lesion MR image triage-aid software), acceptance no. CQZ2201476, applicant 语坤(北京)网络科技有限公司. 22 November 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743664577098001803.pdf""}]","{""kind"": ""Official documents""}" AIBD-1088,2023-11-07,source publication,day,tested,China's CMDE finds that AneurDoc flagged suspected head and neck aneurysms on CT angiograms with 95.42% sensitivity in the maker's trial,"In the maker's trial that China's CMDE reviewed, AneurDoc flagged suspected head and neck aneurysms with 95.42% sensitivity and 96.34% specificity against an expert panel.",*AneurDoc* flagged aneurysms on CT angiograms in China's review,95.42% sensitivity and 96.34% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,AneurDoc (颅内动脉瘤CT血管造影图像辅助分诊软件),Release 2.0 (full version 2.0.1.001),"Yukun (Beijing) Network Technology Co., Ltd. (语坤(北京)网络科技有限公司)",China,Yukun (Beijing) Network Technology (prospective multicenter registration trial with 486 cases),China,"General Hospital of the PLA Northern Theater Command and Huangshi Central Hospital, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"A target of 90% for the lower 95% confidence bounds of sensitivity and specificity, with an expert panel's reading as the reference",Target of 90% for the lower confidence bounds,"Sensitivity 95.42% (95%CI:91.95%,97.69%) and specificity 96.34% (95%CI:93.17%,98.31%)",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743665461431073055.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT血管造影图像辅助分诊软件 (technical review report for the registration of intracranial aneurysm CT angiography image triage-aid software), acceptance no. CQZ2300190, applicant 语坤(北京)网络科技有限公司. 7 November 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743665461431073055.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT血管造影图像辅助分诊软件 (technical review report for the registration of intracranial aneurysm CT angiography image triage-aid software), acceptance no. CQZ2300190, applicant 语坤(北京)网络科技有限公司. 7 November 2023. Section 四、产品收益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743665461431073055.pdf""}]","{""kind"": ""Official documents""}" AIBD-1089,2023-11-03,source publication,day,tested,China's CMDE finds that AI-SONIC-TH flagged patients with thyroid nodules of TI-RADS 4 or higher with 97.07% sensitivity in the maker's trial,"In the maker's trial that China's CMDE reviewed, AI-SONIC-TH flagged patients with thyroid nodules of TI-RADS 4 or higher with 97.07% sensitivity and 90.54% specificity.",*AI-SONIC-TH* flagged suspicious thyroid nodules in China's review,97.07% sensitivity and 90.54% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,AI-SONIC-TH (甲状腺结节超声影像辅助诊断软件),Release 1 (models AI-SONIC-TH-B to AI-SONIC-TH-I),"Zhejiang Deshang Yunxing Medical Technology Co., Ltd. (浙江德尚韵兴医疗科技有限公司)",China,"Zhejiang Deshang Yunxing Medical Technology (prospective registration trial with 1,043 patients at three sites)",China,"Three trial sites that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,Targets for the lower 95% confidence bounds of per-patient sensitivity and specificity (the report does not give the values),,Sensitivity 97.07% (95%CI:95.06%,98.28%) and specificity 90.54% (95%CI:87.91%,92.64%) per patient,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1710381379631085314.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:甲状腺结节超声影像辅助诊断软件 (technical review report for the registration of thyroid nodule ultrasound image diagnosis-aid software), acceptance no. CQZ2200673, applicant 浙江德尚韵兴医疗科技有限公司. 3 November 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710381379631085314.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:甲状腺结节超声影像辅助诊断软件 (technical review report for the registration of thyroid nodule ultrasound image diagnosis-aid software), acceptance no. CQZ2200673, applicant 浙江德尚韵兴医疗科技有限公司. 3 November 2023. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710381379631085314.pdf""}]","{""kind"": ""Official documents""}" AIBD-1066,2023-11-02,source publication,day,tested,China's CMDE finds that endoscopists using EC01-01 detected more colon polyps in the maker's trial,"In the maker's trial that China's CMDE reviewed, endoscopists using EC01-01 detected 94.7% of polyps, against 84.5% without it.",*EC01-01* helped endoscopists find more colon polyps in a trial,"detected 94.7% of polyps, against 84.5% without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,EC01-01 (肠息肉电子下消化道图像辅助检测软件),Release V1,"Xiamen Yingnuo Medical Technology Co., Ltd. (厦门影诺医疗科技有限公司)",China,"Xiamen Yingnuo Medical Technology (prospective parallel-controlled trial with 1,020 subjects at four sites)",China,Four trial sites in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,3,1,,,1,,organizational,2,,0,"Endoscopists performing conventional colonoscopy in the parallel control group, with two experts' video review as the reference",84.5% polyp-level sensitivity,94.7% polyp-level sensitivity,measured,scaled,2025-05-22,shown,https://www.cmde.org.cn/directory/web/cmde/images/1700788508279067087.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道图像辅助检测软件 (technical review report for the registration of colon polyp detection-aid software for electronic lower gastrointestinal images), acceptance no. CQZ2200605, applicant 厦门影诺医疗科技有限公司. 2 November 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1700788508279067087.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道图像辅助检测软件 (technical review report for the registration of colon polyp detection-aid software for electronic lower gastrointestinal images), acceptance no. CQZ2200605, applicant 厦门影诺医疗科技有限公司. 2 November 2023. Benefit-risk determination and overall opinion, CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1700788508279067087.pdf""}]","{""kind"": ""Official documents""}" AIBD-0698,2023-11-01,source publication,month,reported,UNDP's evaluation office finds that the AI system of Brazil's National Council of Justice let courts speed up high-risk cases from vulnerable groups,UNDP's evaluation office found that the AI system of Brazil's National Council of Justice let courts prioritize urgent cases. It let them prioritize high-risk cases from vulnerable groups.,Brazil's court AI helps speed up cases from vulnerable groups,,,found,Found by an evaluation office,no comparison,very low,program,false,Artificial Intelligence System of Brazil's National Council of Justice (CNJ),,"Not named in the evaluation (the system belongs to the National Council of Justice, CNJ)",,"Brazilian courts under the National Council of Justice (CNJ), with UNDP",Brazil,Brazil,Brazil,Justice administration: managing court cases,,Public sector,Law and Crime,Court Administration,Prediction from data,Women and mothers,16,Upper middle income,operational_improvement,"Faster data management, decision-making",,,,4,3,,,organizational; personal,2,,0,,,,,persisted,2025-03-11,not shown,https://www.unevaluation.org/get-download-file/4444,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""UNDP Independent Evaluation Office. Evaluation of the UNDP Support to Digitalization of Public Services. November 2023. The report is an independent publication of the office. Section on justice and the rule of law."", ""url"": ""https://www.unevaluation.org/get-download-file/4444""}, {""label"": ""Regulatory document"", ""value"": ""Conselho Nacional de Justiça (copy held by the Superior Tribunal de Justiça library). “Resolução Nº 615, de 11 de março de 2025.” 2025-03-11."", ""url"": ""https://www.stj.jus.br/internet_docs/biblioteca/clippinglegislacao/Res_615_2025_CNJ.pdf""}]","{""kind"": ""Official documents""}" AIBD-0952,2023-10-20,source publication,day,intended,Japan's Kanto District Transport Bureau approves TIER IV's automated shuttle at the GLP ALFALINK Sagamihara logistics campus as a Level 4 vehicle,On 20 October 2023 a Japanese transport bureau confirmed that TIER IV's automated operation device met the safety standards. It approved a shuttle at GLP ALFALINK Sagamihara to run with no driver.,Japan approves *AI Pilot* for a driverless shuttle at a logistics campus,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (TIER IV's AI Pilot) on a Tajima GSM8 shuttle,,"TIER IV, Inc.",Japan,"TIER IV, Inc. (operator at GLP ALFALINK Sagamihara)",Japan,"GLP ALFALINK Sagamihara, Sagamihara, Kanagawa Prefecture, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Other,Machines that act,,11,High income,operational_improvement; physical_health,Enhanced productivity,,,,,,,,organizational,3,,0,,,,,unknown,,not shown,https://web.archive.org/web/20260416085611id_/https://technode.global/prnasia/tier-iv-certified-in-level-4-autonomous-driving-sharing-its-design-and-process-with-partners/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Kanto District Transport Bureau. 関東で初めて自動運転車(レベル4)の認可を行いました (First approvals of Level 4 automated vehicles in Kanto). Press release, 20 October 2023, paragraphs 1 to 3 and the table's GLP ALFALINK Sagamihara column."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000304988.pdf""}]","{""kind"": ""Official documents""}" AIBD-1213,2023-10-20,source publication,day,intended,Japan's Kanto District Transport Bureau approves a NAVYA ARMA shuttle at Haneda Innovation City as a Level 4 automated vehicle that needs no driver,On 20 October 2023 the Kanto District Transport Bureau confirmed that the ARMA's automated operation device met the safety standards. It approved the shuttle as a Level 4 vehicle on a 1.3 km loop.,NAVYA's *ARMA* may run with no driver at Haneda Innovation City,,,found,Found by a regulator,,very low,benefit created,false,Automated operation device (自動運行装置) on a NAVYA ARMA shuttle,,NAVYA (maker of the ARMA shuttle),France,"BOLDLY Inc. (BOLDLY株式会社), the applicant and operator, inside Haneda Innovation City",Japan,"Haneda Innovation City, Ota, Tokyo, Japan",Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Mass,Machines that act,,11,High income,physical_health; operational_improvement,,,,,,,,,societal,1,,0,,,,,persisted,2024-06-27,shown,https://www.anyauto.com.au/?p=16136,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 関東で初めて自動運転車(レベル4)の認可を行いました (The first approvals of Level 4 automated vehicles in Kanto). Press release, 20 October 2023."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000304988.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Kanto District Transport Bureau, Ministry of Land, Infrastructure, Transport and Tourism (国土交通省関東運輸局). 関東で初めて自動運転車(レベル4)の認可を行いました (The first approvals of Level 4 automated vehicles in Kanto). Press release, 20 October 2023."", ""url"": ""https://wwwtb.mlit.go.jp/kanto/content/000304988.pdf""}]","{""kind"": ""Official documents""}" AIBD-0803,2023-09-19,source publication,day,tested,FDA found that SigTuple's AI100 with Shonit matched manual microscopy on 882 blood smears in a comparison of methods at four sites,"In FDA's review of AI100 with Shonit, results on 882 blood smears agreed with manual microscopy, with 92.7% sensitivity and 95.4% specificity for abnormal white cells.",*AI100 with Shonit* matched manual microscopy on 882 blood smears,92.7% sensitivity and 95.4% specificity for abnormal white cells,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,AI100 with Shonit,,SigTuple Technologies Pvt. Ltd.,India,SigTuple (method comparison against manual microscopy at four sites),India,,,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Manual microscopy of the same 882 smears,Manual differential (reference),Sensitivity 92.7% and specificity 95.4% for abnormal white-cell results,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K221309.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for AI100 with Shonit (K221309). Cleared 2023-09-19."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K221309.pdf""}]","{""kind"": ""Official documents""}" AIBD-1090,2023-09-14,source publication,day,tested,China's CMDE finds that DrBrain-AD flagged hippocampal abnormalities on brain MRI with a sensitivity of 0.9328 in the maker's trial,"In the maker's trial that China's CMDE reviewed, DrBrain-AD flagged hippocampal abnormalities on brain MRI with a sensitivity of 0.9328 and a specificity of 0.9042.",*DrBrain-AD* flagged hippocampal changes on brain MRI in China's review,a sensitivity of 0.9328 and a specificity of 0.9042,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,DrBrain-AD (磁共振图像辅助评估软件),Release 1.0 (full version 1.0.0.01),"Shenzhen Yiwei Medical Technology Co., Ltd. (深圳市铱硙医疗科技有限公司)",China,Shenzhen Yiwei Medical Technology (registration trial with 514 patients at three hospitals),China,"Xuanwu Hospital of Capital Medical University, the Second Xiangya Hospital of Central South University and the First Affiliated Hospital of Wenzhou Medical University, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,Targets of 85% for sensitivity and 80% for specificity for the lower 95% confidence bounds,Targets of 85% and 80%,Sensitivity 0.9328 (0.9020,0.9637) and specificity 0.9042 (0.8685,0.9399),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1710381691379018965.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:磁共振图像辅助评估软件 (technical review report for the registration of magnetic resonance image assessment-aid software), acceptance no. CQZ2201033, applicant 深圳市铱硙医疗科技有限公司. 14 September 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710381691379018965.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:磁共振图像辅助评估软件 (technical review report for the registration of magnetic resonance image assessment-aid software), acceptance no. CQZ2201033, applicant 深圳市铱硙医疗科技有限公司. 14 September 2023. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710381691379018965.pdf""}]","{""kind"": ""Official documents""}" AIBD-0631,2023-08-03,source publication,day,tested,FDA De Novo review of Viz HCM: AI detects hypertrophic cardiomyopathy on 12-lead ECGs from three Massachusetts hospitals,"In FDA's review of Viz HCM, the software detected hypertrophic cardiomyopathy on 12-lead ECGs from three hospitals with 68.4% sensitivity. Specificity was 99.1%.",*Viz HCM* picked out a hard-to-diagnose heart disease from ECGs,a sensitivity of 68.4% and a specificity of 99.1%,,found,Found by a regulator,no comparison,very low,aggregate result,false,Viz HCM,,"Viz.ai, Inc.",United States,Viz.ai (retrospective study on ECGs from three Massachusetts hospitals),United States,"Boston area and Salem, Massachusetts, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,,,,,persisted,2026-03-23,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230003.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Viz HCM (DEN230003): decision summary. Granted 2023-08-03."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230003.pdf""}]","{""kind"": ""Official documents""}" AIBD-1067,2023-07-11,source publication,day,tested,"China's CMDE finds that with EASYASPECT, doctors' scores of stroke CT scans agreed better with an expert panel in the maker's trial","In the maker's reader trial that China's CMDE reviewed, doctors' judgments of stroke CT agreed with an expert panel at a kappa of 0.80 with EASYASPECT, against 0.55 without it.",*EASYASPECT* brought doctors' scores of stroke CT closer to experts',"a kappa of 0.80 with EASYASPECT, against 0.55 without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,EASYASPECT (缺血性卒中CT图像辅助评估软件),Release 1.0 (full version 1.0.0.007),"Yukun (Beijing) Network Technology Co., Ltd. (语坤(北京)网络科技有限公司)",China,Yukun (Beijing) Network Technology (retrospective reader trial at the Second Affiliated Hospital of Nanchang University and Hwa Mei Hospital of the University of Chinese Academy of Sciences in Ningbo),China,"Ningbo, Zhejiang and Nanchang, Jiangxi, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,1,,0,"The same eight doctors scoring the same cases without the software, with an expert panel as the reference",Kappa 0.55 between doctors without the software and the expert panel,Kappa 0.80 between doctors with the software and the expert panel (lower 95% confidence bound 0.79),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743664671250013909.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:缺血性卒中CT图像辅助评估软件 (technical review report for the registration of ischemic stroke CT image assessment-aid software), acceptance no. CQZ2201543, applicant 语坤(北京)网络科技有限公司. 11 July 2023. Section 三、临床评价概述 (clinical evaluation), pp. 7-8."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743664671250013909.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:缺血性卒中CT图像辅助评估软件 (technical review report for the registration of ischemic stroke CT image assessment-aid software), acceptance no. CQZ2201543, applicant 语坤(北京)网络科技有限公司. 11 July 2023. Section 综合评价意见 (concluding opinion), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743664671250013909.pdf""}]","{""kind"": ""Official documents""}" AIBD-0736,2023-07-05,source publication,day,tested,NICE finds that AI lung nodule software with clinician review could detect more cancers at slightly lower cost in targeted lung cancer screening,"In a model by NICE's assessors, AI nodule software with clinician review in targeted lung screening found more people needing follow-up at slightly lower cost. It found slightly more cancers.",Lung screening centers may use AI nodule detection under NICE guidance,"In all nine studies of reading time, review was faster with the software",,found,Found by an assessment body,controlled comparison,very low,aggregate result,false,"AI-derived computer-aided detection software for lung nodules: AI-Rad Companion Chest CT, AVIEW LCS+, ClearRead CT, contextflow SEARCH Lung CT, InferRead CT Lung, Lung AI, qCT-Lung, SenseCare-Lung Pro, Veolity, Veye Lung Nodules and VUNO Med-LungCT AI",,"Siemens Healthineers, Coreline Soft, Riverain Technologies, contextflow, Infervision, Arterys, Qure.ai, SenseTime, MeVis, Aidence and VUNO","Multiple: Germany, South Korea, United States, Austria, China, India, Netherlands",Screening centers in the studies reviewed by NICE and NHS targeted lung cancer screening centers in England during evidence generation,Multiple,"England, United Kingdom (guidance), with studies in several countries",United Kingdom,Healthcare (lung cancer screening),,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health; operational_improvement,Medical diagnosis,,,1,,,,,organizational,3,,0,Clinician review of screening CT scans without the software,,More sensitive but less specific in nearly all studies,measured,persisted,,shown,https://www.iqwig.de/download/t24-04_ai-unterstuetzte-diagnose-bei-lungenkrebs_themencheck-bericht_v1-0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images. HealthTech guidance HTG687 (formerly DG55), section 3: Committee discussion. 5 July 2023."", ""url"": ""https://www.nice.org.uk/guidance/htg687/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG687, section 1: Recommendations. 5 July 2023."", ""url"": ""https://www.nice.org.uk/guidance/htg687/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), ThemenCheck Medizin (2026). Lungenkrebs: Kann Künstliche Intelligenz die Auswertung von Röntgen- oder CT-Bildern der Lunge unterstützen? ThemenCheck-Bericht T24-04, Version 1.0, Kurzfassung, Fazit (pp. 6-7); included studies in Tabelle 11 (Lee 2025: LuCAS-Plus; Lo 2018: ClearRead CT)."", ""url"": ""https://www.iqwig.de/download/t24-04_ai-unterstuetzte-diagnose-bei-lungenkrebs_themencheck-bericht_v1-0.pdf""}]","{""kind"": ""Official documents""}" AIBD-1140,2023-07-01,source publication,month,tested,"The EU's ECIBC guideline group suggests AI-supported double reading of mammograms, finding that it may detect one more cancer per 1,000 women","In July 2023, the ECIBC guideline group suggested AI-supported double reading of screening mammograms. It found that AI support may detect one more breast cancer for every 1,000 women screened.",EU guideline group backs *AI-supported double reading* of mammograms,"one more breast cancer for every 1,000 women screened",,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"AI support for double reading of screening mammograms: three commercial algorithms kept anonymous in the study behind the estimate, with Transpara, Lunit INSIGHT MMG, Mia and a DeepHealth model in the other studies reviewed",,"Three vendors that asked to remain anonymous in the study behind the estimate, with ScreenPoint Medical (Transpara), Lunit (INSIGHT MMG), Kheiron Medical Technologies (Mia) and DeepHealth in the other studies reviewed","Multiple: Netherlands, South Korea, United Kingdom, United States","Screening services in the studies that the ECIBC guideline group reviewed, with Karolinska University Hospital's archived examinations behind the estimate and organized screening programs in the EU as intended users",Multiple,"European Union (guideline), with the study behind the estimate in Stockholm, Sweden",Sweden,Healthcare,,Health,Health,Disease Prevention,Images and video,Women and mothers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,3,,0,"Double reading without AI support, pooled from six studies that the guideline group reviewed",,one more breast cancer detected for every 1 000 women screened,measured,persisted,2026-11-06,shown,https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc/european-breast-cancer-guidelines?topic=64&usertype=60,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""European Commission Initiative on Breast Cancer (ECIBC), Guidelines Development Group, European Commission Joint Research Centre. European guidelines on breast cancer screening and diagnosis, printed overview of the recommendations. Breast cancer screening, 4. Use of artificial intelligence, recommendation 4.2. Issued July 2023."", ""url"": ""https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc/recommendations/print""}, {""label"": ""Assessment report"", ""value"": ""European Commission Initiative on Breast Cancer (ECIBC), Guidelines Development Group. European guidelines on breast cancer screening and diagnosis, 4. Use of artificial intelligence, recommendations 4.1 and 4.2 with their justifications. Issued July 2023. Supporting material: GRADE Evidence-to-Decision Framework for recommendation 4.2 (https://dbep.ec.gdt.evidenceprime.com/profile/PNED9kXB-h0), which cites Salim et al. 2020 for double reading with AI support and pools that study with Dahlblom et al. 2022, Dembrower et al. 2023, Larsen et al. 2022, Marinovich et al. 2023 and Sharma et al. 2023 for double reading without it."", ""url"": ""https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc/european-breast-cancer-guidelines?topic=64&usertype=60""}]","{""kind"": ""Official documents""}" AIBD-0776,2023-06-29,source publication,day,tested,FDA's De Novo review of KidneyIntelX.dkd shows that its risk levels separated patients with diabetic kidney disease by their five-year risk of serious decline,"In FDA's review, adults whom KidneyIntelX.dkd placed at low risk had an estimated 5.9% rate of serious kidney decline over five years. The rate was 21.5% at moderate risk. At high risk it was 66.9%.",*KidneyIntelX.dkd* sorted diabetic patients by risk to their kidneys,"5.9%, 21.5% and 66.9%",,found,Found by a regulator,no comparison,very low,aggregate result,false,KidneyIntelX.dkd,,"Renalytix AI, Inc.",United States,Renalytix (retrospective validation on biobanked samples from 657 adults),United States,A single biorepository drawing on 10 clinical sites (not named in the decision summary),,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,,physical_health,Medical diagnosis,,,,3,,,,organizational,5,,0,,,,,persisted,2026-04-22,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200052.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of automatic class III designation for KidneyIntelX.dkd (DEN200052): decision summary. Granted 2023-06-29."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200052.pdf""}, {""label"": ""Assessment report"", ""value"": ""Wellpoint Federal (formerly National Government Services), Medicare Administrative Contractor, Jurisdictions 6 and K (2024). LCD L39726: KidneyIntelX and KidneyIntelX.dkd Testing (original effective date 1 August 2024, revision effective 1 April 2026), Coverage Indications; Summary of Evidence; Analysis of Evidence (Rationale for Determination)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39726""}, {""label"": ""Assessment report"", ""value"": ""Anthem Blue Cross and Blue Shield (Elevance Health), Medical Policy LAB.00041 (2026). Medical Policy LAB.00041: Machine Learning Derived Probability Score for Rapid Kidney Function Decline (last review 14 May 2026, published 1 July 2026), Position Statement; Summary for Members and Families ('What the Studies Show'); Rationale."", ""url"": ""https://www.anthem.com/dam/medpolicies/abcbs/active/policies/mp_pw_e001134.html""}]","{""kind"": ""Official documents""}" AIBD-1068,2023-05-18,source publication,day,tested,China's CMDE finds that Tencent's MY-CJ-01 software raised the detection of polyps on a first pass in the maker's randomized colonoscopy trial,"China's CMDE found that first-pass polyp detection was superior in group B of Tencent's randomized MY-CJ-01 trial. The polyp miss rate was 23.39%, against 44.67% in group A.",*MY-CJ-01* raised detection of polyps on a first pass in Tencent's trial,"The polyp miss rate was 23.39%, against 44.67% in group A",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,MY-CJ-01 (结肠息肉电子内窥镜图像辅助检测软件),Release V2 (full version V2.0.0_build001),"Tencent Healthcare (Shenzhen) Co., Ltd. (腾讯医疗健康(深圳)有限公司)",China,Tencent Healthcare (Shenzhen) (prospective randomized trial with 296 patients at two centers),China,"Two trial centers that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,3,1,,,1,,organizational,2,,0,Group A of the same randomized trial (the report does not say how each group used the software),Polyp miss rate 44.67% (95%CI:39.07%~50.42%) in group A,Polyp miss rate 23.39% (95%CI:18.92%~28.54%) in group B,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1686295172757009730.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:结肠息肉电子内窥镜图像辅助检测软件 (technical review report for the registration of colon polyp electronic endoscope image detection-aid software), acceptance no. CQZ2200455, applicant 腾讯医疗健康(深圳)有限公司. 18 May 2023. Section 三、临床评价概述 (clinical evaluation), pp. 6-7."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1686295172757009730.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:结肠息肉电子内窥镜图像辅助检测软件 (technical review report for the registration of colon polyp electronic endoscope image detection-aid software), acceptance no. CQZ2200455, applicant 腾讯医疗健康(深圳)有限公司. 18 May 2023. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1686295172757009730.pdf""}, {""label"": ""Regulatory document"", ""value"": ""National Medical Products Administration (NMPA), China. Computer-aided Detection Software for Electronic Endoscope for Colon Polyps Approved for Marketing. NMPA English website, 1 June 2023."", ""url"": ""https://english.nmpa.gov.cn/2023-06/01/c_940345.htm""}]","{""kind"": ""Official documents""}" AIBD-2306,2023-03-31,source publication,day,tested,FDA De Novo review of the Masimo SafetyNet Opioid System: pattern recognition matched a fixed-threshold oximeter's sensitivity for opioid-induced respiratory depression with fewer non-actionable alarms,"In data from 641 opioid users that FDA reviewed, Masimo's Opioid Halo software matched a fixed-threshold oximeter's sensitivity for respiratory depression and cut needless alarms by 76% to 96.7%.",*Opioid Halo* cut needless oxygen alarms for people who take opioids,96.7%,,found,Found by a regulator,tested against a standard,very low,program,false,Masimo SafetyNet Opioid System (Opioid Halo),,Masimo Corporation,United States,"Masimo (analysis of recordings from people who took opioids at home, in hospital or illicitly)",United States,United States,United States,Healthcare (opioid safety),,Health,Health,Drug and Alcohol Abuse,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,3,,0,A pulse oximeter with a fixed alarm threshold on the same recordings,Sensitivity 99.2% and specificity 80.6% overall,"Sensitivity 100.0% and specificity 93.9% at the first alarm level, with 76% fewer non-actionable alarms",measured,persisted,2025-02-06,shown,https://www.masimo.de/siteassets/us/documents/pdf/plm-13880b-brochure-opioid-halo---hcp-us.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for the Masimo SafetyNet Opioid System (DEN200011): decision summary. Granted 2023-03-31. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200011.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. Artificial Intelligence-Enabled Medical Devices. List current as of 4 September 2026. The quotation is the device's name in the list. The list contains no benefit finding."", ""url"": ""https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices""}]","{""kind"": ""Official documents""}" AIBD-1070,2023-03-03,source publication,day,tested,"China's CMDE finds that pathologists read cervical cytology slides faster with CCAA.91360, with accuracy no worse, in the maker's trial","In the maker's trial that China's CMDE reviewed, pathologists took a mean 64.12 seconds per cervical cytology slide with CCAA.91360, against 333.49 seconds reading digital slides alone.",*CCAA.91360* cut the time to read cervical cytology slides,"a mean 64.12 seconds per cervical cytology slide with CCAA.91360, against 333.49 seconds",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,CCAA.91360 (宫颈细胞学数字病理图像计算机辅助分析软件),Release V2,"91360 Medical Technology (Nanjing) Co., Ltd. (玖壹叁陆零医学科技南京有限公司)",China,91360 Medical Technology (Nanjing) (registration trial at the First Affiliated Hospital of Nanjing Medical University and the Affiliated Drum Tower Hospital of Nanjing University Medical School),China,"Nanjing, Jiangsu, China",China,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,Upper middle income,operational_improvement,Enhanced productivity,,,1,,,1,,organizational,1,,0,Digital reading of the same slides without the software,Mean diagnosis time 333.49 seconds,Mean diagnosis time 64.12 seconds,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1710380539480034481.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:宫颈细胞学数字病理图像计算机辅助分析软件 (technical review report for the registration of cervical cytology digital pathology image computer-aided analysis software), acceptance no. CQZ2101339, applicant 玖壹叁陆零医学科技南京有限公司. 3 March 2023. Section 三、临床评价概述 (clinical evaluation), pp. 7-8."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380539480034481.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:宫颈细胞学数字病理图像计算机辅助分析软件 (technical review report for the registration of cervical cytology digital pathology image computer-aided analysis software), acceptance no. CQZ2101339, applicant 玖壹叁陆零医学科技南京有限公司. 3 March 2023. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380539480034481.pdf""}]","{""kind"": ""Official documents""}" AIBD-0778,2023-02-24,source publication,day,tested,FDA finds that Caption Health's AutoEF met its goal for accuracy when it estimated ejection fraction on echocardiograms from 186 patients,"In FDA's review of Caption Interpretation AutoEF, its estimates of ejection fraction on 186 patient studies differed from expert readings by an RMSD of 7.21. The goal was below 9.2%.",*AutoEF* met its goal for accuracy in measuring how well the heart pumps,an RMSD of 7.21,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Caption Interpretation Automated Ejection Fraction Software (AutoEF),,"Caption Health, Inc.",United States,Caption Health (retrospective validation on 186 patient studies from three US sites),United States,"Minneapolis Heart Institute, Duke University and Northwestern University, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Pre-specified acceptance criterion for the root mean square deviation from expert measurements,Goal of RMSD below 9.2%,RMSD 7.21 for the best available view,measured,scaled,2024-04-11,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220063.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for Caption Interpretation Automated Ejection Fraction Software (DEN220063): decision summary. Granted 2023-02-24."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220063.pdf""}]","{""kind"": ""Official documents""}" AIBD-1071,2023-01-03,source publication,day,tested,"China's CMDE finds that with Deepwise's AI-BAC, doctors detected more breast lesions on mammograms in the maker's trial","In Deepwise's crossover trial that China's CMDE reviewed, doctors reading mammograms with AI-BAC detected 87.32% of breast lesions, against 66.20% without it.",*AI-BAC* helped doctors find more breast lesions on mammograms,"detected 87.32% of breast lesions, against 66.20% without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,AI-BAC (乳腺X射线图像辅助检测软件),Release 2 (full version 2.0.0.1),Deepwise (杭州深睿博联科技有限公司),China,Deepwise (randomized crossover reader trial with 855 cases at three institutions),China,"Three trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Women and mothers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"The same doctors reading without the software, with three breast imaging experts' consensus as the reference",66.20% lesion-level sensitivity,87.32% lesion-level sensitivity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1710380744697008254.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺X射线图像辅助检测软件 (technical review report for the registration of mammography image detection-aid software), acceptance no. CQZ2200165, applicant 杭州深睿博联科技有限公司. 3 January 2023. Section 三、临床评价概述 (clinical evaluation), pp. 6-7."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380744697008254.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:乳腺X射线图像辅助检测软件 (technical review report for the registration of mammography image detection-aid software), acceptance no. CQZ2200165, applicant 杭州深睿博联科技有限公司. 3 January 2023. Section 综合评价意见 (concluding opinion), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380744697008254.pdf""}]","{""kind"": ""Official documents""}" AIBD-0927,2022-12-19,source publication,day,tested,"AQuAS found that the iBox score, which EMA qualified for drug trials, predicted kidney graft loss better than transplant physicians",EMA qualified the iBox score as a secondary endpoint in drug trials for kidney transplants. AQuAS found that iBox predicted seven-year graft survival better than nine transplant physicians.,EMA backs the *iBox* score to forecast kidney graft loss in trials,every c-statistic was 0.70 or greater,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,iBox Scoring System (iBox prediction algorithm),Full and abbreviated models,"Paris Transplant Group (INSERM UMR 970, AP-HP and University of Paris)",France,C-Path's Transplant Therapeutics Consortium (validation for EMA) and the Paris Transplant Group (comparison with nine physicians),"Multiple: United States, France","France (derivation data from four transplant centers), with validation in the United States, Finland and two international trials",France | United States | Finland,Healthcare (kidney transplantation),,Health,Health,Drug Industry,Prediction from data,Researchers,3,High income,physical_health; operational_improvement,,,,,,,,,organizational,3,,0,Predictions of nine transplant physicians from the same 400 records (study reviewed by AQuAS),"0,638 to 0,786 discrimination for the physicians","0,789 for iBox",measured,scaled,,shown,https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1316,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients. EMADOC-1700519818-946771, 19 December 2022, adopted by CHMP on 15 December 2022. Section 1, CHMP qualification opinion statement."", ""url"": ""https://www.ema.europa.eu/en/documents/scientific-guideline/qualification-opinion-ibox-scoring-system-secondary-efficacy-endpoint-clinical-trials-investigating-novel-immunosuppressive-medicines-kidney-transplant-patients_en.pdf""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), for the Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del SNS. Prieto Durán I, Moltó-Puigmartí C, Mestre Lleixà B, Ibeas J, Estrada Sabadell MD, Vivanco-Hidalgo RM. Algoritmo predictivo para monitorizar y evaluar el impacto de los tratamientos en trasplante de riñón. Ficha de evaluación de tecnologías nuevas y emergentes. Madrid: Ministerio de Sanidad, 2025. DOI 10.62727/DSalut.AQUAS/13303. Puntos clave."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1316""}]","{""kind"": ""Official documents""}" AIBD-1032,2022-12-01,source publication,day,tested,Norwegian Institute of Public Health finds that screening with the FMF algorithm probably predicts preterm preeclampsia better than current practice,The Norwegian Institute of Public Health found that first-trimester screening with an algorithm probably improves prediction of delivery with preeclampsia before week 37 of pregnancy.,*FMF screening algorithm* probably predicts preterm preeclampsia better,the sensitivity for preeclampsia before week 37 was 0.728,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"Fetal Medicine Foundation (FMF) first-trimester preeclampsia screening algorithm (maternal characteristics, mean arterial pressure, uterine artery pulsatility index and PlGF)",,Fetal Medicine Foundation,United Kingdom,"Screening studies in Asia and Europe that FHI pooled, with screening proposed for Norway's specialist health service","Multiple: United Kingdom, Spain, Italy, Belgium, Greece, Russia, India, China, Japan, Taiwan, Thailand, Singapore","Studies in Asia and Europe, assessed for Norway",Norway,Healthcare (antenatal screening),,Health,Health,Disease Prevention,Prediction from data,Women and mothers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational; personal,3,,0,"Screening by maternal factors, which FHI assumed to be current Norwegian practice","44,8 (40,5-49,2)","74,8 (70,8-78,5)",assumed,unknown,,shown,https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2022/forste-trimester-screening-for-utvikling-av-preeklampsi-med-bruk-av-algoritme-rapport-2022.pdf,~ NOK 17 million per year,Projected yearly saving for the health service from screening with the algorithm and aspirin prophylaxis,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Norwegian Institute of Public Health (FHI). First trimester-screening for the development of preeclampsia with the use of an algorithm: a health technology assessment. English summary page, published 1 December 2022."", ""url"": ""https://www.fhi.no/en/publ/2022/First-trimester-screening-for-the-development-of-preeclampsia-with-the-use-of-an-algorithm/""}, {""label"": ""Assessment report"", ""value"": ""Folkehelseinstituttet. Første trimester-screening for utvikling av preeklampsi med bruk av algoritme: en fullstendig metodevurdering. Rapport 2022, chapter 'Organisatoriske aspekter'."", ""url"": ""https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2022/forste-trimester-screening-for-utvikling-av-preeklampsi-med-bruk-av-algoritme-rapport-2022.pdf""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series, 2022. PMCID PMC10530459. Ontario Health is the health agency of the province of Ontario."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series, 2022. PMCID PMC10530459. Ontario Health is the health agency of the province of Ontario."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series, 2022. PMCID PMC10530459. Ontario Health is the health agency of the province of Ontario."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}, {""label"": ""Assessment report"", ""value"": ""Ontario Health. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment. Ontario Health Technology Assessment Series, 2022. PMCID PMC10530459. Ontario Health is the health agency of the province of Ontario."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC10530459/""}]","{""kind"": ""Official documents""}" AIBD-1072,2022-11-02,source publication,day,tested,China's CMDE finds that lab staff identified white blood cells more accurately with CellaScope in the maker's trial,"In the maker's trial that China's CMDE reviewed, lab staff correctly identified 70.22% of abnormal white blood cells on smears with CellaScope, against 39.10% alone.",*CellaScope* helped lab staff identify white blood cells on smears,"70.22% of abnormal white blood cells on smears with CellaScope, against 39.10% alone",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,CellaScope (外周血细胞图像白细胞辅助识别软件),Release 1,"Beijing Xiaoying Technology Co., Ltd. (北京小蝇科技有限责任公司)",China,"Beijing Xiaoying Technology (registration trial at Peking Union Medical College Hospital, the Second Xiangya Hospital of Central South University and Dongyang People's Hospital)",China,"Beijing, Changsha (Hunan) and Dongyang (Zhejiang), China",China,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,"The same investigators reading the same smears alone, with an expert panel's reading as the reference",39.10% of abnormal white blood cells identified correctly,70.22% of abnormal white blood cells identified correctly,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1710380134133032056.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:外周血细胞图像白细胞辅助识别软件 (technical review report for the registration of white blood cell recognition-aid software for peripheral blood cell images), acceptance no. CQZ2100110, applicant 北京小蝇科技有限责任公司. 2 November 2022. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380134133032056.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:外周血细胞图像白细胞辅助识别软件 (technical review report for the registration of white blood cell recognition-aid software for peripheral blood cell images), acceptance no. CQZ2100110, applicant 北京小蝇科技有限责任公司. 2 November 2022. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1710380134133032056.pdf""}]","{""kind"": ""Official documents""}" AIBD-0790,2022-10-31,source publication,day,tested,FDA finds that the Avive AED's neural network exceeded the goals of the American Heart Association for reading heart rhythms in bench tests on ECG recordings,"In bench tests that FDA reviewed, the Avive AED's neural network detected coarse ventricular fibrillation with 98.9% sensitivity. It detected normal rhythm with 100% specificity.",*Avive AED* exceeded the goals of the AHA for spotting shockable rhythms,98.9% sensitivity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Avive AED System rhythm recognition detector,,"Avive Solutions, Inc.",United States,Avive Solutions (bench tests on a held-out set of ECG recordings),United States,,,Healthcare,,Health,Health,Disease Prevention,Prediction from data; Machines that act,The public; Patients,3,,physical_health,,,,,,,,,personal,2,,0,American Heart Association performance goals for arrhythmia analysis,Above 90% sensitivity for coarse ventricular fibrillation and above 99% specificity for normal sinus rhythm,98.9% sensitivity and 100% specificity,measured,persisted,2025-08-13,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf21/P210015B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P210015: Avive Automated External Defibrillator (AED) System. Approved 2022-10-31."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf21/P210015B.pdf""}]","{""kind"": ""Official documents""}" AIBD-1083,2022-10-18,source publication,day,tested,China's CMDE finds that the JF CXR-1 software for tuberculosis agreed with a central reading panel on 92.70% of cases in the maker's trial,"In the maker's six-center trial that China's CMDE reviewed, JF CXR-1 agreed with a central reading panel on 94.19% of positive and 91.17% of negative chest X-rays.",*JF CXR-1* agreed with expert readers on TB chest X-rays in a trial,94.19% of positive and 91.17% of negative chest X-rays,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,JF CXR-1 (肺结核X射线图像辅助评估软件),Release 2 (full version 2.0.0),"Jiangxi Zhongke Jiufeng Smart Medical Technology Co., Ltd. (江西中科九峰智慧医疗科技有限公司)",China,"Jiangxi Zhongke Jiufeng Smart Medical Technology (prospective trial with 1,165 cases at six centers)",China,Six trial centers in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,Preset targets for agreement with an independent central reading panel,Targets of 85% positive agreement and 70% negative agreement,94.19% positive agreement and 91.17% negative agreement,measured,persisted,2024-10-28,shown,https://www.cmde.org.cn/directory/web/cmde/images/1666746162220026616.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺结核X射线图像辅助评估软件 (technical review report for the registration of pulmonary tuberculosis X-ray image assessment-aid software), acceptance no. CQZ2100859, applicant 江西中科九峰智慧医疗科技有限公司. 18 October 2022. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1666746162220026616.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺结核X射线图像辅助评估软件 (technical review report for the registration of pulmonary tuberculosis X-ray image assessment-aid software), acceptance no. CQZ2100859, applicant 江西中科九峰智慧医疗科技有限公司. 18 October 2022. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment of benefit and risk."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1666746162220026616.pdf""}]","{""kind"": ""Official documents""}" AIBD-1073,2022-08-29,source publication,day,tested,China's CMDE finds that Tencent's MY-YD-01 fundus software raised detection of glaucoma-like optic nerve damage in the maker's trial,"In Tencent's trial of 1,092 subjects that China's CMDE reviewed, the trial group's sensitivity for glaucoma-like optic nerve changes exceeded the control group's by 16.42%.",*MY-YD-01* raised detection of glaucoma-like damage on fundus photos,exceeded the control group's by 16.42%,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,MY-YD-01 (慢性青光眼样视神经病变眼底图像辅助诊断软件),Release V1,"Tencent Healthcare (Shenzhen) Co., Ltd. (腾讯医疗健康(深圳)有限公司)",China,"Tencent Healthcare (Shenzhen) (registration trial with 1,092 subjects at four institutions)",China,"Four trial institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,Upper middle income,physical_health,Medical diagnosis,,,1,,,1,,organizational,1,,0,The control group of the same trial (the report does not describe how either group read the photographs),,Subject-level sensitivity higher by 16.42% (FAS) and 18.97% (PPS) in the trial group,measured,persisted,2024-06-11,shown,https://www.cmde.org.cn/directory/web/cmde/images/1663555091904022046.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:慢性青光眼样视神经病变眼底图像辅助诊断软件 (technical review report for the registration of fundus image diagnosis-aid software for chronic glaucoma-like optic neuropathy), acceptance no. CQZ2100700, applicant 腾讯医疗健康(深圳)有限公司. 29 August 2022. Section 三、临床评价概述 (clinical evaluation), p. 7."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1663555091904022046.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:慢性青光眼样视神经病变眼底图像辅助诊断软件 (technical review report for the registration of fundus image diagnosis-aid software for chronic glaucoma-like optic neuropathy), acceptance no. CQZ2100700, applicant 腾讯医疗健康(深圳)有限公司. 29 August 2022. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1663555091904022046.pdf""}]","{""kind"": ""Official documents""}" AIBD-0809,2022-07-06,source publication,day,tested,"FDA found that all 466 lay users completed the Minuteful kidney test on their own urine, with results matching a trained operator in 92.7% of cases","In FDA's review of the Minuteful - kidney test, all 466 lay users tested their own urine with a smartphone. Their ACR results matched a trained operator's in 92.7% of cases.",*Minuteful - kidney test* let lay users test their own urine albumin,matched a trained operator's in 92.7% of cases,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Minuteful - kidney test,,Healthy.io Ltd.,Israel,Healthy.io (method comparison with 466 lay users),Israel,,,Healthcare,,Health,Health,Drug Industry,Images and video,Patients,3,,physical_health,Medical access,,3,1,2,,1,,personal,3,,0,A trained operator testing the same urine on the predicate device,Predicate results (reference),"Exact ACR match of 92.0% for normal, 94.0% for abnormal and 90.9% for high-abnormal results",measured,scaled,2024-12-13,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K210069.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for Minuteful - kidney test (K210069). Cleared 2022-07-06."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K210069.pdf""}, {""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group (SHTG), Healthcare Improvement Scotland (2022). Minuteful Kidney for home testing of albumin-to-creatinine ratio (ACR): Innovative Medical Technology Overview, Key findings."", ""url"": ""https://web.archive.org/web/20250622185744id_/https://shtg.scot/our-advice/minuteful-kidney-for-home-testing-of-albumin-to-creatinine-ratio-acr/""}]","{""kind"": ""Official documents""}" AIBD-0996,2022-04-20,source publication,day,tested,The FCC certifies Hamilton Relay's fully automatic captions after its test lab measured fewer word errors than in human-assisted captions,"In the FCC's National Test Lab, Hamilton's automatic captions had average error rates of 0.9 to 7.7 across five scenarios, against 10.7 to 23.3 for human-assisted providers.",*Hamilton*'s automatic captions top assisted ones in the FCC's lab tests,average error rates of 0.9 to 7.7,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Hamilton's ASR-only (fully automatic) Internet Protocol Captioned Telephone Service (IP CTS),,"Hamilton Relay, Inc., on speech recognition from several unnamed vendors",United States,"Hamilton Relay, Inc.",United States,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,5,,personal,3,,0,Average word error rates of CA-assisted providers on the same five call scenarios,10.7 to 23.3,0.9 to 7.7,measured,persisted,2024-12-17,shown,https://docs.fcc.gov/public/attachments/DA-22-442A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 22-442, CG Docket No. 03-123 (conditional certification of Hamilton Relay, Inc. to provide IP CTS on a fully automatic basis). Adopted and released 20 April 2022."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-22-442A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 22-442, CG Docket No. 03-123 (conditional certification of Hamilton Relay, Inc. to provide IP CTS on a fully automatic basis). Adopted and released 20 April 2022."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-22-442A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 24-1265, CG Docket No. 03-123 (full certification of Hamilton Relay, Inc. to provide IP CTS). Adopted and released 17 December 2024."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-24-1265A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0825,2022-04-01,event,month,tested,EPA approves Clean Connect's LeakFinder System for methane screening after finding that it reaches a 90% probability of detection below 5 kg per hour,EPA found that Clean Connect's LeakFinder System reaches a 90% probability of detection below 5 kg/hr of methane. It uses neural networks to spot gas in camera footage.,*LeakFinder* meets EPA's threshold of 5 kg per hour for leaks,a 90% probability of detection below 5 kg/hr,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"LeakFinder System, in the Minerva Sensor-Fusion Platform",,Clean Connect AI Inc.,United States,"Oil and gas operators (approved use), with operators of Colorado facilities running the test releases",United States,"Colorado, United States",United States,Climate change mitigation / methane emissions monitoring,,Environment,Environment,Air Pollution,Images and video,,13,High income,environmental_impact,Environmental impacts,,,,,,,,societal,1,,0,The 5 kg/hr detection threshold for periodic screening,5 kg/hr threshold,90% probability of detection below 5 kg/hr,measured,unknown,,shown,https://www.epa.gov/system/files/documents/2025-05/clean-connect-alternative-test-method-signed.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards. Approval letter for the Clean Connect AI LeakFinder System as Methane Alternative Test Method MATM-011, 13 May 2025. The Acceptance Justification memorandum of 12 May 2025 accompanies it (docket EPA-HQ-OAR-2024-0619)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-05/clean-connect-alternative-test-method-signed.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Office of Air Quality Planning and Standards. Approval letter for the Clean Connect AI LeakFinder System as Methane Alternative Test Method MATM-011, 13 May 2025. The Acceptance Justification memorandum of 12 May 2025 accompanies it (docket EPA-HQ-OAR-2024-0619)."", ""url"": ""https://www.epa.gov/system/files/documents/2025-05/clean-connect-alternative-test-method-signed.pdf""}]","{""kind"": ""Official documents""}" AIBD-0807,2022-03-22,source publication,day,tested,"FDA found that at home, lay users of Athelas Home got white-cell counts that matched trained operators on the predicate device","In FDA's review of Athelas Home, lay users ran finger-prick tests at home for 61 patients. The counts matched trained operators on the predicate device, with a correlation of 0.97.",*Athelas Home* let patients run white-cell counts at home,with a correlation of 0.97,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Athelas Home,,"Athelas, Inc.",United States,Athelas (at-home study in which 61 patients or their caregivers ran the tests),United States,,,Healthcare,,Health,Health,Drug Industry,Images and video,Patients,3,,physical_health,Medical access,,2,1,,,,,personal,2,,0,Trained operators testing the same patients on the predicate Athelas One,Mean of triplicate predicate measurements (reference),"Correlation 0.97 for white-cell count and 0.95 for neutrophil percentage, with slopes of 1.00",measured,scaled,2026-02-12,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K200828.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for Athelas Home (K200828). Cleared 2022-03-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K200828.pdf""}]","{""kind"": ""Official documents""}" AIBD-1076,2022-03-04,source publication,day,tested,"China's CMDE finds that uAI-HematomaCare met its targets for accuracy in the maker's trial, judging that it makes screening for brain bleeds more efficient","In the maker's trial that China's CMDE reviewed, uAI-HematomaCare flagged acute brain bleeds on stored head CT of 600 subjects with a sensitivity of 97.32%. Its specificity was 99.67%.",*uAI-HematomaCare* flagged brain bleeds on CT in China's review,a sensitivity of 97.32% and a specificity of 99.67%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,uAI-HematomaCare (颅内出血CT影像辅助分诊软件),Release R002,"Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)",China,Shanghai United Imaging Intelligence (retrospective registration trial on head CT of 600 subjects from three centers),China,"Three centers that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health; operational_improvement,Medical diagnosis,,,,,,,,organizational,1,,0,"Target values of 90% for sensitivity and specificity, with senior doctors' readings as the reference",target value 90%,"sensitivity 97.32% (95%CI: 94.80%, 98.84%) and specificity 99.67% (95%CI:98.16%, 99.99%)",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/wq3E2rP20apDVNOwzG4qNb6t9bV78jtvP6jqENRWjIxMDA2NzajqS5wZGY=.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内出血CT影像辅助分诊软件 (technical review report for the registration of intracranial hemorrhage CT image triage-aid software), acceptance no. CQZ2100676, applicant 上海联影智能医疗科技有限公司. 4 March 2022. Section 四、产品受益风险判定 (benefit-risk determination)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/wq3E2rP20apDVNOwzG4qNb6t9bV78jtvP6jqENRWjIxMDA2NzajqS5wZGY=.pdf""}]","{""kind"": ""Official documents""}" AIBD-0873,2022-02-15,source publication,day,tested,Japan's PMDA finds that the AI in the nodoca throat camera met its preset goals for accuracy in detecting influenza against PCR,"In Japan's review of nodoca, its AI reading of throat photos detected influenza with 76.0% sensitivity against PCR. Its specificity was 88.1%. Both met goals set in advance.",*nodoca* throat photos met preset goals for accuracy in Japan's review,76.0% sensitivity and 88.1% specificity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,nodoca (ノドカ),,"Aillis, Inc. (アイリス株式会社)",Japan,"Aillis (trial at 11 sites in Japan, with the approved version run on stored trial data)",Japan,Japan (11 trial sites),Japan,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational; personal,2,,0,Sensitivity and specificity goals set before the additional test (the published report withholds the goal values),,Sensitivity 76.0% (lower 95% confidence limit 70.7%) and specificity 88.1% (lower limit 85.5%) against PCR,measured,scaled,2025-10-09,shown,https://www.mhlw.go.jp/content/12404000/000989561.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Pharmaceuticals and Medical Devices Agency (PMDA). 審査報告書 nodoca(ノドカ), review report on the application by Aillis, Inc., 15 February 2022, published with the deliberation report of the Ministry of Health, Labour and Welfare dated 9 March 2022. Summary of review results and section 4 (総合評価)."", ""url"": ""https://www.pmda.go.jp/medical_devices/2022/M20220516002/112714000_30400BZX00101_A100_4.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Pharmaceuticals and Medical Devices Agency (PMDA). 審査報告書 nodoca(ノドカ), 15 February 2022, section ヘ, PMDA's review of efficacy and safety. It adds PMDA's finding on pain and tearing, measured in the trial against the swab of the rapid antigen test."", ""url"": ""https://www.pmda.go.jp/medical_devices/2022/M20220516002/112714000_30400BZX00101_A100_4.pdf""}, {""label"": ""Assessment report"", ""value"": ""Central Social Insurance Medical Council (Chuikyo, 中央社会保険医療協議会) general assembly, on the advice of the expert organisation on insured medical materials; papers prepared by MHLW (2022). 医療機器の保険適用について(令和4年12月収載予定)(中医協 総-1-1), 総-1-1, 区分C2(新機能・新技術) table and pp. 2-5."", ""url"": ""https://www.mhlw.go.jp/content/12404000/000989561.pdf""}]","{""kind"": ""Official documents""}" AIBD-0624,2021-09-21,source publication,day,tested,FDA De Novo review of Paige Prostate: Pathologists aided by AI detect more cancer in prostate biopsy images,"In the reader study that FDA reviewed for Paige Prostate, assisted reads improved sensitivity in 7.3% of prostate biopsy images with cancer. Specificity rose 1.1 points.",*Paige Prostate* helped pathologists catch cancer missed on a first read,improvement in sensitivity in 7.3% of biopsy images,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,Paige Prostate,2.1.501,"Paige.AI, Inc.",United States,Paige.AI (pivotal reader study with sixteen pathologists),United States,United States,United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,4,,0,The same pathologists reading the same images without the software,Specificity 88.45%,Specificity 89.50%,measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200080.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Paige Prostate (DEN200080): decision summary. Granted 2021-09-21."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200080.pdf""}, {""label"": ""Evaluation report"", ""value"": ""ARTICULATE PRO consortium (Oxford University Hospitals, University Hospitals Coventry and Warwickshire, North Bristol NHS Trust, University of Oxford, with Paige), funded by the AI in Health and Care Award (2026). An evaluation of artificial intelligence assisted prostate biopsy reporting in the Articulate Pro study (npj Digital Medicine 2026), Abstract."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC13365413/""}]","{""kind"": ""Official documents""}" AIBD-1123,2021-09-13,source publication,day,mixed,"Scotland's SHTG advises that HeartFlow FFRCT may reduce invasive coronary angiography, on supporting evidence of limited quality",SHTG advised NHSScotland in September 2021 that HeartFlow FFRCT may reduce the need for invasive coronary angiography. The test may also save costs. SHTG judged the evidence limited in quality.,Scotland backs *HeartFlow FFRCT* as an option to avoid invasive tests,,,found,Found by an assessment body,controlled comparison,low,aggregate result,false,HeartFlow FFRCT,,"HeartFlow, Inc.",United States,"NHSScotland health boards, with a pilot at NHS Western Isles from December 2020",United Kingdom,"Scotland, United Kingdom",United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,2,,,personal,6,,0,Standard care for assessing coronary artery disease after CT coronary angiography,,,measured,persisted,2026-05-01,not shown,https://admin.shtg.scot/media/2087/20210714-heartflow-adaptation-v20.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group, Healthcare Improvement Scotland. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography: Recommendation for NHSScotland (SHTG Adaptation of NICE guidance). Published 13 September 2021. Archived copy of 27 April 2025."", ""url"": ""https://web.archive.org/web/20250427064346id_/https://shtg.scot/our-advice/heartflow-ffrct-for-estimating-fractional-flow-reserve-from-coronary-ct-angiography/""}, {""label"": ""Assessment report"", ""value"": ""Scottish Health Technologies Group. SHTG Adaptation: HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. 3 September 2021, Scottish Health Technology Council considerations."", ""url"": ""https://admin.shtg.scot/media/2087/20210714-heartflow-adaptation-v20.pdf""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. HealthTech guidance HTG429 (formerly MTG32), section 1: Recommendations. 13 February 2017, last updated 19 May 2021."", ""url"": ""https://www.nice.org.uk/guidance/htg429/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. HealthTech guidance HTG429 (formerly MTG32), section 1: Recommendations. 13 February 2017, last updated 19 May 2021."", ""url"": ""https://www.nice.org.uk/guidance/htg429/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. HealthTech guidance HTG429 (formerly MTG32), section 6: Conclusions. 13 February 2017, last updated 19 May 2021."", ""url"": ""https://www.nice.org.uk/guidance/htg429/chapter/6-Conclusions""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}]","{""kind"": ""Official documents""}" AIBD-1042,2021-09-01,source publication,month,reported,"GAFILAT assessors find that SIMONE, among other systems, gives Chile's financial intelligence unit timely, good-quality analysis","GAFILAT assessors found that SIMONE, among other systems, gives Chile's financial intelligence unit timely, good-quality analysis. They found that it checks UN sanctions lists every 5 minutes.",*SIMONE* gives Chile's financial intelligence unit timely analysis,more than 60 million records and transactions,,found,Found by an assessment body,no comparison,very low,program,false,SIMONE (Sistema de Monitoreo Estratégico),,"Unidad de Análisis Financiero (UAF), strategic intelligence area",Chile,"Unidad de Análisis Financiero (UAF), Chile's financial intelligence unit",Chile,Chile (national),Chile,Anti-money laundering: financial intelligence,,Finance,Law and Crime,White Collar Crime,Prediction from data,Public servants,16,High income,operational_improvement,"Faster data management, decision-making",,1,,,3,5,,organizational,1,,0,,,,,unknown,,shown,https://biblioteca.gafilat.org/wp-content/uploads/2024/07/IEM-Chile.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""GAFILAT. Informe de Evaluación Mutua de la República de Chile (cuarta ronda). September 2021, adopted at the XLIII GAFILAT Plenary of July 2021. Chapter 3, main findings for Immediate Outcome 6, paras 164 and 179, and para 371."", ""url"": ""https://biblioteca.gafilat.org/wp-content/uploads/2024/07/IEM-Chile.pdf""}]","{""kind"": ""Official documents""}" AIBD-0824,2021-08-31,source publication,day,tested,The FCC certifies CaptionCall's fully automatic captions after its test lab measured fewer word errors than in captions made with human assistants,"In the FCC's National Test Lab, CaptionCall's automatic captions had median error rates of 2.9 to 14.5 across five scenarios. Human-assisted providers had 8.9 to 19.5 on average.",*CaptionCall*'s automatic captions beat assisted ones in the FCC's lab,median error rates of 2.9 to 14.5,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,CaptionCall ASR-only (fully automatic) Internet Protocol Captioned Telephone Service (IP CTS),,"CaptionCall, LLC (with Sorenson Communications, LLC), on a speech recognition platform from an unnamed vendor",United States,"CaptionCall, LLC",United States,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,,,personal,2,,0,Median error rates of CA-assisted providers on the same five call scenarios,8.9 to 19.5 on average,2.9 to 14.5,measured,persisted,2025-06-24,shown,https://docs.fcc.gov/public/attachments/DA-25-542A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 21-1080, CG Docket No. 03-123 (conditional certification of CaptionCall, LLC to provide IP CTS on a fully automatic basis). Adopted and released 31 August 2021."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-21-1080A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 21-1080, CG Docket No. 03-123 (conditional certification of CaptionCall, LLC to provide IP CTS on a fully automatic basis). Adopted and released 31 August 2021."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-21-1080A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau (2025). Public Notice, DA 25-542, CG Docket No. 03-123: Grant of Certification for CaptionCall, LLC, to Provide Internet Protocol Captioned Telephone Service under Ownership of Ariel GP Holdco, LLC, p. 1 and the paragraph on consent decrees (p. 3-4)."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-25-542A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0993,2021-08-10,source publication,day,intended,A California federal court held that Southwest Airlines' keyword searches with technology-assisted review were consistent with a reasonable inquiry,In August 2021 a federal court in California held that Southwest Airlines' use of keyword searches with technology-assisted review was consistent with a reasonable inquiry in a class action.,Court backs Southwest's *technology-assisted review* with keywords,"over 47,000 responsive documents",,found,Found by a court,,very low,benefit created,false,"Technology-assisted review, used with keyword searches",,Not named in the order,,Southwest Airlines Co. (defendant),United States,"California, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,,,,,unknown,,not shown,https://storage.courtlistener.com/recap/gov.uscourts.cand.336694/gov.uscourts.cand.336694.131.0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Northern District of California (Judge Phyllis J. Hamilton). Huntsman v. Southwest Airlines Co., No. 19-cv-00083-PJH, Discovery Order (Doc. 131), 10 August 2021, pp. 3-5. CourtListener RECAP copy."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.cand.336694/gov.uscourts.cand.336694.131.0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0780,2021-05-01,event,month,tested,FDA finds that ScanNav Anatomy Peripheral Nerve Block helped 19 of 30 anesthesiologists obtain the correct ultrasound view in a study,"In a study that FDA reviewed, 63% (19/30) of anesthesiologists judged that ScanNav Anatomy Peripheral Nerve Block helped them obtain the correct ultrasound view before a block.",*ScanNav Anatomy PNB* helped anesthesiologists find the right view,63% (19/30) of anesthesiologists,,found,Found by a regulator,no comparison,very low,aggregate result,false,ScanNav Anatomy Peripheral Nerve Block,,Intelligent Ultrasound Limited,United Kingdom,Intelligent Ultrasound (study with 15 expert and 15 trainee anesthesiologists at Oregon Health & Science University),United States,"Portland, Oregon, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Value above replacement,,2,1,,,1,,organizational,2,,0,,,,,persisted,2023-10-06,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220024.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for ScanNav Anatomy Peripheral Nerve Block (DEN220024): decision summary. Granted 2022-10-18."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN220024.pdf""}]","{""kind"": ""Official documents""}" AIBD-1000,2021-04-13,source publication,day,tested,The FCC certifies ClearCaptions' automatic captions after its test lab measured fewer word errors than in human-assisted captions,"In the FCC's test lab, ClearCaptions' automatic captions had median word error rates of 3.5% to 14.8%, against 8.9% to 19.5% for assisted providers. The FCC fully certified the service in 2023.",*ClearCaptions*' automatic captions beat assisted ones in the FCC's lab,median word error rates of 3.5% to 14.8%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,ClearCaptions fully automatic (ASR-only) Internet Protocol Captioned Telephone Service (IP CTS),,"ClearCaptions, LLC, on the platform of a speech-to-text vendor that the FCC does not name",,"ClearCaptions, LLC",,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,4,4,,5,,personal,3,,0,"Median word error rates of CA-assisted providers, on average, on the same call scenarios",8.9% to 19.5%,3.5% to 14.8%,measured,persisted,2023-04-04,shown,https://docs.fcc.gov/public/attachments/DA-21-419A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 21-419, CG Docket No. 03-123 (conditional certification of ClearCaptions, LLC to provide IP CTS on a fully automatic basis). Adopted and released 13 April 2021."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-21-419A1.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Order, DA 23-291, CG Docket No. 03-123 (full certification of ClearCaptions, LLC to provide IP CTS). Adopted and released 4 April 2023."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-23-291A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0782,2021-04-01,source publication,day,tested,FDA finds that the Gili Pro BioSensor measured two vital signs without contact within its limits for accuracy in a study of 120 adults,"In a study of 120 adults that FDA reviewed, the Gili Pro BioSensor met limits of ±3 bpm against ECG and ±2 breaths per minute against capnography, without touching patients.",*Gili Pro BioSensor* measured two vital signs without contact,limits of ±3 bpm against ECG,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Gili Pro BioSensor (Gili BioSensor System),,ContinUse Biometrics Ltd.,Israel,ContinUse Biometrics (clinical accuracy study in 120 adults against ECG and capnography),Israel,,,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,,physical_health,Hazard reduction,,,,,,,,organizational,2,,0,Pre-specified acceptance limits against ECG and capnography,Limits of ±3 bpm for heart rate and ±2 breaths per minute for breathing rate,"Both limits met, with intercepts of 0.51 for heart rate and 0.17 for breathing rate",measured,unknown,,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200038.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for Gili Pro BioSensor (Gili BioSensor System) (DEN200038): decision summary. Granted 2021-04-01."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200038.pdf""}]","{""kind"": ""Official documents""}" AIBD-0781,2021-03-26,source publication,day,tested,FDA finds that Oxehealth Vital Signs measured two vital signs from video of a room within its goals for accuracy in a study of 60 adults,"In a study of 60 adults that FDA reviewed, Oxehealth Vital Signs measured pulse from video with an RMSD of 1.81 bpm. Breathing rate had an RMSD of 1.17 breaths/minute.",*Oxehealth Vital Signs* read two vital signs from a camera in the room,an RMSD of 1.81 bpm,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Oxehealth Vital Signs,,Oxehealth Limited,United Kingdom,Oxehealth (clinical accuracy study in 60 adults against a contact device),United Kingdom,,,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,,physical_health,,,,,,,,,organizational,3,,0,Study objectives for the root mean square difference from a contact device,Objectives of three beats per minute and two breaths per minute,1.81 bpm for pulse and 1.17 breaths/minute for breathing,measured,challenged,2023-07-12,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200019.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for Oxehealth Vital Signs (DEN200019): decision summary. Granted 2021-03-26."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200019.pdf""}, {""label"": ""Follow-up"", ""value"": ""In July 2023 the Stop Oxevision campaign and the National Survivor User Network asked NHS England and mental health trusts to halt the rollout of Oxevision, the system's name in English wards, pending an independent review."", ""url"": ""https://www.nsun.org.uk/?p=5465""}]","{""kind"": ""Challenges""}" AIBD-0734,2021-03-22,source publication,day,tested,"WHO recommends software that reads chest X-rays for TB for people aged 15 and older, finding it about as accurate as human readers",WHO's guideline group found that three CAD programs read chest X-rays for TB about as accurately as human readers. In March 2021 WHO conditionally recommended such software from age 15.,WHO recommends AI reading of chest X-rays for TB screening,specificity ranged from 0.23 to 0.66,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,"CAD4TB, Lunit INSIGHT CXR and qXR (computer-aided detection software for TB)",CAD4TB v6 and qXR v2 (no version given for Lunit INSIGHT CXR),"Delft Imaging (CAD4TB), Lunit (Lunit INSIGHT CXR) and Qure.ai (qXR)","Multiple: Netherlands, South Korea, India",TB screening and triage studies in three independent evaluations reviewed by WHO,Multiple,Global,,Healthcare (tuberculosis screening),,Health,Health,Disease Prevention,Images and video,Patients,3,,physical_health,Medical diagnosis,,,,2,,,,organizational,1,,0,Human readers interpreting the same chest X-rays (screening use case),"Sensitivity 0.82–0.93, specificity 0.14–0.63","Sensitivity 0.90–0.92, specificity 0.23–0.66",measured,scaled,2025-06-11,shown,https://iris.who.int/server/api/core/bitstreams/0d7e8935-879e-4ab6-8c07-e41f7be1465b/content,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2, screening: systematic screening for tuberculosis disease. Geneva, 22 March 2021. Recommendation 10 and section 3.2.1. ISBN 978-92-4-002267-6."", ""url"": ""https://iris.who.int/server/api/core/bitstreams/0633a78b-581c-47f2-a148-bad704cc0e50/content""}]","{""kind"": ""Official documents""}" AIBD-1077,2021-03-15,source publication,day,tested,"China's CMDE finds that Yitu_AICare_Bone_Age estimated bone age within its target for error in the maker's trial, judging that it makes reading more efficient","In the maker's trial of 1,000 subjects that China's CMDE reviewed, Yitu_AICare_Bone_Age gave TW3 bone ages within its target for error against an expert panel. The report gives no figures.",*Yitu_AICare_Bone_Age* kept errors within its target in China's review,,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Yitu_AICare_Bone_Age (儿童手部X射线影像骨龄辅助评估软件),Release 2 (full version 2.2.0),"Hangzhou Yitu Healthcare Technology Co., Ltd. (杭州依图医疗技术有限公司)",China,"Hangzhou Yitu Healthcare Technology (prospective registration trial with 1,000 subjects at four institutions)",China,"Four clinical institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Children,3,Upper middle income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,"An expert panel's TW3-RUS and TW3-Carpal bone ages as the gold standard, with a preset error target",Expert panel's TW3 bone ages (the gold standard),Mean absolute error within the preset target (no figures given),measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/tvnNr8rWsr9YyeTP39OwzG5x8HkuKjW+sbAucDI7bz+o6hDUVoyMDAwMjczo6lzLnBkZg==.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:儿童手部X射线影像骨龄辅助评估软件 (technical review report for the registration of pediatric hand X-ray bone age assessment-aid software), acceptance no. CQZ2000273, applicant 杭州依图医疗技术有限公司. 15 March 2021. Section 四、产品受益风险判定 (benefit-risk determination)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/tvnNr8rWsr9YyeTP39OwzG5x8HkuKjW+sbAucDI7bz+o6hDUVoyMDAwMjczo6lzLnBkZg==.pdf""}]","{""kind"": ""Official documents""}" AIBD-0746,2021-02-01,source publication,month,tested,"Québec's assessment agency INESSS finds that AI grading of diabetic eye photos appears cost-efficient, at the price of lower specificity",INESSS reviewed two economic studies from the UK and Singapore. It found that AI grading of retinal photos seems efficient because its cost savings would offset its lower specificity.,INESSS finds *AI retinopathy screening* cheaper per correct result,£11.81 per correct result with Retmarker,,found,Found by an assessment body,no comparison,very low,aggregate result,false,"AI diabetic retinopathy screening systems (IARD) in the two economic studies, EyeArt and Retmarker in the UK and SELENA+ in Singapore",EyeArt 1.0 and Retmarker 0.8.2 in the UK study,"Eyenuk (EyeArt), Retmarker Ltd (Retmarker) and EyRIS (SELENA+)","Multiple: United States, Portugal, Singapore","Diabetic retinopathy screening programs in the United Kingdom and Singapore, as modeled in the studies that INESSS reviewed","Multiple: United Kingdom, Singapore","United Kingdom and Singapore (studies), with guidance for Québec, Canada",United Kingdom | Singapore | Canada,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Diabetic retinopathy tele-screening with human graders only,,Lower cost and lower specificity with AI grading,assumed,unknown,,shown,https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Technologies/INESSS_IA_TDRD_EC.pdf,489 000 $,Projected costs avoided when semi-automated AI screening replaces manual grading,True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Institut national d'excellence en santé et en services sociaux (INESSS). Télédépistage de la rétinopathie diabétique à l'aide d'une solution d'intelligence artificielle. État des connaissances. Québec, February 2021. Résumé, Efficience."", ""url"": ""https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Technologies/INESSS_IA_TDRD_EC.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut national d'excellence en santé et en services sociaux (INESSS). Artificial intelligence-assisted diabetic retinopathy tele-screening, English summary, Efficiency. Québec, February 2021."", ""url"": ""https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Technologies/INESSS_IA_TDRD_EC.pdf""}]","{""kind"": ""Official documents""}" AIBD-0775,2021-01-01,event,year,tested,FDA's De Novo review of NaviCam ProScan shows that doctors using it found bleeding lesions in more patients while reading capsule videos of the small bowel faster,"In the ARTIC study that FDA reviewed, readers using NaviCam ProScan took 3 minutes and 50 seconds per video, against 33 minutes and 42 seconds. They found lesions in more patients.",*NaviCam ProScan* helped doctors find more lesions in less time,3 minutes and 50 seconds per video,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,NaviCam ProScan,,"Ankon Technologies Co., Ltd.",China,Seven European centers in the prospective ARTIC study (22 capsule endoscopy readers),"Multiple: Italy, France, Germany, Hungary, Spain, Sweden, United Kingdom","Seven centers in Italy, France, Germany, Hungary, Spain, Sweden and the United Kingdom",Italy | France | Germany | Hungary | Spain | Sweden | United Kingdom,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement; physical_health,Enhanced productivity,,2,1,,,1,,organizational,2,,0,Standard reading of the same videos without AI at the enrolling center,"Mean reading time of 33 minutes and 42 seconds, diagnostic yield 62.4%","Mean reading time of 3 minutes and 50 seconds, diagnostic yield 73.7%",measured,persisted,2026-10-11,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230027.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for NaviCam ProScan (DEN230027): decision summary. Granted 2023-12-12."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN230027.pdf""}]","{""kind"": ""Official documents""}" AIBD-1069,2021-01-01,event,year,tested,China's CMDE finds that endoscopists using EndoAngel's EA PC-LGI detected more polyps in the maker's colonoscopy trial,"In EndoAngel's colonoscopy trial that China's CMDE reviewed, endoscopists using EA PC-LGI detected 84.97% of polyps, against 72.07% in colonoscopies without it.",*EA PC-LGI* helped endoscopists find more polyps in a Chinese trial,"detected 84.97% of polyps, against 72.07% in colonoscopies without it",,found,Found by a regulator,controlled comparison,very low,aggregate result,false,EA PC-LGI (肠息肉电子下消化道内窥镜图像辅助检测软件),Release V1.0,"Wuhan EndoAngel Medical Technology Co., Ltd. (武汉楚精灵医疗科技有限公司)",China,"Wuhan EndoAngel Medical Technology (prospective trial at Ruijin Hospital, Beijing Cancer Hospital and the Central Hospital of Wuhan)",China,"Shanghai, Beijing and Wuhan, China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,physical_health,Medical diagnosis,,3,1,,,1,,organizational; personal,3,,0,"Colonoscopy without the software in the same trial, with experts' review of the recorded videos as the reference",72.07% polyp-level sensitivity,84.97% polyp-level sensitivity,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1742968427970072912.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道内窥镜图像辅助检测软件 (technical review report for the registration of intestinal polyp lower gastrointestinal endoscope image detection-aid software), acceptance no. CQZ2200536, applicant 武汉楚精灵医疗科技有限公司. 20 April 2023. Section 三、临床评价概述 (clinical evaluation)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742968427970072912.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子下消化道内窥镜图像辅助检测软件 (technical review report for the registration of intestinal polyp lower gastrointestinal endoscope image detection-aid software), acceptance no. CQZ2200536, applicant 武汉楚精灵医疗科技有限公司. 20 April 2023. Section 四、产品受益风险判定 (benefit-risk determination), CMDE's own judgment."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1742968427970072912.pdf""}, {""label"": ""Regulatory document"", ""value"": ""National Medical Products Administration (NMPA), China. Computer Aided Detection Software for Intestinal Polyps in Lower Gastrointestinal Endoscopy Approved for Marketing. NMPA English website, 12 May 2023."", ""url"": ""https://english.nmpa.gov.cn/2023-05/12/c_923528.htm""}]","{""kind"": ""Official documents""}" AIBD-1078,2020-11-23,source publication,day,tested,"China's CMDE finds that doctors using MIDS-PNAS met clinical needs in the maker's trial, judging that it makes reading of lung CT more efficient","In the maker's randomized crossover trial that China's CMDE reviewed, doctors using MIDS-PNAS met clinical needs for sensitivity to lung nodules without losing specificity. No figures are given.",*MIDS-PNAS* aided the detection of lung nodules on CT in China's review,,,found,Found by a regulator,randomized trial,moderate,aggregate result,false,MIDS-PNAS (肺结节CT影像辅助检测软件),Release 1 (full version 1.2.0.1),Deepwise (杭州深睿博联科技有限公司),China,Deepwise (prospective randomized crossover registration trial),China,"Qualified medical institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,operational_improvement; physical_health,Enhanced productivity,,,,,,,,organizational,1,,0,"The same doctors reading without the software, in a randomized crossover design with three senior chest radiologists' consensus as the reference",Doctors reading without the software (no figures given),"Sensitivity met clinical needs, and patient-level specificity did not fall (no figures given)",measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1743643287649029450.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肺结节CT影像辅助检测软件 (technical review report for the registration of lung nodule CT image detection-aid software), acceptance no. CQZ2000139, applicant 杭州深睿博联科技有限公司. 23 November 2020. Section 四、产品受益风险判定 (benefit-risk determination)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1743643287649029450.pdf""}]","{""kind"": ""Official documents""}" AIBD-0892,2020-11-11,source publication,day,tested,"Japan's transport ministry approved Honda's Traffic Jam Pilot after a safety examination, in the world's first type designation of a Level 3 car",On 11 November 2020 Japan's transport ministry approved the Honda Legend with Traffic Jam Pilot after an examination against the safety standards. The system drives in traffic jams on expressways.,Japan approves *Traffic Jam Pilot* for driving in expressway jams,,,found,Found by a regulator,no comparison,very low,benefit created,false,Traffic Jam Pilot (automated operation device) on the Honda Legend,,"Honda Motor Co., Ltd.",Japan,"Honda Motor Co., Ltd. (factory-fitted on the Legend)",Japan,Japan,Japan,Road vehicle automated driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,High income,physical_health,,,,,,,,,personal,2,,0,,,,,withdrawn,2021-06-17,not shown,https://www.mlit.go.jp/report/press/jidosha08_hh_003888.html,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""Ministry of Land, Infrastructure, Transport and Tourism (Japan), Road Transport Bureau. 世界初!自動運転車(レベル3)の型式指定を行いました (World first: type designation of a Level 3 automated vehicle). Press release, 11 November 2020, section 1."", ""url"": ""https://www.mlit.go.jp/report/press/jidosha08_hh_003888.html""}, {""label"": ""Follow-up"", ""value"": ""Honda told Carscoops in June 2021 that production of the Legend, the car that carries Traffic Jam Pilot, would end for the Japanese market at the end of 2021 as the Sayama plant closed."", ""url"": ""https://www.carscoops.com/2021/06/death-of-jdm-honda-odyssey-wont-impact-us-spec-model/""}]","{""kind"": ""Withdrawals""}" AIBD-1079,2020-10-27,source publication,day,tested,"China's CMDE finds that CoronaryDoc met its targets for triage of stenosis in the maker's trial, judging that it can shorten reading time","In the maker's trial at three institutions that China's CMDE reviewed, CoronaryDoc's triage of coronary stenosis met its target for sensitivity. The same held for specificity. No figures are given.",*CoronaryDoc* met its targets for triage of stenosis in China's review,,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,CoronaryDoc (冠脉CT造影图像血管狭窄辅助分诊软件),Release 2.0 (full version 2.0.0.005),"Yukun (Beijing) Network Technology Co., Ltd. (语坤(北京)网络科技有限公司)",China,Yukun (Beijing) Network Technology (retrospective blinded registration trial at three institutions),China,"Three qualified medical institutions that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income,operational_improvement; physical_health,Enhanced productivity,,,,,,,,organizational,1,,0,"Manual reading as the gold standard, with preset targets for sensitivity and specificity",Preset targets (values not given),Sensitivity and specificity reached the targets (no figures given),measured,persisted,2020-11-10,shown,https://www.cmde.org.cn/directory/web/cmde/images/udrC9kNU1OzTsM28zHRqrncz8HVrbio1vq31tXvyO28qOoQ1FaMjAwMDE0M6Opcy5wZGY=.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:冠脉CT造影图像血管狭窄辅助分诊软件 (technical review report for the registration of coronary CT angiography stenosis triage-aid software), acceptance no. CQZ2000143, applicant 语坤(北京)网络科技有限公司. 27 October 2020. Section 五、临床受益-风险评估 (clinical benefit-risk assessment)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/udrC9kNU1OzTsM28zHRqrncz8HVrbio1vq31tXvyO28qOoQ1FaMjAwMDE0M6Opcy5wZGY=.pdf""}]","{""kind"": ""Official documents""}" AIBD-0804,2020-10-02,source publication,day,tested,"FDA found that examiners matched manual microscopy on 645 blood specimens with Scopio's X100, which classifies white cells with a neural network","In FDA's review of the X100 with Full Field PBS, examiners used its neural network to classify white cells. They matched manual microscopy on 645 specimens, with 96.29% agreement.",*X100 with Full Field PBS* matched manual microscopy on 645 smears,"matched manual microscopy on 645 specimens, with 96.29% agreement",,found,Found by a regulator,tested against a standard,very low,aggregate result,false,X100 with Full Field Peripheral Blood Smear Application,,Scopio Labs Ltd.,Israel,Scopio Labs (method comparison against manual microscopy at three sites),Israel,,,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Manual light microscopy of the same 645 specimens,Manual differential (reference),"Agreement 96.29%, sensitivity 87.86% and specificity 97.62% for white-cell differentials",measured,persisted,2022-02-09,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K201301.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for X100 with Full Field Peripheral Blood Smear (PBS) Application (K201301). Cleared 2020-10-02."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K201301.pdf""}]","{""kind"": ""Official documents""}" AIBD-0984,2020-09-03,source publication,day,intended,A Chicago federal court found that the City's plan to review 1.3 million pages with Relativity Active Learning was reasonable,In September 2020 a US magistrate judge found that Chicago's plan to review 1.3 million pages with Relativity Active Learning was reasonable. The judge found that it was also proportional to the case.,Court backs Chicago's *Active Learning* review of 1.3 million pages,1.3 million pages,,found,Found by a court,,very low,benefit created,false,Relativity Active Learning (AL),,Relativity (Relativity ODA LLC),United States,City of Chicago (defendant) and its attorneys,United States,"Chicago, Illinois, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Value above replacement,,,,,,,,organizational,1,,0,Manual review or keyword searches,,,assumed,unknown,,shown,https://storage.courtlistener.com/recap/gov.uscourts.ilnd.332956/gov.uscourts.ilnd.332956.309.0_1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Northern District of Illinois (Magistrate Judge Young B. Kim). Livingston v. City of Chicago, No. 16 CV 10156, Memorandum Opinion and Order (Doc. 309), 3 September 2020. CourtListener RECAP copy of the filed order."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.ilnd.332956/gov.uscourts.ilnd.332956.309.0_1.pdf""}]","{""kind"": ""Official documents""}" AIBD-1080,2020-07-31,source publication,day,tested,China's CMDE finds that AIDRscreening met its targets for accuracy on stage II or worse diabetic retinopathy in the maker's trials,"In the maker's prospective multicenter trial that China's CMDE reviewed, AIDRscreening detected stage II or worse diabetic retinopathy with accuracy that met its targets. No figures are given.",*AIDRscreening* met its targets for retinopathy in China's review,,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,AIDRscreening (糖尿病视网膜病变眼底图像辅助诊断软件),Release V01 (full version V01.00.00.00),"Shenzhen SiBionics Intelligent Technology Co., Ltd. (深圳硅基智能科技有限公司)",China,Shenzhen SiBionics Intelligent Technology (prospective multicenter and retrospective registration trials),China,"Trial centers that the report does not name, for a registration in China",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Senior doctors' readings as the gold standard, with preset accuracy targets",Preset targets (values not given),Diagnostic accuracy reached the targets (no figures given),measured,persisted,2020-08-11,shown,https://www.cmde.org.cn/directory/web/cmde/images/zMfE8rKhytPN+MSksqGx5NHbtdfNvMxuKjW+tXvtsI7bz+o6hDUVoxOTAwNjY4o6lzLnBkZg==.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:糖尿病视网膜病变眼底图像辅助诊断软件 (technical review report for the registration of diabetic retinopathy fundus image diagnosis-aid software), acceptance no. CQZ1900668, applicant 深圳硅基智能科技有限公司. 31 July 2020. Section 三、临床评价摘要 (clinical evaluation summary)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/zMfE8rKhytPN+MSksqGx5NHbtdfNvMxuKjW+tXvtsI7bz+o6hDUVoxOTAwNjY4o6lzLnBkZg==.pdf""}]","{""kind"": ""Official documents""}" AIBD-1081,2020-07-31,source publication,day,tested,China's CMDE finds that Airdoc-AIFUNDUS met its targets for accuracy on diabetic retinopathy in the maker's trial,"In the maker's trial that China's CMDE reviewed, Airdoc-AIFUNDUS reached its preset target for sensitivity to diabetic retinopathy. The same held for specificity. The report gives no figures.",*Airdoc-AIFUNDUS* met its targets for retinopathy in China's review,,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Airdoc-AIFUNDUS (糖尿病视网膜病变眼底图像辅助诊断软件),Release V1.0 (full version V1.0.2020.04.02.01),"Shanghai Airdoc Medical Technology Co., Ltd. (上海鹰瞳医疗科技有限公司)",China,Shanghai Airdoc Medical Technology (prospective multicenter registration trial),China,Trial sites in China that the report does not name,China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,"Preset targets for sensitivity and specificity, with senior doctors' reading as the reference standard",Preset targets that the report does not state,Sensitivity and specificity reached the targets,measured,scaled,2026-03-31,shown,https://www.cmde.org.cn/directory/web/cmde/images/zMfE8rKhytPN+MSksqGx5NHbtdfNvMxuKjW+tXvtsI7bz+o6hDUVoxOTAwNjUzo6lzLnBkZg==.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:糖尿病视网膜病变眼底图像辅助诊断软件 (technical review report for the registration of diabetic retinopathy fundus image diagnosis-aid software), acceptance no. CQZ1900653, applicant 上海鹰瞳医疗科技有限公司. 31 July 2020. Section 三、临床评价摘要 (clinical evaluation summary)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/zMfE8rKhytPN+MSksqGx5NHbtdfNvMxuKjW+tXvtsI7bz+o6hDUVoxOTAwNjUzo6lzLnBkZg==.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:糖尿病视网膜病变眼底图像辅助诊断软件 (technical review report for the registration of diabetic retinopathy fundus image diagnosis-aid software), acceptance no. CQZ1900653, applicant 上海鹰瞳医疗科技有限公司. 31 July 2020. Section 综合评价意见 (concluding evaluation), CMDE's own recommendation to approve, with a condition for further study after approval."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/zMfE8rKhytPN+MSksqGx5NHbtdfNvMxuKjW+tXvtsI7bz+o6hDUVoxOTAwNjUzo6lzLnBkZg==.pdf""}]","{""kind"": ""Official documents""}" AIBD-1011,2020-07-01,event,month,mixed,South Korea's Board of Audit and Inspection finds that the AI job recommendation service scores evenly across occupations but drew fewer applications,South Korea's audit board found in December 2025 that the AI job recommender scored about 80% for top and other occupations alike. In 2022 it found lower application rates than with an older system.,*AI job recommendation service* scores evenly but drew fewer applicants,scored about 80% for top and other occupations alike,,found,Found by an auditor,tested against a standard,low,aggregate result,false,"AI 일자리 추천서비스 (AI job recommendation service), called The Work AI on Worknet",,"Korea Employment Information Service (한국고용정보원), for the Ministry of Employment and Labor",South Korea,"Korea Employment Information Service, on the Worknet jobs portal of the Ministry of Employment and Labor",South Korea,South Korea (national),South Korea,Public employment services (job matching),,Public sector,Labor,General,Planning and control,Other workers,8,High income,opportunity_access,Employment access,,,4,3,2,,,personal,2,,0,"The older rule-based recommender on Worknet (The Work) in the same periods, from July 2020 to October 2021",15.22% and 18.36% of views led to applications,9.45% and 12.99% of views of AI recommendations led to applications,measured,scaled,2026-10-28,shown,https://www.bai.go.kr/api/files/download?fileId=jj20220412%20141606&fileSn=1,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Board of Audit and Inspection of Korea (감사원). 감사보고서 - 인공지능 대비실태 Ⅰ(신뢰성 확보 분야) - [Performance audit report, AI preparedness I: ensuring reliability]. Report dated December 2025, published 5 January 2026. Chapter 3, section 4, printed p. 54 and footnotes 52 and 53."", ""url"": ""https://www.bai.go.kr/api/files/download?fileId=jj20260303%20152833&fileSn=1""}, {""label"": ""Audit report"", ""value"": ""Board of Audit and Inspection of Korea (감사원). 감사보고서 - 취업알선정보망 구축 및 관리실태 - [Performance audit report, construction and management of the employment placement information network]. Report dated March 2022, released April 2022. Printed pp. 20-24 and [표 13]."", ""url"": ""https://www.bai.go.kr/api/files/download?fileId=jj20220412%20141606&fileSn=1""}]","{""kind"": ""Official documents""}" AIBD-0822,2020-06-04,source publication,day,tested,"The FCC certifies Clarity's automatic CaptionMate captions, which arrived faster than assisted captions in its lab tests, with fewer errors in four of five scenarios","In the FCC's lab tests, Clarity's automatic CaptionMate captions arrived in 1.1 to 1.6 seconds, against 4.8 to 6.9 for assisted providers. They had fewer errors in four of five scenarios.",*CaptionMate* tops assisted captions for accuracy in four of five tests,arrived in 1.1 to 1.6 seconds,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"CaptionMate, Clarity's ASR-only Internet Protocol Captioned Telephone Service (IP CTS) app",,"Clarity Products, LLC",,"Clarity Products, LLC",,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,,4,,,,personal,1,,0,Average error rates of CA-assisted providers on the same call scenarios,8.9% to 19.5%,"6.3% to 35.9% (Clarity's median error rates), lower in four of five scenarios",measured,unknown,,shown,https://docs.fcc.gov/public/attachments/DA-20-587A1.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 20-587, CG Docket No. 03-123 (conditional certification of Clarity Products, LLC to provide IP CTS using only automatic speech recognition). Adopted and released 4 June 2020."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-20-587A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-0629,2020-06-01,event,month,tested,FDA De Novo review of the Cognoa ASD Diagnosis Aid: AI autism diagnosis aid validated at 14 US sites,"In the 14-site study that FDA reviewed, the Cognoa ASD Diagnosis Aid gave a result for 32% of 425 children. Against specialist diagnosis, its PPV was 81%. Its sensitivity was 98%.",*Cognoa ASD Diagnosis Aid* matched specialists when it gave a result,a positive predictive value of 81%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Cognoa ASD Diagnosis Aid,,"Cognoa, Inc.",United States,Fourteen US sites in the Cognoa ASD Diagnosis Aid validation study,United States,"Fourteen sites, United States",United States,Healthcare,,Health,Health,Infants and Children,Prediction from data,Children; People with disabilities; Health workers,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational,7,,0,Specialist diagnosis validated by blinded central reviewers,Reference diagnosis,"PPV 81%, NPV 98%, sensitivity 98%, specificity 79% among determinate outputs",measured,challenged,2024-11-21,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC9072329,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Cognoa ASD Diagnosis Aid (DEN200069): decision summary. Granted 2021-06-02."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200069.pdf""}, {""label"": ""Assessment report"", ""value"": ""New York State Department of Health, Medicaid Evidence Based Benefit Review Advisory Committee (EBBRAC); health technology assessment prepared under contract by the Center for Evidence-based Policy, Oregon Health & Science University (2024). Canvas Dx as a Diagnostic Aid for Autism in Young Children: Health Technology Assessment (November 2024), Executive Summary, Conclusions (pp. 3-4)."", ""url"": ""https://www.health.ny.gov/health_care/medicaid/ebbrac/meetings/2024/docs/2024-11-21_canvas_rpt.pdf""}, {""label"": ""Assessment report"", ""value"": ""New York State Medicaid Evidence Based Benefit Review Advisory Committee (EBBRAC), New York State Department of Health (2024). EBBRAC Meeting Summary, 21 November 2024: Canvas Dx (recommendation against coverage), Canvas Dx discussion and recommendation (pp. 4-6)."", ""url"": ""https://www.health.ny.gov/health_care/medicaid/ebbrac/meetings/2024/docs/2024-11-21_minutes.pdf""}, {""label"": ""Assessment report"", ""value"": ""BlueCross BlueShield of Tennessee (BCBST), Medical Policy Manual (2026). Digital Health Technologies: Diagnostic Applications (BCBST medical policy; original effective date 30 August 2023, most recent review 8 October 2026), Policy; Additional Information."", ""url"": ""https://www.bcbst.com/MPManual/Digital_Health_Technologies__Diagnostic_Applications.htm""}, {""label"": ""Follow-up"", ""value"": ""New York's Medicaid Evidence Based Benefit Review Advisory Committee voted 16 to 0 on 21 November 2024 not to recommend Medicaid coverage of Canvas Dx, and BlueCross BlueShield of Tennessee still calls it investigational in 2026."", ""url"": ""https://www.health.ny.gov/health_care/medicaid/ebbrac/meetings/2024/docs/2024-11-21_minutes.pdf""}]","{""kind"": ""Challenges""}" AIBD-0821,2020-03-01,event,month,tested,The FCC certifies MachineGenius's automatic Olelo captions after MITRE's tests measured fewer word errors than in human-assisted captions,"In testing for the FCC, MachineGenius's fully automatic phone captions had average error rates of 2.7% to 8.2%, against 8.9% to 19.5% for providers that use human assistants.",*Olelo* phone captions beat human-assisted ones in tests for the FCC,average error rates of 2.7% to 8.2%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,"Olelo, MachineGenius's ASR-only Internet Protocol Captioned Telephone Service (IP CTS)",,"MachineGenius, Inc. (speech recognition licensed from an unnamed vendor)",,"MachineGenius, Inc.",,United States,United States,Telecommunications relay services / accessibility for people with hearing loss,,Accessibility,Technology,Telecommunications,Speech and sound,People with disabilities,10,High income,accessibility,,,,,4,,,,personal,2,,0,"CA-assisted IP CTS providers, tested on the same call scenarios in 2018 and 2019",8.9% to 19.5% average error rates,2.7% to 8.2%,measured,persisted,,shown,https://www.machinegenius.com/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Federal Communications Commission, Consumer and Governmental Affairs Bureau. Memorandum Opinion and Order, DA 20-485, CG Docket No. 03-123 (conditional certification of MachineGenius, Inc. to provide IP CTS using only automatic speech recognition). Adopted and released 5 May 2020."", ""url"": ""https://docs.fcc.gov/public/attachments/DA-20-485A1.pdf""}]","{""kind"": ""Official documents""}" AIBD-1082,2020-01-06,source publication,day,tested,"China's CMDE judges that DEEPVESSEL FFR can diagnose coronary ischemia better than CT angiography, sparing patients unneeded invasive procedures",China's CMDE judged that DEEPVESSEL FFR can diagnose functional myocardial ischemia better than coronary CT angiography alone. The report gives no figures from the maker's trials.,*DEEPVESSEL FFR* judged better than CT angiography in China's review,,,found,Found by a regulator,no comparison,very low,aggregate result,false,DEEPVESSEL FFR (冠脉血流储备分数计算软件),Release 1.0 (full version 1.0.1),"Keya Medical, with 北京昆仑医云科技有限公司 (Beijing Kunlun Medical Cloud Technology Co., Ltd.) as the applicant in China",China,"北京昆仑医云科技有限公司 (Beijing Kunlun Medical Cloud Technology Co., Ltd.), the applicant (prospective trial at three institutions and retrospective trial at six)",China,"Trial institutions in China that the report does not name, three in the prospective trial and six in the retrospective trial",China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,Upper middle income,physical_health,Medical diagnosis,,,,,,,,organizational; personal,2,,0,"Coronary CT angiography alone, in CMDE's statement of the main clinical benefit, which gives no figures",,,assumed,persisted,2020-01-15,shown,https://www.cmde.org.cn/directory/web/cmde/images/1738726326302048199.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:冠脉血流储备分数计算软件 (technical review report for the registration of coronary fractional flow reserve computation software), acceptance no. CQZ1900346, applicant 北京昆仑医云科技有限公司. 6 January 2020. Section 五、临床受益风险评估 (clinical benefit-risk assessment)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1738726326302048199.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:冠脉血流储备分数计算软件 (technical review report for the registration of coronary fractional flow reserve computation software), acceptance no. CQZ1900346, applicant 北京昆仑医云科技有限公司. 6 January 2020. Section 综合评价意见 (concluding evaluation), CMDE's own judgment of benefit and risk and its recommendation to approve."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1738726326302048199.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:冠脉血流储备分数计算软件 (technical review report for the registration of coronary fractional flow reserve computation software), acceptance no. CQZ1900346, applicant 北京昆仑医云科技有限公司. 6 January 2020. Section 三、临床评价摘要 (clinical evaluation summary), the conclusion of the prospective trial."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1738726326302048199.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}, {""label"": ""Assessment report"", ""value"": ""Evaluación de Tecnologías Sanitarias de Andalucía (AETSA). Sistemas de estimación del flujo coronario y de la perfusión miocárdica mediante software de análisis de angiografías. Informe de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2025. The quotations are in Spanish."", ""url"": ""https://www.aetsa.org/download/publicaciones/22_2025_AETSA_-Sistema-de-estimacion-flujo-coronario_web.pdf""}]","{""kind"": ""Official documents""}" AIBD-0783,2019-11-01,event,month,tested,FDA finds that Fifth Eye's AHI flagged hemodynamic instability from a single ECG lead with 95.6% sensitivity in 222 hospital patients,"In a study of 222 patients that FDA reviewed, the Analytic for Hemodynamic Instability flagged low blood pressure with a fast heart rate from one ECG lead with 95.6% sensitivity.",*AHI* flagged unstable circulation from a single ECG lead,95.6% sensitivity,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Analytic for Hemodynamic Instability (AHI),,Fifth Eye Inc.,United States,Fifth Eye (prospective observational study at the University of Michigan Medical Center),United States,"Ann Arbor, Michigan, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational,2,,0,Pre-specified performance goals per window,Sensitivity above 85% and specificity above 75%,Sensitivity 95.6% and specificity 84.9%,measured,persisted,2022-07-14,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200022.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for Analytic for Hemodynamic Instability (AHI) (DEN200022): decision summary. Granted 2021-03-01."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200022.pdf""}]","{""kind"": ""Official documents""}" AIBD-0625,2019-05-01,event,month,tested,FDA De Novo review of Caption Guidance: Nurses with no echo training acquire diagnostic heart ultrasound with AI guidance,"In FDA's review of Caption Guidance, eight nurses new to echocardiography scanned 240 patients with AI guidance. Cardiologists judged left ventricular size assessable in 98.8% of exams.",*Caption Guidance* let nurses take usable heart scans,left ventricular size in 98.8% of exams,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Caption Guidance,,"Caption Health, Inc. (listed as Bay Labs, Inc. in the FDA database)",United States,Northwestern Memorial Hospital and Minneapolis Heart Institute,United States,"Chicago, Illinois, and Minneapolis, Minnesota, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical access,,3,1,3,,1,,organizational; societal,5,,0,Unguided scans of the same patients by trained sonographers,Sonographer exams (reference),Agreement in qualitative visual assessment of 92.5% to 99.6% for primary parameters,measured,scaled,2024-09-19,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8204203,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for Caption Guidance (DEN190040): decision summary. Granted 2020-02-07."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN190040.pdf""}]","{""kind"": ""Official documents""}" AIBD-1007,2019-04-01,event,day,tested,"Four Medicare contractors cover Veracyte's Envisia classifier, finding that it can inform a diagnosis of lung fibrosis without surgical lung biopsy","Four Medicare contractors cover the Envisia test for suspected idiopathic pulmonary fibrosis. In a cited interim analysis, diagnoses with it matched those with histopathology in 92% of 56 cases.",Medicare contractors cover *Envisia* to spare patients lung surgery,the same IPF or non-IPF diagnosis with the classifier as with histopathology in 92% of cases,,found,Found by an assessment body,tested against a standard,very low,aggregate result,false,Envisia Genomic Classifier,,"Veracyte, Inc.",United States,Pulmonologists who order the test for Medicare patients with suspected idiopathic pulmonary fibrosis in the four contractors' jurisdictions,United States,"United States (the Medicare jurisdictions of Palmetto GBA, CGS, Noridian and WPS)",United States,Healthcare (pulmonology),,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,personal,4,,0,Diagnoses that expert multidisciplinary teams made from histopathology for the same patients,,"a 92% categorical agreement in IPF vs non-IPF diagnosis (interim results, n=56)",measured,persisted,2026-05-28,shown,https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37857,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Palmetto GBA, Medicare Administrative Contractor for Jurisdictions J and M. Local Coverage Determination L37857: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test. Original effective date 1 April 2019, revision effective 29 June 2023. CMS Medicare Coverage Database, Summary of Evidence (Clinical Utility)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37857""}, {""label"": ""Assessment report"", ""value"": ""CGS Administrators, Medicare Administrative Contractor for Jurisdiction 15. Local Coverage Determination L37905: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test. Original effective date 20 May 2019, revision effective 28 May 2026. CMS Medicare Coverage Database, Analysis of Evidence (Rationale for Determination)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37905""}, {""label"": ""Assessment report"", ""value"": ""Noridian Healthcare Solutions, Medicare Administrative Contractor for Jurisdictions E and F. Local Coverage Determination L37887: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test. Original effective date 27 May 2019, revision effective 22 January 2026. CMS Medicare Coverage Database, Summary of Evidence (Clinical Utility)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37887""}, {""label"": ""Assessment report"", ""value"": ""Wisconsin Physicians Service Insurance Corporation, Medicare Administrative Contractor for Jurisdictions 5 and 8. Local Coverage Determination L37919: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test. Original effective date 13 May 2019, revision effective 29 June 2023. CMS Medicare Coverage Database, Summary of Evidence (Clinical Utility)."", ""url"": ""https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37919""}]","{""kind"": ""Official documents""}" AIBD-0995,2019-01-01,event,year,mixed,Brazil's Federal Court of Accounts named AI batching of repetitive appeals as one possible reason that Carf's panels outpaced new appeals in 2019,"Brazil's Federal Court of Accounts found that Carf's panels decided more appeals than arrived in 2019, for the first time. It named AI batching of repetitive appeals as one possible reason.",Audit court cites *AI batching* as a possible reason for Carf's output,"22,404 decisions in 2019, up 107.50% from 10,797 in 2017",,found,Found by an auditor,before and after,very low,aggregate result,false,"Artificial intelligence for forming batches of appeals for repetitive judgment (inteligência artificial para formação de lotes de processos para julgamentos repetitivos), not named in the audit",,Not named in the audit,,"Conselho Administrativo de Recursos Fiscais (Carf), Ministry of Economy, through its ordinary and extraordinary panels",Brazil,Brazil,Brazil,Justice administration: administrative tax appeals,,Public sector,Law and Crime,Court Administration,Text and language,Public servants,16,Upper middle income,operational_improvement,Enhanced productivity,,1,4,,2,,,organizational,1,,0,Decisions by Carf's ordinary and extraordinary panels in 2017,10.797 em 2017,22.404 em 2019,measured,unknown,,shown,https://confeb.liveuniversity.com/blog/inteligencia-artificial-no-carf-espantoso-ou-necessario,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Tribunal de Contas da União. Acórdão 336/2021 – TCU – Plenário (TC 038.047/2019-5), relator Ministro Bruno Dantas, session of 24 February 2021. Operational audit of the Conselho Administrativo de Recursos Fiscais (Carf) by the Secretaria de Controle Externo da Gestão Tributária, da Previdência e da Assistência Social (SecexPrevi), report paragraphs 138-140."", ""url"": ""https://contas.tcu.gov.br/sagas/SvlVisualizarRelVotoAc?codFiltro=SAGAS-SESSAO-ENCERRADA&seOcultaPagina=S&item0=736630""}]","{""kind"": ""Official documents""}" AIBD-1012,2019-01-01,event,year,tested,"Korea's Board of Audit and Inspection finds that a rule dropped 422 higher-risk children from e-Child Happiness visits, of whom 14 were later found abused",South Korea's Board of Audit and Inspection found that a rule had dropped 422 children whom the e-Child Happiness model ranked higher. Fourteen of them were later found abused.,*e-Child Happiness* flagged 14 abused children whom a rule left out,Fourteen of them were later found abused,,found,Found by an auditor,tested against a standard,very low,aggregate result,false,e아동행복지원시스템 (e-Child Happiness Support System) risk prediction model,,"Ministry of Health and Welfare (보건복지부), with data processing by the Korea Social Security Information Service (사회보장정보원)",South Korea,"Ministry of Health and Welfare, with local government officials who visit the selected households",South Korea,South Korea (national),South Korea,Child protection,,Social care,Law and Crime,Child Abuse,Prediction from data,Children; Public servants,16,High income,physical_health,Crime reduction or prevention,,,,,,,,personal; organizational,1,,0,The 422 lower-scoring children who were selected while the exclusion rule applied,No confirmed abuse case among the 422 lower-scoring children,14 confirmed abuse cases among the 422 higher-scoring children whom the rule had excluded,measured,scaled,2026-01-26,not shown,https://www.bai.go.kr/api/files/download?fileId=jj20211111%20162757&fileSn=1,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Board of Audit and Inspection of Korea (감사원). 감사보고서 - 보호대상아동 지원실태 - [Performance audit report, support for children in need of protection]. November 2019. Chapter 3, section 2, part 2-2-4, printed pp. 65-70 and [표 44]."", ""url"": ""https://www.bai.go.kr/api/files/download?fileId=jj20211111%20162757&fileSn=1""}]","{""kind"": ""Official documents""}" AIBD-1074,2019-01-01,event,year,tested,China's CMDE finds that endoscopists using EndoScreener missed fewer adenomas in the maker's randomized tandem colonoscopy trial,"In the maker's randomized tandem trial that China's CMDE reviewed, the first colonoscopy missed 20.12% of adenomas with EndoScreener, against 31.25% without it.",*EndoScreener* lowered the rate of missed adenomas in China's review,"missed 20.12% of adenomas with EndoScreener, against 31.25% without it",,found,Found by a regulator,randomized trial,moderate,aggregate result,false,EndoScreener (肠息肉电子结肠内窥镜图像辅助检测软件),Version V1,"Chengdu Wision Medical Device Co., Ltd. (成都微识医疗设备有限公司, the applicant) and Shanghai Wision AI",China,Chengdu Wision Medical Device (registration trial with 223 patients at four US academic medical centers),China,Four US academic medical centers (CMDE's report says only that they were outside China),United States | China,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,Upper middle income; High income,physical_health,Medical diagnosis,,3,1,,,1,,organizational,2,,0,"Colonoscopy without the software as the first exam, with each patient also having the other exam in tandem",31.25% adenoma miss rate with the standard exam first,20.12% adenoma miss rate with the software first,measured,unknown,,shown,https://www.cmde.org.cn/directory/web/cmde/images/1660271573567013524.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:肠息肉电子结肠内窥镜图像辅助检测软件 (technical review report for the registration of colonoscopy polyp image detection-aid software), acceptance no. CQZ2100679, applicant 成都微识医疗设备有限公司. 21 July 2022. Section 四、产品受益风险判定 (benefit-risk determination)."", ""url"": ""https://www.cmde.org.cn/directory/web/cmde/images/1660271573567013524.pdf""}]","{""kind"": ""Official documents""}" AIBD-0784,2018-12-28,source publication,day,tested,FDA finds that Oculogica's EyeBOX missed its goals for accuracy but ruled out concussion with a 94.5% negative predictive value,"In FDA's review of EyeBOX, the eye-tracking test missed its goals for accuracy in 282 patients with head injury, but its negative predictive value was 94.5%.",*EyeBOX* missed its goals for accuracy but helped rule out concussion,its negative predictive value was 94.5%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,EyeBOX,,"Oculogica, Inc.",United States,Oculogica (clinical study in 282 patients with head injury),United States,,,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Pre-specified goals for the lower confidence limits of sensitivity and specificity,Lower limits above 70%,"Sensitivity 80.4% and specificity 66.1%, with neither goal met",measured,persisted,,shown,https://www.technologyreview.com/2018/04/25/240754/looking-concussion-in-the-eye/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for EyeBOX (DEN170091): decision summary. Granted 2018-12-28."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170091.pdf""}]","{""kind"": ""Official documents""}" AIBD-0861,2018-11-16,source publication,day,tested,FDA found that 100 lay users of Bonraybio's LensHooke X1 semen analyzer got results for sperm concentration that closely matched a reference analyzer,"In FDA's review of the LensHooke X1, 100 lay users tested semen with the AI analyzer. Their results for sperm concentration tracked a reference analyzer with a slope of 0.98. The R2 was also 0.98.",*LensHooke X1* let lay users measure sperm concentration accurately,a slope of 0.98 and an R2 of 0.98,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,LensHooke X1 and X1 PRO Semen Quality Analyzer,,"Bonraybio Co., Ltd.",Taiwan,Bonraybio (user performance study with 100 lay users at three evaluation sites),Taiwan,,,Healthcare,,Health,Health,Drug Industry,Images and video,Patients,3,,physical_health,Medical access,,3,1,,,1,,personal,2,,0,A point-of-care professional testing the same samples on the SQA-V reference analyzer,SQA-V results (reference),"Sperm concentration slope 0.98 and R2 0.98, motility slope 0.98 and R2 0.95, morphology slope 0.78 and R2 0.73",measured,persisted,2020-10-28,not shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K180343.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for LensHooke X1 PRO and X1 Semen Quality Analyzer (K180343). Cleared 2018-11-16. Section X.A.4, Accuracy (Instrument), Method Comparison, pp. 9-10."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K180343.pdf""}]","{""kind"": ""Official documents""}" AIBD-0627,2018-05-24,source publication,day,tested,FDA De Novo review of OsteoDetect: 24 clinicians detect wrist fractures more accurately with AI,"In the reader study that FDA reviewed for OsteoDetect, 24 clinicians found distal radius fractures with 80.3% sensitivity when aided, against 74.7% unaided.",*OsteoDetect* helped clinicians find wrist fractures on X-rays,Sensitivity rose from 74.7% to 80.3%,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,OsteoDetect,,"Imagen Technologies, Inc.",United States,Imagen Technologies (reader study with 24 clinicians),United States,United States,United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,3,,1,,organizational,3,,1,The same clinicians reading the same cases without OsteoDetect,"Sensitivity 74.7%, specificity 88.9%","Sensitivity 80.3%, specificity 91.4%",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180005.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for OsteoDetect (DEN180005): decision summary. Granted 2018-05-24."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180005.pdf""}]","{""kind"": ""Official documents""}" AIBD-0622,2018-02-13,source publication,day,tested,"FDA De Novo review of Viz.ai ContaCT: In a test on past scans, stroke alerts came about 51 minutes before usual care","In a retrospective test that FDA reviewed, Viz.ai ContaCT sent its stroke alert in 7.32 minutes on average, against 58.72 minutes for usual-care notification of the specialist.",*ContaCT* alerts came sooner than usual care in a test on past scans,a mean difference of 51.40 minutes,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,ContaCT,,"Viz.ai, Inc.",United States,Viz.ai (standalone performance test on archived CT angiograms),United States,"Two clinical sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Usual-care time from CT angiogram to specialist notification in radiology reports,58.72 minutes mean,7.32 minutes mean,measured,persisted,2025-11-20,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for ContaCT (DEN170073): decision summary. Granted 2018-02-13."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf""}]","{""kind"": ""Official documents""}" AIBD-0687,2018-01-01,event,year,reported,Cour des comptes finds that the Cnam's data mining for CMU-C checks helped raise irregularities found in selected files to 24% in 2018,The Cour des comptes found that data mining by France's national health insurer helped raise the irregularities found in CMU-C files selected for checks to 24% in 2018.,Health insurer's *datamining* model finds more irregular CMU-C files,irregularities found in CMU-C files selected for checks to 24% in 2018,,found,Found by an auditor,no comparison,very low,aggregate result,false,Data-mining model for after-the-fact checks of CMU-C files,,Caisse nationale de l'assurance maladie (Cnam),France,"Caisses primaires d'assurance maladie (CPAM), all funds since June 2019",France,France (national),France,Health insurance (complementary cover for people on low incomes),,Finance,Health,Insurance,Prediction from data,,16,High income,privacy_protection,Fraud detection,,1,4,,3,5,,organizational,2,,0,,,,,challenged,2026-04-27,not shown,https://www.ccomptes.fr/system/files/2020-09/20200908-rapport-Lutte-contre-fraudes-prestations-sociales_0.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Audit report"", ""value"": ""Cour des comptes. La lutte contre les fraudes aux prestations sociales. Communication à la commission des affaires sociales de l’Assemblée nationale, September 2020, p. 51."", ""url"": ""https://www.ccomptes.fr/system/files/2020-09/20200908-rapport-Lutte-contre-fraudes-prestations-sociales_0.pdf""}, {""label"": ""Audit report"", ""value"": ""Défenseur des droits (France) (2026). La lutte contre la fraude aux prestations sociales à l'ère de son industrialisation (rapport, version du 27 avril 2026), Part 3, C.1, discussion of targeting algorithms and protected criteria (p. 36)."", ""url"": ""https://www.defenseurdesdroits.fr/sites/default/files/2026-04/ddd_rapport_fraude-prestations-sociales-2026_20260427.pdf""}, {""label"": ""Follow-up"", ""value"": ""In April 2026 the Défenseur des droits said that an anomaly rate of about 8% in the Cnam's bank-statement control of C2S holders, whose files a learning algorithm mainly selects, raised doubts about proportionality."", ""url"": ""https://www.defenseurdesdroits.fr/sites/default/files/2026-04/ddd_rapport_fraude-prestations-sociales-2026_20260427.pdf""}]","{""kind"": ""Challenges""}" AIBD-0805,2017-08-01,source publication,day,tested,FDA found that CellaVision's Advanced RBC Application met its criteria against manual microscopy when it pre-sorted red cells with neural networks,"In FDA's review of the Advanced RBC Application, operators reviewed its results for five findings on red cells. These matched manual microscopy with 90.6% efficiency.",*Advanced RBC Application* sorted red cells close to manual microscopy,matched manual microscopy with 90.6% efficiency,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Advanced RBC Application (CellaVision DM96 and DM1200),,CellaVision AB,Sweden,CellaVision (method comparison studies at five clinical sites),Sweden,"Five clinical sites, two in the United States and three outside it",United States,Healthcare,,Health,Health,Drug Industry,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Manual microscopy of the same smears,Manual microscopy (reference),"Efficiency 90.6%, sensitivity 85% and specificity 93.6% for schistocytes, target cells, sickle cells, tear drop cells and parasites",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K171315.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision memorandum for the Advanced RBC Application on CellaVision DM96 and DM1200 (K171315). Cleared 2017-08-01."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K171315.pdf""}]","{""kind"": ""Official documents""}" AIBD-0628,2017-07-19,source publication,day,tested,FDA De Novo review of QuantX: Radiologists' breast MRI accuracy rises modestly with AI analysis,"In the reader study that FDA reviewed for QuantX, 19 radiologists reading 111 breast MRI cases raised their AUC from 0.7055 to 0.7575 with the software.",*QuantX* gave radiologists a small gain on breast MRI,rose from 0.7055 to 0.7575,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,QuantX,,"Quantitative Insights, Inc.",United States,Quantitative Insights (reader study with 19 radiologists),United States,United States,United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,2,,0,The same radiologists reading the same cases without QuantX,AUC 0.7055,AUC 0.7575,measured,persisted,2021-08-03,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170022.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for QuantX (DEN170022): decision summary. Granted 2017-07-19."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170022.pdf""}]","{""kind"": ""Official documents""}" AIBD-0621,2017-07-01,event,month,tested,FDA De Novo review of IDx-DR: Autonomous AI detects diabetic retinopathy in a 900-person primary care trial,"In the trial that FDA reviewed for the IDx-DR De Novo grant, the AI found more than mild diabetic retinopathy in primary care with 87.4% sensitivity. Specificity was 89.5%.",An autonomous eye exam passed its trial in primary care clinics,an observed sensitivity of 87.4%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,IDx-DR,,"IDx, LLC",United States,Ten primary care sites in the IDx-DR pivotal trial,United States,"Ten primary care sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,3,,,,organizational; societal,14,,0,Pre-specified FDA performance goals for sensitivity and specificity,Goals of 85.0% sensitivity and 82.5% specificity,87.4% observed sensitivity and 89.5% observed specificity,measured,scaled,2025-09-04,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC6550188,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for IDx-DR (DEN180001): decision summary. Granted 2018-04-11."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180001.pdf""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), for the Spanish Network of HTA Agencies (RedETS) and the Ministry of Health (2025). Sistema de detección automática de retinopatía diabética mediante inteligencia artificial (IA) (Ficha de evaluación de tecnologías nuevas y emergentes), X. Puntos clave (PDF p. 72)."", ""url"": ""https://redets.sanidad.gob.es/productos/buscarProductos.do?metodo=descargarFichero&idProducto=1301""}, {""label"": ""Assessment report"", ""value"": ""Blue Cross & Blue Shield of Rhode Island (BCBSRI), Medical Coverage Policy (2025). Medical Coverage Policy: Retinal Telescreening for Diabetic Retinopathy (effective 1 March 2023, last reviewed 16 April 2025), Background, evidence summary for digital retinal imaging with automated image interpretation (pp. 2-3)."", ""url"": ""https://www.bcbsri.com/providers/sites/providers/files/policies/2025/04/2025%20Retinal%20Telescreening%20for%20Diabetic%20Retinopathy.pdf""}, {""label"": ""Assessment report"", ""value"": ""New York State Department of Health, Medicaid Evidence Based Benefit Review Advisory Committee (EBBRAC); health technology assessment prepared under contract by the Center for Evidence-based Policy, Oregon Health & Science University (2026). AI-Enabled Devices for Autonomous Detection of Diabetic Retinopathy: Health Technology Assessment (July 2026), Executive Summary, Conclusions (pp. 10-11); Clinical Utility (p. 6)."", ""url"": ""https://www.health.ny.gov/health_care/medicaid/ebbrac/2026/docs/2023-07-23_diabetic_retinopathy.pdf""}, {""label"": ""Assessment report"", ""value"": ""New York State Medicaid Evidence Based Benefit Review Advisory Committee (EBBRAC), New York State Department of Health (2026). EBBRAC Meeting Summary, 23 July 2026: AI-Enabled Devices for Autonomous Screening for Diabetic Retinopathy (recommendation for coverage), Topic: AI-Enabled Devices for Autonomous Screening for Diabetic Retinopathy; recommendation development and vote (pp. 9-15)."", ""url"": ""https://www.health.ny.gov/health_care/medicaid/ebbrac/meetings/2026/docs/2023-07-23_meeting_summary.pdf""}, {""label"": ""Assessment report"", ""value"": ""BlueCross BlueShield of Tennessee (BCBST), Medical Policy Manual (2026). Retinal Telescreening for Diabetic Retinopathy (BCBST medical policy; original effective date 14 January 2012, most recent review 8 January 2026), Policy; Sources (evidence levels assigned by BCBST)."", ""url"": ""https://www.bcbst.com/mpmanual/Retinal_Telescreening_for_Diabetic_Retinopathy_.htm""}, {""label"": ""Assessment report"", ""value"": ""Triple-S Salud (Grupo Triple-S, Blue Cross Blue Shield licensee in Puerto Rico), Medical Policy 09.003.013 (2025). Retinal Telescreening for Diabetic Retinopathy (Medical Policy 09.003.013, last review 9 May 2025, since archived), Summary of Evidence; Rationale, Population Reference No. 2: Automated Image Interpretation (Policy Statement: Medically Necessary)."", ""url"": ""https://salud.grupotriples.com/medicalpolicy/docs/09.003.013.html""}, {""label"": ""Assessment report"", ""value"": ""Anthem Blue Cross and Blue Shield (Elevance Health), Medical Policy and Technology Assessment Committee (MPTAC), Clinical UM Guideline CG-MED-35 (2026). Clinical UM Guideline CG-MED-35: Retinal Telescreening Systems (last review 19 February 2026, published 15 April 2026), Summary for Members and Families, 'What the Studies Show'; Clinical Indications; Coding (CPT 92229 covered when criteria are met); Discussion."", ""url"": ""https://www.anthem.com/dam/medpolicies/abcbs/active/guidelines/gl_pw_a053783.html""}, {""label"": ""Assessment report"", ""value"": ""Blue Shield of California, Medical Policy 9.03.13 (2023). Medical Policy 9.03.13: Retinal Telescreening for Diabetic Retinopathy (effective 1 June 2023), Policy Statement II; Rationale, digital retinal imaging with automated image interpretation (chain of evidence)."", ""url"": ""https://npe-www.blueshieldca.com/content/dam/bsca/en/provider/docs/2023/June/PRV_Retinal_Telescreening_Diabetic_Retinopathy.pdf""}, {""label"": ""Assessment report"", ""value"": ""Blue Cross Blue Shield of Michigan and Blue Care Network (BCBSM/BCN), Joint Medical Policy (2026). Joint Medical Policy: Retinal Care for Diabetic Retinopathy (current policy effective date 1 January 2026), Medical Policy Statement; Rationale, automated image interpretation (Artificial Intelligence Technology)."", ""url"": ""https://www.bcbsm.com/amslibs/content/dam/public/mpr/mprsearch/pdf/2018850.pdf""}, {""label"": ""Assessment report"", ""value"": ""BlueCross BlueShield of South Carolina, Medical Policy CAM 90313 (2024). Retinal Telescreening for Diabetic Retinopathy - CAM 90313 (annual review 8 October 2024; archived copy), Policy; Rationale, digital retinal imaging with automated image interpretation (chain of evidence)."", ""url"": ""https://web.archive.org/web/20260116192235id_/https://www.southcarolinablues.com/web/public/brands/medicalpolicy/external/external-policies/retinal-telescreening-for-diabetic-retinopathy/""}, {""label"": ""Assessment report"", ""value"": ""Oregon Health Evidence Review Commission (HERC), Oregon Health Authority, with its Value-based Benefits Subcommittee (VbBS) (2020). HERC and VbBS meeting materials, 1 October 2020: 2021 CPT Code Review, Automated Analysis of Retinal Imaging (CPT 92229), VbBS Issue Summaries, '2021 CPT Code Review: Automated Analysis of Retinal Imaging', HERC staff summary and recommendation."", ""url"": ""https://www.oregon.gov/oha/HPA/DSI-HERC/MeetingDocuments/HERC%20Materials%2010-1-2020.pdf""}]","{""kind"": ""Official documents""}" AIBD-0791,2017-06-28,source publication,day,tested,FDA finds that Nevisense detected 95.9% of melanomas among lesions chosen for excision,"In FDA's review of Nevisense, the device detected 256 of 267 melanomas (95.9%) at 31.3% specificity. With its output, dermatologists' sensitivity rose from 77.2% to 83.6%.",*Nevisense* caught nearly all melanomas at low specificity,256 of 267 melanomas (95.9%),,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Nevisense (electrical impedance spectroscopy with a trained lesion classifier),,SciBase AB,Sweden,"Dermatology sites in the SIMPS study in Europe and the United States, and 41 US dermatologists in a reader study",,Twenty-two dermatology sites in Europe and the United States,United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,2,,1,,organizational,3,,0,The same dermatologists judging the same lesion images without the device output,Sensitivity 77.2%,Sensitivity 83.6%,measured,scaled,2026-04-07,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150046B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P150046: Nevisense. Approved 2017-06-28."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150046B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0806,2017-06-01,event,month,tested,FDA found that the FluChip-8G Influenza A+B Assay agreed with a cleared molecular test on 984 swab specimens when read by trained neural networks,"In FDA's review of FluChip-8G, sensitivity against a cleared molecular test was 87.9% for influenza A, with 98.8% specificity. For influenza B, sensitivity was 100.0%, with 99.8% specificity.",*FluChip-8G* read by neural networks matched a cleared influenza test,sensitivity was 87.9% for influenza A and 100.0% for influenza B,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,FluChip-8G Influenza A+B Assay,,"InDevR, Inc.",United States,InDevR (clinical study at three US testing sites on archived surveillance swabs),United States,United States,United States,Healthcare,,Health,Health,Drug Industry,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,An FDA-cleared influenza molecular assay on the same specimens,Comparator assay results (reference),"Sensitivity 87.9% and specificity 98.8% for influenza A, 100.0% and 99.8% for influenza B",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf""}]","{""kind"": ""Official documents""}" AIBD-2303,2017-04-01,event,month,tested,"IQWiG's benefit assessment of fundus photography: in the study with EyeArt as the only reader, photographs found 96.6% of diabetic retinopathy that needs work-up, against 28.0% for ophthalmoscopy","IQWiG drew on a U.S. study in which EyeArt alone read retinal photographs of 521 people with diabetes. It found 96.6% of retinopathy that needs work-up, against 28.0% for dilated eye exams.",*EyeArt* found more diabetic eye disease than dilated eye exams,96.6%,,found,Found by an assessment body,tested against a standard,very low,program,false,EyeArt,,"Eyenuk, Inc.",United States,"10 study centers in the United States (trial), with an assessment for German statutory health care",United States,United States (trial) and Germany (assessment),United States | Germany,Healthcare (diabetic eye screening),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Ophthalmologists' examination of the same people with dilated pupils,"Sensitivity 28.0%, specificity 99.6%","Sensitivity 96.6%, specificity 86.7%",measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC9636573/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}, {""label"": ""Assessment report"", ""value"": ""Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Fundusfotografie zur Diagnostik der diabetischen Retinopathie. Abschlussbericht D25-01, dated 9 July 2026 and published in August 2026. doi:10.60584/D25-01. IQWiG is Germany's institute for the assessment of benefits in health care, and the Federal Joint Committee commissioned the report. The quotations are in German."", ""url"": ""https://www.iqwig.de/download/d25-01_fundusfotografie-zur-diagnostik-der-diabetischen-retinopathie_abschlussbericht_v1-0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0792,2017-03-24,source publication,day,tested,FDA finds that radiologists read 3D mammograms 29.2% faster with iCAD's PowerLook Tomo Detection Software at non-inferior accuracy,"In a reader study that FDA reviewed, 20 radiologists read 240 tomosynthesis exams 29.2% faster with PowerLook Tomo Detection Software. Their AUC was non-inferior.",*PowerLook Tomo* cut radiologists' reading time on 3D mammograms,29.2% faster,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,iCAD PowerLook Tomo Detection Software,,"iCAD, Inc.",United States,iCAD (reader study with 20 radiologists on 240 GE tomosynthesis cases),United States,"San Antonio, Texas, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,,2,1,,,1,,organizational,2,,0,The same radiologists reading the same cases without the software,AUC 0.841,"AUC 0.850, with reading time 29.2% shorter",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160009B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P160009: PowerLook Tomo Detection Software. Approved 2017-03-24."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160009B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0928,2017-03-01,event,month,tested,France's HAS rated the DBLG1 closed-loop insulin system a moderate improvement over a pump used with a sensor after a 12-week trial,HAS found that people using the DBLG1 closed loop spent 68.5% of the time in the target glucose range against 59.4% on pump and sensor alone. It rated the gain as moderate.,*DBLG1* closed loop kept glucose in range longer in a French trial,68.5% of the time in the target glucose range against 59.4%,,found,Found by an assessment body,randomized trial,moderate,aggregate result,false,DBLG1 System,DBLG1 algorithm v2017.04.20 in the SP7 trial (listed system: software version 1.3.0 of 16 May 2019),Diabeloop,France,12 French diabetes centers in the SP7 randomized crossover trial,France,France (12 trial centers),France,Healthcare (type 1 diabetes),,Health,Health,Disease Prevention,Prediction from data; Machines that act,Patients,3,High income,physical_health,,,,3,,,5,,personal,1,,0,Open-loop systems in which an insulin pump and a glucose sensor work independently,"59,4 (± 1,3) % of time in 70-180 mg/dL with pump and sensor in the SP7 trial","68,5 (± 1,2) % with DBLG1, rated amélioration modérée du service attendu (ASA III)",measured,scaled,2024-12-17,shown,https://www.has-sante.fr/upload/docs/evamed/CNEDIMTS-5998_DBLG1%205998_occultation.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Haute Autorité de santé, Commission nationale d'évaluation des dispositifs médicaux et des technologies de santé (CNEDiMTS). Avis de la CNEDiMTS du 28 janvier 2020, DBLG1, système de boucle semi-fermée dédié à la gestion automatisée du diabète de type 1 (dossier 5998, version publiée après occultation). Section 06.2, Niveau(x) d'ASA."", ""url"": ""https://www.has-sante.fr/upload/docs/evamed/CNEDIMTS-5998_DBLG1%205998_occultation.pdf""}]","{""kind"": ""Official documents""}" AIBD-0832,2016-12-02,source publication,day,intended,"The Supreme Court of Victoria ordered technology assisted review for about 1.4 million documents that would take over 23,000 hours to review by hand","In December 2016 the Supreme Court of Victoria ordered technology assisted review for about 1.4 million documents. It said that manual review would take a junior solicitor over 23,000 hours.",Victorian court orders *TAR* for 1.4 million pipeline documents,"over 23,000 hours",,found,Found by a court,,very low,benefit created,false,Predictive coding technology (TAR or Technology Assisted Review),,Not named in the judgment,,"McConnell Dowell Constructors (Aust) Pty Ltd (plaintiff), with the agreement of all parties",Australia,"Melbourne, Australia",Australia,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,"Manual review of 1,400,000 documents at one minute each","over 23,000 hours, equating to over 583 working weeks",,assumed,persisted,,shown,https://web.archive.org/web/20251018042102if_/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/vic/VSC/2016/734.html,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Supreme Court of Victoria, Commercial Court, Technology, Engineering and Construction List (Vickery J). McConnell Dowell Constructors (Aust) Pty Ltd v Santam Ltd & Ors (No 1) [2016] VSC 734, 2 December 2016. AustLII copy, read through the Internet Archive."", ""url"": ""https://web.archive.org/web/20251018042102if_/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/vic/VSC/2016/734.html""}]","{""kind"": ""Official documents""}" AIBD-0793,2016-11-09,source publication,day,tested,"FDA finds that radiologists read automated breast ultrasound a third faster with QView's QVCAD, with non-inferior cancer detection","In a reader study that FDA reviewed, 18 radiologists took 144 seconds per ultrasound case with QVCAD against 215 seconds without it, with non-inferior AUC.",*QVCAD* cut reading time for breast ultrasound by a third,a 71-second or 33% reduction,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,QVCAD System,,"QView Medical, Inc.",United States,QView Medical (reader study with 18 radiologists on 185 automated breast ultrasound cases),United States,United States,United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,,2,1,,,1,,organizational,2,,0,The same radiologists reading the same cases without QVCAD,215 seconds per case,144 seconds per case,measured,scaled,2017-12-21,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150043B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P150043: QVCAD System. Approved 2016-11-09."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150043B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0831,2016-05-17,source publication,day,intended,"The High Court in London ordered predictive coding over a petitioner's objection, finding that it would cost about £132,000 against at least £250,000","In May 2016 Mr Registrar Jones ordered disclosure by predictive coding over the petitioner's objection. He found that it would cost about £132,000, against at least £250,000 for a keyword search.","Court orders *predictive coding* at £132,000 over a keyword search","about £132,000, against at least £250,000",,found,Found by a court,,very low,benefit created,false,Predictive coding,,Not named in the judgment,,BCA Trading Ltd and the other respondents,United Kingdom,"London, United Kingdom",United Kingdom,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,A keyword search approach to disclosure,"at least £250,000 (and indeed I believe that figure may even reach £338,000 on a worst case scenario)","in the region of £132,000",assumed,persisted,2018-08-28,shown,https://web.archive.org/web/20251018042102if_/https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/vic/VSC/2016/734.html,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""High Court of Justice, Chancery Division, Companies Court (Mr Registrar Jones). Brown v BCA Trading Ltd & Ors [2016] EWHC 1464 (Ch), approved judgment of 17 May 2016. Find Case Law copy."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/ch/2016/1464""}]","{""kind"": ""Official documents""}" AIBD-0830,2016-02-16,source publication,day,intended,"The High Court in London approved predictive coding software for over 3 million documents, finding no evidence that it gives less accurate disclosure",In February 2016 Master Matthews approved predictive coding for over 3 million documents. He found no evidence that it gives less accurate disclosure. He judged it far cheaper than manual review.,English court approves *predictive coding* for 3 million documents,over 3 million documents,,found,Found by a court,,very low,benefit created,false,Predictive coding software,,Not named in the judgment,,"MWB Business Exchange Ltd (second claimant), with the agreement of all parties",United Kingdom,"London, United Kingdom",United Kingdom,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,A full manual review of over 3 million documents,several million pounds at least,"£181,988 plus monthly hosting costs of £15,717, to £469,049 plus monthly hosting costs of £20,820",assumed,unknown,,shown,https://caselaw.nationalarchives.gov.uk/ewhc/ch/2016/256,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""High Court of Justice, Chancery Division (Master Matthews). Pyrrho Investments Ltd & Anor v MWB Property Ltd & Ors [2016] EWHC 256 (Ch), approved judgment of 16 February 2016. Find Case Law copy, a scan of the approved judgment."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/ch/2016/256""}, {""label"": ""Court document"", ""value"": ""High Court of Justice, Chancery Division, Companies Court (Mr Registrar Jones). Brown v BCA Trading Ltd & Ors [2016] EWHC 1464 (Ch), 17 May 2016, para. 10, quoting Pyrrho para. 33 with its cost estimates."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/ch/2016/1464""}]","{""kind"": ""Official documents""}" AIBD-0829,2015-03-03,source publication,day,intended,"The High Court of Ireland approved technology assisted review for 680,809 documents, finding predictive coding at least as accurate as manual review","In March 2015 the High Court of Ireland approved predictive coding for 680,809 documents over the defendants' objection. It found that the method was at least as accurate as manual review.","Irish court backs *predictive coding* for 680,809 bank documents","less than 10% of the 680,809 documents",,found,Found by a court,,very low,benefit created,false,Technology assisted review using predictive coding,,"Not named in the judgment (the bank's expert took his target f-measure from Symantec, the provider of the Clearwell system)",,"Irish Bank Resolution Corporation and its solicitors, in discovery",Ireland,"Dublin, Ireland",Ireland,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,"Manual (linear) review of the 680,809 documents","9 months at a cost of €2 m by the bank's solicitor's estimate, or 113 days at €220,000 by the defendants' expert's","less than 10% of the 680,809 documents would need to be manually reviewed",assumed,persisted,2016-03-01,shown,https://web.archive.org/web/20240428025752if_/https://www.bailii.org/ie/cases/IEHC/2015/H175.html,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""High Court of Ireland (Fullam J.). Irish Bank Resolution Corporation Ltd & ors v Quinn & ors [2015] IEHC 175, judgment of 3 March 2015. BAILII copy, read through the Internet Archive."", ""url"": ""https://web.archive.org/web/20240428025752if_/https://www.bailii.org/ie/cases/IEHC/2015/H175.html""}]","{""kind"": ""Official documents""}" AIBD-0981,2015-03-02,source publication,day,intended,"A New York federal court approved Rio Tinto and Vale's agreed TAR protocol, stressing that TAR must face no higher standard than manual review",In March 2015 a US magistrate judge approved Rio Tinto and Vale's protocol for predictive coding. He wrote that TAR must face no higher standard than manual review. He wrote the same of keywords.,Federal court approves a *TAR* protocol agreed by Rio Tinto and Vale,,,found,Found by a court,,very low,benefit created,false,"Relativity Assisted Review (Rio Tinto) and Deloitte's Dynamic Review (Vale), under a stipulated predictive coding protocol",,"Relativity (Relativity Assisted Review) and Deloitte (Dynamic Review), as the parties' letter attached to the opinion names the tools",United States (Relativity); not verified for Deloitte,"Rio Tinto plc (plaintiff), with its vendor Precision Discovery, and Vale S.A. (defendant)",United Kingdom and Brazil,"New York, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Keyword searches or manual review,,,assumed,persisted,2015-07-15,shown,https://static.case.law/frd/306/html/0125-01.html,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Southern District of New York (Magistrate Judge Andrew J. Peck). Rio Tinto PLC v. Vale S.A., 306 F.R.D. 125 (S.D.N.Y. 2015), Opinion and Order of 2 March 2015, with the parties' letter and stipulated protocol attached as an appendix. Caselaw Access Project copy of the Federal Rules Decisions report."", ""url"": ""https://static.case.law/frd/306/html/0125-01.html""}]","{""kind"": ""Official documents""}" AIBD-0786,2014-11-17,source publication,day,tested,FDA finds that the BrainScope Ahead 100 missed its endpoints for accuracy but ruled out brain injury on CT with an 89.5% negative predictive value,"In FDA's review of the BrainScope Ahead 100, the EEG test missed its endpoints for accuracy in 552 patients with head injury. Its negative predictive value for injury on CT was 89.5%.",*Ahead 100* EEG test missed its goals but helped rule out injury on CT,negative predictive value for injury on CT was 89.5%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,BrainScope Ahead 100 (Models CV-100 and M-100),,"BrainScope Company, Inc.",United States,BrainScope (B-AHEAD II study at 11 US emergency department sites),United States,"Eleven emergency department sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Pre-specified endpoints for the lower confidence limits of sensitivity and specificity,Lower limits above 78% for sensitivity and 50% for specificity,"Sensitivity 78.5% and specificity 48.6%, with the endpoints missed",measured,persisted,2015-05-15,shown,https://www.brainscope.com/sciencetechnology,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for BrainScope Ahead 100, Models CV-100 and M-100 (DEN140025): decision summary. Granted 2014-11-17."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN140025.pdf""}]","{""kind"": ""Official documents""}" AIBD-0833,2014-09-17,source publication,day,intended,"The US Tax Court let two taxpayers answer a discovery request from the IRS with predictive coding, crediting an estimate of $80,000 to $85,000 for review","In September 2014 the US Tax Court allowed predictive coding over the IRS's objection. It credited an estimate of 200,000 to 400,000 documents to review at $80,000 to $85,000.",Tax Court lets taxpayers use *predictive coding* though the IRS objects,"200,000 to 400,000 documents to review at $80,000 to $85,000",,found,Found by a court,,very low,benefit created,false,Predictive coding,,Not named in the opinion,,"Dynamo Holdings Limited Partnership and Beekman Vista, Inc. (petitioners)",United States,United States,United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,"Review under the Commissioner's approach, a privilege search of all restored data","3.5 million to 7 million documents at a cost of $500,000 to $550,000","200,000 to 400,000 documents at a cost of $80,000 to $85,000",assumed,litigated,2016-07-13,shown,https://static.case.law/tc/143/html/0183-01.html,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States Tax Court (Judge Ronald L. Buch). Dynamo Holdings Ltd. Partnership v. Commissioner, 143 T.C. 183 (2014), opinion of 17 September 2014. Caselaw Access Project copy of the Tax Court report."", ""url"": ""https://static.case.law/tc/143/html/0183-01.html""}, {""label"": ""Follow-up"", ""value"": ""The review ran, and the Commissioner moved to compel more documents. On 13 July 2016 the court denied the motion and held that the response was complete."", ""url"": ""https://www.ediscoverylaw.com/wp-content/uploads/2016/08/Dynamo-II-Order.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0812,2014-08-11,source publication,day,tested,"FDA found that Cologuard detected 92.3% of colorectal cancers against 73.8% for a fecal immunochemical test, at lower specificity","In FDA's review of Cologuard, the stool DNA test detected 92.3% of colorectal cancers against 73.8% for FIT in 9,989 adults. Its specificity was 86.6% against 94.9%.",*Cologuard* caught more colorectal cancers than a standard stool test,detected 92.3% of colorectal cancers against 73.8% for FIT,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Cologuard,,Exact Sciences Corporation,United States,Exact Sciences (DeeP-C study at 90 sites in the United States and Canada),United States,90 sites in the United States and Canada,United States | Canada,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,,,2,,,,organizational,2,,0,A commercial fecal immunochemical test (OC FIT-CHEK) in the same adults,"Sensitivity 73.8% for colorectal cancer, specificity 94.9%","Sensitivity 92.3%, specificity 86.6%",measured,scaled,2024-10-04,not shown,https://www.accessdata.fda.gov/cdrh_docs/pdf13/P130017B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for Cologuard (P130017). Approved 2014-08-11."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf13/P130017B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0983,2014-07-22,source publication,day,intended,"A Tennessee federal court let Bridgestone review over two million documents with predictive coding over IBM's objection, citing efficient discovery","In July 2014 a US magistrate judge let Bridgestone review over two million documents with predictive coding, over IBM's objection. He cited Rule 26's call for efficient discovery.",Court lets Bridgestone use *predictive coding* over IBM's objection,over two million documents,,found,Found by a court,,very low,benefit created,false,Predictive coding,,Not named in the order,,"Bridgestone Americas, Inc. (plaintiff), with its attorneys, experts and the companies doing the work",United States,"Nashville, Tennessee, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,,,,,challenged,2015-02-05,shown,https://storage.courtlistener.com/recap/gov.uscourts.tnmd.57186/gov.uscourts.tnmd.57186.89.0.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Middle District of Tennessee (Magistrate Judge Joe B. Brown). Bridgestone Americas, Inc. v. International Business Machines Corp., No. 3:13-1196, Order (Doc. 89), 22 July 2014. CourtListener RECAP copy of the filed order."", ""url"": ""https://storage.courtlistener.com/recap/gov.uscourts.tnmd.57186/gov.uscourts.tnmd.57186.89.0.pdf""}, {""label"": ""Follow-up"", ""value"": ""In January 2015 the parties told the court that some seed set documents listed as nonresponsive were in fact responsive, and the magistrate judge reminded both sides that he expected full transparency. A later opinion in another case recounts this."", ""url"": ""https://static.case.law/frd/306/html/0125-01.html""}]","{""kind"": ""Challenges""}" AIBD-0787,2013-08-21,source publication,day,tested,FDA finds that VITEK MS correctly identified 87.5% of 7068 isolates from patient cultures with a machine-learned classifier of spectra,"In a study in five US clinical laboratories that FDA reviewed, VITEK MS gave a correct single identification for 87.5% (6184/7068) of isolates from patient cultures.",*VITEK MS* identified microbes from patient cultures in five labs,87.5% (6184/7068),,found,Found by a regulator,no comparison,very low,aggregate result,false,VITEK MS (MALDI-TOF mass spectrometry with the Advanced Spectrum Classifier),VITEK MS V2.0 Knowledge Base,"bioMérieux, Inc.",United States,Five US clinical microbiology laboratories in the prospective clinical study,United States,"Five clinical microbiology laboratories, United States",United States,Healthcare,,Health,Health,Drug Industry,Prediction from data,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,1,,0,,,,,scaled,2017-07-22,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K124067.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of Automatic Class III Designation (De Novo) for VITEK MS (K124067 / DEN130013): decision summary. Granted 2013-08-21."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K124067.pdf""}]","{""kind"": ""Official documents""}" AIBD-0988,2012-04-23,source publication,day,intended,"The Circuit Court for Loudoun County, Virginia, let the Landow defendants use predictive coding in the Dulles Jet Center cases over objections",In April 2012 a Virginia state court let defendants use predictive coding over objections. The suits concerned a hangar collapse at Dulles Jet Center. The order gives no reasons.,Virginia court lets defendants use *predictive coding* over objections,,,found,Found by a court,,very low,benefit created,false,Predictive coding,,Not named in the order or in the defendants' memorandum,,"Landow Aviation Limited Partnership, Landow Aviation I, Inc. and Landow & Company Builders, Inc. (defendants)",United States,"Loudoun County, Virginia, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,,,,,persisted,2013-01-21,shown,https://www.ediscoverylaw.com/wp-content/uploads/2013/11/MemoSupportPredictiveCoding.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Circuit Court for Loudoun County, Virginia (Judge James H. Chamblin). Global Aerospace Inc., et al. v. Landow Aviation, L.P. d/b/a Dulles Jet Center, et al., Consolidated Case No. CL 61040, Order Approving the Use of Predictive Coding for Discovery, entered 23 April 2012. Copy of the signed order on the eDiscovery Law blog of K&L Gates."", ""url"": ""https://www.ediscoverylaw.com/wp-content/uploads/2013/11/Order-Approving-Predictive-Coding-.pdf""}]","{""kind"": ""Official documents""}" AIBD-0828,2012-02-24,source publication,day,intended,"A New York federal court approved predictive coding with Axcelerate for over three million emails, finding it superior to manual review",In February 2012 a US magistrate judge approved predictive coding with Recommind's Axcelerate for over three million emails. He found that it beat manual review.,Federal court approves *Axcelerate* for three million emails,over three million emails,,found,Found by a court,,very low,benefit created,false,Axcelerate software by Recommind (predictive coding),,Recommind,United States,"MSL Group (defendant), with its counsel Jackson Lewis LLP",United States,"New York, United States",United States,Legal services / e-discovery,,Work and industry,Law and Crime,Court Administration,Text and language,Other workers,16,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,1,,0,Linear manual review or keyword searches,,,assumed,litigated,,shown,https://static.case.law/frd/287/html/0182-01.html,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""United States District Court for the Southern District of New York (Magistrate Judge Andrew J. Peck). Moore v. Publicis Groupe & MSL Group, 287 F.R.D. 182 (S.D.N.Y. 2012), Opinion and Order, 24 February 2012. Caselaw Access Project copy of the Federal Rules Decisions report."", ""url"": ""https://static.case.law/frd/287/html/0182-01.html""}, {""label"": ""Follow-up"", ""value"": ""The plaintiffs objected, and District Judge Andrew L. Carter Jr. adopted the rulings in April 2012, as Master Matthews recounts in a later English judgment."", ""url"": ""https://caselaw.nationalarchives.gov.uk/ewhc/ch/2016/256""}]","{""kind"": ""Legal proceedings""}" AIBD-0910,2010-07-01,event,month,tested,EPA approves trained Pavilion8 models in place of hardware analyzers for NOx on seven turbines in Arkansas after they passed its tests of accuracy,"EPA found that trained Pavilion8 models matched hardware analyzers for NOx on seven turbines in Arkansas, with relative accuracy of 1.38% to 3.15%. It approved them in their place.",EPA lets *Pavilion8 PEMS* stand in for NOx analyzers in Arkansas,relative accuracy of 1.38% to 3.15%,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Pavilion8 Software PEMS (predictive emission monitoring systems) on Units G1 through G7,,"Rockwell Automation (maker of Pavilion8, which the letter names only as a product)",United States,"Arkansas Electric Cooperative Corporation (AECC), Harry L. Oswald Generating Station",United States,"Pulaski County, Arkansas, United States",United States,Air emissions monitoring (power generation),,Environment,Environment,Air Pollution,Prediction from data,,,High income,operational_improvement,,,1,1,,,1,,organizational,1,,0,Certified hardware NOx analyzers (CEMS) on the same turbines,,"Relative accuracy of 1.38% to 3.15% across the seven units, with all three statistical tests passed",measured,persisted,2015-03-16,shown,https://www.epa.gov/sites/default/files/2015-05/documents/harry_l._oswald_generating_station_0.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Letter to the Arkansas Electric Cooperative Corporation approving alternative monitoring systems (PEMS) for Units G1 through G7 at the Harry L. Oswald Generating Station (ORISPL 55221), signed by Reid Harvey, Director, 21 November 2012."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/harry_l._oswald_generating_station_0.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Environmental Protection Agency, Clean Air Markets Division. Letter to the Arkansas Electric Cooperative Corporation, 21 November 2012. Background."", ""url"": ""https://www.epa.gov/sites/default/files/2015-05/documents/harry_l._oswald_generating_station_0.pdf""}]","{""kind"": ""Official documents""}" AIBD-0905,2010-05-12,source publication,day,tested,FDA found that white cell differentials from Medica's EasyCell correlated 0.93 to 0.99 with manual microscopy after a neural network preclassified the cells,"In FDA's review, technologists reviewed EasyCell's white cell differentials on 304 specimens. These correlated with manual microscopy at 0.93 to 0.99, including 0.99 for neutrophils.",*EasyCell*'s white cell counts track manual microscopy in FDA's review,correlation coefficients of 0.99 for neutrophils,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,EasyCell Cell Locator (EasyCell),,Medica Corporation,United States,Medica Corporation (method comparison study at three sites),United States,Three study sites (not named in the decision summary),,Healthcare (laboratory hematology),,Health,Health,Drug Industry,Images and video,Health workers,3,,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Manual WBC differential by microscopy on the same specimens,Manual 200-cell differential (reference),"Correlation coefficient 0.99 for neutrophils, 0.98 for lymphocytes, 0.97 for eosinophils and 0.93 for monocytes",measured,persisted,2023-04-24,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K092116.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary, k092116: EasyCell Cell Locator (Medica Corporation). Decision date 12 May 2010."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K092116.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary, k092116: EasyCell Cell Locator (Medica Corporation). Principles of operation."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K092116.pdf""}]","{""kind"": ""Official documents""}" AIBD-0808,2008-07-30,source publication,day,tested,FDA found that the machine-learned Pathwork Tissue of Origin Test agreed with the known diagnosis for most of 545 tumor specimens,"In FDA's review of the Pathwork Tissue of Origin Test, results agreed with the available diagnosis for 86.3% of metastatic and 92.0% of primary tumor specimens among 545.",*Pathwork Tissue of Origin Test* matched the known origin of most tumors,86.3% of metastatic and 92.0% of primary tumor specimens,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,Pathwork Tissue of Origin Test,,"Pathwork Diagnostics, Inc.",United States,Pathwork Diagnostics (clinical validation at four processing laboratories),United States,,,Healthcare,,Health,Health,Drug Industry,Prediction from data,Patients,3,,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,The available diagnosis for each specimen,Available diagnosis (reference),Agreement for 86.3% of metastatic and 92.0% of primary tumor specimens,measured,persisted,2013-08-26,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K080896.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for the Pathwork Tissue of Origin Test (K080896). Cleared 2008-07-30."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K080896.pdf""}]","{""kind"": ""Official documents""}" AIBD-0813,2007-02-06,source publication,day,tested,FDA found that the 70-gene signature of MammaPrint separated patients with node-negative breast cancer by risk of metastasis in an independent validation,"In FDA's review of MammaPrint, 95% of low risk patients were free of distant metastasis at five years, against 78% of high risk patients. The validation covered 302 European patients.",*MammaPrint* separated node-negative breast cancers by risk of spread,95% of low risk and 78% of high risk patients were free of distant metastasis,,found,Found by a regulator,tested against a standard,very low,aggregate result,false,MammaPrint,,Agendia BV,Netherlands,TRANSBIG consortium (independent validation on tumors from five European centers),,"Villejuif and Saint-Cloud, France; Stockholm, Sweden; London and Oxford, United Kingdom",France | Sweden | United Kingdom,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,,,,,,,,,organizational,1,,0,Clinical risk assessment with Adjuvant on-line,Unadjusted hazard ratio of 2.32 (95% CI: 1.35 to 4.00),Hazard ratio of 2.13 (95% CI: 1.19 to 3.82) after adjustment for clinical risk,measured,persisted,2017-03-21,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/K062694.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for MammaPrint (k062694), classified through the de novo process (DEN070009). Granted 2007-02-06."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/K062694.pdf""}]","{""kind"": ""Official documents""}" AIBD-0795,2007-01-01,event,year,tested,"FDA finds that MelaFind detected 98.3% of melanomas among lesions chosen for biopsy, at a low specificity that still beat dermatologists'","In FDA's review of MelaFind, the device detected 112 of 114 melanomas (98.3%), with 10.6% specificity against 5.5% for the study dermatologists.",*MelaFind* caught nearly all melanomas at low specificity,112 of 114 melanomas (98.3%),,found,Found by a regulator,tested against a standard,very low,aggregate result,false,MelaFind,,"MELA Sciences, Inc.",United States,Seven dermatology sites in the blinded study (Protocol 20061) and physicians in a web-based reader study (Protocol 20063),United States,"Seven dermatology sites, United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,Study dermatologists' specificity on the same lesions,5.5%,10.6%,measured,withdrawn,2024-06-15,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf9/P090012B.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data (SSED), P090012: MelaFind. Approved 2011-11-01."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf9/P090012B.pdf""}, {""label"": ""Follow-up"", ""value"": ""A 2024 review in npj Digital Medicine reports that MelaFind was discontinued because of low specificity that led to unnecessary biopsies, narrow uses, poor workflow fit and limited coverage."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC11180084/""}]","{""kind"": ""Withdrawals""}" AIBD-0797,2002-01-31,source publication,day,tested,"FDA concluded that Second Look would have cut missed cancers on earlier screening mammograms by at least 26.2%, with work-ups rising from 16.6% to 17.2%","FDA concluded that Second Look's marks would have cut missed cancers on earlier screening mammograms by at least 26.2%. In a prospective test, work-ups rose from 16.6% to 17.2%.",*Second Look* would have cut missed breast cancers by at least a quarter,cut missed cancers on earlier screening mammograms by at least 26.2%,,found,Found by a regulator,no comparison,very low,aggregate result,false,Second Look,,"CADx Medical Systems, Inc. (listed as iCAD, Inc. in the FDA database)",Canada,CADx Medical Systems (ROSE-1 study on earlier screening mammograms from 17 institutions and ROSE-2 study at 5 institutions),Canada,,,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,"Unaided readings of the same earlier mammograms, which had missed every one of the cancers",306 retrospectively visible false negatives at most,At least 80.3 of them estimated to be worked up with the marks,assumed,scaled,2005-03-15,not shown,https://www.accessdata.fda.gov/cdrh_docs/pdf/P010034B.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for Second Look (P010034). Approved 2002-01-31."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P010034B.pdf""}]","{""kind"": ""Official documents""}" AIBD-0798,2001-07-12,source publication,day,tested,"FDA found that with the RapidScreen RS-2000, radiologists detected lung cancers of 9.5-27.5 mm on chest X-rays better than without it","In the reader study that FDA reviewed for the RapidScreen RS-2000, 15 radiologists raised their area under the ROC curve for lung cancers from 0.8288 to 0.8654 with the system.",*RapidScreen RS-2000* helped radiologists spot small lung cancers,the area under the ROC curve rose from 0.8288 to 0.8654,,found,Found by a regulator,controlled comparison,very low,aggregate result,false,RapidScreen RS-2000,,"Deus Technologies, LLC (listed as Riverain Medical Group in the FDA database)",United States,Deus Technologies (reader study with 15 radiologists at Georgetown University Medical Center),United States,"Washington, D.C., United States",United States,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,2,1,,,1,,organizational,2,,0,The same radiologists reading the same films without the system,"Area under the ROC curve 0.8288, sensitivity 71%","Area under the ROC curve 0.8654, sensitivity 78%",measured,challenged,2006-05-04,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf/P000041B.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for RapidScreen RS-2000 (P000041). Approved 2001-07-12. Scanned document without a text layer."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P000041B.pdf""}, {""label"": ""Follow-up"", ""value"": ""Riverain Medical, which bought Deus in 2004, began a Class 3 recall of the successor RapidScreen RS-Digital under the same PMA on 4 May 2006 because its sensitivity was below the approved level. The recall ended in 2013."", ""url"": ""https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=46160""}]","{""kind"": ""Challenges""}" AIBD-2304,1998-06-26,source publication,day,tested,FDA approval review of the ImageChecker M1000: the first detection aid for mammography marked 81.3% of cancers that radiologists judged visible on earlier screening films,"In the studies that FDA reviewed, the ImageChecker M1000 marked 91 of 112 earlier mammograms (81.3%) on which radiologists, looking back, judged that a later cancer already called for action.",*ImageChecker M1000* marked cancers that screening readers had missed,81.3%,,found,Found by a regulator,tested against a standard,very low,program,false,ImageChecker M1000,,"R2 Technology, Inc. (Hologic is the applicant in FDA's database today)",United States,R2 Technology (studies on screening mammograms from 13 institutions and a prospective study at five institutions),United States,United States,United States,Healthcare (breast screening),,Health,Health,Disease Prevention,Images and video,Women and mothers; Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,4,,0,"Screening readings without the system, which had not acted on the same earlier films","112 earlier films judged actionable by most of five radiologists, none of them acted on at the time",91 of the 112 (81.3%) correctly marked by the system,measured,challenged,2007-04-05,shown,https://spie.org/news/computer-aided-diagnosis-becomes-a-reality-in-mammography,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data for the ImageChecker M1000 System (P970058). Approved 1998-06-26. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P970058.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. Artificial Intelligence-Enabled Medical Devices. List current as of 4 September 2026. The quotation is the device's name in the list. The list contains no benefit finding."", ""url"": ""https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices""}, {""label"": ""Follow-up"", ""value"": ""A study of 43 facilities in three U.S. states, published in 2007, compared screening before and after facilities adopted computer-aided detection. Specificity fell from 90.2% to 87.2%, and the authors found no clear gain in the detection of invasive cancer."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/17409321/""}]","{""kind"": ""Challenges""}" AIBD-2307,1995-11-08,source publication,day,tested,FDA approval review of the PAPNET Testing System: a neural network's rescreening found abnormal cells in earlier negative Pap smears of 31.6% of women with later cervical lesions,"In the trial that FDA reviewed, rescreening with PAPNET found abnormal cells in earlier smears, read as negative, of 72 of 228 women (31.6%) who later had a cervical lesion confirmed by biopsy.",*PAPNET* found abnormal cells that Pap smear readers had missed,31.6%,,found,Found by a regulator,tested against a standard,very low,program,false,PAPNET Testing System,,"Neuromedical Systems, Inc. (BD Diagnostics is the applicant in FDA's database today)",United States,Neuromedical Systems (trial on stored smears from 10 medical institutions),United States,United States,United States,Healthcare (cervical cytology),,Health,Health,Disease Prevention,Images and video,Women and mothers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,"Manual screening and routine rescreening, which had reported the same smears as negative",All 487 earlier smears of the 228 women reported as negative,Abnormal cells found in earlier smears of 72 of the 228 women (31.6%),measured,withdrawn,2009-06-04,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the PAPNET Testing System (P940029). Approved 1995-11-08. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P940029.pdf""}, {""label"": ""Follow-up"", ""value"": ""FDA's database lists the approval as withdrawn on 4 June 2009, with BD Diagnostics as the applicant. The entry gives no reason."", ""url"": ""https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P940029""}]","{""kind"": ""Withdrawals""}" AIBD-2302,1995-09-29,source publication,day,tested,FDA approval review of the AutoPap 300 QC System: a statistical classifier's choice of Pap smears for quality control recovered up to five times the missed abnormal slides of a random choice,"In the study at six laboratories that FDA reviewed, rescreening the tenth of normal Pap smears that the AutoPap 300 QC selected recovered up to five times the missed abnormal slides of a random tenth.",*AutoPap 300 QC* found up to five times more missed abnormal Pap smears,50%,,found,Found by a regulator,controlled comparison,very low,program,false,AutoPap 300 QC System,,"NeoPath, Inc. (BD Diagnostics is the applicant in FDA's database today)",United States,NeoPath (study at three academic institutions and three commercial laboratories),United States,United States,United States,Healthcare (cervical cytology),,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,3,,0,"A random selection of a tenth of the smears judged normal, the quality control then required",A tenth of the missed abnormal slides recovered,Up to half of the missed abnormal slides recovered,measured,unknown,,shown,https://pubmed.ncbi.nlm.nih.gov/9022727/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness for the AutoPap 300 QC System (P950009). Approved 1995-09-29. Parts of the summary speak in the applicant's voice. The summary is a scanned document, and the quotations follow its text as a machine reads it."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf/P950009.pdf""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. Artificial Intelligence-Enabled Medical Devices. List current as of 4 September 2026. The quotation is the device's name in the list. The list contains no benefit finding."", ""url"": ""https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices""}]","{""kind"": ""Official documents""}" AIBD-0042,2021-02-12,event,day,reported,"Baricitinib, identified with BenevolentAI's knowledge graph, lowered COVID-19 deaths in the RECOVERY trial","BenevolentAI researchers used the Benevolent Platform's knowledge graph to identify baricitinib for COVID-19, and in the RECOVERY trial mortality was 12% with the drug and 14% with usual care alone.",Drug found with a knowledge graph lowered COVID-19 deaths in a trial,mortality was 12% with the drug and 14% with usual care alone,"On 4 February 2020 BenevolentAI researchers reported in The Lancet that their knowledge graph had helped them identify a possible treatment for COVID-19. It was baricitinib, an arthritis drug. In the ACTT-2 trial, 1,033 hospitalized adults received remdesivir with either baricitinib or a placebo. Median recovery took 7 days with baricitinib and 8 days with the placebo. In the COV-BARRIER trial, 8% of patients receiving baricitinib had died by day 28, compared with 13% receiving a placebo. Mortality was a secondary outcome in that trial. The trial did not meet its primary outcome of reduced disease progression.[1] In the later RECOVERY trial, 8,156 patients were randomly assigned to usual care with or without baricitinib. Mortality, its primary outcome, was 12% with baricitinib and 14% with usual care alone.[2] On 14 January 2022 the World Health Organization strongly recommended baricitinib with corticosteroids. The recommendation covered patients severely or critically ill with COVID-19. On 10 May 2022 the U.S. Food and Drug Administration approved baricitinib for hospitalized adults with COVID-19 who need supplemental oxygen or other respiratory support. The European Medicines Agency reached the provisional opinion that three trials did not conclusively show meaningful benefit. Eli Lilly then withdrew its European application on 7 December 2022.[3] None of the trials compared discovery with AI against discovery without it. The knowledge graph's part in the choice rests on a letter and a methods paper by BenevolentAI researchers.[4]",studied,Independently studied,randomized trial,moderate,aggregate result,false,Benevolent Platform,,BenevolentAI,United Kingdom,BenevolentAI research team,United Kingdom,"Multicountry trials (ACTT-2, COV-BARRIER, and RECOVERY): Argentina; Brazil; Denmark; Germany; India; Italy; Japan; Mexico; Russia; Singapore; South Korea; Spain; United Kingdom; United States",Argentina | Brazil | Denmark | Germany | India | Italy | Japan | Mexico | Russia | Singapore | South Korea | Spain | United Kingdom | United States,Biomedicine / infectious disease therapeutics,Hospitalized COVID-19 patients requiring supplemental oxygen or ventilatory support,Science,Health,R&D,Prediction from data,Patients,3,Lower middle income; Upper middle income; High income,physical_health,,5,3,5,3,5,1,0.480,personal; organizational; societal,13,,2,ACTT-2: remdesivir plus placebo versus remdesivir plus baricitinib,"8 days (95% CI, 7 to 9)","7 days (95% confidence interval [CI], 6 to 8)",measured,challenged,2022-12-07,shown,https://europepmc.org/article/PMC/PMC7137985,,,,"[{""id"": ""AIBD-0042-benefit-mortality"", ""title"": ""Fewer deaths"", ""statement"": ""In RECOVERY, 12% of patients receiving baricitinib died within 28 days, compared with 14% receiving usual care alone."", ""status"": ""reported"", ""beneficiaries"": ""Patients hospitalized with COVID-19."", ""source_refs"": [""AIBD-0042-source-0002""], ""ratings"": [{""group"": ""personal"", ""depth"": 5, ""reason"": ""RECOVERY found lower 28-day mortality with baricitinib, a life-preserving benefit.""}], ""evidence_word"": ""studied""}, {""id"": ""AIBD-0042-benefit-recovery"", ""title"": ""Faster recovery"", ""statement"": ""In ACTT-2, patients receiving remdesivir recovered in a median of 7 days with baricitinib, compared with 8 days with a placebo."", ""status"": ""reported"", ""beneficiaries"": ""Patients hospitalized with COVID-19."", ""source_refs"": [""AIBD-0042-source-0005""], ""ratings"": [{""group"": ""personal"", ""depth"": 2, ""reason"": ""ACTT-2 found a shorter median recovery time in a randomized comparison, a measurable improvement in patients’ health.""}], ""evidence_word"": ""studied""}]",Querist,The benefit was later disputed.,"[{""label"": ""Press release"", ""value"": ""U.S. Food and Drug Administration. “Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19.” 19 November 2020. Authorization, evidentiary standard, and ACTT-2 results."", ""url"": ""https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19""}, {""label"": ""Assessment report"", ""value"": ""World Health Organization (2022). WHO recommends two new drugs to treat COVID-19."", ""url"": ""https://www.who.int/news/item/14-01-2022-who-recommends-two-new-drugs-to-treat-covid-19""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Emergency Use Authorization (EUA) for Baricitinib, CDER Review, EUA 092, November 2020. FDA clinical, statistical and pharmacology reviewers assessed the ACTT-2 data and concluded that it was reasonable to believe that the benefits of baricitinib with remdesivir outweighed its risks. They also found that the mortality result was not statistically significant and could only rule out an unacceptable increase in deaths."", ""url"": ""https://www.fda.gov/media/144473/download""}, {""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. NDA 207924/S-006 supplement approval letter to Eli Lilly and Company, 10 May 2022. FDA approved baricitinib for COVID-19 in hospitalized adults after its review of the supplemental application."", ""url"": ""https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/207924Orig1s006ltr.pdf""}, {""label"": ""Regulatory document"", ""value"": ""European Medicines Agency. Olumiant: withdrawal of application for variation to marketing authorisation, questions and answers EMA/931846/2022, first published 16 December 2022. EMA assessed three trials in hospitalized patients that match ACTT-2, COV-BARRIER and RECOVERY, and its provisional opinion was that the evidence did not conclusively show meaningful benefit. Lilly withdrew the application on 7 December 2022."", ""url"": ""https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/olumiant""}, {""label"": ""Follow-up"", ""value"": ""FDA approved the COVID-19 indication on 10 May 2022. In Europe, Lilly withdrew its application on 7 December 2022 after EMA reached the provisional opinion that the benefit-risk balance was negative."", ""url"": ""https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/olumiant""}]","{""kind"": ""Challenges""}" AIBD-2230,2016-08-01,event,month,reported,Automated Identification of Adults at Risk for In-Hospital Clinical Deterioration,"At Kaiser Permanente hospitals in Northern California, patients who set off the Advance Alert Monitor died less often within 30 days where the program ran than where it did not yet run.",Kaiser's *Advance Alert Monitor* is tied to fewer deaths after alerts,an adjusted relative risk of 0.84,,studied,Independently studied,controlled comparison,low,aggregate result,false,Advance Alert Monitor,,Kaiser Permanente Northern California,United States,Kaiser Permanente Northern California (19 hospitals),United States,"Northern California, United States",United States,Inpatient care (early warning of deterioration from the electronic health record),,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health; operational_improvement,Medical diagnosis,5,4,5,,3,5,,personal,4,,0,Patients who reached the alert threshold at hospitals where the program did not yet run,the comparison cohort's mortality within 30 days,an adjusted relative risk of 0.84,measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC7787261/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Winters BD, Rosen M, Sharma R, Zhang A, Bass EB. Patient Monitoring Systems To Prevent Failure To Rescue: Rapid Review. Making Healthcare Safer IV. Agency for Healthcare Research and Quality, December 2024. The review treats early warning systems as a class."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/39841855/""}]","{""kind"": ""Official documents""}" AIBD-2228,2011-12-01,source publication,month,reported,Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial,"In a randomized trial of 3,003 premature infants in nine U.S. intensive care units, showing clinicians a heart rate index cut mortality from 10.2% to 8.1%.",*HeRO* heart rate monitoring cuts deaths of premature infants in a trial,from 10.2% to 8.1%,,studied,Independently studied,randomized trial,moderate,aggregate result,false,HeRO heart rate characteristics monitor,,University of Virginia and Medical Predictive Science Corporation,United States,Nine neonatal intensive care units in the United States,United States,United States,United States,Neonatal intensive care (early warning of sepsis from heart rate),,Health,Health,Infants and Children,Prediction from data,Children; Health workers,3,High income,physical_health,Medical diagnosis,5,3,5,,3,5,,personal,4,,0,"Infants whose index was masked from clinicians, by individual randomization",10.2% mortality,8.1% mortality,measured,challenged,2023-12-14,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC3215822/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Assessment report"", ""value"": ""Kim YJ, Lee WS. PP121 Assessment of Heart Rate Characteristics Analysis. International Journal of Technology Assessment in Health Care 39(S1):S84, 14 December 2023. doi:10.1017/S0266462323002350. The authors work at Korea's National Evidence-based Healthcare Collaborating Agency and report its committee's assessment of the technique, which rested on a systematic review of eight studies."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC11569983/""}, {""label"": ""Follow-up"", ""value"": ""Korea's National Evidence-based Healthcare Collaborating Agency assessed the technique, and its staff reported the assessment in December 2023. The committee judged the technique safe and wrote that further research is needed to determine its effectiveness. No later trial was found."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC11569983/""}]","{""kind"": ""Challenges""}" AIBD-0026,2021-10-01,event,month,reported,Detection by a Fitbit Sense ECG leads to diagnosis of ventricular tachycardia,"A Fitbit Sense watch detected an irregular heart rate of 164 beats per minute in a man in Jamshedpur, India. He was treated for ventricular tachycardia after he sought care.",Doctors treat ventricular tachycardia after Fitbit flags a fast heart,detected an irregular heart rate of 164 beats per minute with irregular rhythm,"In October 2021 a 55-year-old man in Jamshedpur, India, had symptoms at work. His Fitbit Sense showed an irregular rhythm at 164 beats per minute. He felt the need to visit a doctor immediately and went to Tata Main Hospital. Cardiologists there diagnosed idiopathic fascicular ventricular tachycardia from a 12-lead electrocardiogram (ECG) and further tests. They restored sinus rhythm by electrical cardioversion. On verapamil, he was later reported to be doing well.[1] The U.S. Food and Drug Administration cleared the watch's ECG app to tell atrial fibrillation from sinus rhythm. Ventricular tachycardia lies outside the rhythms that it was cleared to classify.[2] The benefit also rests on an assumption that he would have waited longer without the reading. A single case report leaves no way to check it.",studied,Independently studied,no comparison,very low,benefit created,false,Fitbit Sense ECG app and heart-rate monitoring,Fitbit Sense,Fitbit (Google),United States,,,"Jamshedpur, India",India,Healthcare (cardiology),Consumer wearables,Health,Health,Disease Prevention,Prediction from data,Patients,3,Lower middle income,physical_health,Medical diagnosis,3,1,,,3,1,,personal,4,,0,"the man's symptoms alone, without the watch reading","palpitations, sweating, anxiety and mild dizziness for half an hour while at work",he sought a doctor at once after the watch showed an irregular rhythm at 164 beats per minute,assumed,unknown,,not shown,https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200948.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Fitbit, Inc., 510(k) summary and FDA clearance letter for the Fitbit ECG App, K200948, 11 September 2020. Fitbit wrote the summary. It shows that the app was cleared to tell atrial fibrillation from sinus rhythm and that its atrial fibrillation detection is not recommended for people with other known arrhythmias."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200948.pdf""}]","{""kind"": ""Official documents""}" AIBD-0063,2020-03-01,event,month,reported,Lunit INSIGHT CXR flags nodules on chest radiographs taken for other reasons in 13 patients at Yongin Severance Hospital with resectable lung cancer,Lunit INSIGHT CXR flagged nodules on chest radiographs taken for other reasons in 13 patients at Yongin Severance Hospital. All 13 had their lung cancer removed. Seven were stage I.,Lunit INSIGHT CXR flags 13 resectable lung cancers on routine X-rays,13 (17.3%) had cancers found incidentally because the software flagged a nodule,,studied,Independently studied,no comparison,very low,benefit created,false,Lunit INSIGHT CXR,versions 2 and 3,Lunit Inc.,South Korea,"Yongin Severance Hospital, Yonsei University College of Medicine",South Korea,"Yongin, South Korea",South Korea,Healthcare - thoracic radiology / lung cancer,AI applied to routine hospital chest radiographs,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical diagnosis,3,2,,,4,1,,personal; organizational,4,,1,The radiologists' official reports on the same radiographs; the study has no group without AI,Radiologists' reports described a lung abnormality in 12 of 13 patients and read no active lung disease in one,The software flagged a nodule in all 13 patients,measured,persisted,2024-08-07,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC10004566/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Austrian Institute for Health Technology Assessment (AIHTA). AI-supported Chest X-Ray Analysis for Lung Cancer Detection: Systematic Review of clinical outcomes and organisational implications. AIHTA Project Report No. 171b. Vienna, February 2026."", ""url"": ""https://eprints.aihta.at/1598/1/HTA-Projektbericht_Nr.171b.pdf""}, {""label"": ""Assessment report"", ""value"": ""Austrian Institute for Health Technology Assessment (AIHTA). AI-supported Chest X-Ray Analysis for Lung Cancer Detection: Systematic Review of clinical outcomes and organisational implications. AIHTA Project Report No. 171b. Vienna, February 2026."", ""url"": ""https://eprints.aihta.at/1598/1/HTA-Projektbericht_Nr.171b.pdf""}]","{""kind"": ""Official documents""}" AIBD-0639,2026-04-12,source publication,day,reported,"In a Leeds Trinity University trial, the Woebot chatbot reduced anxiety in adults with persistent tinnitus","In a Leeds Trinity University trial of 105 adults with tinnitus, 8 weeks of Woebot cut anxiety scores against a waitlist. It cut depression scores. Tinnibot did more.",A mental health chatbot eased low mood in tinnitus,Woebot users lowered depression scores on the PHQ-9 from 10.03 to 8.06,,studied,Independently studied,randomized trial,moderate,aggregate result,false,Woebot,,Woebot Health,United States,Leeds Trinity University School of Social Sciences (trial),United Kingdom,United Kingdom (online trial recruited with Tinnitus UK),United Kingdom,Mental health care,,Health,Health,Mental Health,Text and language,Patients,3,High income,emotional_health,,2,2,2,,3,,,personal,1,,1,Waiting-list control,Waitlist PHQ-9 from 9.29 to 9.64 over eight weeks,Woebot PHQ-9 from 10.03 to 8.06 over eight weeks,measured,withdrawn,2025-06-01,shown,https://spectrum.ieee.org/woebot,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""The authors report that Woebot was withdrawn from public use in June 2025."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC13097093""}]","{""kind"": ""Withdrawals""}" AIBD-2246,2025-12-02,source publication,day,reported,Artificial intelligence imaging decision support for acute stroke treatment in England: a prospective observational study,"At 26 English hospitals that introduced Brainomix 360 Stroke, the share of stroke patients who received thrombectomy rose from 2.3% to 4.6%, against a rise from 1.6% to 2.6% elsewhere.",*Brainomix 360 Stroke* hospitals double their thrombectomy rate,from 2.3% to 4.6%,,studied,Independently studied,controlled comparison,very low,aggregate result,false,Brainomix 360 Stroke,,Brainomix,United Kingdom,26 NHS hospitals in England (six large stroke centers that perform thrombectomy and 20 primary stroke centers),United Kingdom,"England, United Kingdom",United Kingdom,Acute stroke care (imaging decision support),,Health,Health,Disease Prevention,Images and video,Patients; Health workers,3,High income,physical_health,Medical access,2,4,,,3,,,personal; organizational,4,,0,"The 81 other English hospitals that admit stroke patients, and the 26 hospitals before the introduction",2.3% of stroke patients received thrombectomy,4.6% of stroke patients received thrombectomy,measured,challenged,2026-07-24,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231837.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""A research group in Barcelona wrote in July 2026 that missing data and the comparison hospitals' own access to AI limit the attribution of the higher thrombectomy rates to the software. A review of clinical AI restated the study's results in September 2026."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC13458394/""}]","{""kind"": ""Challenges""}" AIBD-1125,2025-03-27,source publication,day,mixed,"ESGE's panel weakly recommends AI detection of polyps in screening colonoscopy, citing more adenomas found in trials, with a small modeled drop in cancer","ESGE's panel voted 13 to 6 for a weak recommendation of CADe in screening colonoscopy. In 44 pooled trials, adenomas were found in 44.7% of patients with CADe against 36.7% without.",European endoscopists weakly back *CADe* in screening colonoscopy,44.7% of patients with CADe against 36.7% without,,studied,Independently studied,randomized trial,moderate,aggregate result,false,"Computer-aided detection (CADe) colonoscopy systems in the 44 trials behind ESGE's position, including GI Genius, CAD EYE and EndoScreener",,"Medtronic (GI Genius), Fujifilm (CAD EYE), Wision AI (EndoScreener) and other makers","Multiple: Ireland, Japan, China","Endoscopy services in the 44 randomized trials that the evidence pooled, with screening and surveillance services in Europe as intended users",Multiple,"Multiple countries (trials), with a position for Europe",,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,,physical_health,Medical diagnosis,2,4,,,2,1,,personal,4,,0,Colonoscopy without CADe in 44 randomized trials,36.7%,44.7%,measured,challenged,2025-08-12,shown,https://web.archive.org/web/20250106192510id_/https://www.acpjournals.org/doi/10.7326/ANNALS-24-00981,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Assessment report"", ""value"": ""European Society of Gastrointestinal Endoscopy. Bretthauer M, Ahmed J, Antonelli G, et al. Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2025;57(6):667-673, published online 27 March 2025. doi:10.1055/a-2543-0370. Abstract, Recommendation. Two panel members were paid by makers of the systems tested."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/40148135/""}, {""label"": ""Assessment report"", ""value"": ""Foroutan F, Vandvik PO, Helsingen LM, et al. Computer aided detection and diagnosis of polyps in adult patients undergoing colonoscopy: a living clinical practice guideline. BMJ Rapid Recommendations, BMJ 2025;388:e082656. PMID 40147837. Abstract, Recommendation."", ""url"": ""https://europepmc.org/abstract/MED/40147837""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Assessment report"", ""value"": ""Behandlingsrådet (Danish Health Technology Council). Kunstig intelligens som beslutningsstøtte ved koloskopiske undersøgelser til diagnosticering af neoplastisk sygdom. Recommendation in force from 1 February 2023. Archived copy of 15 September 2025 of the council's page. The quotations are in Danish."", ""url"": ""https://web.archive.org/web/20250915185757id_/https://behandlingsraadet.dk/find-evalueringer-analyser/analyser/2021/kunstig-intelligens-som-beslutningsstotte-ved-koloskopiske-undersogelser-til-diagnosticering-af-neoplastisk-sygdom""}, {""label"": ""Follow-up"", ""value"": ""A multicenter observational study in Poland, published in The Lancet Gastroenterology & Hepatology in August 2025, found that endoscopists' adenoma detection in colonoscopies without AI fell from 28.4% to 22.4% after they began using AI."", ""url"": ""https://wrap.warwick.ac.uk/id/eprint/191005""}]","{""kind"": ""Challenges""}" AIBD-0143,2025-02-25,event,day,reported,ECMWF's machine-learning forecast model AIFS Single goes operational on 25 February 2025. ECMWF reports lower errors than the physics-based IFS for many measures. Two independent studies in China partly confirm the gain,ECMWF's AIFS Single forecast model went into operation on 25 February 2025. ECMWF reports 5–15% lower errors than IFS. Two teams in China with no tie to ECMWF partly confirm the gain.,ECMWF's AIFS Single goes operational with 5–15% lower errors,5–15% lower errors than IFS,,studied,Independently studied,tested against a standard,low,aggregate result,false,ECMWF Artificial Intelligence Forecasting System (AIFS),AIFS Single v1 (operational from 25 February 2025),ECMWF,United Kingdom,ECMWF,United Kingdom,"Reading, United Kingdom",United Kingdom,Weather forecasting,Public-sector meteorological service,Environment,Technology,Weather Forecasting,Prediction from data,,13,High income,environmental_impact,Weather and environmental forecasting,2,3,4,,5,5,,personal; organizational; societal,9,,2,ECMWF's physics-based Integrated Forecasting System (IFS),,errors 5 to 15% lower in the medium range (out to 15 days),measured,scaled,2025-07-01,shown,https://journals.ametsoc.org/view/journals/wefo/40/9/WAF-D-24-0227.1.xml,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Deutscher Wetterdienst. Application and verification of ECMWF products 2024: Germany. ECMWF Green Book 2024, section 3.6 b, p. 4. Germany's national weather service verified the AI forecasts against observations. It neither built nor runs them. Germany, which DWD serves, is a member state that funds ECMWF, the developer."", ""url"": ""https://www.ecmwf.int/sites/default/files/elibrary/092024/81600-application-and-verification-of-ecmwf-products-2024-germany.pdf""}]","{""kind"": ""Official documents""}" AIBD-2271,2024-01-30,event,day,reported,Artificial Intelligence-Based Automated Echocardiographic Analysis and the Workflow of Sonographers: A Randomized Crossover Trial (AI-Echo RCT),"In a crossover trial in Tokyo, four sonographers with Us2.ai's automated measurements examined 16.7 patients a day against 14.1, and each examination took 13.0 minutes against 14.3.",*Us2.ai* lets sonographers examine more patients with less fatigue,13.0 minutes,,studied,Independently studied,randomized trial,moderate,aggregate result,false,Us2.ai platform (automated echocardiographic measurements),,Us2.ai (Singapore),Singapore,"Echocardiography laboratory of Juntendo University, Tokyo",Japan,"Tokyo, Japan",Japan,Echocardiography (measurement and reporting),,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,operational_improvement,Enhanced productivity,2,2,3,,3,5,,organizational; personal,3,,0,The manual workflow on days without the platform,14.3 minutes per examination,13.0 minutes per examination,measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC12909003/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment. HealthTech guidance HTG779, section 1: Recommendations. 19 May 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg779/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment. HealthTech guidance HTG779, section 1: Recommendations. 19 May 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg779/chapter/1-Recommendations""}]","{""kind"": ""Official documents""}" AIBD-0737,2024-01-23,source publication,day,mixed,"NICE allows e-Stroke, RapidAI and Viz in NHS stroke care while evidence is gathered, though it cannot tell how much they speed treatment","In studies that NICE reviewed, stroke treatment came faster after centers adopted e-Stroke, RapidAI or Viz. Treatment rates rose. NICE could not tell how much was due to the software.","Faster stroke treatment followed *e-Stroke*, *RapidAI* and *Viz*",,,studied,Independently studied,before and after,very low,aggregate result,false,"e-Stroke, RapidAI and Viz (AI-derived software for CT brain scans in suspected stroke)",,"Brainomix (e-Stroke), iSchemaView (RapidAI) and Viz.ai (Viz)","Multiple: United Kingdom, United States","NHS stroke centers in England, with AI decision support live at 99 of 107 stroke units",United Kingdom,"England, United Kingdom",United Kingdom,Healthcare (acute stroke care),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,physical_health,Medical access,2,,1,,2,1,,personal,4,,0,"Time to treatment before centers adopted the software, in seven observational studies",,Shorter time to thrombectomy or thrombolysis in most of the studies,measured,persisted,2025-12-02,shown,https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-derived software to help clinical decision making in stroke. HealthTech guidance HTG708 (formerly DG57), section 1: Recommendations. 23 January 2024, last updated 2 May 2024."", ""url"": ""https://www.nice.org.uk/guidance/htg708/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. HTG708, section 3: Committee discussion. 23 January 2024, last updated 2 May 2024."", ""url"": ""https://www.nice.org.uk/guidance/htg708/chapter/3-Committee-discussion""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Evaluación de la utilidad diagnóstica, la seguridad, la eficacia y efectividad clínica, la eficiencia y los aspectos técnicos y organizativos de los softwares de inteligencia artificial (IA) para el análisis de imágenes de perfusión cerebral en el ictus isquémico agudo de inicio indeterminado o del despertar. Informes de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2026. The quotations are in Spanish."", ""url"": ""https://scientiasalut.gencat.cat/bitstream/11351/14344/4/evaluacion-softwares-inteligencia-artificial-ia-analisis-imagenes-perfusion-cerebral-ictus-sistemico-agudo-2026.pdf""}, {""label"": ""Assessment report"", ""value"": ""Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Evaluación de la utilidad diagnóstica, la seguridad, la eficacia y efectividad clínica, la eficiencia y los aspectos técnicos y organizativos de los softwares de inteligencia artificial (IA) para el análisis de imágenes de perfusión cerebral en el ictus isquémico agudo de inicio indeterminado o del despertar. Informes de Evaluación de Tecnologías Sanitarias, Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud. Ministerio de Sanidad, 2026. The quotations are in Spanish."", ""url"": ""https://scientiasalut.gencat.cat/bitstream/11351/14344/4/evaluacion-softwares-inteligencia-artificial-ia-analisis-imagenes-perfusion-cerebral-ictus-sistemico-agudo-2026.pdf""}]","{""kind"": ""Official documents""}" AIBD-0184,2022-05-01,event,month,reported,A machine learning model that flags risky Universal Credit advance requests saved the UK benefits department an estimated £4.4 million from 2022–23 to 2024–25,A machine-learning model at the Department for Work and Pensions flags risky Universal Credit advance requests for caseworkers. The department estimates that it saved £4.4 million in three years.,"UK model flags risky benefit advances, saving an estimated £4.4 million",DWP estimates that the model saved £4.4 million from 2022–23 to 2024–25,,studied,Independently studied,no comparison,very low,aggregate result,false,Universal Credit advances machine learning model,,Department for Work & Pensions (DWP),United Kingdom,Department for Work & Pensions (DWP),United Kingdom,Great Britain,United Kingdom,Benefit fraud and error,Universal Credit advances,Finance,Social Welfare,Low-Income Assistance,Prediction from data,Public servants,16,High income,privacy_protection,Fraud detection,2,1,4,2,4,5,0.405,organizational; societal,6,,2,a randomized control group sample of advance requests,fraud-risk identification rate of the random control sample (not quantified),around three times more effective at identifying fraud risk,measured,persisted,2026-07-09,shown,https://www.gov.uk/algorithmic-transparency-records/dwp-universal-credit-advances-model,£4.4 million,"advances that would otherwise have been overpaid, saved from 2022-23 to 2024-25",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""House of Commons Committee of Public Accounts (UK) (2023). The Department for Work & Pensions Annual Report and Accounts 2022-23 (Fourth Report of Session 2023-24, HC 290), Paragraph 32 (section 'Using machine learning to flag potentially fraudulent benefit claims') and conclusion 6."", ""url"": ""https://web.archive.org/web/20240411110206id_/https://publications.parliament.uk/pa/cm5804/cmselect/cmpubacc/290/report.html""}]","{""kind"": ""Official documents""}" AIBD-2272,2022-02-22,source publication,day,reported,Effect of Artificial Intelligence Tutoring vs Expert Instruction on Learning Simulated Surgical Skills Among Medical Students: A Randomized Clinical Trial,"In a Montreal trial of 70 medical students learning a simulated brain tumor operation, an AI tutor raised practice performance scores by 0.66 points over remote expert instruction.",*Virtual Operative Assistant* raises scores in simulated surgery,0.66 points,,studied,Independently studied,randomized trial,low,aggregate result,false,"Virtual Operative Assistant (VOA), an AI tutor for virtual reality surgical simulation",,"Neurosurgical Simulation and Artificial Intelligence Learning Centre, McGill University",Canada,"Neurosurgical Simulation and Artificial Intelligence Learning Centre, McGill University (trial with students of four institutions)",Canada,"Montreal, Quebec, Canada",Canada,Surgical education in simulation,,Education,Health,Manpower,Prediction from data,Students,3; 4,High income,knowledge_discovery,Increased/personalized knowledge,2,2,1,,3,1,,personal,2,,0,Remote expert instruction,,0.66 points higher practice score,measured,challenged,2023-09-05,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8864513/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""A follow-up analysis of the trial by the same group, published in September 2023, found that the tutor's feedback also slowed the students' dominant hand and lowered their rate of tumor removal, which moved these measures away from the experts' benchmarks. Later trials of the group paired AI tutoring with human instructors."", ""url"": ""https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37725373&rettype=abstract&retmode=text""}]","{""kind"": ""Challenges""}" AIBD-0636,2019-03-01,event,month,reported,HYPE randomized trial at Amsterdam UMC: The Hypotension Prediction Index with a treatment protocol cuts intraoperative hypotension,"In the HYPE trial at Amsterdam UMC, the Hypotension Prediction Index cut median time in hypotension during surgery from 32.7 to 8.0 minutes per patient.",An early warning helps Amsterdam anesthetists keep blood pressure up,median time in hypotension fell from 32.7 to 8.0 minutes per patient,,studied,Independently studied,randomized trial,low,aggregate result,false,Hypotension Prediction Index (HPI),,Edwards Lifesciences,United States,"Amsterdam UMC, location AMC",Netherlands,"Amsterdam UMC, location AMC, Amsterdam, the Netherlands",Netherlands,Healthcare,,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,,2,2,1,,5,1,,personal,7,,3,Standard care with the same blood pressure goal,32.7 minutes median time in hypotension per patient,8.0 minutes median time in hypotension per patient,measured,challenged,2020-12-01,shown,https://www.nice.org.uk/advice/mib266/chapter/Clinical-and-technical-evidence,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration. De Novo Classification Request for Acumen Hypotension Prediction Index (HPI) Feature Software, DEN160044, decision summary, 16 March 2018, pp. 3 and 7. The FDA authorized the software on retrospective accuracy, which does not measure the clinical benefit in this record."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN160044.pdf""}, {""label"": ""Follow-up"", ""value"": ""In a pilot randomized trial in moderate- to high-risk noncardiac surgery, guidance from the index produced no reduction in hypotension."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/32960954/""}]","{""kind"": ""Challenges""}" AIBD-0295,2018-05-01,event,month,reported,"Dexcom G6's “Urgent Low Soon” predictive alert may cut time below 54 mg/dL, by less in controlled trials","Dexcom staff link the G6's Urgent Low Soon alert to less hypoglycemia in 1,424 users. A second cohort had 15,000. In a Dexcom-funded trial in 24 adults, the reduction appeared only below 2.8 mmol/L.",Dexcom G6's Urgent Low Soon alert may cut time below 54 mg/dL,time below 54 mg/dL fell from 1.0% to 0.6%,,studied,Independently studied,before and after,very low,aggregate result,false,"Dexcom G6 real-time continuous glucose monitoring system, 'Urgent Low Soon' predictive low glucose alert (also present on the G7 in one independent study)",Dexcom G6 (vendor analyses; PACE trial); Dexcom G7 (Preechasuk et al.),"Dexcom, Inc.",United States,,,"United States (vendor analyses); London, United Kingdom (Imperial College trials)",United States | United Kingdom,Healthcare (diabetes technology),Diabetes technology,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,,2,4,4,3,5,5,0.650,personal; organizational,11,,5,"the same users on the preceding Dexcom G5 system, which had no predictive alert (before-and-after)","1.0 (1.5) percent of time <54 mg/dL on G5 (70 mg/dL low-alert setting, Table 1)","0.6 (1.0) percent of time <54 mg/dL on G6 (70 mg/dL low-alert setting, Table 1)",measured,persisted,2022-09-08,not shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC6477579/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration (2018). Evaluation of Automatic Class III Designation for Dexcom G6 Continuous Glucose Monitoring System, Decision Summary, DEN170088 (decision date 27 March 2018)."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170088.pdf""}]","{""kind"": ""Official documents""}" AIBD-0058,2016-07-01,event,month,reported,Stanford's Superpower Glass gives children with autism cues about emotions on Google Glass and raises a socialization score that fades after treatment,"In a trial of 71 children, Stanford's Superpower Glass, which classifies emotions on Google Glass, added 4.58 points on a socialization scale. Spectrum reported that the gain was gone six weeks later.",Superpower Glass briefly raises social scores of children with autism,gained 4.58 points more on the Vineland socialization subscale than controls (P = .005),,studied,Independently studied,randomized trial,moderate,aggregate result,false,Superpower Glass: Google Glass with a real-time machine-learning facial emotion classifier and companion smartphone app,,"Stanford University (Wall lab, Division of Systems Medicine and Department of Computer Science)",United States,Participating families at home under the Stanford studies,,"Palo Alto, United States",United States,Autism intervention / digital therapeutics,Children with autism spectrum disorder aged 6-12,Health,Health,Mental Health,Images and video,Children; People with disabilities,3,High income,emotional_health; accessibility,Emotional analysis/intelligence,2,2,2,4,3,4,0.350,personal; societal,4,,0,applied behavioral analysis therapy alone (treatment as usual),,"mean [SD] treatment impact, 4.58 [1.62]; P = .005",measured,challenged,2019-05-02,shown,https://europepmc.org/article/PMC/PMC6550272,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Spectrum reported that Cognoa held an exclusive license and FDA breakthrough status for the therapy, and that independent experts called the trial weak. The FDA's decisions on Cognoa cover only its aids for diagnosis, and nothing in the sources shows that Superpower Glass reached the market."", ""url"": ""https://www.thetransmitter.org/spectrum/tech-firms-superpower-glass-autism-not-super-experts-say/""}]","{""kind"": ""Challenges""}" AIBD-0947,2026-10-06,source publication,day,mixed,ADAC finds in a two-hour test drive in Denmark that Tesla's FSD Supervised drove well over long stretches but still made driving errors,"In a two-hour drive in Denmark, ADAC found that Tesla's FSD Supervised drove well over long stretches but made errors that would have failed it twice in a German driving test.",ADAC finds that *FSD Supervised* drives well in Denmark but still errs,,,studied,Independently studied,no comparison,very low,benefit created,false,"Tesla FSD Supervised (renamed Tesla Assisted Driving), on a Tesla Model 3",,Tesla,United States,"Tesla, under a special permit in Denmark",United States,"Copenhagen, Denmark",Denmark,Road vehicle assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,High income,physical_health,,1,1,1,,2,1,,personal,1,,0,,,,,challenged,2026-10-12,shown,https://web.archive.org/web/20201022181519/https://www.tesla.com/autopilotAI,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""ADAC reported on 12 October 2026 that Tesla responded to the criticism of FSD Supervised by renaming it Tesla Assisted Driving, which makes clearer that it is an assistance system and not an autonomous one."", ""url"": ""https://www.adac.de/rund-ums-fahrzeug/autokatalog/marken-modelle/tesla/tesla-fsd-supervised-testfahrt/""}]","{""kind"": ""Challenges""}" AIBD-1129,2026-07-28,source publication,day,reported,"Which? finds that Apple's Live Translation on AirPods Pro 3 was generally accurate in Italian, Spanish, German and French conversations","In tests published on 28 July 2026, Which? found that Apple's Live Translation on AirPods Pro 3 was generally accurate in Italian, Spanish, German and French conversations.",*Live Translation* on AirPods is generally accurate in tests by Which?,,,studied,Independently studied,no comparison,very low,aggregate result,false,"Live Translation, as tested on AirPods Pro 3 with an iPhone",,Apple,United States,Apple (feature of iOS 26 for AirPods and iPhone),United States,United Kingdom (Which? tests),United Kingdom,Consumer technology,,Everyday technology,Technology,Computers,Speech and sound; Text and language,Consumers,,High income,accessibility,,1,,1,,3,,,personal,3,,0,,,,,persisted,2026-09-17,shown,https://support.apple.com/guide/iphone/translate-messages-calls-and-conversations-iph22b72984d/26/ios/26,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Testaankoop (expertise Richard Motte, editing Evelien De Bal). Beste vertaal oortjes: onze test van translator earbuds en hun werkelijke prestaties. 8 March 2026. Section on ordinary earbuds with built-in translation, on Apple Live Translate on AirPods Pro 3, tested under iOS 26.1. In the quoted passage, Testaankoop lists instability, an unnatural voice and patchy availability as drawbacks. It concludes that the feature may be stronger in the future but is still too unstable for daily use. Cited as a contrary finding from an earlier test."", ""url"": ""https://www.test-aankoop.be/hightech/koptelefoons-en-oortjes/nieuws/earbuds-vertaal-oortjes""}]","{""kind"": ""Official documents""}" AIBD-0300,2026-05-26,source publication,day,reported,A 79-year-old starts CPAP without polysomnography once ECGs on his Apple Watch Series 11 show atrial fibrillation on mornings after nights of “elevated” breathing disturbance,Apple Watch sleep apnea notifications brought a 79-year-old man in Fukuoka to his cardiologists. His watch ECGs showed atrial fibrillation after nights rated “elevated”. He began CPAP therapy.,Apple Watch breathing alerts send a 79-year-old to CPAP therapy,,,studied,Independently studied,no comparison,very low,benefit created,false,Apple Watch Sleep Apnea Notification Feature (breathing-disturbance notifications) and the ECG app,Apple Watch Series 11 with iPhone 15 Pro,Apple,United States,,,"Fukuoka, Japan",Japan,Healthcare (cardiology; sleep medicine),Consumer wearables,Health,Health,Disease Prevention,Prediction from data,Patients; Older people,3,High income,physical_health,Medical diagnosis,1,1,,,3,,,personal,3,,0,"ambulatory monitoring and standard 12-lead ECG, which had documented no paroxysms since his retirement",AF paroxysms were not documented by ambulatory monitoring or standard ECG,"AF paroxysms were detected repeatedly in the morning after notification of nocturnal “elevated” breathing disturbance, but not in the morning after nights when breathing disturbance was “not elevated”",measured,unknown,,shown,https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240929.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Apple Inc. (2024). Sleep Apnea Notification Feature: 510(k) Summary, K240929, device description and performance testing, pp. 2 and 5–7, filed with the FDA. File includes FDA's substantial-equivalence letter of 13 September 2024."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240929.pdf""}]","{""kind"": ""Official documents""}" AIBD-0176,2015-01-01,event,year,reported,Some subprime borrowers get lower-priced credit at LendingClub,LendingClub's rating grades relied increasingly on alternative data. They moved some borrowers who are subprime by traditional criteria into better grades with lower-priced credit.,Some subprime borrowers get lower-priced credit at LendingClub,about 8 percent of A-rated and 28 percent of B-rated borrowers had FICO scores below 680,,studied,Independently studied,tested against a standard,low,aggregate result,false,LendingClub rating-grade model (grades A to G),,LendingClub,United States,LendingClub,United States,United States,United States,Consumer credit,Marketplace consumer lending,Finance,Domestic Commerce,Consumer Finance,Prediction from data,Consumers,8; 10,High income,economic_access,Fair pricing,1,,4,4,3,3,,personal; societal,3,,1,classification of borrowers by traditional credit criteria,classified as subprime by traditional criteria,"slotted into “better” loan grades, which allowed them to get lower-priced credit",measured,litigated,2021-07-14,shown,https://web.archive.org/web/2026id_/https://www.sec.gov/Archives/edgar/data/1409970/000140997020000212/a201910-k.htm,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""The FTC sued LendingClub in April 2018 over up-front origination fees hidden from loan applicants, and LendingClub settled for $18 million in July 2021; this bears on the full price borrowers paid, not on the rating grades themselves."", ""url"": ""https://web.archive.org/web/2026id_/https://www.ftc.gov/news-events/news/press-releases/2021/07/lendingclub-agrees-pay-18-million-settle-ftc-charges""}]","{""kind"": ""Legal proceedings""}" AIBD-0390,2025-12-05,source publication,day,tested,"Dentbird software designs dental crowns faster in university tests, but Ohio State researchers conclude that its designs need human review","In university tests, Imagoworks' Dentbird software let technicians design crowns about four times faster. Ohio State researchers concluded that its designs needed human review.",Dentbird software designs crowns faster but still needs human review,,,studied,Independently studied,controlled comparison,very low,aggregate result,false,Dentbird Solutions,,Imagoworks Inc.,South Korea,,,,,Healthcare,,Health,Health,Drug Industry,Images and video,Other workers,3,,operational_improvement,Enhanced productivity,,2,1,3,,1,,organizational; personal,7,"ITU, AI for Good: Innovate for Impact",0,Crowns designed by the same five technicians in conventional CAD software (3Shape Dental System),397.2 ± 80.4 min for the premolar crown with conventional CAD,99.4 ± 17.1 min for the premolar crown with Dentbird,measured,challenged,2025-12-05,shown,https://www.dental-tribune.com/news/imagoworks-propels-digital-dentistry-into-the-ai-era-at-ids-2023/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Ohio State researchers found that Dentbird saved time on three-unit bridges but underperformed on esthetic and functional criteria, and they concluded that human oversight is still needed. Their April 2025 study of single crowns reached a similar result."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/41353038/""}]","{""kind"": ""Challenges""}" AIBD-1162,2025-04-30,source publication,day,tested,Singapore's ACE finds that EchoGo Heart Failure reclassified most cases that clinical scores left indeterminate,Singapore's ACE found that EchoGo Heart Failure appeared safe on retrospective data. It appeared accurate. It reclassified 73.5% of cases left indeterminate by the HFA-PEFF score.,*EchoGo Heart Failure* reclassified most cases that scores left open,reclassified 73.5% of cases left indeterminate by the HFA-PEFF score,,studied,Independently studied,tested against a standard,very low,aggregate result,false,EchoGo Heart Failure,,Ultromics Ltd.,United Kingdom,Hospitals in the retrospective US and UK studies that ACE reviewed (not yet in use in Singapore),United States and United Kingdom,"United States and United Kingdom (studies), assessed for Singapore",United States | United Kingdom | Singapore,Healthcare,,Health,Health,Disease Prevention,Images and video,Health workers,3,High income,physical_health,Medical diagnosis,,,,,,,,organizational,2,,0,The HFA-PEFF and H2FPEF clinical scores in the main training and validation study,54.6% and 60.4% non-diagnostic outcomes,7.3% non-diagnostic outputs,measured,unknown,,shown,https://isomer-user-content.by.gov.sg/68/55e34a4a-9a64-4e9d-9fe9-dea47842f372/EchoGo%20Heart%20Failure%20to%20Aid%20in%20the%20Diagnosis%20of%20Heart%20Failure%20with%20Preserved%20Ejection%20Fraction.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment. HealthTech guidance HTG779, section 1: Recommendations. 19 May 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg779/chapter/1-Recommendations""}, {""label"": ""Assessment report"", ""value"": ""National Institute for Health and Care Excellence. Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment. HealthTech guidance HTG779, section 1: Recommendations. 19 May 2026."", ""url"": ""https://www.nice.org.uk/guidance/htg779/chapter/1-Recommendations""}]","{""kind"": ""Official documents""}" AIBD-0764,2025-01-02,source publication,day,tested,University of Geneva researchers find that GraphCast and Pangu-Weather forecast the 2021 North American winter storm better than ECMWF's HRES,"In three case studies, GraphCast and Pangu-Weather forecast the February 2021 North American winter storm better than ECMWF's HRES. They did less well on two heatwaves.",*GraphCast* and *Pangu-Weather* beat ECMWF on the 2021 winter storm,,,studied,Independently studied,tested against a standard,very low,aggregate result,false,"GraphCast, Pangu-Weather and FourCastNet",,"Google DeepMind (GraphCast), Huawei (Pangu-Weather) and NVIDIA (FourCastNet)","Multiple: United Kingdom, China, United States",,,"Texas and the southern United States (2021 winter storm), the Pacific Northwest (2021 heatwave) and South Asia (2023 humid heatwave)",United States,Weather forecasting / extreme events,,Environment,Technology,Weather Forecasting,Prediction from data,Researchers,13,High income,environmental_impact,Natural disaster prediction,,,,,,,,organizational,1,,0,ECMWF HRES forecasts for the same events and lead times,"HRES errors in wind chill near College Station, Texas","Much lower errors for Pangu-Weather and GraphCast, especially from 9 to 17 February",measured,challenged,2025-08-21,shown,https://journals.ametsoc.org/view/journals/aies/4/1/AIES-D-24-0033.1.xml,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""In August 2025 two of the study's authors and colleagues reported that ECMWF's HRES consistently beat GraphCast, Pangu-Weather and other AI models on unprecedented heat, cold and wind extremes across nearly all lead times."", ""url"": ""https://arxiv.org/abs/2508.15724""}]","{""kind"": ""Challenges""}" AIBD-0763,2024-11-07,source publication,day,tested,Uppsala University researchers find that Pangu-Weather and GraphCast mostly beat ECMWF's deterministic model on global error in 2020 forecasts,"In 2020 forecasts, Pangu-Weather and GraphCast mostly beat ECMWF's IFS HRES on global error 1 to 10 days ahead. They matched it on temperature extremes in most regions. The same held for wind.",*Pangu-Weather* and *GraphCast* rival ECMWF on weather extremes,,,studied,Independently studied,tested against a standard,very low,aggregate result,false,Pangu-Weather and GraphCast (operational versions),,Huawei (Pangu-Weather) and Google DeepMind (GraphCast),"Multiple: China, United Kingdom",,,"Global, with the regions of ECMWF's operational scorecards",,Weather forecasting / temperature and wind extremes,,Energy and infrastructure,Technology,Weather Forecasting,Prediction from data,Researchers,13,,environmental_impact,Weather and environmental forecasting,,,,,,,,organizational,2,,0,ECMWF IFS HRES forecasts from the same initial conditions,IFS HRES errors in the tropics and the North Pacific,Lower GraphCast errors there for all variables and lead times,measured,challenged,2025-08-21,shown,https://gmd.copernicus.org/articles/17/7915/2024/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""A Geneva-led preprint of August 2025 found that ECMWF's HRES consistently beat GraphCast and Pangu-Weather on unprecedented heat, cold and wind extremes at nearly all lead times."", ""url"": ""https://arxiv.org/pdf/2508.15724""}]","{""kind"": ""Challenges""}" AIBD-0261,2023-11-29,event,day,tested,"GNoME predicts 2.2 million crystal structures, of which few may be useful new compounds","DeepMind's GNoME graph networks proposed 2.2 million crystal structures (380,000 stable). Independent researchers found duplicates. They found scant evidence of useful new compounds.","GNoME predicts 2.2 million crystals, among which critics find duplicates","2.2 million crystal structures (380,000 stable)",,studied,Independently studied,no comparison,very low,aggregate result,false,GNoME (Graph Networks for Materials Exploration),,DeepMind,United Kingdom,DeepMind (dataset released openly; stable structures contributed to the Materials Project),United Kingdom,"Mountain View, California, USA",United States,Materials science,Materials researchers,Science,Technology,R&D,Prediction from data,Researchers,9,High income,knowledge_discovery,,,1,4,,,1,,personal; organizational; societal,11,,3,stable crystals previously identified by computational studies before GNoME,"48,000 computationally stable materials","a total of 421,000 stable crystals",measured,challenged,2026-10-09,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC10700131/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Independent chemists and mathematicians challenged the claims from 2024 to 2026. The Nature paper carries no correction or editorial note, and DeepMind told 404 Media that it stands by its claims, so the benefit shows a challenge and no reversal."", ""url"": ""https://arxiv.org/abs/2610.13885""}]","{""kind"": ""Challenges""}" AIBD-0749,2021-08-01,source publication,month,tested,Assessors for AHRQ find that the ExaCT tool cut the time to extract data from 75 randomized trials from 21.6 to 17.9 hours,"In an evaluation for AHRQ, using ExaCT cut data extraction for 75 randomized trials from 21.6 to 17.9 hours, a modest gain. Reviewers still had to check its output.",*ExaCT* cut data extraction for 75 trials from 21.6 to 17.9 hours,cut total extraction time from 21.6 to 17.9 hours,,studied,Independently studied,controlled comparison,very low,aggregate result,false,ExaCT (machine learning and text mining tool for extracting trial data),,"National Research Council of Canada and the University of California, San Francisco",Canada and United States,AHRQ's University of Alberta Evidence-based Practice Center (prospective evaluation on 75 randomized trials),Canada,"University of Alberta, Canada",Canada,Evidence synthesis / systematic reviews,,Work and industry,Health,R&D,Text and language,Researchers,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,2,,0,Manual data extraction by a single reviewer,21.6 hours total extraction time across 75 randomized trials,17.9 hours with ExaCT assisting the first reviewer,measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8369614/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Gates A, et al. Creating Efficiencies in the Extraction of Data From Randomized Trials: A Prospective Evaluation of a Machine Learning and Text Mining Tool. AHRQ Methods for Effective Health Care, Report No. 21-EHC006. Agency for Healthcare Research and Quality, August 2021. NCBI Bookshelf NBK572890, PMID 34403225 (structured abstract). The authors are the University of Alberta team that ran ExaCT."", ""url"": ""https://europepmc.org/abstract/MED/34403225""}]","{""kind"": ""Official documents""}" AIBD-0071,2021-04-21,source publication,day,tested,"An AI analysis of handwriting divides the Great Isaiah Scroll (1QIsaa) into two groups of columns, which its authors attribute to two scribes, but researchers in Norway question the method in 2025","An AI method from Groningen split the 54 columns of the Great Isaiah Scroll into two groups of handwriting, which its authors attribute to two scribes. Researchers in Norway questioned it in 2025.",AI detects two groups of handwriting in the Great Isaiah Scroll,"two statistically distinct groups, with a transition in columns 27–29",,studied,Independently studied,no comparison,very low,benefit created,false,Groningen AI-based writer-identification pipeline (neural-network binarization with textural and allographic feature analysis),BiNet,"University of Groningen (Dhali, Schomaker, Popović)",Netherlands,University of Groningen,Netherlands,"Groningen, Netherlands",Netherlands,History and archives,Palaeography of the Dead Sea Scrolls,Culture and history,Culture,General,Images and video,Researchers,11,High income,knowledge_discovery,,,,5,,,1,,organizational; societal,5,,0,the prevailing scholarly view that a single scribe copied the whole scroll,"the entire manuscript was copied by one scribe, with minor interventions by other, contemporaneous and also much later, scribes","two main scribes, each showing different writing patterns, were responsible for the Great Isaiah Scroll",measured,challenged,2025-06-24,shown,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249769,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Tabita Tobing and Patrick Bours of the Norwegian University of Science and Technology retraced a column-based method on the same images in June 2025. They argue that the 2021 analysis was framed to validate a two-scribe hypothesis. They found that the two-scribe split separates letters better than other groupings, with only moderate scores, and they judge that hinge features alone cannot attribute scribes reliably."", ""url"": ""https://library.imaging.org/admin/apis/public/api/ist/website/downloadArticle/archiving/22/1/14""}]","{""kind"": ""Challenges""}" AIBD-0221,2020-12-02,source publication,day,tested,"The online screener Dytective detects 80.6% of children with dyslexia among 3,644 participants, though two re-analyses in 2026 show a demographic confound","Dytective is a gamified online test for dyslexia with a random-forest classifier. It screened 3,644 children with 79.8% accuracy. Two papers in 2026 showed a demographic confound in its dataset.",Dytective detects 80.6% of dyslexia cases in a study later challenged,79.8% accuracy with 80.6% recall and 79.3% precision,,studied,Independently studied,tested against a standard,very low,aggregate result,false,Dytective online gamified dyslexia screening test with a random-forest classifier,Weka 3.8.3 implementation with 200 trees and unlimited height,"Luz Rello and co-authors (IE University, Northeastern, University of Washington, Carnegie Mellon, University of Barcelona), per the paper's author list",,"Schools, dyslexia centers and non-profits in Argentina, Chile, Colombia, Spain and the USA (study participants); public online use in Spanish-speaking countries",,"Argentina, Chile, Colombia, Spain and the United States (study participants)",Argentina | Chile | Colombia | Spain | United States,Education / learning-disability screening,School-age dyslexia screening,Accessibility,Education,Special,Prediction from data,Children; People with disabilities,4,Upper middle income; High income,incentivization,,,,,,,,,personal; organizational,4,,1,a trivial classifier that labels every participant as not having dyslexia,89.2% accuracy with no child with dyslexia detected,79.8% accuracy with 80.6% recall and 79.3% precision for the dyslexia class,measured,challenged,2026-09-23,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC7710040/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Two independent papers by Sudha and Murali (2 September and 23 September 2026) re-analyzed the public dataset. They report that four demographic columns carry much of the discrimination and that false-positive rates differ twelve-fold between language groups. They do not test the deployed tool on new children, so the screener's results are questioned on this dataset without a finding that the tool fails in use."", ""url"": ""https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2026.1927725/full""}]","{""kind"": ""Challenges""}" AIBD-0066,2020-09-01,event,month,reported,The developers of TREWS report that sepsis patients whose alert was confirmed within three hours had lower mortality at five hospitals,"In a five-hospital study by the TREWS developers, patients whose sepsis alert was confirmed within three hours had 3.3% absolute lower in-hospital mortality, a link that outside researchers question.",Confirmed TREWS sepsis alerts are linked to 3.3% lower mortality,3.3% absolute (18.7% relative) lower in-hospital mortality,,studied,Independently studied,controlled comparison,very low,aggregate result,false,TREWS (Targeted Real-time Early Warning System),,Johns Hopkins University (Suchi Saria's group),United States,Johns Hopkins Medicine (five hospitals),United States,"Baltimore, United States",United States,Healthcare - sepsis / critical care,EHR-integrated early warning system,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,Medical diagnosis,,3,4,,3,5,,personal; societal,9,,0,alerted sepsis patients whose alert was not confirmed by a provider within 3 h,patients whose alert was not confirmed by a provider within 3 h,"reduced in-hospital mortality rate (3.3%, confidence interval (CI) 1.7, 5.1%, adjusted absolute reduction, and 18.7%, CI 9.4, 27.0%, adjusted relative reduction)",measured,scaled,2026-08-04,shown,https://undark.org/2022/10/12/a-new-transparent-ai-tool-may-help-detect-blood-poisoning/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""Bayesian Health, 510(k) summary for the Bayesian Health Sepsis Flagging Device (K250680), with the FDA clearance letter of 30 April 2026. Bayesian Health holds a license agreement with Johns Hopkins and wrote the summary. The FDA found substantial equivalence to an earlier sepsis device and made no finding on mortality."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf25/K250680.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Centers for Medicare & Medicaid Services. Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and Fiscal Year 2027 Rates (final rule). Federal Register 91 FR 49570, 4 August 2026."", ""url"": ""https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-ipps-and""}, {""label"": ""Regulatory document"", ""value"": ""Centers for Medicare & Medicaid Services. Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and Fiscal Year 2027 Rates (final rule). Federal Register 91 FR 49570, 4 August 2026."", ""url"": ""https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-ipps-and""}]","{""kind"": ""Official documents""}" AIBD-1104,2020-06-01,event,month,tested,Consumer Reports finds that Tesla's Autopilot on a Model Y did the best lane keeping of 17 driving assistance systems in its 2020 tests,"Consumer Reports tested 17 driving assistance systems in 2020. Tesla's Autopilot, on a Model Y, did the best lane keeping. It scored 9 of 10 for capability and performance, the top score.",*Autopilot* did the best lane keeping of 17 systems in CR's 2020 tests,9 of 10 for capability and performance,,studied,Independently studied,tested against a standard,very low,aggregate result,false,"Autopilot, as fitted to the Tesla Model Y (2020)",,Tesla,United States,Tesla (fitted to the Model Y),United States,United States,United States,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,High income,physical_health,Hazard reduction,,,,,,,,personal,2,,0,The 16 other active driving assistance systems in the same Consumer Reports tests,8 of 10 or less for capability and performance,9 of 10,measured,challenged,2024-04-26,shown,https://web.archive.org/web/20201022181519/https://www.tesla.com/autopilotAI,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""In April 2024 NHTSA closed its Autopilot investigation, citing 13 fatal crashes related to misuse, and said that Tesla's weak driver engagement system was not appropriate for Autopilot's permissive operating capabilities."", ""url"": ""https://techcrunch.com/2024/04/26/tesla-nhtsa-autopilot-investigation-closed-fatal-crashes""}]","{""kind"": ""Challenges""}" AIBD-0949,2020-01-01,event,year,tested,ADAC reports that Tesla's Autopilot on the Model 3 had the most advanced assistance in Euro NCAP's 2020 tests but weak driver engagement,"In Euro NCAP's 2020 tests, Tesla's Autopilot on the Model 3 scored 95% for safety backup. It avoided a crash in every test of adaptive cruise control. Weak driver engagement left it graded Moderate.",*Autopilot* on the Model 3 assists best but engages drivers weakly,95% for safety backup,,studied,Independently studied,no comparison,very low,aggregate result,false,"Autopilot, as fitted to the Tesla Model 3 (2020)",Software 2020.36.10,Tesla,United States,Tesla (factory-fitted and updated over the air),United States,Europe,,Road vehicle crash avoidance / assisted driving,,Safety and rescue,Transportation,Highways,Machines that act,Drivers and travelers,11,,physical_health,Hazard reduction,,,,,,,,personal,3,,0,,,,,challenged,2023-12-12,shown,https://web.archive.org/web/20201022181519/https://www.tesla.com/autopilotAI,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""After an NHTSA investigation of driver misuse, Tesla recalled 2,031,220 vehicles with Autosteer, part of Autopilot, including 2017 to 2023 Model 3 cars. It filed the recall without concurring with NHTSA's analysis."", ""url"": ""https://static.nhtsa.gov/odi/rcl/2023/RCLRPT-23V838-8276.PDF""}]","{""kind"": ""Challenges""}" AIBD-0931,2017-01-01,event,year,tested,"Researchers in the NHS screening program find that EyeArt could halve the grading of 30,405 episodes of English eye screening without missing moderate-to-severe or proliferative disease","In 30,405 episodes of English eye screening, EyeArt flagged 95.7% of referable retinopathy. It flagged all disease from moderate to proliferative. Its grades would have cleared about half of episodes.",*EyeArt* could halve retinal grading and miss no high-risk retinopathy,"15,091 of 30,405, would still have needed human grading",,studied,Independently studied,tested against a standard,very low,aggregate result,false,EyeArt,v2.1.0,"Eyenuk, Inc.",United States,"Three NHS diabetic eye screening programs in England (North East London, South East London and Gloucestershire), in a research evaluation run in parallel with usual care",United Kingdom,"North East London, South East London and Gloucestershire, England, United Kingdom",United Kingdom,Healthcare (diabetic eye screening),,Health,Health,Disease Prevention,Images and video,Patients,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,3,,0,"The current pathway, in which human graders grade every screening episode",All 30 405 episodes graded by humans,15 091/30 405 episodes needing further human grading after EyeArt,measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8077216/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""UK National Screening Committee (UK NSC) (2026). UK NSC consults on use of artificial intelligence in the diabetic eye screening programme (UK NSC blog, on its 2025 evidence summary), Paragraph on the 2024 resubmission; 'The evidence' section."", ""url"": ""https://nationalscreening.blog.gov.uk/2026/05/11/uk-nsc-consults-on-use-of-artificial-intelligence-in-the-diabetic-eye-screening-programme/""}]","{""kind"": ""Official documents""}" AIBD-0328,2026-04-05,event,day,reported,"A CIA tool called “Ghost Murmur”, pairing quantum magnetometry with AI, may have located downed F-15E officer “Dude 44 Bravo” in Iran before his rescue in April 2026, but CBS later reports that unnamed CIA technology pinpointed him","Two anonymous sources credit the CIA's Ghost Murmur, quantum sensing paired with AI, with locating a downed F-15E officer in Iran. CBS reports that CIA technology pinpointed him. It names no tool.",*Ghost Murmur* may have located a downed F-15E officer in Iran,"one rescued airman, with the claimed AI contribution unverified",The rescue of a downed American airman in Iran is established by the White House briefing of 6 April.[1] The claim that an AI-assisted quantum sensor located him comes from two anonymous sources in the New York Post. President Trump later told the Post that the tool was important but did not explain how it worked.[2] Physicists interviewed by the Post and by Scientific American questioned the capability as described.[3] The contribution attributed to Ghost Murmur remains unverified.,reported,Independently reported,no comparison,very low,harm prevented,false,"'Ghost Murmur': long-range quantum (nitrogen-vacancy diamond) magnetometry paired with AI software that isolates heartbeat signatures from background noise, as described by the NY Post's anonymous sources",,"Lockheed Martin Skunk Works, per two NY Post sources; the company declined to comment",United States,"US Central Intelligence Agency, per the NY Post; the CIA and White House named no tool",United States,Mountains of southern Iran,Iran,Defense and intelligence: combat search and rescue,Remote personnel-location sensing,Defense,Defense,Foreign Operations,Prediction from data,Public servants,3,Upper middle income,physical_health,,5,1,5,,3,1,,personal; organizational,6,,0,,,,,challenged,2026-04-08,not shown,https://nypost.com/2026/04/07/us-news/ghost-murmur-a-never-used-secret-tool-deployed-to-find-lost-airman-in-iran-in-daring-mission/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Physicists interviewed by the Post and Scientific American disputed the public technical description. The claim about the rescue has not been formally reversed or withdrawn."", ""url"": ""https://www.scientificamerican.com/article/what-is-the-quantum-ghost-murmur-purportedly-used-in-iran-scientists/""}]","{""kind"": ""Challenges""}" AIBD-2229,2025-04-02,source publication,day,reported,Real-time surveillance system for patient deterioration: a pragmatic cluster-randomized controlled trial,"In a cluster-randomized trial in two U.S. health systems, patients on units that used the CONCERN early warning system had a 35.6% lower risk of death in the hospital than patients in usual care.",*CONCERN* alerts from nurses' charting cut hospital deaths in a trial,35.6% lower risk of death,,reported,Independently reported,randomized trial,high,aggregate result,false,CONCERN early warning system,,Columbia University with Brigham and Women's Hospital,United States,Two health systems in the United States,United States,United States,United States,Inpatient care (early warning of deterioration from nursing documentation),,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health; operational_improvement,Medical diagnosis,5,4,5,,3,,,personal,3,,0,"Clinical units in usual care, by cluster randomization","265 deaths among 27,869 encounters","181 deaths among 33,024 encounters",measured,unknown,,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC12818231/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Winters BD, Rosen M, Sharma R, Zhang A, Bass EB. Patient Monitoring Systems To Prevent Failure To Rescue: Rapid Review. Making Healthcare Safer IV. Agency for Healthcare Research and Quality, December 2024. The review treats early warning systems as a class."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/39841855/""}]","{""kind"": ""Official documents""}" AIBD-0579,2022-12-07,event,day,reported,Sepsis alerts from COMPOSER are associated with lower mortality in two emergency departments at UC San Diego Health,"After UC San Diego Health deployed COMPOSER, a deep-learning model that alerts nurses to sepsis, mortality was 9.49%, against a modeled 11.39% without it.",Fewer sepsis patients die after COMPOSER alerts UC San Diego nurses,1.9 percentage points,"COMPOSER is a deep-learning model that flags possible sepsis to nurses. It went live in two emergency departments at UC San Diego Health on 7 December 2022. The evaluation covered 6,217 adults with sepsis seen before and after that date. Mortality after deployment was 9.49%, against a modeled 11.39% without COMPOSER. That is an adjusted reduction of 1.9 percentage points, with a confidence interval of 0.3–3.5 at the 95% level. Raw mortality before deployment was 10.3%. The comparison rests on historical controls, with no randomization and no concurrent untreated group. The estimated benefit reached statistical significance at only one of the two hospitals.[1] In a meta-analysis published on 13 May 2025, Yale authors pooled seven randomized trials of other alert systems for sepsis. They found no statistically significant effect on mortality.[2] The COMPOSER team reported in August 2026 that the alerts stayed in use in both emergency departments through October 2025. A large language model was added as a layer in July 2024. The mortality result is an association, reported by the team that built COMPOSER and the health system that deployed it.",reported,Independently reported,no comparison,very low,aggregate result,false,COMPOSER deep-learning sepsis prediction and nurse alert system,,University of California San Diego research team,United States,UC San Diego Health,United States,"San Diego, California, United States",United States,Healthcare - sepsis,Electronic-health-record early warning system,Health,Health,Disease Prevention,Prediction from data,Patients; Health workers,3,High income,physical_health,Medical diagnosis,5,3,5,2,4,5,0.675,personal,6,,1,"Modeled post-deployment mortality without COMPOSER, using historical data and adjustment for confounders",11.39% modeled counterfactual mortality,9.49% observed post-deployment mortality,assumed,persisted,2026-08-05,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC10805720/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Cherian J, Segal J, Sharma R, Zhang A, Bass EB, Rosen M. Patient Safety Practices Focused on Sepsis Prediction and Recognition: Rapid Review. Making Healthcare Safer IV. Agency for Healthcare Research and Quality, 2024. The review treats the practices as a class. Its search ended in August 2023, before the study of COMPOSER appeared."", ""url"": ""https://pubmed.ncbi.nlm.nih.gov/38709865/""}]","{""kind"": ""Official documents""}" AIBD-0296,2016-11-01,event,month,reported,"A seizure alert from an Empatica Embrace reaches the mother of a 26-year-old teacher, who calls paramedics after a seizure left her daughter not breathing (Fulton, Missouri)","An Embrace wristband detected a seizure that stopped a 26-year-old teacher's breathing. It alerted her mother, who called paramedics. IEEE Spectrum reports that she survived.","Embrace wristband alerts a mother, who calls paramedics",,"In November 2016 a 26-year-old teacher from Fulton, Missouri, had an epileptic seizure. It left her unresponsive and not breathing.[1] Her Embrace wristband detected the seizure and alerted her mother, who called paramedics. The teacher survived. Her rescue rests on a single IEEE Spectrum report. The U.S. Food and Drug Administration cleared the device on 26 January 2018, after the event.[2] Later evidence comes from hospital units where patients with epilepsy are monitored. Researchers in Montreal published a study of the device in their own unit on 7 January 2026. They found that the Embrace2 detected all 16 convulsive seizures that occurred while it was worn and working. It raised 29 false alarms in 373 days of monitoring. It detected none of 510 focal seizures without convulsions, a type that the device is not cleared to detect.[3]",reported,Independently reported,no comparison,very low,harm prevented,false,"Empatica Embrace wrist-worn seizure detection (electrodermal activity and accelerometer, on-board algorithm) with the Alert smartphone app",Embrace (the article does not state the generation); echoes concern Embrace2,Empatica,United States,,,"Fulton, Missouri, United States",United States,Healthcare (epilepsy; seizure monitoring),Prescription wearable seizure monitor used at home,Health,Health,Disease Prevention,Prediction from data,Patients,3,High income,physical_health,,5,1,5,,5,1,,personal,5,,3,"seizures recorded during more than 6,500 hours of monitoring of 135 patients (device test reported by IEEE Spectrum)",,"the device correctly identified nearly every single seizure, with a false alarm rate below that of the seizure frequency for most individuals",measured,persisted,2026-01-07,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8418082/,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Food and Drug Administration (2018). 510(k) Summary K172935, Embrace, Empatica S.r.l., decision 26 January 2018 (text extracted from the PDF)."", ""url"": ""https://www.accessdata.fda.gov/cdrh_docs/pdf17/K172935.pdf""}]","{""kind"": ""Official documents""}" AIBD-0112,2022-03-20,event,day,reported,ASENA analysis program flags a car at Yüksekova carrying 52.5 kg of explosives bound for Istanbul,The Turkish police's ASENA analysis program flagged a car at Yüksekova on 20 March 2022. Officers found 52.5 kg of explosives. The interior minister said that they were bound for Istanbul.,ASENA flags a car at Yüksekova carrying 52.5 kg of explosives,"133 packets, 52.5 kg, of factory-made explosive","On 20 March 2022 officers of the Hakkari Provincial Police Directorate stopped a car at a checkpoint in Yüksekova, Turkey. Work on the directorate's ASENA analysis program had flagged the car. A hidden compartment under the spare-wheel well held 133 packets of factory-made explosive, 52.5 kg in all. The explosive was assessed as PETN-RDX.[1] The driver was a police officer posted in Istanbul. On 20 November 2023 the Hakkari 2nd Heavy Penal Court sentenced him to 21 years in prison for supplying weapons to a terrorist organization. It sentenced four co-defendants to 17.5 years each for the same offense.[2] ASENA was designed to flag drug crime. This find lay outside its purpose. Interior Minister Süleyman Soylu said on 21 March 2022 that police had identified a suspicious vehicle thought to be carrying drugs. He said that the police had used analysis programs, “what they call artificial intelligence”.[3] The head of the police Narcotics Crimes Department spoke in June 2022. He listed the explosives among the finds of operations that, by his account, had started with ASENA.[4] No source records the data that ASENA matched for this car. None of the sources says whether an analyst checked the flag before the stop. The driver spoke in court of “those who informed”, but no informant is reported.[5]",reported,Independently reported,no comparison,very low,harm prevented,true,"ASENA (Analiz Sistemleri Narkotik Ağı), Turkish National Police narcotics analysis software",,"Turkish National Police (Emniyet Genel Müdürlüğü), Narcotics Crimes Department; described as written by Turkish engineers, no contractor named",Turkey,"Hakkari Provincial Police Directorate, Turkish National Police",Turkey,"Yüksekova, Turkey",Turkey,Public safety and counter-terrorism policing,"Government, security, and defense",Public sector,Law and Crime,Police,Prediction from data,Public servants,16,Upper middle income,physical_health,Crime reduction or prevention,4,,4,,3,1,,societal; organizational,8,,0,,,,,litigated,2023-11-20,not shown,https://www.aa.com.tr/tr/gundem/yapay-zeka-asena-uyusturucunun-izini-suruyor/2603769,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""On 20 November 2023 the Hakkari 2nd Heavy Penal Court sentenced the police officer A.K. to 21 years in prison. It sentenced the four co-defendants to 17 years 6 months each."", ""url"": ""https://kisadalga.net/haber/detay/aracinda-52-kilo-patlayici-bulunan-polise-21-yil-hapis-cezasi_86842""}]","{""kind"": ""Legal proceedings""}" AIBD-1538,2020-12-31,event,year,reported,Sentry airstrike warnings for civilians in northwest Syria,Hala Systems estimates that its Sentry warnings cut deaths from airstrikes in northwest Syria by 20% in 2019 and 2020. Evaluators for a funder report the estimate and did not validate it.,*Sentry* warns Syrians of airstrikes minutes before they land,20%,,reported,Independently reported,controlled comparison,low,aggregate result,false,Sentry early warning system,,Hala Systems,United States,Hala Systems with the Syrian Civil Defence (White Helmets),Syria,Northwest Syria,Syria,Humanitarian protection (airstrike early warning),,Humanitarian,International Affairs,Human Rights,Prediction from data; Text and language,The public,16,Low income,physical_health,Hazard reduction,4,5,,4,3,,,personal; organizational; societal,3,,0,"Areas and periods without timely warnings, in Hala Systems' own analysis",,20% lower mortality in 2019 and 2020,measured,unknown,,shown,https://aiforsocialgood.github.io/neurips2019/accepted/track1/posters/73_aisg_neurips2019.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Hale S, Poulson C, Winslow E, Mahrousa MB, Alhayes M. Outcome case study: Hala Systems. Triple Line Consulting for Creating Hope in Conflict: A Humanitarian Grand Challenge, December 2023. The funders of Hala Systems' grant commissioned the study. The evaluators report the developer's casualty estimates and state that they did not validate its method."", ""url"": ""https://alnap.org/documents/22146/Hala-Systems-Outcome-Case-Study.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Hale S, Poulson C, Winslow E, Mahrousa MB, Alhayes M. Outcome case study: Hala Systems. Triple Line Consulting for Creating Hope in Conflict: A Humanitarian Grand Challenge, December 2023. The funders of Hala Systems' grant commissioned the study. The evaluators report the developer's casualty estimates and state that they did not validate its method."", ""url"": ""https://alnap.org/documents/22146/Hala-Systems-Outcome-Case-Study.pdf""}, {""label"": ""Evaluation report"", ""value"": ""Hale S, Poulson C, Winslow E, Mahrousa MB, Alhayes M. Outcome case study: Hala Systems. Triple Line Consulting for Creating Hope in Conflict: A Humanitarian Grand Challenge, December 2023. The funders of Hala Systems' grant commissioned the study. The evaluators report the developer's casualty estimates and state that they did not validate its method."", ""url"": ""https://alnap.org/documents/22146/Hala-Systems-Outcome-Case-Study.pdf""}]","{""kind"": ""Official documents""}" AIBD-0239,2026-06-19,event,day,reported,OpenAI alert relayed through the FBI leads Espírito Santo police to detain a father a day before his stated date to kill his son,"OpenAI's safety systems flagged a ChatGPT user's plan to kill his 8-year-old son. Alerted through the FBI, Brazilian police held him a day before his stated date.",OpenAI flag leads Brazilian police to hold a father a day early,held him a day before his stated date,,reported,Independently reported,no comparison,very low,protective response,false,ChatGPT with OpenAI's safety-monitoring pipeline (automated classifiers plus human review and law-enforcement referral),,OpenAI,United States,OpenAI,United States,"São Gabriel da Palha, Brazil",Brazil,Public safety,Law enforcement and child protection,Safety and rescue,Law and Crime,Child Abuse,Text and language,Children,16,Upper middle income,physical_health,Crime reduction or prevention,3,2,2,,3,1,,personal; organizational,9,,1,the date of 20 June 2026 that the user gave in his messages,Police received the tip on 16 June 2026.,"Police arrested him on 19 June 2026, a day before that date.",assumed,litigated,2026-08-13,shown,https://web.archive.org/web/2026id_/https://openai.com/index/helping-people-when-they-need-it-most/,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""He was released on 13 August 2026 after a court granted habeas corpus, under an ankle monitor and a no-contact order, with the inquiry continuing."", ""url"": ""https://www.bbc.com/portuguese/articles/c8dn1l7vr6ro""}]","{""kind"": ""Legal proceedings""}" AIBD-0260,2026-05-29,event,day,reported,"A man pleads guilty to stalking after OpenAI refers his threats to the FBI, which passes them to local police","Through the FBI, OpenAI disclosed threats that a man wrote in ChatGPT against his ex-girlfriend. He later pleaded guilty to stalking.",A man pleads guilty after OpenAI refers his threats to the FBI,"eight years of probation, including two years of GPS monitoring",,reported,Independently reported,no comparison,very low,protective response,false,"ChatGPT (OpenAI), with OpenAI's automated detection and human review pipeline for users planning to harm others",,OpenAI,United States,OpenAI,United States,"South Palm Beach, United States",United States,Public safety - stalking and threat investigation,Consumer chatbot trust-and-safety referral to law enforcement,Safety and rescue,Law and Crime,Family Issues,Text and language,Women and mothers,5; 16,High income,physical_health,Crime reduction or prevention,3,1,4,,3,1,,personal,4,,0,"the situation before the referral, when the threatened woman had received anonymous threats but had not reported the man to police",no report to law enforcement; the threats came from burner numbers,detectives matched the anonymous texts to the man through the ChatGPT records and arrested him six days after the FBI notice,assumed,litigated,2026-08-13,shown,https://web.archive.org/web/2026id_/https://openai.com/index/helping-people-when-they-need-it-most/,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""The man pleaded guilty on 13 August 2026 to written threats to kill, aggravated stalking and misuse of a two-way device, with adjudication withheld and eight years of probation."", ""url"": ""https://bocanewsnow.com/2026/08/27/man-flagged-by-chatgpt-pleads-guilty-in-stalking-case/""}]","{""kind"": ""Legal proceedings""}" AIBD-0149,2025-10-09,event,day,reported,"Frankfurt police find a missing 16-year-old in crisis on Taunusstraße within a day of her disappearance, after a judge-confirmed emergency order let the Bahnhofsviertel camera system's AI search for her face","Frankfurt police found a missing 16-year-old in crisis within a day. The face recognition software VAS Videmo360 had flagged her on a Bahnhofsviertel camera, under an order that a judge confirmed.",Police find a missing 16-year-old after Frankfurt camera AI flags her,found a missing 16-year-old in crisis within a day,,reported,Independently reported,no comparison,very low,protective response,false,"AI-assisted video analysis with real-time biometric remote identification in the Frankfurt Bahnhofsviertel police video surveillance system (Videoschutzanlage), monitored from the police Video-Operation-Center","VAS Videmo360 video analysis system (product named in the police data protection impact assessment, as cited in the GFF filing); the police say that only the vendor knows the exact specifications of the face-template model",,,Polizeipräsidium Frankfurt am Main (Hessian police),Germany,"Frankfurt am Main, Germany",Germany,Policing and missing-person search,Public safety,Safety and rescue,Law and Crime,Child Abuse,Images and video,Children,3; 16,High income,physical_health,,3,1,1,,3,1,,personal; organizational,9,,0,"all persons searched for with the Bahnhofsviertel face-recognition system since July 2025, a low double-digit number",,"Erfolg gab es nur einmal, als eine vermisste 16-Jährige mit der Kamera-KI identifiziert wurde.",measured,litigated,2026-04-22,shown,https://www.presseportal.de/blaulicht/pm/4970/6138810,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""Gesellschaft für Freiheitsrechte, Doña Carmen e. V. and Prigge, J. (2026). Klagebegründung an das Verwaltungsgericht Frankfurt am Main, 22 April 2026. The plaintiffs oppose the system and wrote this filing. They report what the police said in their reply of 17 December 2025 and in their data protection impact assessment. They argue that the law allows searches for missing persons without a set danger threshold."", ""url"": ""https://freiheitsrechte.org/uploads/documents/Freiheit-im-digitalen-Zeitalter/Biometrische-Videoueberwachung-Frankfurt/2026-04-22_Klagebegruendung-an-das-Verwaltungsgericht-Frankfurt-am-Main.pdf""}, {""label"": ""Follow-up"", ""value"": ""By April 2026 the Hessian Greens had asked the Staatsgerichtshof to review the amendment to the police law behind real-time face recognition. Juanita Henning of Doña Carmen had sued with the GFF at the Frankfurt administrative court and asked for a referral to the Federal Constitutional Court. The system kept running, with an evaluation phase due from July 2026."", ""url"": ""https://netzpolitik.org/2026/rotlichtviertel-frankfurt-am-main-hier-analysiert-die-polizei-jedes-gesicht/""}]","{""kind"": ""Legal proceedings""}" AIBD-0228,2022-10-26,event,day,reported,"INEC's Automated Biometric Identification System invalidates 2,780,756 ineligible voter registrations (22.6%) before Nigeria's 2023 election","Nigeria's electoral commission reported on 26 October 2022 that its Automated Biometric Identification System (ABIS) flagged 2,780,756 (22.6%) of 2021–22 registrations as ineligible.","Nigeria's biometric matching flags 2,780,756 registrations as ineligible","2,780,756 registrations (22.6%) were identified as ineligible and invalidated",,reported,Independently reported,no comparison,very low,benefit created,false,Automated Biometric Identification System (ABIS),,Not named in the sources,,"Independent National Electoral Commission (INEC), Nigeria",Nigeria,Nigeria (national),Nigeria,Electoral integrity / voter registration,Government,Public sector,Government Operations,Political Campaigns,Images and video,,16,Lower middle income,privacy_protection; social_improvement,Fraud detection,3,5,3,2,5,1,0.390,societal; organizational,5,,2,the raw Continuous Voter Registration data before ABIS cleaning,"12,298,944 Nigerians successfully completed the registration as new voters","the number of valid registrations (post-ABIS) is 9,518,188",measured,challenged,2023-06-27,not shown,https://www.ndr.org.ng/nigerias-voter-register-hits-93-5-million-as-12m-new-registrants-are-added/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""The EU observer mission reported that underage registrants remained on the final register in unknown numbers and that the register has never been audited. It recommended an independent audit that includes the quality of biometric data. BusinessDay had raised similar doubts on 20 January 2023. No official reversal of the removals was found."", ""url"": ""https://web.archive.org/web/20261004011619id_/https://www.eeas.europa.eu/sites/default/files/documents/2023/EU%20EOM%20NGA%202023%20FR.pdf""}]","{""kind"": ""Challenges""}" AIBD-0226,2026-05-02,event,day,reported,A ZeroEyes alert sends Florida State University police to a man whom they charge on four counts for pointing a stolen Glock at bystanders,"According to court documents, ZeroEyes gun detection flagged a man pointing a gun in a Florida State University garage on 2 May 2026. Police found a stolen Glock 19 on him. They charged him.",*ZeroEyes* alert sends police to an armed man in a Florida State garage,,,reported,Independently reported,no comparison,very low,protective response,false,ZeroEyes AI gun detection,,ZeroEyes,United States,Florida State University Police Department,United States,"Tallahassee, United States",United States,Public safety / weapons detection,Education,Education,Law and Crime,Crime Control,Images and video,Public servants,16,High income,physical_health,Crime reduction or prevention,2,2,1,,4,1,,societal; personal,4,,1,a police response without the camera notification,,,assumed,litigated,2026-05-03,shown,https://zeroeyes.com/faqs/,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""The man was charged on four counts and bonded out of jail on Sunday 3 May 2026, according to court documents cited by WCTV."", ""url"": ""https://www.wctv.tv/2026/05/04/court-documents-19-year-old-arrested-after-brandishing-weapon-fsu-parking-garage-early-saturday-morning/""}]","{""kind"": ""Legal proceedings""}" AIBD-0158,2025-12-01,event,month,reported,"After Paul Conyngham used ChatGPT and AlphaFold to choose targets for a personalized mRNA vaccine that UNSW made, his dog Rosie's largest tumor halved before her mast cell cancer returned","Paul Conyngham used ChatGPT and AlphaFold to choose targets for an mRNA vaccine. Given with a checkpoint inhibitor, it halved Rosie's largest tumor by early 2026 before the cancer returned.",The tumor halves after an owner designs his dog's cancer vaccine with AI,halved Rosie's largest tumor by early 2026,,reported,Independently reported,no comparison,very low,benefit created,false,"ChatGPT (OpenAI) and AlphaFold (Google DeepMind), used with Conyngham's own analysis to select tumor neoantigen targets for a personalized mRNA vaccine",,OpenAI (ChatGPT); Google DeepMind (AlphaFold); xAI (Grok),United States,"Paul Conyngham (owner), with UNSW's Ramaciotti Centre for Genomics (sequencing), the UNSW RNA Institute (vaccine manufacture) and the University of Queensland School of Veterinary Science, Gatton (administration)",,"Sydney, Australia",Australia,Veterinary oncology / personalized mRNA vaccine design,Companion animal with mast cell cancer,Health,Agriculture,Animal and Crop Disease,Text and language; Prediction from data,,,High income,animal_health,,2,1,3,,3,2,,personal; organizational,13,,0,veterinary chemotherapy and surgery given before the vaccine,slowed but failed to shrink the tumours,the tennis ball-sized tumour on Rosie’s hock has shrunk in half,assumed,reversed,2026-08-24,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC8371605/,,,,[],Querist,The benefit was later reversed.,"[{""label"": ""Follow-up"", ""value"": ""On 24 August 2026 机器之心 reported, in a piece that 36Kr republished, that Conyngham had written on X in June 2026 about Rosie's end. A later surgery took the cancer out of remission, the tumors spread within four weeks, and he chose to have her euthanized. The date of her death has not been reported. In its release of 17 August 2026, GAMGEE writes of her in the past tense."", ""url"": ""https://www.36kr.com/p/3952021490269573""}]","{""kind"": ""Challenges""}" AIBD-1174,2025-03-31,event,day,reported,The World Bank's Independent Evaluation Group reports that logging shifts with facial recognition reduced absenteeism among health staff in Andhra Pradesh,The World Bank's evaluation office reports that Andhra Pradesh logged the shifts of health staff with facial recognition. This reduced absenteeism. It cut salary spending on absent staff.,Facial log-ins cut absences of health staff in Andhra Pradesh,,,reported,Independently reported,no comparison,very low,aggregate result,false,Facial recognition attendance system with geo-location for health staff in Andhra Pradesh's public health facilities (not named in the review),,Not named in the review,,Andhra Pradesh Department of Health and Family Welfare (DoHFW),India,"Andhra Pradesh, India",India,Healthcare (workforce management),,Health,Health,Manpower,Images and video,,3,Lower middle income,operational_improvement,Enhanced productivity,2,1,,,3,5,,organizational,3,,0,,,,,persisted,2025-11-19,,,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""MediaNama (relaying The Times of India's report of a National Medical Commission finding) (2024). Andhra Pradesh medical colleges to switch from facial recognition to biometric attendance, Article body, paragraphs 1 and 4."", ""url"": ""https://www.medianama.com/2024/01/223-andhra-medical-colleges-attendance-frt-biometrics/""}]","{""kind"": ""Official documents""}" AIBD-0132,2025-01-10,event,day,reported,Metropolitan Police live facial recognition flags a sex offender at Denmark Hill who is alone with a six-year-old girl in breach of his court order,The Metropolitan Police's Live Facial Recognition cameras identified a sex offender who was alone with a six-year-old girl on 10 January 2025. He was jailed for two years.,Police cameras flag a sex offender alone with a six-year-old girl,Kingston Crown Court jailed him for two years,,reported,Independently reported,no comparison,very low,protective response,false,Live Facial Recognition (LFR) cameras mounted on a Metropolitan Police van,,,,Metropolitan Police Service,United Kingdom,"London, United Kingdom",United Kingdom,Policing / public protection,Law enforcement use of live facial recognition in public places,Safety and rescue,Law and Crime,Child Abuse,Images and video,Children; Public servants,16,High income,physical_health,Crime reduction or prevention,2,1,4,,3,1,,personal; societal,5,,0,not being identified (no live facial recognition check),"it’s possible if he hadn’t been identified using this technology, he could have gone on to abuse this child","his face was identified by Live Facial Recognition cameras attached to the back of a van, alerting officers to his presence",assumed,litigated,2026-04-21,not shown,https://southwarknews.co.uk/area/camberwell/sex-offender-caught-in-denmark-hill-thanks-to-facial-recognition-cameras/,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""Holgate LJ and Farbey J. R (Thompson and Carlo) v Commissioner of Police of the Metropolis [2026] EWHC 915 (Admin), High Court, King's Bench Division, 21 April 2026. The judges have no stake in the system. They found that the Met's LFR policy, including watchlists of offenders subject to court orders, is lawful. They also state that they did not consider whether LFR is effective."", ""url"": ""https://www.judiciary.uk/wp-content/uploads/2026/04/AC-2024-LON-001764-R-Thompson-and-Carlo-version-for-hand-down-21-04-2026.pdf""}, {""label"": ""Follow-up"", ""value"": ""On 21 April 2026 the High Court dismissed a judicial review brought by Shaun Thompson, whom LFR had misidentified at London Bridge, and Silkie Carlo of Big Brother Watch. The court held that the Met's LFR policy is lawful. William Page of Birmingham Law School wrote in May 2026 that Thompson intends to appeal. Earlier, on 4 July 2025, the Met had announced more than 1,000 LFR arrests and published the man's case as one of its examples."", ""url"": ""https://www.judiciary.uk/wp-content/uploads/2026/04/AC-2024-LON-001764-R-Thompson-and-Carlo-version-for-hand-down-21-04-2026.pdf""}]","{""kind"": ""Legal proceedings""}" AIBD-0095,2024-08-29,event,day,reported,"GiveDirectly pays over 4,600 people in Kogi State, Nigeria, on Google Flood Hub forecasts, mostly before floods peaked in October 2024","GiveDirectly used Google Flood Hub forecasts to trigger $105 payments to over 4,600 people in Ibaji, Kogi State, most of them before floods peaked on 21 October 2024.","GiveDirectly pays over 4,600 people in Kogi on Flood Hub forecasts","weekly incomes rising from ₦4,500 to ₦10,000 and food shortages falling from 97% to 7%",,reported,Independently reported,no comparison,very low,protective response,false,"Google Flood Hub AI river-flood forecasts accessed via API, with JBA Global Resilience hydrology analysis and a 20%-of-community-area trigger rule",,Google (Flood Hub); trigger design by GiveDirectly with JBA Global Resilience,United States,GiveDirectly,United States,"Ibaji, Kogi State, Nigeria",Nigeria,Humanitarian anticipatory action and cash transfers,NGO cash assistance,Humanitarian,International Affairs,Foreign Aid,Prediction from data,People at risk of disaster,13; 1,Lower middle income,environmental_impact,Natural disaster prediction,2,3,,2,4,2,,personal; organizational; societal,4,,4,"the recipients' own situation before the transfers, from GiveDirectly's follow-up survey without a control group","weekly income ₦4,500; 97% facing food shortages","weekly income ₦10,000; 7% facing food shortages",measured,challenged,2026-08-31,shown,https://doi.org/10.1038/s41586-024-07145-1,$105,anticipatory cash transfer per recipient before the flood peak (a second $210 transfer followed),False,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""On 31 August 2026 The New Humanitarian reported that data mismatches and phone-access barriers kept some of the poorest Ibaji residents from early aid. Earlier, on 14 October 2025, Rest of World reported that GiveDirectly planned a 2026 randomized trial of the approach with over 100,000 families in northern Bangladesh."", ""url"": ""https://web.archive.org/web/20260922092208/https://www.thenewhumanitarian.org/investigations/2026/08/31/givedirectlys-ai-experiment-left-flood-victims-behind-nigeria""}]","{""kind"": ""Challenges""}" AIBD-0216,2024-05-17,event,day,reported,"Stanford's Tutor CoPilot, built on GPT-4, helps tutors raise students' mastery of topics by 4 percentage points in a randomized trial with 900 tutors, but end-of-year math scores show no significant gain","Tutor CoPilot, a Stanford system built on GPT-4, gives human tutors suggested moves. It made students 4 percentage points more likely to master topics, with no significant gain on end-of-year tests.",Tutor CoPilot helps tutors raise students' mastery of math topics,4 percentage points more likely to master topics,,reported,Independently reported,randomized trial,moderate,aggregate result,false,Tutor CoPilot using GPT-4 and Bridge teaching strategies within FEV Tutor’s platform,,"Stanford University (Wang, Ribeiro, Robinson, Loeb, Demszky)",United States,FEV Tutor with a large southern U.S. school district (nine schools),United States,A school district in the southern United States,United States,Education,K-12 virtual math tutoring (grades 3-8),Education,Education,Excellence,Text and language,Students; Teachers,4,High income,incentivization,Increased/personalized knowledge,2,3,3,5,3,,,personal; organizational,7,,0,students of control-group tutors on the same platform who did not have access to Tutor CoPilot,62% student passing rate on exit tickets (control tutors),"66% passing rate (tutors with Tutor CoPilot), 4 percentage points higher",measured,withdrawn,2025-01-25,shown,https://arxiv.org/pdf/2410.03017v2,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""FEV Tutor, the provider that ran the trial, shut down on 25 January 2025 after failing to raise money or find a buyer. The 74 reported that the trial result did not save the business."", ""url"": ""https://www.the74million.org/article/tutoring-giants-sudden-demise-linked-to-end-of-federal-relief-funds/""}]","{""kind"": ""Withdrawals""}" AIBD-0447,2024-01-01,event,year,reported,AI over 5G-A networks to protect wildlife in areas shared with people,China Mobile reports that its AI monitoring system on 5G-A widened the monitored area of a Xiamen reserve from 120 to 330 square kilometers. It reports 97% fewer animal deaths from collisions.,AI over 5G-A widens the area monitored in a Xiamen dolphin reserve,widened the monitored area of a Xiamen reserve from 120 to 330 square kilometers,,reported,Independently reported,before and after,very low,aggregate result,false,Intelligent Symbiosis: AI + 5G-A Redefining Sustainable Guardianship in Human-Wildlife Shared Zones,,China Mobile,,Xiamen Chinese White Dolphin Amphioxus Nature Reserve Affairs Center,,"Xiamen, China",China,Telecommunications,,Energy and infrastructure,Environment,Species & Forest,,,14,Upper middle income,environmental_impact; animal_health,Environmental impacts,2,1,4,4,3,5,0.440,organizational; personal; societal,6,"ITU, AI for Good: Innovate for Impact",0,traditional monitoring methods,120 square kilometers monitored,330 square kilometers monitored,measured,persisted,2025-11-11,shown,https://www.itu.int/dms_pub/itu-t/opb/ai4g/T-AI4G-AI4GOOD-2025-5-PDF-E.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Lenoci J, Wang H. Terminal Evaluation Report, UNDP-GEF project Strengthening Marine Protected Areas in SE China to conserve globally significant coastal biodiversity (China Protected Areas System Reform Program, Child Project 4), UNDP PIMS ID 5379, GEF Project ID 9463. Final version, 15 September 2024. UNDP Evaluation Resource Centre. Results framework, Indicator 10a (Chinese white dolphins and other cetaceans found dead with external injuries due to human activities); the Xiamen Rare Marine Species National Nature Reserve is a target protected area of the project's Xiamen Bay pilot (XBCW)."", ""url"": ""https://erc.undp.org/evaluation/documents/download/23746""}]","{""kind"": ""Official documents""}" AIBD-0018,2023-10-19,source publication,day,reported,Convolutional neural network finds 72 previously undetected pulses from fast radio burst FRB 121102 in Green Bank Telescope data,"A convolutional neural network built at the University of California, Berkeley, found 72 missed pulses from the fast radio burst FRB 121102. A search in 2023 found 12 of them again.",Neural network finds 72 missed pulses from a repeating fast radio burst,found 72 previously undetected pulses from the repeating fast radio burst FRB 121102,,reported,Independently reported,tested against a standard,very low,benefit created,false,"Convolutional neural network for FRB pulse detection (Zhang et al., Breakthrough Listen / Berkeley SETI Research Center)",,"University of California, Berkeley (Berkeley SETI Research Center, Breakthrough Listen)",United States,"Breakthrough Listen, on Green Bank Telescope data",United States,"Berkeley, United States",United States,Astrophysics / radio transients,Academic research,Science,Technology,Space,Prediction from data,Researchers,,High income,knowledge_discovery,,2,,5,,4,1,,organizational; societal,5,,1,the conventional search algorithm previously run on the same observation,21 bursts have been previously detected,"72 new pulses, totaling 93 pulses in five hours",measured,challenged,2023-10-19,shown,https://arxiv.org/abs/1809.03043,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""A new search in 2023 of the first 30 minutes of the same data found 30 of the 46 candidates of the CNN for that span again. Its burst table shows that 18 of the 30 were bursts that the classical search had already found, so 12 were pulses that only the CNN had found. The authors report that the 16 candidates that they missed were faint pulses whose astrophysical nature is unclear. The rest of the observation was not searched again."", ""url"": ""https://arxiv.org/html/2307.02303v2""}]","{""kind"": ""Challenges""}" AIBD-0243,2023-02-14,event,day,reported,Camera-based AI feedback on 100 Spin e-scooters in Santa Monica cuts time ridden on sidewalks by 22% in a randomized field test,"Camera-based computer vision from an unnamed maker detected sidewalk riding on Spin e-scooters in Santa Monica. In a randomized test, its feedback cut the time ridden on sidewalks by 22%.",Camera AI on Spin e-scooters cuts time ridden on sidewalks 22%,The feedback group spent 22% less time and 20% less distance on sidewalks,,reported,Independently reported,randomized trial,moderate,aggregate result,false,"Camera-based computer-vision riding-surface detection with in-app notifications, audible beeps and speed reduction on Spin shared e-scooters (maker not named in the paper)",,Not named in the paper,,"Spin (shared e-scooter operator), with University of Washington researchers",United States,"Santa Monica, United States",United States,Micromobility safety,Shared e-scooters / pedestrian conflict,Safety and rescue,Transportation,Highways,Images and video,Drivers and travelers,11,High income,physical_health,Hazard reduction,2,,3,,3,,,societal; organizational; personal,2,,2,the no-feedback group (50 scooters with feedback mechanisms disabled at random),"0.22 (mean fraction of trip time on sidewalks, no-feedback group, Table 1)","0.17 (mean fraction of trip time on sidewalks, feedback group, Table 1)",measured,withdrawn,2024-11-20,shown,https://findingspress.org/article/125892-ai-driven-feedback-systems-reduce-sidewalk-riding-on-shared-e-scooters,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""The study's own limitations section says that Spin withdrew all camera-equipped scooters from service after they were targeted by thieves. The withdrawal is dated only by the paper's publication."", ""url"": ""https://findingspress.org/article/125892-ai-driven-feedback-systems-reduce-sidewalk-riding-on-shared-e-scooters""}]","{""kind"": ""Withdrawals""}" AIBD-0346,2023-02-01,event,month,reported,Responders in Türkiye used machine-learning maps of damage from xView2 after the earthquakes of 6 February 2023,"xView2 is a machine-learning model that grades building damage in satellite images. After the 2023 Türkiye earthquakes, it gave responders maps that UN rescue teams used in Adıyaman.",Rescue workers in Türkiye find damaged areas with xView2 maps,would typically take weeks and now takes hours or minutes,,reported,Independently reported,no comparison,very low,protective response,false,"xView2 building damage assessment models (semantic segmentation on satellite imagery, trained on the xBD dataset)",,US Defense Innovation Unit (DIU) with Carnegie Mellon University Software Engineering Institute; research partners Microsoft AI for Good and UC Berkeley,United States,"UN INSARAG (search and rescue ground teams in Adıyaman); AFAD, World Bank, IFRC and WFP (per the developer's account); Microsoft AI for Good delivered estimates to AFAD (per Microsoft)",Switzerland,Adıyaman and four cities in southeast Türkiye including Kahramanmaraş (Marash),Turkey,Disaster response / post-earthquake damage assessment,Humanitarian and civil-protection organizations,Humanitarian,International Affairs,Foreign Aid,Images and video,Public servants,11,Upper middle income,operational_improvement,"Faster data management, decision-making",2,2,1,,3,,,personal; organizational; societal,5,,2,conventional damage assessment,weeks,hours or minutes,assumed,challenged,2025-10-27,shown,https://www.technologyreview.com/2023/02/20/1068824/ai-actually-helpful-disaster-response-turkey-syria-earthquake/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Researchers from Stanford and Direct Relief tested the Microsoft model built on xBD against reference damage data for hospitals and dialysis centers in Antakya, Kahramanmaraş and Iskenderun. They report that it found 42.86% of damaged facilities, with 93.55% specificity. They conclude that such models cannot yet replace ground surveys."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC12558478/""}]","{""kind"": ""Challenges""}" AIBD-0003,2022-09-01,event,month,reported,"Brain implant at the University of California, San Francisco, decodes a woman's attempted speech at 78 words per minute 17 years after a stroke, before its removal in February 2024 for an unrelated reason","A brain implant at the University of California, San Francisco, decoded Ann Johnson's attempts to speak at a median 78 words per minute. It drove a speaking avatar.",Brain implant lets a woman speak via an avatar 17 years after a stroke,decoded text at a median 78 words per minute,,reported,Independently reported,before and after,very low,benefit created,false,UCSF multimodal speech neuroprosthesis (BRAVO trial),"253-channel high-density ECoG array; bidirectional RNN decoders with CTC loss producing text, synthesized speech and avatar gestures; 1,024-word vocabulary",UCSF Chang Lab with UC Berkeley,United States,UCSF Medical Center,United States,"San Francisco, United States",United States,Healthcare / assistive communication,Post-stroke anarthria,Accessibility,Health,Long-term Care,Prediction from data; Speech and sound,People with disabilities; Patients,3; 10,High income,physical_health; accessibility,,2,1,3,,5,5,,personal,6,,2,"the commercial device that she usually used, which tracks the movement of her head",about 14.2 words per minute with her assistive device,"a median 78.3 words per minute of decoded text, with a median word error rate of 25% over a 1,024-word vocabulary",measured,withdrawn,2024-02-01,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC10826467/,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""Johnson took part in the study of streaming speech synthesis in 2025, but its data predate the removal of her implant. Berkeley News reported that the implant was removed in February 2024 for a reason unrelated to the trial. It also reported that she still writes to the team with the assistive technology that she uses now."", ""url"": ""https://news.berkeley.edu/2025/08/13/a-stroke-stole-her-ability-to-speak-eighteen-years-later-scientists-used-ai-to-bring-it-back/""}]","{""kind"": ""Withdrawals""}" AIBD-0031,2022-06-01,event,month,reported,"Randomized evaluation of volunteers relaying AI-based flood warnings in Bihar, India (2022–2025 monsoons)","In a trial in Bihar, volunteers relayed flood alerts from Google and the Central Water Commission. Under severe floods, their villages' homes were 12.7 percentage points less likely to flood.",Flood alerts relayed by volunteers cut home flooding in Bihar,12.7 percentage points less likely to have their own home flooded,,reported,Independently reported,randomized trial,low,aggregate result,false,"Google flood forecasting with Android push alerts (Google Public Alerts), plus community dissemination by Yuganter volunteers",,Google,United States,Central Water Commission of India with Google; last-mile dissemination by Yuganter (NGO) under the Jagnani-Pande evaluation,India,"Bihar (twelve flood-prone districts), India",India,Disaster risk reduction / flood early warning,Rural households in riverine flood zones,Humanitarian,Domestic Commerce,Disaster Relief,Prediction from data,People at risk of disaster,13,Lower middle income,environmental_impact,Natural disaster prediction,2,5,4,4,4,2,0.450,personal; societal,4,Google.org,1,control village councils that received the same CWC and Google forecasts and alerts but had no community volunteers,"control households under severe flooding, whose chance of home flooding was 23.7 percentage points higher than in a season with no flood",treated households under severe flooding were 12.7 percentage points less likely to have their own home flooded,measured,challenged,2026-09-01,shown,https://arxiv.org/abs/2111.02780,"INR 6,500",less spent on illness treatment per household over the flood season,False,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""In the September 2026 version, which covers four seasons from 2022 to 2025, the same authors report no treatment effect on physical health. The 16.6 percent drop in illness symptoms and the lower medical spending from the April 2024 version are not repeated. They report gains in home flooding, food security and borrowing instead."", ""url"": ""https://www.dropbox.com/scl/fi/gpwdwa4hkm9e2e81c2ne5/floods_EWS.pdf?rlkey=3n4l804arm1zms5y0pt0ac5sp&raw=1""}]","{""kind"": ""Challenges""}" AIBD-0369,2022-03-10,event,day,reported,Westchester County police use Rekor's analysis of plate-reader patterns to stop a man in Scarsdale. Officers find crack cocaine. He is convicted,Rekor Scout software flagged a man's trips past Westchester County's 480 plate-reader cameras. Officers who stopped him in Scarsdale on 10 March 2022 found crack cocaine. They found a pistol.,Police find drugs in Scarsdale after Rekor flags a driver's trips,,,reported,Independently reported,no comparison,very low,protective response,false,Rekor license-plate-reader pattern analysis (Rekor Public Safety Network data) used by the Westchester County Police Department,Rekor Scout (Interdiction Analysis report),Rekor,United States,Westchester County Police Department,United States,"Scarsdale, United States",United States,Policing / drug trafficking,Government,Public sector,Law and Crime,Illegal Drugs,Images and video; Prediction from data,Public servants,16,High income,physical_health,Crime reduction or prevention,2,,4,,3,1,,societal,5,,0,,,,,persisted,2025-01-17,not shown,https://static.foxnews.com/foxnews.com/content/uploads/2023/07/david-zayas-march-10-court-filing-defense.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""United States v. Zayas, 22 Cr. 178 (NSR), defense motion filed 10 March 2023, pp. 1–6 and footnote 8. Direct litigation account of the license-plate search and disputed analytic report. Statements are the defense’s account. They are not judicial findings."", ""url"": ""https://static.foxnews.com/foxnews.com/content/uploads/2023/07/david-zayas-march-10-court-filing-defense.pdf""}, {""label"": ""Court document"", ""value"": ""U.S. District Court for the Southern District of New York, United States v. Zayas, 7:22-cr-00178 (NSR), Judgment in a Criminal Case. Signed by Judge Nelson S. Román on 30 April 2024 (docket text in the RECAP archive). The court has no stake in the system. The judgment records the guilty plea, the 48-month sentence and the forfeiture of $34,000. The analysis from the plate readers does not appear in it."", ""url"": ""https://www.courtlistener.com/?q=docket_id%3A63178722&type=r&order_by=entry_date_filed+desc""}]","{""kind"": ""Official documents""}" AIBD-0167,2018-08-01,event,day,reported,"IdentiFlight stops wind turbines when it detects eagles at a Wyoming wind farm, where disputed estimates put the cut in eagle deaths at 50% to 85%","Researchers estimated an 82% (75%–89%) relative cut in eagle deaths at a Wyoming wind farm after IdentiFlight began curtailing turbines. Two federal statisticians later put it at 50% (−159%, 89%).",How many eagles IdentiFlight's turbine stops save is disputed,82% (75%–89%) relative cut in eagle deaths at a Wyoming wind farm,,reported,Independently reported,controlled comparison,very low,aggregate result,false,IdentiFlight automated eagle detection and turbine curtailment (camera system with machine-learning classification),,IdentiFlight (Boulder Imaging),United States,"Top of the World Windpower Facility, Wyoming",United States,"Wyoming, United States",United States,Energy,Wind power wildlife mitigation,Energy and infrastructure,Environment,Species & Forest,Images and video,,15,High income,environmental_impact; animal_health,Environmental impacts,2,,5,,4,,,societal; organizational,7,,3,"a control wind facility 15 km away without automated curtailment, before and after the installation",increasing at the control site by 113% (51%–218%),the number of fatalities at the treatment site declined by 63% (95% CI = 59%–66%),measured,persisted,,shown,https://doi.org/10.1371/journal.pone.0278754,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""U.S. Fish and Wildlife Service, Permits for Incidental Take of Eagles and Eagle Nests (final rule), Federal Register 89 FR 9920, 12 February 2024. The Service regulates eagle take and has no stake in IdentiFlight. It allows permittees to use the system but finds that the efficacy of such technologies has not been studied enough to require them."", ""url"": ""https://www.federalregister.gov/documents/2024/02/12/2024-02182/permits-for-incidental-take-of-eagles-and-eagle-nests""}]","{""kind"": ""Official documents""}" AIBD-0177,2017-06-01,event,month,reported,"In a one-week pilot in 2017, VeriPol flags 25 false robbery reports in Murcia and 39 in Málaga, and Spain's police drop it in 2024","In a pilot week in June 2017, the Spanish National Police's VeriPol text classifier flagged 25 false robbery reports in Murcia. It flagged 39 in Málaga. The police stopped using it on 21 October 2024.","In 2024 police drop VeriPol, which flagged false robbery reports in 2017","25 and 39 false robberies respectively, against 3 and 12 in the same month",,reported,Independently reported,before and after,very low,aggregate result,false,VeriPol,,"Universidad Complutense de Madrid and Universidad Carlos III de Madrid, with Spanish National Police officer Miguel Camacho-Collados",Spain,"Spanish National Police (Policía Nacional), Ministry of the Interior",Spain,"Murcia and Málaga, Spain",Spain,Fraud and false reporting,False robbery reports filed with police,Finance,Law and Crime,White Collar Crime,Text and language,Public servants,16,High income,privacy_protection,Fraud detection,2,1,4,,3,5,,organizational; societal,7,,3,the average monthly number of false robbery reports detected and closed in June of 2008 to 2016 in the same two cities,an average of 3.33 in Murcia and 12.14 in Málaga per June month,25 in Murcia and 39 in Málaga in one week,measured,withdrawn,2024-10-21,shown,https://doi.org/10.1016/j.knosys.2018.03.010,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""The Interior Ministry told Civio that the National Police stopped using VeriPol on 21 October 2024. It said that the tool lacks validity in judicial proceedings, and it refused to release usage data."", ""url"": ""https://civio.es/transparencia/2025/03/25/national-police-stop-using-veripol-its-star-ai-for-detecting-false-reports/""}]","{""kind"": ""Withdrawals""}" AIBD-0727,2017-01-01,event,year,mixed,"Stanford evaluators find that the Allegheny Family Screening Tool made screen-in decisions more accurate, with a possible small loss for screen-outs","Stanford evaluators found that the Allegheny Family Screening Tool, with related policies, made screen-ins more accurate, with roughly 24 more children a month screened in accurately.",Screen-in calls more accurate with the *Allegheny Family Screening Tool*,Roughly 24 more children each month were screened in accurately,,reported,Independently reported,before and after,very low,aggregate result,false,"Allegheny Family Screening Tool (AFST), a predictive risk model that scores child welfare hotline referrals",,Not named in the evaluation (built for the Allegheny County Department of Human Services),,"Allegheny County Department of Human Services, Office of Children, Youth and Families (hotline call screeners)",United States,"Allegheny County, Pennsylvania, United States",United States,Child welfare,,Public sector,Law and Crime,Family Issues,Prediction from data,Children; Public servants,16,High income,operational_improvement; physical_health,"Faster data management, decision-making",2,4,4,2,2,5,0.420,organizational,6,,0,"General protective service referrals before the tool, January 2015 to July 2016",,Roughly 24 more children each month screened in accurately,measured,challenged,2023-01-31,shown,https://www.alleghenycountyanalytics.us/wp-content/uploads/2024/05/24-ACDHS-04-Predictive-Risk-Algorithms.pdf,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Evaluation report"", ""value"": ""Goldhaber-Fiebert JD, Prince L. Impact Evaluation of a Predictive Risk Modeling Tool for Allegheny County's Child Welfare Office. Stanford University, 20 March 2019. Published by the Allegheny County Department of Human Services."", ""url"": ""https://analytics.alleghenycounty.us/wp-content/uploads/2019/05/Impact-Evaluation-from-16-ACDHS-26_PredictiveRisk_Package_050119_FINAL-6.pdf""}, {""label"": ""Regulatory document"", ""value"": ""Stanford University evaluators (report published by the Allegheny County Department of Human Services) (2023). Impact Evaluation of a Predictive Risk Modeling Tool for Allegheny County (Phase 2), Executive Summary, Short-term outcomes, p. 2."", ""url"": ""https://analytics.alleghenycounty.us/wp-content/uploads/2024/05/23-ACDHS-19_FamilyScreeningToolUpdate_v2.pdf""}, {""label"": ""Follow-up"", ""value"": ""The AP reported that the Justice Department's Civil Rights Division was examining the AFST after complaints that it could discriminate against families with disabilities."", ""url"": ""https://www.wafb.com/2023/01/31/child-welfare-algorithm-faces-justice-department-scrutiny/""}]","{""kind"": ""Challenges""}" AIBD-0166,2016-01-01,event,year,reported,ActiveRemediation helps Flint locate hazardous water pipes,"Researchers at the University of Michigan built ActiveRemediation, a model that ranked Flint homes by the chance of a hazardous service line, such as one of lead. Its held-out accuracy was 91.6%.",Flint uses a prediction model to find homes with hazardous water pipes,held-out prediction accuracy was 91.6%,,reported,Independently reported,no comparison,very low,benefit created,false,"ActiveRemediation, combining XGBoost predictions, a hierarchical Bayesian spatial model, and active learning",,"University of Michigan (Jacob Abernethy, Alex Chojnacki, Arya Farahi, Eric Schwartz, Jared Webb)",United States,City of Flint (FAST Start service-line replacement program),United States,"Flint, United States",United States,Water infrastructure,Lead service-line replacement,Energy and infrastructure,Environment,Drinking Water,Prediction from data,The public,6,High income,physical_health; operational_improvement,Hazard reduction,2,3,5,4,3,1,0.280,personal; organizational; societal,8,,0,The recorded sequence of inspection and replacement work in a simulation,"Estimated US$5,818 per replacement","Estimated US$5,196 per replacement",assumed,persisted,2021-01-14,shown,https://arxiv.org/abs/1806.10692,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Concerned Pastors for Social Action v. Khouri, No. 16-10277, ECF No. 208 (E.D. Mich. 26 March 2019)."", ""url"": ""https://www.nrdc.org/sites/default/files/order-amending-settlement-agreement-flint-20190326.pdf""}]","{""kind"": ""Official documents""}" AIBD-0054,2013-03-01,event,month,reported,Myoelectric pattern recognition with augmented reality relieves phantom limb pain of 48 years in a treatment-resistant amputee,BioPatRec decoded the signals of the muscles in a man's stump to move a limb in augmented reality. His phantom limb pain of 48 years eased to periods without pain.,Amputee with 48 years of phantom limb pain reaches pain-free periods,after ten weeks near-absent pain developing into completely pain-free periods,,reported,Independently reported,before and after,very low,benefit created,false,Phantom motor execution: BioPatRec myoelectric pattern recognition (LDA and MLP classifiers) driving augmented/virtual reality and a racing game,"BioPatRec, LDA one-vs-one and MLP per degree of freedom","Chalmers University of Technology, Biomedical Engineering Division (academic lab; study part-funded by Integrum AB)",Sweden,"Chalmers University of Technology and Sahlgrenska University Hospital, Gothenburg (inferred from author affiliations; the paper does not name the treatment site)",Sweden,"Gothenburg, Sweden (inferred from author affiliations)",,Rehabilitation medicine / chronic pain,Upper-limb amputees with phantom limb pain,Health,Health,Long-term Care,Prediction from data,Patients; People with disabilities,3,,physical_health,,2,1,3,,5,4,,personal; societal,5,,3,"the patient's pain after 48 years of conventional treatments (mirror therapy, drugs, acupuncture, hypnosis)",constant burning pain of an intensity of 3 on a scale from 0 to 10 (SF-MGPQ),gradually reduced to complete pain-free periods,measured,challenged,2024-09-05,shown,https://pmc.ncbi.nlm.nih.gov/articles/PMC3935120/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""A double-blind randomized trial in 81 patients at 9 clinics in 7 countries reported that pain fell by 64.5% with machine-learning phantom motor execution and by 68.2% with guided motor imagery. The authors found no evidence that the decoded execution was superior. The pain relief recurred, and the added value of the machine-learning decoding was not shown."", ""url"": ""https://pmc.ncbi.nlm.nih.gov/articles/PMC11808706/""}]","{""kind"": ""Challenges""}" AIBD-0240,2026-09-30,event,day,reported,"After Anthropic's threat monitoring flags a Bonita Springs woman's messages about shooting up the Lee County Sheriff's Office, human reviewers tip police, who detain her without incident","Anthropic's safety monitoring flagged a chat user's threat to shoot up a Florida sheriff's office. After human review, the tip led deputies to detain her. No weapon was seized.",Anthropic flag on a shooting threat leads to a Florida arrest,,,reported,Independently reported,no comparison,very low,protective response,false,"Anthropic Claude consumer-chat safety monitoring: automated flagging of threatening content, escalation to a human review team, referral to law enforcement",,Anthropic,United States,Anthropic,United States,"Bonita Springs, United States",United States,Online safety and threat referral to law enforcement,"Media, social platforms, and marketing",Safety and rescue,Law and Crime,Crime Control,Text and language,Public servants,16,High income,physical_health,Crime reduction or prevention,1,1,1,,5,1,,organizational; societal,9,,3,,,,,litigated,2026-10-08,shown,https://www.anthropic.com/news/building-safeguards-for-claude,,,,[],Querist,The use of the system was taken to court.,"[{""label"": ""Court document"", ""value"": ""Lee County Sheriff's Office, Alejo, T. S. (2026). Arrest / Notice to Appear and Probable Cause Statement, agency report 26-530248, clerk case 26CF017549, [name withheld]. Redacted copy hosted by the Daily Caller."", ""url"": ""https://cdn01.dailycaller.com/wp-content/uploads/2026/10/26-530248_Heller__Carli_Redacted.pdf""}, {""label"": ""Follow-up"", ""value"": ""The woman pleaded not guilty, and her arraignment was set for 2 November 2026 while prosecutors had not yet filed a formal charge. The arrest form set a $10,000 bond and an appearance date of 20 October 2026. The First Amendment scholar Eugene Volokh doubts that the charge will hold."", ""url"": ""https://san.com/cc/a-chatbot-message-led-to-a-felony-charge-experts-say-it-may-not-hold-up/""}]","{""kind"": ""Legal proceedings""}" AIBD-1058,2026-06-30,event,day,reported,Ofsted finds that artificial intelligence based professional learning is helping staff at a Redditch first school to save time,Ofsted found that AI-based professional learning was helping staff at St George's CofE First School in Redditch to save time. It helped them plan more effectively. They were developing expertise.,*Artificial intelligence based professional learning* saves staff time,,,reported,Independently reported,no comparison,very low,benefit created,false,"Artificial intelligence based professional learning, particularly in relation to inclusion",,Not named in the report,,"St George's CofE First School and Nursery, Redditch (Shires Multi Academy Trust)",United Kingdom,"Redditch, Worcestershire, United Kingdom",United Kingdom,Primary education,,Education,Education,Elementary & Secondary,,Teachers,4,High income,operational_improvement; incentivization,Enhanced productivity,1,,,,3,,,personal,2,,0,,,,,unknown,,not shown,https://files.ofsted.gov.uk/v1/file/50311654,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Ofsted. St George's CofE First School and Nursery (URN 146754): inspection report card, 30 June 2026. Section 'About this inspection'. It records how inspectors gathered evidence."", ""url"": ""https://files.ofsted.gov.uk/v1/file/50311654""}]","{""kind"": ""Official documents""}" AIBD-0258,2026-01-20,event,day,reported,"A passenger's iPhone Crash Detection sends a “strong impact” alert to the local fire service before a sightseeing helicopter near Mount Aso goes missing, 20 January 2026",Apple Crash Detection on a passenger's iPhone called the fire service about 46 minutes before the operator reported a sightseeing helicopter missing near Mount Aso. All three aboard died.,Apple Crash Detection alerts firefighters to a Mount Aso crash,called the fire service about 46 minutes before the operator reported,,reported,Independently reported,no comparison,very low,protective response,false,Apple Crash Detection (iPhone 14 and later),iPhone 14或後續機型(所有機型),且搭載iOS 16,Apple,United States,A helicopter passenger's iPhone,,"Mount Aso, Kumamoto Prefecture, Japan",Japan,Aviation / emergency response,Consumer devices / automatic crash alerting,Safety and rescue,Transportation,Air Travel,Prediction from data,Drivers and travelers; Public servants,,High income,operational_improvement,"Faster data management, decision-making",1,1,1,,3,1,,organizational; personal; societal,5,,0,the operator's own report that the helicopter had not returned,the operator's agent called police at about 11:50 on 20 January 2026,"the phone's automatic call reached the fire service at 11:04, about 46 minutes earlier",measured,reversed,2026-02-18,shown,https://www.apple.com/newsroom/2022/09/apple-introduces-iphone-14-and-iphone-14-plus/,,,,[],Querist,The benefit was later reversed.,"[{""label"": ""Follow-up"", ""value"": ""The alert located the crash site, but no one was rescued. On 18 February 2026 the fire department said that bodies believed to be those of the three occupants had been found inside the crater. So the “rapid rescue” framing of the first reports was not borne out."", ""url"": ""https://www.thestar.com.my/aseanplus/aseanplus-news/2026/02/18/three-bodies-found-at-helicopter-crash-site-in-southwest-japan-volcanic-crater""}]","{""kind"": ""Challenges""}" AIBD-0342,2025-11-26,event,day,reported,"An operator in Kazakhstan reroutes gas to stop a methane leak from a pipeline after a United Nations satellite alert, but new emissions appear at the site by May 2026","After an alert from UNEP's Methane Alert and Response System, which uses AI, an operator in Kazakhstan rerouted gas to stop a pipeline leak. By 21 May 2026 UNEP had observed new emissions there.","Kazakh operator stops a methane leak after a UN alert, but it recurs","estimated emissions of 1,200 tonnes",,reported,Independently reported,no comparison,very low,benefit created,false,"UNEP IMEO Methane Alert and Response System (MARS): satellite plume detection and analysis with AI models, notification and satellite confirmation",,UNEP International Methane Emissions Observatory (IMEO),France,UNEP International Methane Emissions Observatory (notification) and an unnamed pipeline operator in Kazakhstan (mitigation),France,"Kamenistoe, Kazakhstan, at 43.39767°, 52.49505°",Kazakhstan,Climate change mitigation / methane emissions monitoring,Oil and gas transmission; intergovernmental observatory,Environment,Environment,Air Pollution,Images and video,,13,Upper middle income,environmental_impact,Environmental impacts,1,,,,5,1,,personal; organizational; societal,5,,6,,,,,challenged,2026-05-21,shown,https://arxiv.org/abs/2511.07719,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""UNEP adds in its case document that IMEO had observed subsequent methane emissions at the location as of 21 May 2026 and continues to engage stakeholders. UNEP still listed the case as a mitigation on 22 October 2026. In its October 2026 snapshot, UNEP says that each counted mitigation is confirmed by satellite data that show no further emissions."", ""url"": ""https://wedocs.unep.org/bitstreams/558dda69-c8e5-42c2-b10a-7b9c3dcc3e79/download""}]","{""kind"": ""Challenges""}" AIBD-0207,2025-09-11,event,day,reported,"After a stock check at the Punggol Central outlet on 10 September 2025, Sheng Siong's staff give its facial-recognition CCTV a shoplifter's face. It matches her to six earlier wine thefts. It alerts the manager's phone when she returns at noon the next day. Staff stop her with three unscanned bottles. Police arrest her. She repays the chain. On 12 May 2026 she is jailed eight days","Sheng Siong's facial recognition system matched a wine thief to six prior thefts and flagged her return, which led to her arrest, restitution and an eight-day jail term.",Sheng Siong's facial recognition catches a repeat wine thief,matched a wine thief to six prior thefts and flagged her return,,reported,Independently reported,no comparison,very low,benefit created,false,"Sheng Siong's AI-driven facial recognition closed-circuit television system: a suspect's photograph, taken from CCTV footage after a theft is found, is uploaded, the system matches the face across footage and sends mobile alerts through a corporate app to staff when that person enters any Sheng Siong outlet",,,,"Sheng Siong (supermarket chain, 83 outlets), Singapore",Singapore,"Punggol, Singapore",Singapore,Retail loss prevention and law enforcement,Supermarket shop-theft detection: facial recognition on store CCTV with mobile alerts to managers,Safety and rescue,Law and Crime,Crime Control,Images and video,,16,High income,physical_health,Crime reduction or prevention,1,1,1,,4,1,,organizational,6,,2,the chain's previous practice of staff manually reviewing CCTV footage to identify suspects,staff members had to manually review CCTV footage to identify suspects,staff receive mobile alerts through a corporate app once a flagged person enters any Sheng Siong branch again,assumed,litigated,2026-05-12,shown,https://www.malaymail.com/news/singapore/2026/10/09/singapore-supermarkets-facial-recognition-system-catches-woman-after-12-shoplifting-trips/238387,about S$470,restitution paid by the shoplifter for the stolen bottles that were not recovered (three bottles were recovered at the interception),False,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""The shoplifter pleaded guilty to an amalgamated theft charge and was jailed for eight days on 12 May 2026 after making full restitution of about S$470."", ""url"": ""https://www.channelnewsasia.com/singapore/shoplifter-caught-sheng-siong-facial-recognition-tech-jail-6115421""}]","{""kind"": ""Legal proceedings""}" AIBD-0669,2024-04-01,event,month,reported,"EEF-funded randomized trial: Science teachers using ChatGPT with a guide cut weekly lesson preparation time by 31% (NFER, 68 schools)","In an NFER trial, teachers using ChatGPT spent 56.2 minutes a week on Year 7 and 8 science lesson preparation against 81.5 minutes for teachers without it.",*ChatGPT* saves science teachers planning time each week,56.2 minutes a week on Year 7 and 8 science lesson preparation against 81.5 minutes,,reported,Independently reported,randomized trial,moderate,aggregate result,false,"ChatGPT, with an online guide to using it for lesson and resource preparation",,OpenAI,United States,Science teachers in 68 secondary schools in a trial run by NFER for the Education Endowment Foundation and the Hg Foundation,United Kingdom,68 state-funded secondary schools in England,United Kingdom,Education (teacher workload),,Education,Education,Elementary & Secondary,Text and language,Teachers,4,High income,operational_improvement,Enhanced productivity,1,3,2,,3,4,,personal; organizational,3,,0,Teachers asked not to use any generative AI tool,81.5 minutes per week,56.2 minutes per week,measured,unknown,,shown,https://d2tic4wvo1iusb.cloudfront.net/production/documents/projects/chatgpt_in_lesson_planning_-_evaluation_report.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Assessment report"", ""value"": ""Roy P, Poet H, Staunton R, Aston K, Thomas D. ChatGPT in lesson preparation - A Teacher Choices Trial. National Foundation for Educational Research, for the Education Endowment Foundation, 12 December 2024. The Hg Foundation co-funded the trial and also funded the teacher guide that is part of the system tested."", ""url"": ""https://www.nfer.ac.uk/publications/chatgpt-in-lesson-preparation-a-teacher-choices-trial/""}, {""label"": ""Assessment report"", ""value"": ""Roy P, Poet H, Staunton R, Aston K, Thomas D. ChatGPT in Lesson Preparation: A Teacher Choices Trial. Evaluation Report. Education Endowment Foundation, December 2024. The Hg Foundation co-funded the trial and also funded the teacher guide that is part of the system tested."", ""url"": ""https://d2tic4wvo1iusb.cloudfront.net/production/documents/projects/chatgpt_in_lesson_planning_-_evaluation_report.pdf""}]","{""kind"": ""Official documents""}" AIBD-0881,2024-01-01,event,month,reported,"In an evaluation for Australia's Digital Transformation Agency, Nous Group finds that Copilot users perceived savings of around an hour a day on three tasks","In the evaluation of Australia's Copilot trial, staff perceived savings of around an hour a day on three tasks, among them summaries. Of survey respondents, 69% agreed that it sped up their work.",Australian public servants perceive time saved with *Copilot*,savings of around an hour a day,,reported,Independently reported,no comparison,very low,aggregate result,false,Microsoft 365 Copilot,,Microsoft,United States,Australian Government agencies in the whole-of-government trial coordinated by the Digital Transformation Agency,Australia,Australia,Australia,Public administration,,Public sector,Government Operations,Bureaucracy,Text and language,Public servants,16,High income,operational_improvement,Enhanced productivity,1,3,3,2,5,,,organizational,4,,2,"Doing the same tasks without Copilot, as participants estimated",,perceived time savings of around an hour a day for these tasks,assumed,scaled,2026-08-21,shown,https://www.aph.gov.au/Parliamentary_Business/Committees/Joint/Public_Accounts_and_Audit/PublicsectoruseofAI/Report/Chapter_2_-_Artificial_intelligence_in_the_public_sector,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Digital Transformation Agency. Australian Government trial of Microsoft 365 Copilot: evaluation report in full, executive summary and glossary. Evaluation by Nous Group, engaged by the DTA, which coordinated the trial. Published October 2024 (archived copy)."", ""url"": ""https://web.archive.org/web/20260925082537/https://www.digital.gov.au/initiatives/copilot-trial/microsoft-365-copilot-evaluation-report-full/executive-summary-glossary""}, {""label"": ""Evaluation report"", ""value"": ""Australian Centre for Evaluation, Department of the Treasury. Evaluation of a trial of generative artificial intelligence (Copilot) in the Department of the Treasury. Summary report, February 2025. Summary of findings: implementation and quality work outcomes."", ""url"": ""https://evaluation.treasury.gov.au/sites/evaluation.treasury.gov.au/files/2025-02/evaluation-generative-artificial-intelligence-summary.pdf""}]","{""kind"": ""Official documents""}" AIBD-0276,2023-07-25,event,day,mixed,"Bradford researchers attribute the de Brecy Tondo to Raphael after an AI comparison of faces scores 97% similarity, though scholars reject the attribution",A University of Bradford deep-learning model found 97% facial similarity with the Sistine Madonna in the de Brecy Tondo. Cartwright Hall showed the painting. Scholars called it a copy.,Bradford gallery shows a painting that software matched to a Raphael,97% facial similarity with the Sistine Madonna,,reported,Independently reported,no comparison,very low,benefit created,false,University of Bradford facial-recognition deep-learning comparison (Hassan Ugail); contrasted with Art Recognition's authentication model,,University of Bradford and University of Nottingham team (Ugail); Art Recognition AG (Carina Popovici),United Kingdom,de Brecy Trust; Bradford Museums & Galleries (Cartwright Hall Art Gallery),United Kingdom,"Bradford, England, UK",United Kingdom,Cultural heritage; art attribution,Museum visitors and the painting's owners,Culture and history,Culture,General,Images and video,,11,High income,knowledge_discovery; culture,,1,1,3,,2,1,,personal; organizational; societal,8,,3,the painting's standing before the analysis,thought by some experts to have been a Victorian copy,"found by the Bradford and Nottingham teams to be highly likely by Raphael, with 97% similarity between the two Madonnas",assumed,challenged,2023-07-26,shown,https://web.archive.org/web/20250120043603id_/https://thecritic.co.uk/issues/october-2023/a-new-madonna/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""Raphael scholars quoted by The Art Newspaper rejected the attribution the day after the display opened. Art Recognition reported in September 2023 that its model found the Tondo not by Raphael. The Bradford team restated the attribution in December 2023 and did not withdraw it. No museum or auction house is on record accepting it."", ""url"": ""https://www.theartnewspaper.com/2023/07/26/clearly-a-copy-from-the-19th-centuryold-masters-scholars-reject-ai-attributed-raphael""}]","{""kind"": ""Challenges""}" AIBD-0841,2023-01-01,event,year,reported,An Australian parliamentary committee reports that South Australia's EdChat trial helped a teacher adapt a task for a student with autism,An Australian parliamentary committee reports that South Australia's EdChat trial yielded benefits for neurodiverse students. A teacher used it to adapt a task for a student with autism.,*EdChat* adapts a task for a student with autism in seconds,,,reported,Independently reported,no comparison,very low,benefit created,false,EdChat,,"South Australian Department for Education, with Microsoft (the OpenAI platform in the department's Azure tenancy)",Australia,South Australian Department for Education (trial schools),Australia,"South Australia, Australia",Australia,Education,,Education,Education,Special,Text and language,Students; People with disabilities; Teachers,4; 10,High income,accessibility; incentivization,Increased/personalized knowledge,1,1,1,,3,1,,personal,2,,0,,,,,scaled,2025-09-16,shown,https://www.aph.gov.au/Parliamentary_Business/Committees/House/Former_Committees/Employment_Education_and_Training/AIineducation/Report/Chapter_2_-_Integration_practices_and_policies,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Inquiry report"", ""value"": ""House of Representatives Standing Committee on Employment, Education and Training, Parliament of Australia. Study Buddy or Influencer, August 2024. Chapter 2, Box 4.1, SA DFE pilot project."", ""url"": ""https://www.aph.gov.au/Parliamentary_Business/Committees/House/Former_Committees/Employment_Education_and_Training/AIineducation/Report/Chapter_2_-_Integration_practices_and_policies""}]","{""kind"": ""Official documents""}" AIBD-0073,2021-10-09,event,day,reported,"The Beethoven Orchester Bonn premieres Beethoven's Tenth Symphony, completed from AI-generated continuations of his sketches, on 9 October 2021","The Beethoven X AI model generated continuations of Beethoven's sketches, which humans arranged into a Tenth Symphony that the Beethoven Orchester Bonn premiered on 9 October 2021.","Bonn orchestra premieres Beethoven's Tenth, completed with AI help",,,reported,Independently reported,no comparison,very low,benefit created,false,Beethoven X AI generative music model (Elgammal/Playform AI team),,Ahmed Elgammal (Rutgers University / Playform AI) with Mark Gotham,,Deutsche Telekom (funder and concert organizer) with Beethoven Orchester Bonn,Germany,"Bonn, Germany",Germany,Music,Classical music performance,Culture and history,Culture,General,Speech and sound,,,High income,culture,,1,,1,,4,1,,organizational; societal,6,,1,"earlier human completion attempts from the sketches, such as Barry Cooper's 1988 version of the first movement",impossible for symphony experts to go beyond that first movement,"a complete symphony, with third and fourth movements generated with the AI, premiered on 9 October 2021",assumed,challenged,2021-10-10,shown,https://theconversation.com/how-a-team-of-musicologists-and-computer-scientists-completed-beethovens-unfinished-10th-symphony-168160,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""The day after the premiere, the BR-Klassik critic judged that the work sounds conventional and is unlikely to enter the concert repertoire. He reports that conductor Dirk Kaftan told the premiere audience that it is not Beethoven."", ""url"": ""https://www.br-klassik.de/aktuell/news-kritik/kritik-urauffuehrung-beethoven-10-symphonie-kuenstliche-intelligenz-computer-bonn-100.html""}]","{""kind"": ""Challenges""}" AIBD-0144,2019-01-01,event,year,reported,"Blackpool Council reports cheaper pothole repairs with Project Amber's AI road surveys, though complaints later nearly doubled","Blackpool Council credits Project Amber, which detects potholes in road imagery with AI, with 5,145 repairs for just under £450,000. Claim payouts fell to £719. Complaints later nearly doubled.","Blackpool uses AI road imagery to fill 5,145 potholes for about £450,000","5,145 potholes were filled in North Shore for just under £450,000",,reported,Independently reported,no comparison,very low,aggregate result,false,Project Amber road-condition imagery and AI survey (Blackpool Council),,,,Blackpool Council,United Kingdom,"Blackpool, United Kingdom",United Kingdom,Municipal services: highway maintenance,Local authority highways,Public sector,Transportation,Highways,Images and video,The public,11,High income,operational_improvement,Enhanced productivity,1,1,4,,3,,,personal; organizational; societal,6,,2,the council's pothole compensation payouts in the years before Project Amber,up to £1.5 million a year,£719,measured,challenged,2026-03-04,shown,https://www.bbc.com/news/uk-england-lancashire-51356855,over £1m,"saved on filling 5,145 potholes in North Shore, final cost just under £450k against £1.5m by traditional methods",False,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""On 4 March 2026 the BBC's local democracy reporting found that complaints about potholes in Blackpool in 2023 to 2025 were nearly twice those of 2020 to 2022. Fewer potholes were fixed. The council leader called roads the top issue that residents raise and pledged a further £3.5m."", ""url"": ""https://www.bbc.co.uk/news/articles/c4gevl5x7gdo""}]","{""kind"": ""Challenges""}" AIBD-0922,2026-06-01,source publication,month,reported,"UNDP's evaluation office reports that at three Zimbabwean irrigation schemes, drones with AI monitored crops, enabling earlier responses to threats",UNDP's evaluation office reported that drones with AI monitored crop health at three Zimbabwean irrigation schemes. This sped up responses to threats of crop loss. The responses were more precise.,Drones with AI watch crop health at three Zimbabwean irrigation schemes,,,reported,Independently reported,no comparison,very low,protective response,false,AI and machine-learning crop health monitoring with drone technology (product not named),,Not named in the evaluation,,"UNDP Zimbabwe, through the resilience-building project funded by the Green Climate Fund and run with the Government of Zimbabwe",Zimbabwe,"Midlo (Matabeleland South), Pikinini/Jawanda and Bindamombe (Masvingo) irrigation schemes, Zimbabwe",Zimbabwe,Agriculture / crop protection,,Agriculture and food,Agriculture,Animal and Crop Disease,Images and video,Farmers,2,Lower middle income,environmental_impact,Environmental impacts,,,,4,3,,,personal,2,,0,,,,,unknown,,shown,https://erc.undp.org/evaluation/documents/download/25595,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Sanhokwe, H. and Diouf, A. Interim evaluation of the 'Building Climate Resilience of Vulnerable Agricultural Livelihoods in Southern Zimbabwe' project: Final report. Interim evaluation under the Green Climate Fund's guidelines for evaluations led by accredited entities, published in the UNDP Evaluation Resource Center, 6 September 2024, p. 48."", ""url"": ""https://erc.undp.org/evaluation/documents/download/23866""}]","{""kind"": ""Official documents""}" AIBD-0245,2026-04-24,event,day,reported,"After a Tesla on Autopilot stops in the middle lane of I-75 with its drunk driver asleep, police arrest her for driving under the influence",Troopers said that the eye detection of a Tesla on Autopilot halted the car on I-75 after its intoxicated driver fell asleep. No vehicle data have been published to confirm it.,Tesla halts on I-75 when its drunk driver falls asleep at the wheel,,,reported,Independently reported,no comparison,very low,protective response,false,"Tesla Autopilot, according to the reported account; the vehicle model and active configuration are unverified.",,Tesla,United States,Private owner,,"Sarasota, United States",United States,Road vehicle crash avoidance,Consumer driver assistance / driver monitoring,Safety and rescue,Transportation,Highways,Machines that act; Images and video,Drivers and travelers,3,High income,physical_health,,,1,1,,5,1,,personal; societal; organizational,4,,2,,,,,unknown,,shown,https://en.wikipedia.org/wiki/Tesla_Autopilot,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Regulatory document"", ""value"": ""NHTSA Office of Defects Investigation, ODI Resume, Engineering Analysis EA22-002: Autopilot System Driver Controls, closed 25 April 2024. Federal regulators found that Autopilot's controls for driver engagement were too weak for what the system allowed. Tesla filed a recall of 2,031,220 cars on 12 December 2023 after NHTSA reviewed these findings with it."", ""url"": ""https://static.nhtsa.gov/odi/inv/2022/INCLA-EA22002-14498.pdf""}]","{""kind"": ""Official documents""}" AIBD-0238,2025-08-08,source publication,day,tested,DARPA's AIxCC final: Autonomous systems find 54 of 63 synthetic vulnerabilities. They patch 43. They also find 18 real bugs in open-source code,"At DEF CON 33 on 8 August 2025, DARPA reported that seven teams' cyber reasoning systems found 54 synthetic vulnerabilities, patched 43, and found 18 real bugs for disclosure.","AIxCC systems find 54 of 63 synthetic vulnerabilities, patching 43","found 54 synthetic vulnerabilities, patched 43, and found 18 real bugs for disclosure",,reported,Independently reported,tested against a standard,very low,aggregate result,false,"AIxCC finalist cyber reasoning systems (Team Atlanta, Trail of Bits, Theori and four others)",,"Seven finalist teams (Team Atlanta et al.), using LLM credits from Anthropic, Google and OpenAI",,"DARPA (with ARPA-H), AIxCC Final Competition",United States,"Las Vegas, United States",United States,Cybersecurity / automated vulnerability discovery and patching,Government,Public sector,Technology,Computers,Text and language,,9,High income,privacy_protection,,,,,,,,,societal; organizational,6,,0,the same competition's semifinal round (2024),37% at semifinals,teams identified 86% of the competition's synthetic vulnerabilities,measured,challenged,2026-09-03,shown,https://www.darpa.mil/news/2025/aixcc-results,$152,"average cost per competition task for the systems' bug reports and patches, which DARPA calls a fraction of the cost of traditional methods",False,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""University of Maryland researchers tested the top three AIxCC systems on a new benchmark in September 2026. They found that crash-only checks overstate patching success. They also found that the AIxCC systems solved fewer tasks than general-purpose coding agents on the same model. In March 2026 Team Atlanta reported that the seven released systems were largely unusable outside their teams and that its ported system found 10 new bugs."", ""url"": ""https://arxiv.org/html/2609.04075v1""}]","{""kind"": ""Challenges""}" AIBD-0325,2025-05-24,source publication,day,unclear,A hospital's account conflicts with a relative’s claim that ChatGPT helped save a teenager from poisoning,A relative credited ChatGPT's advice to drink paraffin oil with saving a teenager from a grain pill. The medical dean at Assiut University said that the teenager showed no signs of poisoning.,Hospital disputes that ChatGPT helped save a teenager from poisoning,,,reported,Independently reported,,very low,protective response,true,"ChatGPT, according to the patient's cousin. He described the model as an advanced AI model and a limited-use trial version of GPT-5, but that identification is unverified. OpenAI publicly introduced GPT-5 on 7 August 2025, after the May report.","GPT-5 trial version, per the cousin's post; unverified",OpenAI,United States,"The patient's cousin, as a consumer user",,"Abnoub and Assiut University Hospital, Assiut Governorate, Egypt",Egypt,Healthcare: emergency toxicology,Consumer chatbot used for first-aid advice,Health,Health,Disease Prevention,Text and language,Children; Patients,3,Lower middle income,physical_health,,,,,,,,,personal; societal,7,,0,"the doctors' prognosis on arrival at the poison unit, by the cousin's account","no treatment protocol, and the case would die","discharged after 24 hours, by the cousin's account",assumed,reversed,2025-05-25,shown,https://web.archive.org/web/2026id_/https://openai.com/index/helping-people-when-they-need-it-most/,,,,[],Querist,The benefit was later reversed.,"[{""label"": ""Follow-up"", ""value"": ""The next day the dean of Assiut University's Faculty of Medicine told Masrawy that the youth showed no clinical signs of phosphine poisoning and had categorically denied swallowing the pill. On 26 May a toxicologist told Al Jazeera Mubasher that the claim that paraffin oil rescues such a case has no scientific basis."", ""url"": ""https://www.masrawy.com/news/news_regions/details/2025/5/25/2793185/""}]","{""kind"": ""Challenges""}" AIBD-0326,2025-05-07,event,day,unclear,"Rafael's X-Guard towed decoy, labeled “AI-powered”, may have diverted Pakistani missiles from Indian Rafales in Operation Sindoor (7–10 May 2025). India's defense chief reports Indian aircraft losses. So does France's air force chief","Commentators credit Rafael's X-Guard towed decoy, labeled “AI-powered”, with diverting Pakistani missiles from Indian Rafales. No official has confirmed its use. India admitted jet losses.",X-Guard decoy may have diverted Pakistani missiles from Indian jets,,,reported,Independently reported,,very low,protective response,false,X-Guard fiber-optic towed decoy from Rafael Advanced Defense Systems. The manufacturer describes its integration with an aircraft’s electronic warfare system but does not identify an AI model or confirm use in Operation Sindoor.,,Rafael Advanced Defense Systems (Israel); several outlets misname it 'Rafale Advanced Defense Systems',Israel,Indian Air Force (claimed by commentary; unconfirmed by any official source),India,"India-Pakistan border airspace, Operation Sindoor, 7-10 May 2025",India | Pakistan,Defense: electronic warfare,Airborne towed radar decoys,Defense,Defense,Foreign Operations,,,,Lower middle income,physical_health,,,,,,,,,personal; organizational,10,,0,,,,,reversed,2025-05-31,not shown,https://www.rafael.co.il/wp-content/uploads/2024/03/X-Guard-Brochure-English-03-2024.pdf,,,,[],Querist,The benefit was later reversed.,"[{""label"": ""Follow-up"", ""value"": ""India's Chief of Defence Staff admitted on 31 May 2025 that an unspecified number of Indian jets were shot down in the May conflict. That contradicts the outlets' claim that the decoy kept missiles from hitting real aircraft."", ""url"": ""https://www.aljazeera.com/news/2025/6/1/india-general-admits-jet-losses-in-clash-with-pakistan-heres-what-he-said""}]","{""kind"": ""Challenges""}" AIBD-0150,2025-01-01,event,year,unclear,"NBC News reported that a Long Beach, California, tenant who lost an eviction jury trial with a lawyer overturned the eviction on appeal with ChatGPT and Perplexity, though court records show that her later petitions were denied in November 2025","NBC News reported that Lynn White used ChatGPT and Perplexity to overturn her eviction on appeal. According to court records, her later petitions in the case were denied in November 2025.",Tenant may have overturned her eviction with ChatGPT and Perplexity,"avoided roughly $55,000 in penalties and over $18,000 in overdue rent",,reported,Independently reported,,very low,benefit created,false,"ChatGPT (paid plan, $20 a month) and Perplexity Pro ($20 a month)","Not reported; NBC News says White moved from the free ChatGPT tier to the $20-a-month plan and used Perplexity Pro, without naming model versions",OpenAI (ChatGPT) and Perplexity AI (Perplexity),United States,,,"Long Beach, United States",United States,Access to justice,Self-represented tenants in eviction proceedings,Public sector,Law and Crime,Court Administration,Text and language,Consumers,16,High income,liberty_protection,,,,,,,,,personal,4,,0,"representation by a lawyer from a local tenant advocacy network, with whom she lost the jury trial",she worked with a lawyer from a local tenant advocacy network but lost in a jury trial,"White managed to overturn her eviction notice and avoid roughly $55,000 in penalties and more than $18,000 in overdue rent",assumed,litigated,2025-11-14,shown,https://web.archive.org/web/2023id_/https://openai.com/blog/chatgpt,"roughly $55,000","penalties avoided, plus more than $18,000 in overdue rent, by overturning the eviction on appeal",False,[],Querist,The use of the system was taken to court.,"[{""label"": ""Follow-up"", ""value"": ""On 5 November 2025 White, representing herself, petitioned the Court of Appeal, Second District, for a writ of mandate and a stay. The petition was against the Los Angeles Superior Court and Judge Ronald F. Frank of the Long Beach courthouse. Best Trailer Park, LLC was the real party in interest. The trial court cases are the eviction case 23LBUD01928 and the appellate division case 24APLC00165. The court denied the petition on 14 November 2025 and rejected a motion to vacate the denial on 17 November. The California Supreme Court allowed a late petition for review with a stay request and denied both on 26 November 2025 (S294091)."", ""url"": ""https://appellatecases.courtinfo.ca.gov/search/searchResults.cfm?dist=2&search=number&query_caseNumber=B350202""}]","{""kind"": ""Legal proceedings""}" AIBD-0338,2023-04-01,event,month,intended,"IRS uses AI models to pick returns of large partnerships for audit, but no examination that a model selected had closed by May 2025","The IRS Large Partnership Compliance Model, an AI model, flagged 150 returns of large partnerships for review in April 2023. No examination that it selected had closed by May 2025.",IRS applies AI to select large partnerships for examination,,,reported,Independently reported,,very low,program,false,"IRS AI and machine-learning case-selection models (two partnership prioritization models; a refundable-credit audit selection model in pilot; machine learning for partnership, income and international tax risk)",TY 2021 LPC model (Large Partnership Compliance return selection model),Internal Revenue Service (in-house data scientists with tax-enforcement experts),United States,Internal Revenue Service,United States,United States (national),United States,Public administration: tax enforcement,National revenue agency,Finance,Government Operations,Tax Administration,Prediction from data,Public servants,16,High income,privacy_protection; operational_improvement,Fraud detection,,,,,,,,personal; organizational; societal,5,,0,large partnership audits selected before the Large Partnership Compliance Model,more than 80 percent of large partnership audits closed with no change to the return,not yet measured; TIGTA reported in May 2025 that no examination selected by the model had closed,measured,persisted,2025-05-19,shown,https://www.oversight.gov/sites/default/files/documents/reports/2025-05/2025308022fr.pdf,approximately $26.1 million,"additional tax assessments yearly that IRS management estimates from reassigning 14 classifiers to examinations after the Form 1040 return classification AI model automated classification (an SB/SE individual-return model, not the partnership models)",True,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration (2025). The IRS Could Leverage Examination Results in Artificial Intelligence Examination Case Selection Models and Improve Processes to Evaluate Performance. Report 2025-308-022, 19 May 2025."", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2025-05/2025308022fr.pdf""}, {""label"": ""Audit report"", ""value"": ""U.S. Government Accountability Office, Tax Enforcement: IRS Audit Processes Can Be Strengthened to Address a Growing Number of Large, Complex Partnerships, GAO-23-106020, 27 July 2023. GAO has no stake in the IRS models. Its auditors report that the IRS first used the Large Partnership Compliance Model in April 2023. They also report that the partnership models were built without representative samples and with untested assumptions."", ""url"": ""https://www.gao.gov/assets/gao-23-106020.pdf""}, {""label"": ""Audit report"", ""value"": ""Treasury Inspector General for Tax Administration (TIGTA). The IRS Has Yet to Develop a Successful Strategy for Examining Large Partnership Returns (Report Number 2026-308-011). 'Preliminary results of the LPC Program', report p. 10, Figure 5"", ""url"": ""https://www.oversight.gov/sites/default/files/documents/reports/2026-03/2026308011fr.pdf""}]","{""kind"": ""Official documents""}" AIBD-0111,2022-01-05,event,day,reported,Google's Android Earthquake Alerts reached phones in Alanya seconds before a quake of magnitude 5.1 in the Mediterranean on 5 January 2022,"Google's Android Earthquake Alerts System sent Android users near Alanya, Turkey, a warning seconds before a magnitude 5.1 offshore quake on 5 January 2022.",Android alerts reach phones in Alanya seconds before an offshore quake,Hürriyet put the lead at about 10 seconds,,reported,Independently reported,no comparison,very low,protective response,false,Android Earthquake Alerts System (crowdsourced phone-accelerometer detection; alerts for magnitude 4.5 and above),,Google,United States,Google,United States,"Alanya, Turkey",Turkey,Disaster risk reduction / earthquake early warning,Consumer smartphones (Android),Humanitarian,Domestic Commerce,Disaster Relief,Prediction from data,People at risk of disaster,11,Upper middle income,environmental_impact,Natural disaster prediction,,,1,,4,1,,personal,16,,2,"Feeling the shaking with no advance notice, as before the system reached Turkey",No warning before the shaking,"A phone alert about 10 seconds before the shaking, by Hürriyet's account; other outlets gave up to one minute",assumed,challenged,2023-07-27,not shown,https://blog.google/products/android/earthquake-detection-and-alerts/,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""BBC Newsnight found no one in three Turkish cities who had received a warning from the same system before the main shock of the deadly earthquake of 6 February 2023. Google's product lead told the BBC that he was confident that the system fired and sent alerts. Google did not give the BBC evidence that the alerts were widely received."", ""url"": ""https://www.bbc.com/news/technology-66316462""}]","{""kind"": ""Challenges""}" AIBD-0203,2021-02-01,event,month,mixed,FDA uses AI to choose where to concentrate food inspections. An imported-seafood pilot ran for years,"FDA reports that its model for imported seafood guided sampling at 328 U.S. ports. It says that its Elsa tool helped find inspection targets. It reports no outcome, such as illnesses prevented.",FDA uses AI to choose where to inspect food,,,reported,Independently reported,no comparison,very low,program,false,FDA AI inspection-targeting tools (imported seafood pilot; Elsa generative AI),,U.S. Food and Drug Administration (details not in the cited source),United States,U.S. Food and Drug Administration,United States,United States (national),United States,Food safety regulation,Import and facility inspection targeting,Agriculture and food,Agriculture,Food Inspection & Safety,Prediction from data; Text and language,Public servants,3,High income,operational_improvement,"Faster data management, decision-making",,1,3,,2,5,,organizational; societal,4,,0,,,,,challenged,2025-07-23,shown,https://www.fda.gov/food/hfp-constituent-updates/fda-moves-third-phase-artificial-intelligence-imported-seafood-pilot-program,,,,[],Querist,The benefit was later disputed.,"[{""label"": ""Follow-up"", ""value"": ""FDA launched Elsa agency-wide on 2 June 2025 and said that it was already helping to identify high-priority inspection targets. On 23 July 2025 CNN reported that FDA staff said that Elsa invents studies, and Makary told CNN that most scientists used it for organizing work."", ""url"": ""https://www.cnn.com/2025/07/23/politics/fda-ai-elsa-drug-regulation-makary""}]","{""kind"": ""Challenges""}" AIBD-0334,2020-07-27,source publication,day,intended,"Colombia's Constitutional Court presents PretorIA (July 2020), an AI system that classifies tutela rulings for selection. It was in user testing in April 2021. It was still in use in 2024, with no published measure of an outcome","Colombia's Constitutional Court presented PretorIA on 27 July 2020 to classify tutela rulings for selection. It was still in use in 2024, with no published measure of outcomes.",Colombia's Constitutional Court adopts PretorIA to sort tutela rulings,,,reported,Independently reported,,very low,program,false,"PretorIA (Corte Constitucional tutela classification and search system, derived from Argentina's Prometea)",,"Corte Constitucional de Colombia with the Universidad de Buenos Aires (IALAB, Juan Corvalán) and the Universidad del Rosario",Colombia,Corte Constitucional de Colombia,Colombia,"Bogotá, Colombia",Colombia,Justice administration: constitutional review case selection,Constitutional court case management,Public sector,Law and Crime,Court Administration,Text and language,Public servants,16,Upper middle income,operational_improvement,"Faster data management, decision-making",,,,,,,,personal; organizational; societal,8,,0,a person reading tutela files by hand to find the chamber's selection criterion,una persona tarda al menos un día para leer 30 expedientes,el sistema puede procesar las sentencias en medio digital en menos de 2 minutos,assumed,persisted,2024-08-02,not shown,https://www.dejusticia.org/wp-content/uploads/2021/04/CPC_informe_Colombia.pdf,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Court document"", ""value"": ""Corte Constitucional de Colombia, Sala Segunda de Revisión, Sentencia T-323 de 2024, 2 August 2024. The court that operates PretorIA wrote this ruling on the use of ChatGPT by a lower-court judge. In it, the court describes PretorIA as a tool that it applies and states that the tool neither selects nor prioritizes cases."", ""url"": ""https://www.corteconstitucional.gov.co/relatoria/2024/T-323-24.htm""}]","{""kind"": ""Official documents""}" AIBD-0748,2019-11-01,source publication,month,tested,Assessors for AHRQ find that Abstrackr's predictions caught 33–90% of records that a single reviewer wrongly excluded in screening simulations,"In simulations on three completed reviews, Abstrackr caught 33–90% of records that a single reviewer wrongly excluded. It cut screening workload by a median 40%.",*Abstrackr* catches studies that a lone reviewer wrongly excluded,33–90% of records that a single reviewer wrongly excluded,,reported,Independently reported,tested against a standard,very low,aggregate result,false,Abstrackr (machine learning citation screening),,"Brown University, Center for Evidence Synthesis in Health",United States,AHRQ's University of Alberta Evidence-based Practice Center (retrospective simulations on three reviews),Canada,"University of Alberta, Canada",Canada,Evidence synthesis / systematic reviews,,Work and industry,Health,R&D,Text and language,Researchers,3,High income,operational_improvement,Enhanced productivity,,,,,,,,organizational,3,,0,"A single reviewer's screening without the tool, checked against dual independent screening",,33–90% of records erroneously excluded by a single reviewer identified,measured,persisted,2020-06-03,shown,https://europepmc.org/abstract/MED/31790164,,,,[],Querist,The sources include an official document about the benefit.,"[{""label"": ""Evaluation report"", ""value"": ""Gates A, et al. Performance and Usability of Machine Learning for Screening in Systematic Reviews: A Comparative Evaluation of Three Tools. AHRQ Methods for Effective Health Care, Report No. 19(20)-EHC027-EF. Agency for Healthcare Research and Quality, November 2019. NCBI Bookshelf NBK550175, PMID 31790164 (structured abstract). The authors are the University of Alberta team that ran Abstrackr in these simulations."", ""url"": ""https://europepmc.org/abstract/MED/31790164""}]","{""kind"": ""Official documents""}" AIBD-0030,2018-09-01,event,day,tested,"Machine-learning model detects more cardiac arrests than dispatchers on emergency calls in Copenhagen, but in a randomized trial its alerts bring no significant gain in recognition by dispatchers","On emergency calls in Copenhagen, Corti's model detected more cardiac arrests than dispatchers did. In a trial, its alerts did not significantly improve how often dispatchers recognized arrests.",Software detects more cardiac arrests than Copenhagen dispatchers do,higher sensitivity than dispatchers (84.1% versus 72.5%),,reported,Independently reported,tested against a standard,very low,aggregate result,false,"Corti machine-learning call-analysis framework for out-of-hospital cardiac arrest recognition (the peer-reviewed papers describe it only as a machine learning framework, and the EENA report names Corti)",,"Corti (Copenhagen, Denmark)",Denmark,"Copenhagen Emergency Medical Services, Emergency Medical Dispatch Center Copenhagen",Denmark,"Copenhagen, Denmark",Denmark,Emergency medical dispatch / public safety,112 emergency call handling,Health,Health,Medical Facilities,Speech and sound; Prediction from data,Health workers; Patients,3,High income,physical_health,Medical diagnosis,,,,,,,,personal; organizational,9,,2,"Dispatchers without alerts in the trial's control group, on confirmed cardiac arrests",77.5% sensitivity for dispatchers without alerts,85.0% sensitivity for the machine learning alerts alone,measured,withdrawn,2025-06-10,shown,https://pubmed.ncbi.nlm.nih.gov/36634755/,,,,[],Querist,The system was later withdrawn.,"[{""label"": ""Follow-up"", ""value"": ""Ingeniøren reported that the emergency dispatch centres had shelved the model and that they did not recognize Corti's account of its effect."", ""url"": ""https://ing.dk/artikel/hjertestop-i-112-opkald-skulle-opdages-med-ai-derfor-blev-det-droppet""}]","{""kind"": ""Withdrawals""}" AIBD-0314,2018-04-10,event,day,mixed,"In a trial, Delhi Police facial recognition matches 2,930 children in care homes, but the Delhi High Court records that it has not helped solve any missing-child case","The Wire identifies Delhi Police's facial recognition as Innefu Labs' AI Vision. It produced 2,930 matches among children in care. The High Court later recorded that it solved no case.","Delhi's face recognition matches 2,930 children without solving a case","produced 2,930 matches among children in care",,reported,Independently reported,no comparison,very low,aggregate result,false,Delhi Police Facial Recognition System (reported by The Wire as Innefu Labs' AI Vision),AI Vision,"Innefu Labs Pvt Ltd (manufacturer, per The Wire citing the BPR&D Compendium of Equipment); supplied by Pelorus Technologies Pvt Ltd",India,"Delhi Police (Crime Branch), using Ministry of Women and Child Development Track Child portal data",India,"Delhi, India",India,Policing / missing persons and child protection,Missing children in child-care institutions,Safety and rescue,Law and Crime,Child Abuse,Images and video,Children; Public servants,16,Lower middle income,physical_health,,,,,,2,,,personal; organizational; societal,10,,2,,,,,reversed,2019-01-22,shown,https://web.archive.org/web/2026id_/https://pulitzercenter.org/stories/looking-back-camera-how-controversial-ai-firms-shaped-delhis-predictive-policing,,,,[],Querist,The benefit was later reversed.,"[{""label"": ""Court document"", ""value"": ""Delhi High Court (2019). Sadhan Haldar v The State NCT of Delhi & Ors, W.P.(CRL) 1560/2017, order of 22 January 2019 (Hima Kohli and Manoj Kumar Ohri JJ). Indian Kanoon."", ""url"": ""https://indiankanoon.org/doc/181795735/""}, {""label"": ""Court document"", ""value"": ""High Court of Delhi (2019). Sadhan Haldar v. The State NCT of Delhi & Ors, W.P.(CRL) 1560/2017, order dated 26 April 2019 (Hima Kohli and Manoj Kumar Ohri JJ.)."", ""url"": ""https://delhihighcourt.nic.in/app/downloadOrderbByDate/W.P.%28CRL%29/1560/2017/26-04-2019""}, {""label"": ""Audit report"", ""value"": ""Comptroller and Auditor General of India (Principal Accountant General (Audit), Delhi) (2023). Performance Audit Report of the Comptroller and Auditor General of India on Children in Need of Care and Protection for the year ended 31 March 2021, Government of National Capital Territory of Delhi, Report No. 1 of the year 2023, Chapter 3, paragraph 3.2 (Delay in taking action by CWCs to use Facial Recognition Software), report pages 13-14."", ""url"": ""https://cag.gov.in/webroot/uploads/download_audit_report/2023/Report-No.-1-of-2023_CNCP_English-_09-02-2023-069c26599054797.71061814.pdf""}, {""label"": ""Follow-up"", ""value"": ""In August 2018 police counsel had reported a match rate of two percent. On 22 January 2019 the Delhi High Court recorded in Sadhan Haldar v. NCT of Delhi that the facial recognition software had not helped crack any case of a missing child."", ""url"": ""https://indiankanoon.org/doc/181795735/""}]","{""kind"": ""Challenges""}"